==============================================================================

As filed with the U.S. Securities and Exchange Commission on February 14, 2024.

Registration No. 333-[     ]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM S-1/AS-1

Amendment No. 2

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

BIO LAB NATURALS,LIMITLESS X HOLDINGS, INC.

(Exact nameName of registrantRegistrant as specifiedSpecified in its charter)Its Charter)

 

DELAWARE

Delaware

4791081-1034163
(State or jurisdictionOther Jurisdiction of incorporation
Incorporation
or organization)

Organization)

7312

(Primary Standard Industrial
Classification Code Number)

84-2288662

(I.R.S. Employer


Identification No.)

Number)

7400 E. Crestline Circle, Suite #130, Greenwood Village, CO 80111/ Phone 720-273-04339454 Wilshire Blvd., #300

Beverly Hills, CA90212

833-888-8923

(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)

W. Edward Nichols, Jaspreet Mathur

Chief Executive Officer

7400 E. Crestline Circle, Suite #130, Greenwood Village, CO 80111/ Phone 720-273-04339454 Wilshire Blvd., #300

Beverly Hills, CA90212

833-888-8923

(Name, address, including zip code, and telephone number, including area code, of agent for service)

COPIES OF ALL COMMUNICATIONS TO:With copies to:

Michael A. Littman, Attorney at Law

Joseph M. Lucosky, Esq.

Lucosky Brookman LLP
101 Wood Avenue South, 5
th Floor
Woodbridge, New Jersey 08830
(732) 395-4402

P.O. Box 1839, Arvada, CO 80001 / phone (720) 530-6184 / malattyco@aol.com

and

Christen Lambert, Attorney at Law /(919) 473-9130

Christen@ChristenLambertLaw.com

Approximate date of commencement of proposed sale to the public: As soon as possiblepracticable after the effective date of this Registration Statement becomes effective.Statement.

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. [X]box: ☒

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ ]

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ ]

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ ]

Indicate by check mark whether the registrantRegistrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer[___] Accelerated filer[___]
Non-accelerated filer[___] Smaller reporting company[_X_]
 Emerging growth company[_X_]

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.

[ ] 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. [_]

CALCULATION OF REGISTRATION FEE

Title of Each Class of Securities To Be RegisteredAmount To Be RegisteredProposed Maximum Offering Price Per ShareProposed Maximum Aggregate Offering Price(1)Amount of Registration Fee
     
Common Stock by Selling Shareholders9,690,999$0.292$2,829,771.71$367.30 (2)
     
     

(1)Estimated solely for the purpose of computing the registration fee pursuant to Rule 457(o) under the Securities Act of 1933 ("the Securities Act") based on the average of the 5-day average of the closing price of the common stock on September 21 , 2020 as reported on the OTC Pink .
(2)$503.16 was paid with original registration statement on Form S-1 filed with the Securities and Exchange Commission on July 2, 2020.

The registrantRegistrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.

ii

 

The information contained in this preliminary prospectus is not complete and may be changed. WeThese securities may not sell these securitiesbe sold until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

PRELIMINARY PROSPECTUS, SUBJECT TO COMPLETION, dated September 22 , 2020

BIO LAB NATURALS, INC.

9,690,999 shares of common stock of selling shareholders

We are registering securities listed for sale on behalf of selling shareholders: 9,690,999 shares of Common Stock.

We will not receive any proceeds from sales of shares by selling shareholders.

Our selling shareholders plan to sell common shares at market prices for so long as our Company is quoted on OTC Pink and as the market may dictate from time to time. There is a limited market for the common stock, as traded on the OTC Pink (“BLAB”) at $ 0.292 in the past 5 days.

TitlePrice Per Share
Common Stock$ 0.292 *

*Five-day average market price (September 14, 2020 – September 21, 2020)

Our security holders may sell their securities on the OTC Pink at a fixed price $ 0.292 , unless and until we achieve OTCQB listing and maintain such listing after which time our selling shareholders may sell at market prices or at any price in privately negotiated transactions. An amendment will be filed with the SEC at a later date if OTCQB listing is achieved.

This offering involves a high degree of risk; see "RISK FACTORS" beginning on page 5 to read about factors you should consider before buying shares of the common stock.

These securities have not been approved or disapproved by the Securities and Exchange Commission (the “SEC”) or any state or provincial securities commission, nor has the SEC or any state or provincial securities commission passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.

This offering will be on a delayed and continuous basis only for sales of selling shareholders shares. The selling shareholders are not paying any of the offering expenses and we will not receive any of the proceeds from the sale of the shares by the selling shareholders. (See “Description of Securities – Shares”).

The information in this prospectus is not complete and may be changed. We may not sell these securities until the date that the registration statement relating to these securities, which has been filed with the Securities and Exchange Commission, becomes effective. Thispreliminary prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

PRELIMINARY PROSPECTUSSUBJECT TO COMPLETIONDATED ____________, 2024

TheUp to [    ] Shares of Common Stock

LIMITLESS X HOLDINGS, INC.

We are offering an aggregate of           shares of common stock, par value $0.0001 (the “Common Stock”) of Limitless X Holdings, Inc. (the “Company” or “Limitless X”), a Delaware corporation based on a public offering price of $          per share.

Our Common Stock is presently quoted on the OTCQB Marketplace operated by OTC Markets Group, Inc. (“OTCQB”) under the symbol “VYBE.” We intend to apply to list our shares of Common Stock on the NYSE American LLC stock exchange market (“NYSE”) under the symbol “VYBE”, respectively, upon our satisfaction of the exchange’s initial listing criteria. If our Common Stock are not approved for listing on NYSE, we will not consummate this offering. No assurance can be given that our application will be approved. As of February 13, 2024, the last reported sale price for our Common Stock on the OTCQB was $1.20 per share.

Our board of directors (the “Board of Directors”) intends to effect a 1-for-        reverse stock split of our issued and outstanding shares of Common Stock following the effective date of the registration statement of which this Prospectusprospectus forms a part, but prior to and in connection with this offering and our intended listing of our Common Stock on NYSE. However, we cannot guarantee that such reverse stock split will occur, that such reverse stock split will be necessary or will occur in connection with the listing of our Common Stock on NYSE, or that NYSE will approve our initial listing application for our Common Stock upon such reverse stock split. The share and per share information in this prospectus does not give effect to the proposed reverse stock split. Unless specifically provided otherwise herein, such numbers and prices above and used elsewhere in this registration statement, of which this prospectus forms a part, do not assume the effectiveness of such reverse stock split or the listing of our Common Stock on NYSE.

The offering is September 22 , 2020.being underwritten on a firm commitment basis. The underwriters may offer the securities from time to time to purchasers directly or through agents, or through brokers in brokerage transactions on NYSE, or to dealers in negotiated transactions or in a combination of such methods of sale, or otherwise, at fixed price or prices, which may be changed, or at market prices prevailing at the time of sale, at prices related to such prevailing market prices.

iiiThe final public offering price per share will be determined through negotiation between us and the underwriter in this offering and will take into account the recent market price of our Common Stock, the general condition of the securities market at the time of this offering, the history of, and the prospects for, the industry in which we compete, and our past and present operations and our prospects for future revenues. The recent market price per share of Common Stock used throughout this prospectus may not be indicative of the final public offering price per share.

 

While we may be a “controlled company” under the rules of NYSE immediately after consummation of this offering, we do not intend to avail ourselves of the corporate governance exemptions afforded to a “controlled company” under the rules of NYSE. See “Risk Factors-Risks Related to this Offering.”

We are an emerging growth company under the federal securities laws and as such, we have elected to take advantage of certain reduced public company reporting requirements for this prospectus and future filings. See “Prospectus Summary—Implications of Being an Emerging Growth Company” for additional information.

Per Share of
Common Stock
Total
Public offering price
Underwriting discounts and commissions (1)
Proceeds to us, before expenses

(1)

The underwriters will receive compensation in addition to the underwriting discount. See “Underwriting” beginning on page 65.

Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 8 of this prospectus for a discussion of information that should be considered in connection with an investment in our securities.

NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

The underwriters expect to deliver the shares of Common Stock to investors on or about ___, 2024.

[     ]

The date of this prospectus is       , 2024

 

TABLE OF CONTENTS

PART I -  INFORMATION REQUIRED IN PROSPECTUSProspectus SummaryPage No.1
ITEM 1.The OfferingFront of Registration Statement and Outside Front Cover Page of Prospectus4
ITEM 2.Summary Financial DataProspectus Cover Page6
ITEM 3.Prospectus Summary Information, Risk Factors and Ratio of Earnings to Fixed Charges28
ITEM 4Cautionary Note Concerning Forward-Looking Statements.27
Use of Proceeds1428
ITEM 5Dividend Policy.Determination of Offering Price1428
ITEM 6.Dilution14
ITEM 7.Selling Security Holders15
ITEM 8.Plan of Distribution17
ITEM 9.Description of Securities17
ITEM 10.Interest of Named Experts and Counsel19
ITEM 11.Information with Respect to the Registrant19
a. Description of Business19
b. Description of Property29
c. Legal Proceedings29
d.Market for Common Equity and Related Stockholder Matters29
e.Capitalization Financial Statements    30
Dilutionf. Selected Financial Data3231
g. Supplementary Financial Information32
h.Management’s Discussion and Analysis of Financial Condition and Results of Operations32
Our Businessi. Changes In and Disagreements With Accountants on Accounting and Financial Disclosure3638
Managementj. Quantitative and Qualitative Disclosures About Market Risk3741
Executive and Director Compensationk. Directors and Executive Officers3747
Certain Relationships and Related Party Transactionsl. Executive and Directors Compensation4051
m.Security Ownership of Certain Beneficial Owners and Management4256
Description of Capital Stockn. Certain Relationships, Related Transactions, Promoters And Control Persons4557
ITEM 11 AUnderwriting.Material Changes4665
ITEM 12Certain Material Federal Income Tax Considerations.Incorporation of Certain Information by Reference4671
ITEM 12 ALegal Matters.Disclosure of Commission Position on Indemnification for Securities Act Liabilities4676
PART II – INFORMATION NOT REQUIRED IN PROSPECTUSExperts76
ITEM 13Where You Can Find More Information.Other Expenses of Issuance and Distribution48
ITEM 14.Indemnification of Directors and Officers48
ITEM 15.Recent Sales of Unregistered Securities49
ITEM 16.Exhibits and Financial Statement Schedules50
ITEM 17.Undertakings51
Signatures5276

i

We have not authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses we have prepared. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the Units offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus is current only as of its date.

For investors outside the United States: We have not, and the underwriters have not, done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than the United States. Persons outside of the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the Units and the distribution of this prospectus outside of the United States.

Unless otherwise indicated, information in this prospectus concerning economic conditions, our industries, and our markets is based on a variety of sources, including information from third-party industry analysts and publications and our estimates and research. This information involves a number of assumptions, estimates, and limitations. The industry publications, surveys and forecasts, and other public information generally indicate or suggest that their information has been obtained from sources believed to be reliable. None of the third-party industry publications used in this prospectus were prepared on our behalf. The industries in which we operate are subject to a high degree of uncertainty and risk due to a variety of factors, including those described in “Risk Factors” in this prospectus. These and other factors could cause results to differ materially from those expressed in these publications.

Table of Contentsii

ITEM 3.

PROSPECTUS SUMMARY INFORMATION, RISK FACTORS AND RATIO OF EARNINGS TO FIXED CHARGES

Our Company

Bio Lab Naturals, Inc. (“We,” “us,” “our,” “Bio Lab,” or “BLAB”),This summary highlights selected information contained in other parts of this prospectus. Because it is incorporated in the State of Delaware with operations located in Denver, Colorado providing large screen outdoor presentation and advertising.

CORPORATE HISTORY

Our predecessor,Vyta Corp, was incorporated in Nevada in June 1996. Until June 2009, Vyta Corp, through its wholly owned subsidiary BioAgra, LLC, was involved in the sale and manufacturing of a natural additive for use in the animal feed industry. On May 15, 2009, Vyta Corp ceased its operational activities. On June 30, 2009, Vyta Corp filed a Form 15-15D, with the Securities and Exchange Commission (“SEC”) to cease its filing obligations under the Securities Act of 1934. On August 20, 2010,summary, it changed its state of incorporation to Delaware and on November 5, 2010, and through a holding company reorganization reorganized as Bio Lab Naturals, Inc. (the “Company or “Bio Lab”). Its predecessor was divested as a subsidiary.

The Company changed its year end from June 30th to December 31st and, therefore the consolidated financial statements represent a short year as of and for the period July 1, 2019 (Inception) through December 31, 2019.

Reorganization Activities

On August 20, 2010, Vyta Corp (Nevada) executed a redomicile merger with its wholly owned subsidiary Vyta Corp (Delaware). As a result of the merger the Company’s corporate domicile moved from Nevada to Delaware. On September 16, 2010, Vyta Corp and its wholly owned subsidiaries, 10 Vyta, Inc., with Bio Lab Naturals, Inc. entered into a Holding Company Reorganization/Merger Transaction pursuant to Delaware Statute 251(g), whereby the Company was reorganized with 10 Vyta, Inc., with Bio Lab Naturals, Inc. being the survivor holding company, and 10 Vyta was divested thereafter. The shareholders of the Company became the shareholders of Bio Lab Naturals, Inc. (hereinafter the “Company”) with no change in the number of shares.

In 2010, the Company executed a merger with Bio Protein, Inc. As part of the merger, the Company exchanged 40 shares of its outstanding common stock for one share of Bio Protein, Inc. (Colorado.) This merger was rescinded April 10, 2013 and 6,868,260 shares were agreed to be cancelled. The name was changed back to Vyta Corp, but such was changed back to Bio Lab Naturals, Inc. when there failed to be shareholder approval.

The Company agreed to a merger with Set Net Global, Inc. in 2015 and changed its name, but the merger was never completed and the name was returned to Bio Lab Naturals, Inc.

On December 31, 2019, Bio Lab Naturals, Inc., PTL Acquisition Sub, Inc. (“PTL Acquisition Sub”), a wholly-owned subsidiary of Bio Lab Naturals, Inc., domiciled in Colorado and Prime Time Live, Inc. (“PTL”), a Colorado corporation entered into a Plan of Reorganization. PTL Acquisition Sub merged with PTL where PTL Acquisition Sub became the surviving entity in exchange for one share of the Company’s common stock being issued for each share of PTL’s 5,500,000 issued and outstanding shares of common stock. A total of 6,931,061 shares of the Company’s common stock were cancelled. PTL Acquisition Sub changed its name to Prime Time Live, Inc.

On September 17, 2019, PTL was incorporated in the State of Colorado and effective October 11, 2019, acquireddoes not contain all of the event services business of Prime Time Mobile Event Screens LLC (“PTMVES”)information that you should consider before investing in exchange for PTL issuing 350,000 shares of itsour common stock to the owner of PTMVES. The transaction was accounted forand it is qualified in its entirety by, PTL as an acquisition of a business under ASC 805. Both PTL and PTMVES financial statements are included as part of this registration statement and they reflect the historical operations of the event services business that was acquired by the Company.

Our executive offices are located at 7400 E. Crestline Circle, Suite #130, Greenwood Village, CO 80111 and the telephone number is (720) 273-0433. We maintain a website at www.primetimeliveevents.com, and such website is not incorporated into or a part of this filing.

Implications of Being an Emerging Growth Company

As a company with less than $1.07 billion of revenue during our last fiscal year, we qualify as an emerging growth company as definedshould be read in the JOBS Act, and we may remain an emerging growth company for up to five years from the date of the first sale in this offering.

Table of Contents

However, if certain events occur prior to the end of such five-year period, including if we become a large accelerated filer, our annual gross revenue exceeds $1.07 billion, or we issue more than $1.07 billion of non-convertible debt in the past three-year period or become a large accelerated filer as defined in Exchange Act Rule 12b-2, we will cease to be an emerging growth company prior to the end of such five-year period. For so long as we remain an emerging growth company, we are permitted and intend to rely on exemptions from certain disclosure and other requirements that are applicable to other public companies that are not emerging growth companies. Emerging growth companies are permitted:

·To include less extensive narrative disclosure than required of other reporting companies, particularly in the description of executive compensation;

·To provide audited financial statements for two fiscal years, in contrast to other reporting companies, which must provide audited financial statements for three fiscal years;

·Not to provide an auditor attestation of internal control over financial reporting under Sarbanes-Oxley Act Section 404(b);

·To defer complying with certain changes in accounting standards; and

·To use test-the-waters communications with qualified institutional buyers and institutional accredited investors.

In particular, in this prospectus, we have provided only two years of audited financial statements and have not included all of the executive compensation related information that would be required if we were not an emerging growth company. Accordingly, the information contained herein may be different than the information you receive from other public companies in which you hold equity interests. However, we have irrevocably elected not to avail ourselves of the extended transition period for complying with new or revised accounting standards, and, therefore, we will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.

Summary of Financial Information

The following tables set forth, for the periods and as of the dates indicated, our summary financial data. The statements of operations for the three and six months ended June 30, 2020, and the balance sheet data as of June 30, 2020 are derived from our unaudited condensed financial statements. The unaudited financial statements include, in the opinion of management, all adjustments consisting of only normal recurring adjustments, that management considers necessary for the fair presentation of the financial information set forth in those statements. You should read the following information togetherconjunction with, the more detailed information containedappearing elsewhere in “Selected Financial Data,this prospectus. You should read the entire prospectus carefully, especially “Risk Factors,” “Special Note Regarding Forward-Looking Statements,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our financial statements and the related notes, included elsewherebefore deciding to invest in shares of our common stock. Unless the context requires otherwise, the words “we,” “us,” “our,” “Company” and “Limitless X” refer collectively to Limitless X Holdings Inc., a Delaware corporation.

Unless otherwise noted the share and per share information in this prospectus.prospectus reflects a 1-for-[ ] reverse stock split of our outstanding common stock effective as of [     ], 2024

Overview

Limitless X is a multinational consumer packaged goods company that specializes in developing and offering ‘Look Good, Feel Great’ products, specifically within the nutrition and beauty industry, through direct response advertising and our distinctive and highly successful celebrity-backed brand awareness strategies. We possess unique capabilities to greatly enhance the reputation and impact of brands, due to our extensive knowledge and expertise in digital marketing and our successful track record in launching new consumer products.

Leadership

Jas Mathur, our Chairman and Chief Executive Officer, is an entrepreneur with over 14 years of experience within the health, wellness, and dietary supplements industry and 25 years of experience as a webmaster and internet marketer. He is the owner of Emblaze One, a global interactive and web development agency with a staff of 100+. Mr. Mathur founded Limitless X in 2021, drawing upon his own personal battles with health and his transformative journey that resulted in a remarkable weight loss of over 250 lbs. His extraordinary achievements in the business world serve as a powerful source of motivation, inspiration, and empowerment for all those who cross paths with him, igniting their dreams, fostering belief, and empowering them to achieve greatness.

Our Services

Leveraging our top-notch business know-how, deep insights in the health and nutrition industry and a broad network in the industry to identify and boost unique investment opportunities, we help design, build, and grow successful e-commerce brands that have unique capabilities in each of their respective markets while enriching people’s lives. We empower founders by fostering connections with customers, strategic partners, and investors, using our unique direct-to-consumer model to maximize profits.

Product Development

We help create and grow strong, memorable brands. We help our partners at all stages of product development level, including with market research and product, label and packaging design. On the market research side, we examine the competitive landscape of industries by analyzing competitors’ products, conducting surveys, finding relevant partners, and researching resources. We then create an actionable plan to break into the relevant market. We also facilitate key introductions to strategic partners in the PR, IT, finance and legal industries and we help design and implement the product fulfillment process.

Product Manufacturing

We maintain complete control over the manufacturing process, from start to finish, including with the sourcing of high-quality ingredients, identifying reliable supply chain, distribution and manufacturers networks, and the designing of quality assurance and compliance processes.

Product Distribution and Fulfillment

Our streamlined omni-channel approach to product distribution prioritizes consumer interests to help deliver better conversion rates. It includes e-commerce websites, social media, shipping, distributed warehousing, payment processing and product returns. Reliable fulfillment and logistics process allows a fast delivery. Product orders are fulfilled via online, direct to consumer, retail, wholesale and big box retail channels.

1

Marketing, Advertising, and Consumer Outreach

In 2023, we shifted our business model from working with third-party affiliates and affiliate networks to now include an in-house, full service digital marketing team to decrease our customer acquisition costs, increase customer retention, satisfaction and build brand trust and loyalty. This shift allows us to control the content and marketing creatives, mitigate chargebacks, decrease refunds, lower customer acquisition costs, impact average order values, and create direct relationships with advertisement platforms.

Our marketing efforts are designed to increase consumer awareness of and demand for the brands we work with or own. Our marketing team helps design, form and generate the right content for each brand, and devises the best strategy for its distribution. We employ a broad mix of traditional marketing strategies, from: product sampling to exhibiting at consumer trade events and hosting celebrity-rich events where our company and brand(s) are prominently highlighted. Our primary driver is the use of social media platforms to communicate with consumers and build interest in the respective brand(s) and product(s). Our advertising and use of online resources are aimed at increasing consumer preference and usage of our products. Operating as an integrated marketing agency, we plan to offer global marketing services across all areas of the sales process in the near future.

Our Competitive Strengths

We constantly strive to find gaps in the relevant marketplace and help develop products that fill those gaps and meet or exceed the needs of the consumers. Because of our turnkey solution, we are able to launch products quickly and efficiently to meet consumer needs and cater to new advances in the health and wellness industry.

We believe that our experience has uniquely positioned us to scale and maintain an ecosystem of opinion leaders following wellness-focused brands. We believe we work with an “A-list” group of influencers who promote the products and services that are offered on our platform.

Our Clients

Currently, all of the brands in our portfolio are with affiliated companies that are owned 100% by our Chief Executive Officer, Jas Mathur.

Our Network of Influencers

We have brought together a network of high profile and influential individuals who have all have two things in common: Look Good and Feel Great. This includes: music artists, movie stars, professional athletes, popular social media influencers, fitness experts, and nutrition coaches. We utilize our network of influencers on an “as needed” basis and compensation terms vary depending on the influencer and product, as decided upon by our management. We do not have any formal long-term contracts with any one influencer. Our marketing team works with the brands to determine the appropriate audience for any given brand and reaches out to those persons in our network, who are then engaged to publicize on their media platforms a pre-approved post provided by our marketing team, and in turn, they receive commissions for sales of products they publicize. All of the products promoted are offered to consumers through our website.

Our Compliance Team

All of our compliance matters are managed in house by our Chief Operating Officer and our VP of Legal Affairs, including our data security, privacy rights, and ensuring that the products that we offer are in compliance with applicable government regulations. (See “Government Regulation” below.)

2

Our Strategy

We have manufacturing and distribution licensing agreements to market, manufacture, sell, and distribute the branded products on behalf of our licensors. The licensor retains the rights to continue its own use of these items under existing or new contracts in its discretion, and to develop new products. Our typical manufacturing and distribution licensing agreements allows us to:

(a)Design or redesign the products;
(b)Manufacture the products under such design specifications as may be mutually agreed upon by the licensor and us from time to time;
(c)Promote, sell, and distribute the products in the United States and its territories;
(d)Use the existing designs of the products and all intellectual property rights associated with or for such products, including all trademarks and patent rights, with the sale, promotion, and distribution of the products in the territory, including the display of any trademarks, and all other designs or marks which could be or that are actually later registered with the federal Patent and Trademark Office, on our vehicles and other merchandising equipment, and on stationery, packaging, and other advertising and promotional materials;
(e)Use the existing domain names, web addresses, telephone lines, third-party vendors, and any other operational element currently in use by the licensor that can be transferred to us; and
(f)Manufacture, promote, sell, and distribute new products designed or created by us that we deem preferable to sell under the licensor’s name; and in such case, we negotiate in good faith to agree on a royalty commission percentage or flat rate amount for the sale of new products using the licensor’s name.

Market Data and Research of Our Verticals

Health and Wellness

According to Zion Market Research, the global health and wellness market size is projected to reach $8,946 billion by the end of 2030, with a compound annual growth rate of approximately 6.9% between 2023 and 2030. In 2022, the market size was estimated to be $5,244 billion.

Corporate History and Background

The Company was formed in the State of Nevada on June 3, 1996, as Vyta Corp. On November 5, 2010, the Company changed its name to Bio Lab Naturals, Inc. On May 11, 2022, Bio Lab Naturals, Inc., a Delaware corporation (“Bio Lab”), entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with Limitless X, Inc., a Nevada corporation (“LimitlessX”), and its 11 shareholders (the “LimitlessX Acquisition”). The parties completed and closed the LimitlessX Acquisition on May 20, 2022. Concurrently with the LimitlessX Acquisition, Jaspreet Mathur, the founder and principal shareholder of LimitlessX, also purchased from Helion Holdings LLC, shares of Bio Lab’s Class A Preferred Convertible Stock, which at all times have a number of votes equal to 60% of all of the issued and outstanding shares of common stock of Bio Lab. On June 10, 2022, the Company changed its name to Limitless X Holdings Inc.

Corporate Information

We are a Delaware corporation. Our corporate headquarters are located at 9454 Wilshire Blvd., #300, Beverly Hills, CA 90212. Our telephone number is (833) 888-8923. We maintain a website at www. https://www.limitlessx.com/.

3

THE OFFERING

Common Stock Offered

Up to [    ] shares of Common Stock based on an assumed public offering price of $[    ] per share, which is the last reported bid price of our Common Stock on the OTCQB on [   ], 2024.

Representative’s WarrantsWe have agreed to issue to the representative of the underwriters or its designees at the closing of this offering, warrants to purchase the number of shares of our Common Stock equal to [7.0]% of the aggregate number of shares sold in this offering(the “Representative’s Warrants”). The exercise price of the Representative’s Warrants will equal 100% of the public offering price per share, subject to adjustments. The Representative’s Warrants provide for registration rights (including a one-time demand registration right and piggyback registration rights that expire 5 years from the commencement of sales of the offering) and customary anti-dilution provisions as permitted under FINRA Rule 5110(g)(8). The registration statement of which this prospectus is a part also covers the Representative’s Warrants and the shares of Common Stock issuable upon the exercise thereof.(See “Underwriting.”)
Shares of Common Stock issued and outstanding prior to this offering3,977,497  shares.

4

Shares of Common Stock to be outstanding after this offering[   ] shares.

Use of Proceeds

We estimate that the net proceeds from this offering will be approximately $[ ] million, based on an assumed combined public offering price of $[ ] per share of Common Stock which was the last reported bid price of our Common Stock on the OTCQB on [ ], 2024, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. We currently intend to use the net proceeds from this offering for inventory, marketing, research and development, and working capital. (See “Use of Proceeds.”)
Lock-Up AgreementsWe and our directors, officers and certain stockholders who are holders of 5% or more of the outstanding shares of common stock as of the effective date of the registration statement, have agreed with the underwriters that we will not, without the prior written consent of the representatives, for a period of 1 year after the date of this prospectus: (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any classes of our stocks or any securities convertible into or exercisable or exchangeable for any classes of our stocks; (ii) file or caused to be filed any registration statement with the SEC, relating to the offering of any classes of our stocks or any securities convertible into or exercisable or exchangeable for any classes of our stocks; (iii) complete any offering of debt securities, other than entering into a line of credit with a traditional bank; or (iv) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any classes of our stocks, whether any such transaction described in clause (i), (ii), (iii) or (iv) above is to be settled by delivery of any classes of our stocks or such other securities, in cash or otherwise.
Dividend PolicyWe currently intend to retain our future earnings, if any, to finance the development and expansion of our business. The determination to pay dividends will be at the discretion of our board of directors and will depend on our financial condition, results of operations, capital requirements, restrictions contained in any financing instruments, and such other factors as our board of directors deems relevant in its discretion. (See “Dividend Policy.”)
Risk FactorsInvesting in our Common Stock involves a high degree of risk. You should carefully review and consider the “Risk Factors” section of this prospectus for a discussion of factors to consider before deciding to purchase any of our securities in this offering.
Stock Exchange SymbolOur shares of Common Stock are quoted on the OTCQB Venture Market under the OTCQB ticker symbol “VYBE.” We intend to apply to list our Common Stock on the NYSE American. We will not consummate this offering unless our Common Stock is approved for listing on the NYSE American or another stock exchange.

The number of shares of our Common Stock outstanding after the completion of this offering is based on 3,976,998 shares of our Common Stock outstanding as of September 30, 2023, and excludes:

1,000,000 shares of Common Stock issuable upon the conversion of our outstanding Class A Preferred Stock;
833,333 shares of Common Stock reserved for the future issuance of awards under our 2022 Incentive and Non-statutory Stock Option Plan;
833,333 shares of Common Stock reserved for future issuance of awards under our 2022 Restricted Stock Plan; and
10,349,097 shares of Common Stock issuable upon the conversion of our Class B Preferred Stock. Class B Preferred Stock was issuable upon the conversion of outstanding convertible notes.

5

SUMMARY FINANCIAL DATA

The following table presents summary financial data. The statement of operations data for the nine and three months ended September 30, 2023 and 2022 and for the years ended December 31, 2022 and 2021 are derived from our audited annual financial statements. Our historical results are not indicative of the results to be expected in the future and results of interim periods are not necessarily indicative of our results for the entire year. The statements of operations for the period July 1, 2019 (Inception) through December 31, 2019, and balance sheet data as of December 31, 2019, are derived from our audited financial statements included elsewhere in this prospectus. any future period.

You should read the following informationsummary financial data together with the more detailed information contained in “Selected Financial Data,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our financial statements and the related notes included elsewhere in this prospectus. Our historical resultsThe summary financial data in this section is not intended to replace our financial statements and the related notes and are qualified in their entirety by the financial statements and related notes included elsewhere in this prospectus.

  For the three months ended
September 30,
  For the nine months ended
September 30,
 
  2023  2022  2023  2022 
             
Revenue                
Product sales $1,005,924  $12,114,278  $13,852,451  $27,382,335 
Service revenue  1,261,814   9,378,900   4,058,818   12,344,100 
Rentals  -   2,500   15,000   7,500 
Total revenue  2,267,738   21,495,678   17,926,269   39,733,935 
                 
Cost of sales                
Cost of sales  644,365   3,037,997   3,717,216   5,837,994 
Cost of sales - other  -   -   -   358 
Total cost of sales  644,365   3,037,997   3,717,216   5,838,352 
                 
Gross profit  1,623,373   18,457,681   14,209,053   33,895,583 
                 
Operating expenses:                
General and administrative  (1,129)  660,068   1,051,630   1,089,109 
Advertising and marketing  1,873,612   17,163,099   18,525,288   34,376,380 
Stock compensation for services  -   -   141,020   1,117,782 
Transaction fees  75,050   1,401,892   1,159,896   1,988,718 
Merchant fees  41,370   917,427   1,098,648   1,656,920 
Royalty fees  18,324   472,082   398,149   704,203 
Professional fees  91,642   272,963   1,211,759   940,945 
Payroll and payroll taxes  859,512   258,934   2,931,357   392,605 
Rent  37,609   41,177   123,401   121,570 
Bad debt expense  -   -   232,374   - 
Consulting fees, related party  -   6,000   10,000   38,500 
Total operating expenses  2,995,990   21,193,642   26,883,522   42,426,732 
                 
Loss from operations  (1,372,617)  (2,735,961)  (12,674,469)  (8,531,149)
                 
Other income (expense)                
Interest expense  (275,856)  (68,286)  (731,616)  (81,394)
Loss on debt settlement  -   -   (142,551)  - 
Other income  -   -   -   57,756 
Other expense  (132,000)  -   (162,000)  - 
Gain on disposal of assets  -   -   -   28,397 
Total other income (expense), net  (407,856)  (68,286)  (1,036,167)  4,759 
                 
Loss before income taxes  (1,780,473)  (2,804,247)  (13,710,636)  (8,526,390)
                 
Income tax provision  (48)  -   -   6,402 
                 
Gain on deconsolidation of subsidiary  -   -   241,365   - 
                 
Net loss $(1,780,425) $(2,804,247) $(13,469,271) $(8,532,792)
                 
Net loss per common share - basic and diluted $(0.45) $(0.74) $(3.41) $(4.28)
                 
Weighted average number of common shares  3,977,497   3,789,565   3,950,911   1,995,073 

6

     For the period from 
     September 27, 2021 
  For the  (Date of formation) 
  year ended  through 
  December 31, 2022  December 31, 2021 
       
Revenue        
Product sales $40,364,955  $302,371 
Service revenue  18,308,341   - 
Rentals  15,000   - 
Total revenue  58,688,296   302,371 
         
Cost of sales        
Cost of sales  6,942,680   3,258 
Cost of sales – other  358   - 
Total cost of sales  6,943,038   3,258 
         
Gross profit  51,745,258   299,113 
         
Operating expenses:        
General and administrative  1,938,640   12,054 
Advertising and marketing  47,164,700   194,679 
Stock compensation for services  1,117,782   - 
Transaction fees  3,201,599   1,416 
Merchant fees  2,459,670   20,092 
Royalty fees  1,114,403   - 
Professional fees  1,647,787   14,000 
Payroll and payroll taxes  1,306,565   17,794 
Rent  205,497   11,508 
Bad debt expense  1,300,855   - 
Consulting fees, related party  43,500   - 
Total operating expenses  61,500,998   271,543 
         
Income (loss) from operations  (9,755,740)  27,570 
         
Other income (expense)        
Interest expense  (348,017)  - 
Other income  57,756   - 
Gain on disposal of assets  28,397   - 
Total other income (expense), net  (261,864)  - 
         
Income (loss) before income taxes  (10,017,604)  27,570 
         
Income tax provision  6,402   22,906 
         
Net income (loss) $(10,024,006) $4,664 
         
Net income (loss) per common share – basic and diluted $(2.71) $0.00 
         
Weighted average number of common shares  3,692,740   1,986,073 

7

RISK FACTORS

An investment in our shares of Common Stock involves a high degree of risk and should be considered highly speculative. Before making an investment decision, you should carefully consider the following risk factors, which address the material risks concerning our business and an investment in shares of Common Stock, together with the other information contained in this prospectus. The risks described below are material risks currently known, expected, or reasonably foreseeable by us. However, the risks described below are not indicativethe only ones that we face. Additional risks not presently known to us or that we currently deem immaterial may also affect our business, operating results, prospects, or financial condition. If any of the risks discussed in this prospectus occur, our business, prospects, liquidity, financial condition, and results toof operations could be expectedmaterially and adversely affected, in which case the trading price of our Common Stock could decline significantly, and you could lose all or part of your investment. Some statements in this prospectus, including statements in the future.following risk factors, constitute forward-looking statements. (See “Cautionary Note Concerning Forward-Looking Statements.”)

The Company changed its year end from June 30thRisks Related to December 31st and, therefore the consolidated financial statements as of and for the period July 1, 2019 (Inception) through December 31, 2019 represents a short year.Our Business

    July 1, 2019 (Inception) through
  June 30, December 31,
  2020 2019
Total Assets $384,573  $243,063 
Current Liabilities $30,781  $22,170 
Stockholders’ Equity $353,792  $220,893 

Table of Contents

  

Six Months Ended

June 30,

2020

(Unaudited)

 

July 1, 2019 (Inception) through December 31, 2019

(Audited)

Revenues $0  $0 
Net Loss $(151,601) $(1,909,107)

Our future profitability is uncertain.

At June 30, 2020, the accumulated deficit was $(35,319,671). At December 31, 2019, the accumulated deficit was ($35,168,070).

We anticipate thathave incurred losses in recent quarters. Because we will operate in a deficit positionhighly competitive industry, we have difficulty predicting our future operating results, and we cannot be certain that our revenue will grow at rates that will allow us to reach or maintain profitability on a quarterly or annual basis.

We have incurred significant losses, we expect to incur losses in the future, and we may not be able to generate sufficient revenue to achieve and maintain profitability.

As of September 30, 2023, we incurred net losses of $13,469,271. We expect to continue to sustain netincur significant expenses and operating losses for the foreseeable future.future as we broaden our customer base, develop our retail and wholesale distribution platforms, and we make expenditures in an effort to enhance our existing online direct-to-consumer website. Historically, we have devoted most of our financial and other resources on sales and marketing; continued expansion of our business; and general administration expenses, including legal, accounting, and other expenses. We may not succeed in increasing our revenues, which historically have been reliant on our online direct-to-consumer website, in a manner that will be sufficient to offset these higher expenses. Any failure to increase our revenues as we implement initiatives to grow our business could prevent us from achieving profitability. We cannot be certain that we will be able to achieve profitability on a quarterly or annual basis, if at all. If we are unable to address these risks and difficulties as we encounter them, our business, financial condition and results of operations may suffer.

CORPORATE ORGANIZATION CHARTIf we do not obtain adequate capital funding or improve our financial performance, we may not be able to continue as a going concern.

BIO LAB NATURALS, INC.

(a Delaware corporation)

Prime Time Live, Inc.

(a wholly-owned subsidiary)
(a Colorado corporation)

The OfferingIf we are unable to obtain adequate funding or if we are unable to grow our revenue substantially to achieve and sustain profitability, we may not be able to continue as a going concern. If we are unable to raise additional capital when required or on acceptable terms, we will be required to significantly delay, scale back, or restrict our operations or obtain funds by entering into agreements on unattractive terms, which would likely have a material adverse effect on our business, stock price, and our relationships with third parties with whom we have business relationships, at least until additional funding is obtained. If we do not have sufficient funds to continue operations, we could be required to seek bankruptcy protection or other alternatives that would likely result in our shareholders losing some or all of their investment in us. In addition, our ability to achieve profitability or to respond to competitive pressures would be significantly limited.

WeAll of the current brands and products that we sell and promote are registering securities listed for saleowned or controlled by our Chief Executive Officer and we may lose all of our business at any time.

All of the current brands and products that we sell and promote are owned or controlled by Jas Mathur, our Chief Executive Officer. If Mr. Mathur chooses, on behalf of selling shareholders: 9,690,999 shares of Common Stock.

Our common stock, only, will be transferable immediately upon the effectivenesshis companies and/or brands, to terminate all of the Registration Statement. (See “Descriptionagreements he has with us, we will effectively lose all of Securities”)

Common shares outstanding before this offering10,753,504
Maximum common shares being offered by our existing selling shareholders9,690,999
Maximum common shares outstanding after this offering10,753,504

Weour current business. All of our licensing agreements with our current marketed brands were entered into in 2021 and have five year terms, whereby the licensors are authorizednot able to issue 200,000,000 shares of common stockterminate the agreement with us except “for cause.” However, all such licensing agreements only grant us a par value of $0.0001non-exclusive license to manufacture, market, and 5,000,000 shares of preferred stock with a par value of $0.0001. Our current shareholders, officers and directors collectively own 10,753,504 shares of restricted common stock as of this date. Our shares being registered were issued indistribute the following amounts and at the following prices:

Number of SharesOriginal ConsiderationIssue Price Per Share
9,690,999Private Placements, Private Purchases, Services and Cash$0.0001 - $0.30

Currentlybrand’s products. Therefore, there is a limited public tradingpossibility that the brands could work with other companies to manufacture, market, and distribute their products or replace us entirely. If this occurs, our revenues will significantly decline or stop completely. In addition, some of the trademarks for our stock on OTC Pink under the symbol “BLAB.name, “Limitless X,Weand logo are in process of uplisting to OTCQB.

Forward Looking Statements

This prospectus contains various forward-looking statementsowned by entities that are based onowned or controlled by Mr. Mathur. In the event that he chooses to restrict our beliefs as well as assumptions made byuse of these trademarks, we will not be able to use our name and information currently availablelogo and would have to us. When used in this prospectus, the words "believe," "expect," "anticipate," "estimate," and similar expressions are intended to identify forward-looking statements. These statements may include statements regarding seeking business opportunities, payment of operating expenses, and the like, and are subject to certain risks, uncertainties and assumptions which could cause actual results to differ materially from projections or estimates. Factors which could cause actual results to differ materially are discussed at length under the heading "Risk Factors." Should one or more of the enumerated risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. Investors should not place undue reliance on forward-looking statements, all of which speak only as of the date made.change our name.

8
Table of Contents

RISK FACTORS RELATED TO OUR BUSINESS

 

WE HAVE AN EVOLVING BUSINESS MODEL.

As event production evolves, so will our business model. We may continue to try to offer additional types of products or services, and we cannot offer any assurance that any of them will be successful. From time to time we may also modify aspects of our business model relating to our product mix and service offerings. We cannot offer any assurance that these or any other modifications will be successful or will not result in harm to the business. We may not be able to successfully continue the business of Prime Time Live.

As a result of the LimitlessX Acquisition, we also acquired the business of Prime Time Live, Inc. (“PTL”), a digital marketer and service provider in the event industry. A major part of our business plan is to integrate the PTL platform with our offered services so that we can establish a more robust in-house digital marketing arm that we can utilize when promoting our customers’ brands and products. If we are not able to manage growththe integration of the PTL business successfully or cost effectively whichincorporate PTL’s platform, systems, and work flow with our brands’ existing marketing plans, our business, financial condition, results of operations and prospects could damagebe adversely affected.

If we fail to cost-effectively acquire new consumers or retain our reputation, limitexisting consumers, our growth,business could be adversely affected.

Our success depends on our ability to attract new customers and engage existing customers cost-effectively. To acquire and engage customers, we must, among other things, promote and sustain our platform, and provide high-quality products, user experiences, and customer service. If customers do not perceive our e-commerce service or products to be reliable and of high quality, if we fail to introduce new and improved products, or if we introduce new products that are not favorably received by the market, we may not be able to attract or retain customers.

We have historically acquired a significant number of our customers through digital advertising on social media. The advertisers we utilize may terminate their agreements with us at any time or introduce factors beyond our control, such as such as adjustments to algorithms that may decrease user engagement or negatively affect our operating results.ability to reach a broad audience; increases in pricing; and changes in policies that may delay or prevent our advertising through these channels, all of which could impact our ability to attract new customers.

OUR SUCCESS WILL DEPEND, TO A LARGE DEGREE, ON THE EXPERTISE AND EXPERIENCE OF THE MEMBERS OF OUR MANAGEMENT TEAM.We have marketing initiatives designed to acquire customers through increased search engine optimization and streaming digital video services. These new acquisition channels may not perform as well as our historical social media advertising channels. Our efforts to diversify customer acquisition channels may not be effective, which could negatively affect our results of operations.

We will rely exclusivelyCustomer acquisition costs may fluctuate and rise on the skillschannels that have been successful for us historically and expertiseon new channels that we are introducing. Rising costs may limit our ability to expand or maintain our customer acquisition efforts which could negatively affect our results of operations.

Other factors may reduce our ability to acquire, maintain, and further engage with customers, including the effectiveness of our management teammarketing efforts and other expenditures we make to continue to acquire new customers and maintain and increase engagement with existing customers; system updates to advertising platforms; changes in conductingsearch algorithms by search engines; the development of new search engines or social media sites that reduce traffic on existing search engines and social media sites; and consumer behavior changes as a result of the COVID-19 pandemic, or otherwise.

Moreover, consumer preferences may change, and customers may not purchase through our business.marketplace as frequently or spend as much with us as historically has been the case. As a result of these potential changes, the revenue generated from customer transactions may not be as high as revenue generated from transactions historically.

We must expend resources to maintain consumer awareness of our brand, build brand loyalty and generate interest in our products. Our management team has experiencemarketing strategies and channels will evolve and our efforts may or may not be successful.

To remain competitive and expand and keep market share for our products across our various channels, we need to increase our marketing and advertising spending. Substantial advertising and promotional expenditures may be required to maintain or improve our brands’ market position or to introduce new products to the market. An increase in identifying, evaluatingour marketing and acquiring prospective businesses for whichadvertising efforts may not maintain our current reputation, lead to increased brand awareness, or attract new customers. If we are unable to maintain and promote a favorable perception of our brand and products on a cost-effective basis, our business, financial condition, results of operations, and prospects could be adversely affected.

Use of social media and influencers may materially and adversely affect our reputation or subject us to fines or other penalties.

We use third-party social media platforms as, among other things, marketing tools. We also maintain relationships with many social media influencers and engage in sponsorship initiatives. As existing e-commerce and social media platforms continue to rapidly evolve and new platforms develop, we must continue to maintain a presence on these platforms and establish presences on new or emerging popular social media platforms. If we are unable to cost-effectively use social media platforms as marketing tools or if the social media platforms we use change their policies or algorithms, we may ultimately enternot be able to fully optimize such platforms, and our ability to maintain and acquire customers and our financial condition may suffer.

9

Furthermore, as laws and regulations and public opinion rapidly evolve to govern the use of these platforms and devices, the failure by us, our employees, our network of social media influencers, our sponsors or third parties acting at our direction to abide by applicable laws and regulations in the use of these platforms and devices or otherwise could subject us to regulatory investigations, class action lawsuits, liability, fines or other penalties and have a joint venture, but therematerial adverse effect on our business, financial condition and operating results.

In addition, an increase in the use of social media for product promotion and marketing may cause an increase in the burden on us to monitor compliance of such materials, and increase the risk that such materials could contain problematic product or marketing claims in violation of applicable regulations. For example, in some cases, the FTC has sought enforcement action where an endorsement has failed to clearly and conspicuously disclose a financial relationship or material connection between an influencer and an advertiser.

We do not prescribe what our influencers post, and if we were held responsible for the content of their posts or their actions, we could be fined or forced to alter our practices, which could have an adverse impact on our business.

Negative commentary regarding us, our products or influencers and other third parties who are affiliated with us may also be posted on social media platforms and may be adverse to our reputation or business. Influencers with whom we maintain relationships could engage in behavior or use their platforms to communicate directly with our customers in a manner that reflects poorly on our brand and may be attributed to us or otherwise adversely affect us. It is not possible to prevent such behavior, and the precautions we take to detect this activity may not be effective in all cases. Our target consumers often value readily available information and often act on such information without further investigation and without regard to its accuracy. The harm may be immediate, without affording us an opportunity for redress or correction.

If we fail to retain existing customers, or fail to maintain average order value levels, we may not be able to maintain our revenue base and margins, which would have a material adverse effect on our business and operating results.

A significant portion of our net sales are generated from sales to existing customers. If existing customers no assurancelonger find our managements assessmentsproduct offerings appealing, or if we are unable to timely update our product offerings to meet current trends and customer demands, our existing customers may make fewer or smaller purchases in the future. A decrease in the number of our customers who make repeat purchases or a decrease in their spending on the merchandise we offer could negatively impact our operating results. Further, we believe that our future success will depend in part on our ability to increase sales to our existing customers over time, and if we are unable to do so, our business may suffer. If we fail to generate repeat purchases or maintain high levels of customer engagement and average order value, our growth prospects, operating results and financial condition could be successfulmaterially adversely affected.

Traffic to our e-commerce webpages and conversion rates may decline.

In order to generate online customer traffic we depend heavily on e-mailed catalogs, outbound emails, and an affiliate program. Our sales volume and e-commerce webpages traffic generally may be adversely affected by, among other things, a change in any joint venture. Accordingly, thereof the above mentioned dependencies as well as economic downturns, system failures, competition from other internet retailers and non-internet retailers. A reduction in traffic to the e-commerce webpages as a result of these or any other factors could have a material adverse effect on our business, results of operations and financial condition. In addition, e-commerce webpages sales conversion rates may decline due to, among other things, system failures and our ability to effectively predict and respond to changing trends and consumer demands, and to translate market trends into appropriate, saleable product offerings in a timely manner, all of which could also have a material adverse effect on our business, results of operations and financial condition.

We must effectively manage our vendors to minimize inventory risk and maintain our margins.

We seek to avoid maintaining high inventory levels in an effort to limit the risk of outdated merchandise and inventory write-downs. If we underestimate quantities demanded by our customers and our vendors cannot restock, then we may disappoint customers who may then turn to our competitors. We require many of our vendors to meet minimum restocking requirements, but if our vendors cannot meet these requirements and we cannot find alternative vendors, we could be forced to carry more inventory than we have in the past. Our risk of inventory write-downs would increase if we were to hold large inventories of merchandise that prove to be unpopular.

10

We rely on third parties for some essential business operations and services, and disruptions or failures in service or changes in terms may adversely affect our ability to deliver goods and services to our customers.

We currently depend on third parties for important aspects of our business, such as printing, shipping, paper supplies and operation of our e-commerce webpages and customer support. We have limited control over these third parties, and we are not their only client. In addition, we may not be able to maintain satisfactory relationships with any of these third parties on acceptable commercial terms. Further, we cannot be certain that the quality or cost of products and services that they provide will remain at currents levels or the levels needed to enable us to conduct our business efficiently and effectively.

Our business, including our costs and supply chain, is onlysubject to risks associated with sourcing, manufacturing, warehousing, distribution, infrastructure and logistics to third-party providers, and the loss of any of our key suppliers or logistical service providers could negatively impact our business.

All of the products we offer are supplied or manufactured by a limited basis upon whichnumber of third-party suppliers and manufacturers, and as a result we may be subject to evaluate our prospects for achieving our intended business objectives.

We willprice fluctuations or supply disruptions. Our operating results would be wholly dependent fornegatively impacted by increases in the selection, structuring, closing and monitoring of allcosts of our investmentsproducts, and we have no guarantees that costs will not rise. In addition, as we expand into new categories and product types, we expect that we may not have strong purchasing power in these new areas, which could lead to higher costs than we have historically seen in our current categories. We may not be able to pass increased costs on to consumers, which could adversely affect our operating results. Moreover, in the diligenceevent of a significant disruption in the supply of the materials used in the manufacture of the products we offer, we and skillthe vendors that we work with might not be able to locate alternative suppliers of materials of comparable quality at an acceptable price.

In addition, products and merchandise we receive from manufacturers and suppliers may not be of sufficient quality or free from damage, or such products may be damaged during shipping, while stored in our management team, under the supervisionwarehouse fulfillment centers or with third-party ecommerce or retail customers or when returned by consumers. We may incur additional expenses and our reputation could be harmed if consumers and potential consumers believe that our products do not meet their expectations, are not properly labelled or are damaged. Quality control problems could also result in regulatory action, such as FDA Warning Letters, restrictions on importation, product liability litigation, product seizures, products of inferior quality or product stock outages or shortages, harming our Boardsales and creating inventory write-downs for unusable products.

We purchase significant amounts of Directors.product from a limited number of suppliers with limited supply capabilities. There can be no assurance that weour current suppliers will attainbe able to accommodate our investment objective. Theanticipated growth or continue to supply current quantities at preferential prices. We generally do not maintain long-term supply contracts with any of our suppliers and any of our suppliers could discontinue selling to us at any time. An inability of our existing suppliers to provide materials in a timely or cost-effective manner could impair our growth and have an adverse effect on our business, financial condition, results of operations and prospects.

We rely or may rely on software-as-a-service (“SaaS”) technologies from third parties in order to operate critical functions of our business, including financial management team will have primary responsibility for the selection of companiesservices, payment processing, customer relationship management services, website platform services, ecommerce services, email services, supply chain services, and data storage services. If these services become unavailable due to which we will finance, the terms and the monitoring of such investments afterextended outages or interruptions or because they are made. However, notno longer available on commercially reasonable terms or prices or for any other reason, or if we fail to migrate successfully to new services, our expenses could increase, our ability to manage our finances could be interrupted, our processes for managing sales of our offerings and supporting our consumers could be impaired, our ability to communicate with our suppliers could be weakened and our ability to access or save data stored to the cloud may be impaired until equivalent services, if available, are identified, obtained and implemented, all of which could have an adverse effect on our business, financial condition, results of operations and prospects.

We utilize cloud services from third-party data center facilities operated by AWS and Cloudflare. Any damage to, failure of or interference with our cloud service that is hosted by us, AWS, Cloudfare, or by third-party providers we may utilize in the management team will devote allfuture, whether as a result of their timeour actions, actions by the third-party data centers, actions by other third parties, or acts of nature, could result in interruptions in our cloud service and/or the loss of our or our customers’ data, including personal information. Impairment of, or interruptions in, our cloud services may subject us to managing the Company. These factors mayclaims and litigation and adversely affect our profitability.

We have limited resources and limited operating history.

OUR OPERATIONS AS AN EVENT SERVICE PROVIDER MAY AFFECT OUR ABILITY TO, AND THE MANNER IN WHICH, WE RAISE ADDITIONAL CAPITAL, WHICH MAY EXPOSE US TO RISKS.

ability to attract new customers. Our business will require a substantial amount of capital to marketalso be harmed if our customers and potential customers believe our services are unreliable. Additionally, any limitation of the capacity of our data centers could impede our ability to scale, onboard new customers or expand the usage of existing customers, which could adversely affect our business, financial condition and then provide the services to clientsresults of operations. While we have disaster recovery arrangements in order to generate revenues. Our revenuesplace, our preparations may not be paid until 30-45 days after providing services. Weadequate to account for disasters or similar events that may acquire additional capital fromoccur in the issuancefuture and may not effectively permit us to continue operating in the event of senior securities, including borrowingsany problems with respect to our systems or those of our third-party data centers or any other third-party facilities. Our disaster recovery and data redundancy measures may be inadequate, and our business interruption insurance may not be sufficient to compensate us for the losses that could occur.

11

If any of our key suppliers becomes insolvent, ceases or significantly reduces its operations or experiences financial distress or if any environmental, economic or other indebtedness,outside factors impact their operations, our operations could be substantially disrupted. If we are unable to identify or enter into distribution relationships with new suppliers or to replace the issuanceloss of additional sharesany of our common stock. However,existing suppliers, we may experience a competitive disadvantage, our business may be disrupted and our business, financial condition, results of operations and prospects could be adversely affected.

If our third-party suppliers and manufacturers do not comply with ethical business practices or with applicable laws and regulations, our reputation, business, financial condition, results of operations and prospects could be harmed.

We continually seek to expand our base of suppliers, especially as we identify new products that necessitate new or additional materials. We also require our new and existing suppliers to meet our ethical and business partner standards. Suppliers may also have to meet governmental and industry standards and any relevant standards required by our consumers, which may require additional investment and time on behalf of suppliers and us.

Our reputation and our consumers’ willingness to purchase our products depend in part on our suppliers’, manufacturers’, and retail partners’ compliance with ethical employment practices, such as with respect to child labor, wages and benefits, forced labor, discrimination, safe and healthy working conditions, and with all legal and regulatory requirements relating to the conduct of their businesses. We do not exercise control over our suppliers, manufacturers, and retail partners and cannot guarantee their compliance with ethical and lawful business practices. If our suppliers, manufacturers, or retail partners fail to comply with applicable laws, regulations, safety codes, employment practices, human rights standards, quality standards, environmental standards, production practices, or other obligations, norms, or ethical standards, our reputation and brand image could be harmed, and we could be exposed to litigation, investigations, enforcement actions, monetary liability, and additional costs that would harm our reputation, business, financial condition, results of operations and prospects.

Shipping is a critical part of our business and any changes in our shipping arrangements or any interruptions in shipping could adversely affect our operating results.

We rely on several vendors for our shipping requirements. If we are not able to negotiate acceptable pricing and other terms with these vendors or if they experience performance problems or other difficulties, it could negatively impact our operating results and our consumer experience. Rising shipping costs and the imposition of surcharges from time to time could negatively impact our operating results. In addition, our ability to receive inbound inventory and ship products to consumers and retailers may be negatively affected by inclement weather, fire, flood, power loss, earthquakes, labor disputes, acts of war or terrorism, trade embargoes, customs and tax requirements and similar factors. We are also subject to risks of damage or loss during delivery by our shipping vendors. If our products are not delivered in a timely fashion or are damaged or lost during delivery, our consumers could become dissatisfied and cease shopping on our site or retailer, which could have an adverse effect on our business, financial condition, operating results and prospects.

We are subject to risks related to online payment methods, including third-party payment processing-related risks.

We currently accept payments using a variety of methods, including credit card, debit card, and gift cards. As we offer new payment options to consumers, we may be subject to additional regulations, compliance requirements, fraud and other risks. We also rely on third parties to provide payment processing services, and for certain payment methods, we pay interchange and other fees, which may increase over time and raise our operating costs and affect our ability to achieve or maintain profitability. We are also subject to payment card association operating rules and certification requirements, including the Payment Card Industry Data Security Standard, or PCI-DSS, and rules governing electronic funds transfers, which could change or be reinterpreted to make it difficult or impossible for us to comply. If we (or a third party processing payment card transactions on our behalf) suffer a security breach affecting payment card information, we may have to pay onerous and significant fines, penalties and assessments arising out of the major card brands’ rules and regulations, contractual indemnifications or liability contained in merchant agreements and similar contracts, and we may lose our ability to accept payment cards for payment for our goods and services, which could materially impact our operations and financial performance.

Furthermore, as our business changes, we may be subject to different rules under existing standards, which may require new assessments that involve costs above what we currently pay for compliance. As we offer new payment options to consumers, including by way of integrating emerging mobile and other payment methods, we may be subject to additional regulations, compliance requirements and fraud. If we fail to comply with the rules or requirements of any provider of a payment method we accept, if the volume of fraud in our transactions limits or terminates our rights to use payment methods we currently accept, or if a data breach occurs relating to our payment systems, we may, among other things, be subject to fines or higher transaction fees and may lose, or face restrictions placed upon, our ability to accept credit card payments from consumers or facilitate other types of online payments. In addition, our customers could lose confidence in certain payment types, which may result in a shift to other payment types or potential changes to our payment systems that may result in higher costs.

12

We also occasionally receive orders placed with fraudulent data and we may ultimately be held liable for the unauthorized use of a cardholder’s card number in an illegal activity and be required by card issuers to pay charge-back fees. Charge-backs result not only in our loss of fees earned with respect to the payment, but also leave us liable for the underlying money transfer amount. If our charge-back rate becomes excessive, card associations also may require us to pay fines or refuse to process our transactions. In addition, we may be subject to additional fraud risk if third-party service providers or our employees fraudulently use consumer information for their own gain or facilitate the fraudulent use of such information. Overall, we may have little recourse if we process a criminally fraudulent transaction. If we fail to adequately control fraudulent credit card transactions, we may face civil liability, diminished public perception of our security measures, and significantly higher credit card-related costs, each of which could harm our business, results of operations and financial condition.

Merchandise returns could harm our business.

We allow our customers to return products, subject to our return policy. If the rate of merchandise returns increases significantly or if merchandise return economics become less efficient, our business, financial condition and operating results could be harmed. Further, we modify our policies relating to returns from time to time, which may result in customer dissatisfaction or an increase in the number of product returns. From time to time our products are damaged in transit, which can increase return rates and harm our brands.

Our operations are currently dependent on a single warehouse and distribution center, and the loss of, or disruption in, the warehouse and distribution center and other factors affecting the distribution of merchandise could have a material adverse effect on our business and operations.

Our warehouse and fulfillment/distribution functions are currently primarily handled from a single facility. Our current fulfillment/distribution operations are dependent on the continued use of this facility. Any significant interruption in the operation of the warehouse and fulfillment/ distribution center due to COVID-19 restrictions, natural disasters, accidents, system issues or failures, or other unforeseen causes that materially impair our ability to access or use our facility, could delay or impair the ability to distribute merchandise and fulfill online orders, which could cause sales to decline.

We also depend upon third-party carriers for shipment of a significant amount of merchandise directly to our customers. An interruption in service by these third-party carriers for any reason could cause temporary disruptions in business, a loss of sales and profits, and other material adverse effects.

Our revenues and income could decline due to general economic trends and declines in consumer spending.

Our revenues are largely generated by discretionary consumer spending. Consumer spending tends to decline during recessionary periods and may also decline at other times. Accordingly, our revenues could decline during any general economic downturn.

We face risks related to recession, inflation, weak growth, and other economic conditions.

Customer demand for our products may be impacted by weak economic conditions, inflation, weak growth, recession, equity market volatility, or other negative economic factors in the United States or other nations. For example, under these conditions, potential customers may delay or cancel purchases of our products. Further, in the event of a recession our manufacturing partners, suppliers, and other third-party partners may suffer their own financial and economic challenges and as a result they may demand pricing accommodations, delay payment, or become insolvent, which could harm our ability to meet our customer demands or otherwise could harm our business, financial condition, and results of operations. Similarly, disruptions in financial and credit markets may impact our ability to manage normal commercial relationships with our customers, suppliers, and lenders and might cause us to not be able to raise additional capitalaccess sources of liquidity, and our borrowing costs could increase. If general macroeconomic conditions deteriorate, our business, financial condition, and results of operations could be materially and adversely affected.

In addition, we are also subject to risk from inflation and increasing market prices of certain supplies and raw materials, which are incorporated into our products or used by our suppliers to manufacture our products. These components, supplies, and commodities may from time to time become restricted, or general market factors and conditions may affect pricing of such components, supplies and commodities, such as inflation or supply chain constraints.

13

Changes in the futureeconomy could have a detrimental impact on favorable terms or at all. We may issue debt securities, other evidences of indebtedness or preferred stock, and we may borrow money from banks or other financial institutions, which we refer to collectively as "senior securities". If the value of our businesses decline, we may be unable to satisfy loan requirements. If that happens, we may be required to reduce operations and repay a portion of our indebtedness at a time when such reduction may be disadvantageous. As a result of issuing senior securities, we would also be exposed to typical risks associated with leverage, including an increased risk of loss. If we issue preferred stock, the preferred stock would rank "senior" to common stock in our capital structure. Preferred stockholders would have separate voting rights and might have rights, preferences, or privileges more favorable than those of our common stockholders. If we raise additional funds by issuing more common stock or senior securities convertible into, or exchangeable for, our common stock, then the percentage ownership of our stockholders at that time will decrease.business.

WE ARE DEPENDENT UPON OUR PART-TIME MANAGEMENT FOR OUR SUCCESS WHICH IS A RISK TO OUR INVESTORS.

Our lack of full-time management may be an impediment to our business achievement. Without full-time officers, we may not have sufficient devoted time and effort to find successful loan prospects, additional capital, or manage our loan portfolio, which could impair our ability to succeed in our business plan and could cause investment in our Company to lose value.

WE HAVE A LIMITED AMOUNT OF FUNDS AVAILABLE FOR INVESTMENT IN VENTURES AND AS A RESULT OUR VENTURES MAY LACK DIVERSIFICATION.

Based on the amount of our existing available funds, it is unlikely that we will be able to commit our funds to a large number of ventures. Prospective investors should understand that our venture investments are not, andChanges in the general economic climate could have a detrimental impact on our revenue. It is possible that recessionary pressures and other economic factors (such as declining incomes, future potential rising interest rates, higher unemployment, and tax increases) may not be, substantially diversified. We may not achieve the same leveladversely affect our business. Any of diversification as larger entities engaged in similar activities. Therefore, our assets may be subject to greater risk of loss than if they were more widely diversified. The loss of onesuch events or more of our limited number of investmentsoccurrences could have a material adverse effect on our financial condition.results and on your investment.

Increases in labor costs, including wages, could adversely affect our business, financial condition and results of operations.

Labor is a significant portion of our cost structure and is subject to many external factors, including unemployment levels, prevailing wage rates, minimum wage laws, potential collective bargaining arrangements, health insurance costs and other insurance costs and changes in employment and labor legislation or other workplace regulation. From time to time, legislative proposals are made to increase the federal minimum wage in the United States, as well as the minimum wage in California and a number of other states and municipalities, and to reform entitlement programs, such as health insurance and paid leave programs. As minimum wage rates increase or related laws and regulations change, we may need to increase not only the wage rates of our minimum wage employees, but also the wages paid to our other hourly or salaried employees. Any increase in the cost of our labor could have an adverse effect on our business, financial condition and results of operations or if we fail to pay such higher wages we could suffer increased employee turnover. Increases in labor costs could force us to increase prices, which could adversely impact our sales. If competitive pressures or other factors prevent us from offsetting increased labor costs by increases in prices, our profitability may decline and could have a material adverse effect on our business, financial condition and results of operations.

We face competition in our market from various companies, most of which have greater financial, production, and other resources than us.

We face significant competition from other marketing companies, and our operating results could suffer if we fail to compete effectively. The marketing industry is intensely competitive and subject to rapid and significant change. We have competitors both in the United States and internationally, including major marketing companies. Many of our competitors have substantially greater financial, technical, and other resources, such as larger staff and experienced marketing and manufacturing organizations. These companies may obtain market acceptance more rapidly than we can and may be more effective in selling and marketing their products and services as well. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large, established companies. Our ability to compete depends, in part, upon a number of factors outside our control, including the ability of our competitors to develop products and services that are superior. Competition may increase further as a result of greater availability of capital for investment in these industries. Our competitors may succeed in developing, acquiring, or licensing similar products or services that we may develop. If we fail to successfully compete in our market, or if we incur significant expenses in order to compete, it could have a material adverse effect on our results of operations.

Our business model is evolving.

Our business model is unproven and is likely to continue to evolve. Accordingly, our initial business model may not be successful and may need to be changed. Our ability to generate significant revenues will depend, in large part, on our ability to successfully market our products to potential users who may not be convinced of the need for our products and services or who may be reluctant to rely upon third parties to develop and provide these products. We intend to continue to develop our business model as our market continues to evolve.

If we fail to maintain and enhance awareness of our brand, our business and financial results could be adversely affected.

We believe that maintaining and enhancing awareness of our brand is critical to achieving widespread acceptance and success of our business. We also believe that the importance of brand recognition will increase due to the relatively low barriers to entry in our market. Maintaining and enhancing our brand awareness may require us to spend increasing amounts of money on, and devote greater resources to, advertising, marketing, and other brand-building efforts and these investments may not be successful. Further, even if these efforts are successful, they may not be cost-effective. If we are unable to continuously maintain and enhance our media presence, our market may decrease and we may fail to attract advertisers and subscribers, which could in turn result in lost revenues and adversely affect our business and financial results.

14

An inability to maintain and enhance product image could harm our business.

It is important that we maintain and enhance a positive perception of any new products. The image and reputation of our products may be impacted for various reasons including, but not limited to, bad publicity, litigation, and complaints from regulatory bodies. Such problems, even when unsubstantiated, could be harmful to our image and the reputation of our products. These claims may not be covered by our insurance policies. Any resulting litigation could be costly for us, divert management attention, and could result in increased costs of doing business, or otherwise have a material adverse effect on our business, results of operations, and financial condition. Any negative publicity generated could damage our reputation and diminish the value of our brand, which could have a material adverse effect on our business, results of operations, and financial condition. Deterioration in our brand equity (brand image, reputation, and product quality) may have a material adverse effect on our financial results.

We could face liability for information displayed via our e-commerce webpages and our other websites.

We may be subjected to claims for defamation, negligence, copyright, or trademark infringement or based on other theories relating to the information we publish on our e-commerce webpages and on any of our websites. These types of claims have been brought, sometimes successfully, against similar companies in the past. Based on links we provide to third-party websites, we could also be subjected to claims based upon online content we do not control that is accessible from our e-commerce webpages.

The actual or perceived failure by us or our vendors to comply with applicable privacy and data protection laws, regulations or industry standards could have an adverse effect on our business, financial condition, results of operations and prospects.

We collect, store, share, use, retain, safeguard, transfer, analyze, and otherwise process, and our vendors process on our behalf, personal information, confidential information, and other information necessary to provide and deliver our products through our e-commerce channel to operate our business, for legal and marketing purposes, and for other business-related purposes. Collection and use of this information might raise privacy and data protection concerns, which could negatively impact our business. Data privacy and information security has become a significant issue in the United States, Europe, and elsewhere. The legal and regulatory framework for privacy and security issues is rapidly evolving and is expected to increase our compliance costs and exposure to liability. There are numerous federal, state, local, and international laws, orders, codes, rules, regulations and regulatory guidance regarding privacy, information security and processing (collectively, “Data Protection Laws”), the number and scope of which is changing, subject to differing applications and interpretations, and which may be inconsistent among jurisdictions, or in conflict with other rules, laws or obligations (collectively, “Data Protection Obligations”). Therefore, the regulatory framework for privacy and data protection worldwide is, and is likely to remain, uncertain and complex for the foreseeable future, and our actual or perceived failure to address or comply with applicable Data Protection Laws and Data Protection Obligations could have an adverse effect on our business, financial condition, results of operations and prospects. We also expect that there will continue to be new Data Protection Laws and Data Protection Obligations, and we cannot yet determine the impact such future Data Protection Laws and Data Protection Obligations may have on our business. Any significant change to Data Protection Laws and Data Protection Obligations, including without limitation, regarding the manner in which the express or implied consent of consumers for processing is obtained, could increase our costs and require us to modify our operations, possibly in a material manner, which we may be unable to complete and may limit our ability to store and process consumer data and operate our business.

We are or may also be subject to the terms of our external and internal privacy and security policies, codes, representations, certifications, industry standards, publications and frameworks (collectively, “Privacy Policies”) and contractual obligations to third parties related to privacy, information security and processing, including contractual obligations to indemnify and hold harmless third parties from the costs or consequences of non-compliance with Data Protection Laws or Data Protection Obligations.

We may not be successful in achieving compliance if our employees, partners, or vendors do not comply with applicable Data Protection Laws, Privacy Policies and Data Protection Obligations. If we or our vendors fail (or are perceived to have failed) to comply with applicable Data Protection Laws, Privacy Policies and Data Protection Obligations, or if our Privacy Policies are, in whole or part, found to be inaccurate, incomplete, deceptive, unfair, or misrepresentative of our actual practices, our business, financial condition, results of operations and prospects could be adversely affected.

In the United States, our obligations include rules and regulations promulgated under the authority of the Federal Trade Commission (the “FTC”), the Electronic Communications Privacy Act, the Computer Fraud and Abuse Act, the California Consumer Privacy Act (the “CCPA”) and other state and federal laws relating to privacy and data security. The CCPA, which took effect on January 1, 2020, requires companies that process information of California residents to make new disclosures to consumers about their data collection, use and sharing practices, allows consumers to opt out of the sale of personal information with third parties and prohibits covered businesses from discriminating against California residents (for example, charging more for services) for exercising any of their rights under the CCPA. The law also provides a private right of action and statutory damages for certain data breaches that result in the loss of personal information. This private right of action is expected to increase the likelihood of, and risks associated with, data breach litigation. However, it remains unclear how various provisions of the CCPA will be interpreted and enforced. Therefore, the CCPA may increase our compliance costs and potential liability.

15

In addition, the California Privacy Rights Act of 2020 (the “CPRA”) went into effect on January 1, 2023. The CPRA significantly modifies the CCPA, and imposes additional data protection obligations on companies doing business in California, resulting in further complexity. The law, among other things, gives California residents the ability to limit the use of their sensitive information, provides for penalties for CPRA violations concerning California residents under the age of 16, and establishes a new California Privacy Protection Agency to implement and enforce the law. The effects of this legislation are far-reaching and may impact our business. The CCPA could mark the beginning of a trend toward more stringent privacy legislation in the United States, which could increase our potential liability and adversely affect our business, financial condition, results of operations and prospects.

Other jurisdictions in the United States have already passed or are considering laws similar to the CCPA and CRPA, with potentially greater penalties and more rigorous compliance requirements relevant to our business. Many state legislatures have already adopted legislation that regulates how businesses operate online, including measures relating to privacy, data security, data breaches and the protection of sensitive and personal information. For example, on March 2, 2021, Virginia enacted the Virginia Consumer Data Protection Act (the “CDPA”), a comprehensive privacy statute that shares similarities with the CCPA, CPRA, and legislation proposed in other states. The CDPA required us to incur additional costs and expenses to comply with it before it became effective on January 1, 2023. June 2021, Colorado also enacted a similar law, the Colorado Privacy Act (the “CPA”), which becomes effective on July 1, 2023. Many other states are currently considering proposed comprehensive data privacy legislation and all 50 states have passed at least some form of data privacy legislation (for example, all 50 states have enacted laws requiring disclosure of certain personal data breaches). At the federal level, the United States Congress is also considering various proposals for comprehensive federal data privacy legislation and, while no comprehensive federal data privacy law currently exists, we are subject to applicable existing federal laws and regulations, such as the rules and regulations promulgated under the authority of the FTC, which regulates unfair or deceptive acts or practices, including with respect to data privacy and security. These state statutes, and other similar state or federal laws, may require us to modify our data processing practices and policies and incur substantial compliance-related costs and expenses.

We rely on a variety of marketing techniques and practices, including email and social media marketing, online targeted advertising, cookie-based processing, and postal mail to sell our products and services and to attract new consumers, and we, and our vendors, are subject to various current and future Data Protection Laws and Data Protection Obligations that govern marketing and advertising practices. Governmental authorities continue to evaluate the privacy implications inherent in the use of third-party “cookies” and other methods of online tracking for behavioral advertising and other purposes, such as by regulating the level of consumer notice and consent required before a company can employ cookies or other electronic tracking tools or the use of data gathered with such tools. Additionally, some providers of consumer devices, web browsers and application stores have implemented, or announced plans to implement, means to make it easier for Internet users to prevent the placement of cookies or to block other tracking technologies, require additional consents, or limit the ability to track user activity, which could if widely adopted result in the use of third-party cookies and other methods of online tracking becoming significantly less effective. Laws and regulations regarding the use of these cookies and other current online tracking and advertising practices or a loss in our ability to make effective use of services that employ such technologies could increase our costs of operations and limit our ability to acquire new consumers on cost-effective terms, which, in turn, could have an adverse effect on our business, financial condition, results of operations and prospects.

Government regulation of the internet and ecommerce is evolving, and unfavorable changes or failure by us to comply with these regulations could have an adverse effect on our business, financial condition, results of operations and prospects.

We are subject to general business regulations and laws as well as regulations and laws specifically governing the internet and ecommerce, including consumer protection regulations that regulate retailers and govern the promotion and sale of merchandise. Existing and future regulations and laws could impede the growth of the Internet, ecommerce or mobile commerce, which could in turn adversely affect our growth. These regulations and laws may involve taxes, tariffs, privacy and data security, anti-spam, content protection, electronic contracts and communications, consumer protection, sales practices, subscription programs and internet neutrality. It is not clear how existing laws governing issues such as property ownership, sales and other taxes and consumer privacy apply to the Internet as the vast majority of these laws were adopted prior to the advent of the Internet and do not contemplate or address the unique issues raised by the internet or ecommerce. It is possible that general business regulations and laws, or those specifically governing the internet or ecommerce, may be interpreted and applied in a manner that is inconsistent from one jurisdiction to another and may conflict with other rules or our practices. We cannot be sure that our practices have complied, comply or will comply fully with all such laws and regulations. Any failure, or perceived failure, by us to comply with any of these laws or regulations could result in damage to our reputation, a loss in business and proceedings or actions against us by governmental entities, customers, suppliers or others. Any such proceeding or action could hurt our reputation, force us to spend significant amounts in defense of these proceedings, distract our management, increase our costs of doing business, decrease the use of our website and mobile applications by customers and suppliers and may result in the imposition of monetary liabilities and burdensome injunctions that could, for example, require changes to our business practices. We may also be contractually liable to indemnify and hold harmless third parties from the costs or consequences of noncompliance with any such laws or regulations. As a result, adverse developments with respect to these laws and regulations could have an adverse effect on our business, financial condition, results of operations and prospects.

(See also “Our Business – Government Regulation” for additional risks.)

16

Advertising inaccuracies or product mislabeling may have an adverse effect on our business by exposing us to lawsuits, product recalls or regulatory enforcement actions, increasing our operating costs and reducing demand for our product offerings.

Many products that we sell are labeled and advertised with claims as to their origin, ingredients or health, wellness, environmental or other benefits, including, by way of example, the use of the term “natural” or “organic” or similar synonyms or implied statements relating to such benefits. The FTC’s Guides For The Use Of Environmental Marketing Claims (the “Green Guides”) provide guidance on how to use environmental marketing claims, provide specific guidance for certain terms (e.g., “recyclable”), and recommend against using unqualified statements about environmental benefits such as “eco-friendly.” Although the FDA and the USDA each have issued statements regarding the appropriate use of the word “natural,” there is no single, U.S. government regulated definition of the term “natural” for use in the consumer and personal care industry.

Consumer class actions, actions from industry groups such as the National Advertising Division of the Better Business Bureau, and public enforcement actions have been brought against numerous companies that market “natural,” “sustainable,” or other ecologically conscious products or ingredients, asserting false, misleading and deceptive advertising and labeling claims.

These suits often identify ingredients or components of a product for which certain marketing claims may not be fully accurate, and claim that their presence in the product renders the statements false and deceptive. For example, some actions concerning “natural” claims have focused on the presence of genetically modified and/or synthetic ingredients or components in products, including synthetic forms of otherwise natural ingredients.

(See also, “Our Business – Government Regulation” for a detailed discussion regarding these risks.)

Many of our products are subject to regulatory enforcement.

-The FDA regulates product labels and other product claims for the consumer products subject to its jurisdiction and has the authority to challenge product labels and claims that it believes are non-compliant or false or misleading, through the use of a variety of enforcement tools (e.g., Warning Letters, untitled letters, and seizure actions). In limited circumstances, the FDA has taken regulatory action against products labeled “natural” but that nonetheless contain synthetic ingredients or components.
 Table
-The FTC has the authority to challenge claims made in product advertising and requires that such claims are adequately substantiated prior to use. The FTC similarly has enforcement tools that it uses to challenge advertising claims that it deems non-compliant with the law.
-The USDA enforces federal standards for organic production and use of Contentsthe term “organic” on product labeling. These laws prohibit a company from selling or labeling products as organic unless they are produced and handled in accordance with the applicable federal law. Failure to comply with these requirements may subject us to liability or regulatory enforcement. Consumers may also pursue state law claims challenging use of the organic label as being intentionally mislabeled or misleading or deceptive to consumers.

State and local regulators also have the authority to prosecute false advertising cases, including relating to environmental marketing claims. Current and potential competitors may make similar claims, which may result in action litigation and inquiries to us from state and federal regulators and governments.

Should we become subject to actions regarding our branding or product marketing, consumers may avoid purchasing products from us or seek alternatives, even if the basis for the claim is unfounded. Moreover, any regulatory or government enforcement actions may trigger class action lawsuits under state consumer protection laws.

Adverse publicity about these matters may discourage consumers from buying our products. The cost of defending against any such claims could be significant and we may incur substantial costs remediating product claims in labeling and advertising if we are unsuccessful in defending such actions. Any loss of confidence on the part of consumers in the truthfulness of our labeling, advertising or ingredient claims would be difficult and costly to overcome and may significantly reduce our brand value. Any of these events could adversely affect our reputation and brand and decrease our sales, which could have an adverse effect on our business, financial condition, results of operations and prospects.

False or misleading marketing claims concerning a product’s registration, or its efficacy may also create the risk for challenges under federal or state law.

(See also “Our Business—Government Regulation” for a detailed discussion regarding these risks.)

17

WE HAVE A LACK OF REVENUE HISTORY AND STOCKHOLDERS CANNOT VIEW OUR PAST PERFORMANCE SINCE WE HAVE A LIMITED OPERATING HISTORY.

 

DuringWe are subject to a number of other laws and regulations, which could impact our business.

We are subject to a broad range of federal, state, local, and foreign laws and regulations intended to protect public and worker health and safety, natural resources, the periodenvironment and consumers. Our operations are subject to regulation by the Occupational Safety and Health Administration (“OSHA”), the FDA, the CPSC, the USDA, the FTC, and by various other federal, state, local and foreign authorities regarding the manufacture, processing, packaging, storage, sale, order fulfillment, advertising, labeling, import and export of inceptionour products. In addition, we and our manufacturing partners are subject to additional regulatory requirements, including state, local and foreign environmental, health and safety legislative and regulatory authorities and the National Labor Relations Board, covering such areas as discharges and emissions to air and water, the use, management, disposal and remediation of, and human exposure to, hazardous materials and wastes, and public and worker health and safety, and Current Good Manufacturing Practice requirements (“GMPs”) enforced by the FDA.

In addition, as the provider of products with a subscription-based element, a variety of laws and regulations govern the ability of users to cancel subscriptions and auto-payment renewals. California’s automatic renewal law in particular has been the basis for both consumer class actions and government enforcement.

Violations of or liability under any of these laws and regulations may result in administrative, civil or criminal fines, penalties or sanctions against us, revocation or modification of applicable permits, licenses or authorizations, environmental, health and safety investigations or remedial activities, voluntary or involuntary product recalls, warning or untitled letters or cease and desist orders against operations that are not in compliance, among other things. Such laws and regulations generally have become more stringent over time and may become more so in the future, and we may incur (directly, or indirectly through our mergermanufacturing partners) material costs to comply with Prime Time Live, Inc.current or future laws and regulations or in any required product recalls.

Liabilities under, and/or costs of compliance, and the impacts on December 31, 2019,us of any non-compliance, with or investigations under any such laws and regulations could have an adverse effect on our business, financial condition, results of operations and prospects.

Failure by our network of retail and ecommerce partners, suppliers, or manufacturers to comply with product safety, environmental or other laws and regulations, or with the specifications and requirements of our products, may disrupt our supply of products and adversely affect our business.

If our network of retail and ecommerce partners, suppliers or manufacturers fail to comply with environmental, health and safety or other laws and regulations, or face allegations of non-compliance, their operations may be disrupted and our reputation could be harmed. Additionally, our retail and ecommerce partners, suppliers and manufacturers are required to maintain the quality of our products and to comply with our standards and specifications. In the event of actual or alleged non-compliance, we did not recognize revenues. We are not profitable. Wemight be forced to find alternative retail or ecommerce partners, suppliers or manufacturers and we may be subject to lawsuits and/or regulatory enforcement actions related to such non-compliance by the suppliers and manufacturers. As a result, our supply of products could be disrupted or our costs could increase, which could adversely affect our business, financial condition, results of operations and prospects. The failure of any partner or manufacturer to produce products that conform to our standards could adversely affect our reputation in the marketplace and result in product recalls, product liability claims, government or third-party actions and economic loss. For example, a manufacturer’s failure to meet GMPs, could result in the delivery of a product that is subject to a product recall, product liability litigation, or government investigations and enforcement. Additionally, actions we may take to mitigate the impact of any disruption or potential disruption in our supply of materials or finished inventory, including increasing inventory in anticipation of a potential supply or production interruption, could have an adverse effect on our business, financial condition, results of operations and prospects.

Our future financial performance and our ability to commercialize our products and services and to compete effectively will depend, in part, on our ability to manage any future growth effectively.

If our operations expand as planned, we expect that we will need to manage additional relationships with various strategic partners, suppliers, and other third parties. Our future financial performance and our ability to commercialize our products and services and to compete effectively will depend, in part, on our ability to manage any future growth effectively. To that end, we must be regarded asable to manage our development efforts effectively and hire, train, and integrate additional management, administrative and sales and marketing personnel. Our projected growth will place a new venturesignificant strain on our administrative, operational, and financial resources. If we are unable to successfully manage our future growth, establish and continue to upgrade our operating and financial control systems, recruit and hire necessary personnel, or effectively manage unexpected expansion difficulties, our financial condition and results of operations could be materially and adversely affected.

18

Our operating plan relies in large part upon our assumptions and analyses. If these assumptions or analyses prove to be incorrect, our actual operating results may be materially different from our forecasted results.

Whether actual operating results and business developments will be consistent with all of the unforeseen costs, expenses, problems, risksour expectations and difficulties to which such ventures are subject. Prime Time Live, Inc. had historical revenues as part of its event services business that was acquired by the Companyassumptions as reflected in PTL’sour operating plan depends on a number of factors, many of which are outside our control, including, but not limited to:

whether we can obtain sufficient capital to sustain and grow our business;
our ability to manage our growth;
results of our research and development activity;
demand for our current and proposed products;
competition;
our ability to retain existing key management and consultants, to integrate recent hires and to attract, retain, and motivate qualified personnel; and
the overall strength and stability of domestic and international economies.

Unfavorable changes in any of these or other factors, most of which are beyond our control, could materially and Prime Time Mobile Video Event Screens LLC’s attachedadversely affect our business, results of operations, and financial statements.condition.

WE ARE NOT DIVERSIFIED, AND WE WILL BE DEPENDENT ON ONLY ONE BUSINESS, EVENT SERVICE PROVIDER.Acts of war or terrorism may seriously harm our business.

BecauseActs of war, any outbreak or escalation of hostilities between the United States and any foreign power, or acts of terrorism may cause disruption to the U.S. economy or the local economies of the limited financial resourcesmarkets in which we operate, cause shortages of materials, increase costs associated with obtaining materials, affect job growth and consumer confidence, or cause economic changes that we cannot anticipate, all of which could reduce demand for our products and services and adversely impact our business, prospects, liquidity, financial condition, and results of operations.

Risks Related to Our Organization and Structure

We have it is unlikely that we will be able to diversify our operations. Our probable inability to diversify our activities into more than one area will subject us to economic fluctuations within the event services industryauthorized and therefore increase the risks associated with our operations due to lackdesignated Class A Preferred Convertible Stock, which have voting rights of diversification.

WE CAN GIVE NO ASSURANCE OF SUCCESS OR PROFITABILITY TO OUR STOCKHOLDERS.

There is no assurance that we will ever operate profitably. There is no assurance that we will generate revenues or profits, or that the market price60% of our common stock will be increased thereby.at all times.

WE MAY HAVE A SHORTAGE OF WORKING CAPITAL IN THE FUTURE WHICH COULD JEOPARDIZE OUR ABILITY TO CARRY OUT OUR BUSINESS PLAN.

Our capital needs consist primarily of expenses related to general and administrative operations and legal and accounting and could exceed $1,000,000 in the next twelve months. Such funds are not currently committed, and we have cash of approximately $60,000 as of the date of this filing.

WE WILL NEED ADDITIONAL FINANCING FOR WHICH WE HAVE NO COMMITMENTS, AND THIS MAY JEOPARDIZE EXECUTION OF OUR BUSINESS PLAN.

We have limited funds, and such funds may not be adequate to carry out our business plan in the event production industry. Our ultimate success depends upon our ability to raise additional capital. We are investigating the availability, sources, and terms that might govern the acquisition of additional capital.

We have no commitment at this time for additional capital. If we need additional capital, we have no assurance that funds will be available from any source or, if available, that they can be obtained on terms acceptable to us. If not available, our operations will be limited to those that can be financed with our modest capital.

WE MAY IN THE FUTURE ISSUE MORE SHARES/UNITS WHICH COULD CAUSE A LOSS OF CONTROL BY OUR PRESENT MANAGEMENT AND CURRENT STOCKHOLDERS.

We may issue further500,000 shares as consideration for the cash or assets or services out of our authorized but unissued common stock that would, upon issuance, represent a majority of the voting power and equity of our Company. The result of such an issuance would be those new stockholders and management would control our Company, and persons unknown could replace our management at that time. Such an occurrence would result in a greatly reduced percentage of ownership of our Company by our current stockholders, which could present significant risks to stockholders.

WE HAVE AUTHORIZED AND DESIGNATED CLASS A PREFERRED SUPER MAJORITY VOTING CONVERTIBLE STOCK, WHICH HAVING VOTING RIGHTS OF 60% TO OUR COMMON STOCK AT ALL TIMES.

Class A Preferred Super Majority Voting Convertible Stock (the “Class A Preferred”) of which 500,000 shares of preferred stock have been authorized for the class.and outstanding. The Class A Preferred are toConvertible Stock have 60% super majority voting rights over our common stock voting 60% at all times.stock. At this time, all shares of the Class A Preferred have beenConvertible Stock are issued to W. Edward Nichols,our CEO, Jaspreet Mathur. Therefore, at all times, our CEO will have voting control over all decisions requiring majority vote or consent.

Jaspreet Mathur, our Chief Executive Officer, owns greater than 50% of our voting securities which will cause us to be deemed a “controlled company” under the rules of NYSE American.

As a result of his ownership of all issued and outstanding shares of our Class A Preferred Convertible Stock, as well as ownership of our Common Stock, Mr. Mathur, our Chief Executive Officer currently holds approximately 87% of our voting securities (and will continue to own at least 60% of our voting stock at all times, including after our offering), and as such, we are a “controlled company” under the NYSE Rules. Under these rules, a company of which more than 50% of the voting power is held by an individual, a group, or another company is a “controlled company” and, as such, may elect to be exempt from certain corporate governance requirements.

Accordingly, should the interests of Mr. Mathur differ from those of other shareholders, the other shareholders may not have the same protections afforded to shareholders of companies that are subject to all of the NYSE American corporate governance standards. Even if we do not avail ourselves of these exemptions, our status as a controlled company could make our common stock less attractive to some investors or otherwise harm our stock price.

Because insiders control our activities, that may cause us to act us in a manner that is most beneficial to them and not to outside shareholder which could cause us not to take actions that outside shareholders might view favorably.

Our officers, directors, and holders of 5% or more of our issued and outstanding common stock beneficially own approximately 77.2% of our issued and outstanding common stock and our CEO owns all of the Class A Preferred Convertible Stock. As a result, insiders and particularly our CEO effectively control all matters requiring shareholder approval, including the election of directors, the approval of significant corporate transactions, such as mergers and related party transaction. These insiders also have the ability to delay or perhaps even block, by their ownership of our stock, an unsolicited tender offer. This concentration of ownership could have the effect of delaying, deterring or preventing a change in control that you might view favorably.

19

Our officers and directors have the ability to effectively control substantially all actions taken by shareholders.

Mr. Mathur, our CEO and a director of the Company controls over 50% of our issued and outstanding common stock including the vote of the Class A Preferred Convertible Stock, and therefore he effectively controls substantially all actions taken by our shareholders, including the election of directors and approval of significant corporate transactions. Such concentration of ownership could also have the effect of delaying, deterring, or preventing a change in control that might otherwise be beneficial to shareholders and may also discourage the market for our stock due to the concentration.

We are dependent upon our management, founders, key personnel, and consultants to execute our business plan, and many of them have concurrent responsibilities at other companies.

Our success is heavily dependent upon the continued active participation of our current executive officers as well as other key personnel and consultants. Many of them have concurrent responsibilities at other entities. Some of the advisors and consultants, and others to whom our ultimate success may be reliant have not signed contracts with us and may not ever do so. Loss of the services of one or more of these individuals could have a material adverse effect upon our business, financial condition, or results of operations. Further, our success and achievement of our growth plans depend on our ability to recruit, hire, train, and retain other highly qualified personnel. Competition for qualified employees and consultants among companies in the applicable industries is intense, and the loss of any of such persons, or an inability to attract, retain, and motivate any additional highly skilled employees and consultants required for the initiation and expansion of our activities, could have a materially adverse effect on it.

We do not have any key person life insurance policies on any of our officers or employees.

We are dependent upon officers and key employees to conduct our operations and execute our business plan. However, we have not purchased any life insurance policies for any individuals in the event of their death or disability. Therefore, should any of those officers and key employees die or become disabled, we will not receive any compensation that would assist with such person’s absence. The loss of such person could negatively affect us and our operations.

There are limitations on the liability of our directors.

Delaware General Corporation Laws exclude personal liability of our directors and our shareholders for monetary damages for breach of fiduciary duty except in certain specified circumstances. Accordingly, we will have a much more limited right of action against our directors than otherwise would be the M.A. Littman Defined Benefit Plan.case. This provision does not affect the liability of any director under federal or applicable state securities laws. Our charter documents also provide for the indemnification of directors to the fullest extent permitted by law and, to the extent permitted by such law, eliminate or limit the personal liability of directors for monetary damages for certain breaches of fiduciary duty. Such indemnification may be available for liabilities arising in connection with this prospectus. Insofar as indemnification for liabilities arising under the Act may be permitted to directors, officers, or persons controlling the Company pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Act and is therefore unenforceable.

We have agreed to indemnification of officers and directors as is allowed by Delaware General Corporation Law.

Delaware General Corporation Law provides for the indemnification of our directors, officers, employees, and agents, under certain circumstances, against attorney’s fees and other expenses incurred by them in any litigation to which they become a party arising from their association with us or activities our behalf. We will also bear the expenses of such litigation for any of our directors, officers, employees, or agents, upon such person’s promise to repay us therefore if it is ultimately determined that any such person shall not have been entitled to indemnification. This indemnification policy could result in substantial expenditures by us that we will be unable to recoup.

20
Table of Contents

 

OUR OFFICERS AND DIRECTORS MAY HAVE CONFLICTS OF INTERESTS AS TO CORPORATE OPPORTUNITIES WHICH WE MAY NOT BE ABLE OR ALLOWED TO PARTICIPATE IN AND MAY RECEIVE COMPENSATION FROM OUR PARENT COMPANY.

Our officers and directors may have conflicts of interests as to corporate opportunities which we may not be able or allowed to participate in.

Presently there is no requirement contained in our Articles of Incorporation, Bylaws,charter documents or minutes which requires officers and directors of our business to disclose to us business opportunities which come to their attention. Our officers and directors do, however, have a fiduciary duty of loyalty to us to disclose to us any business opportunities which come to their attention, in their capacity as an officer and/or director or otherwise. Excluded from this duty would be opportunities which the person learns about through his involvement as an officer and director of another company. We have no intention of merging with or acquiring a business opportunity from any affiliate or officer or director. Our current officersSee Certain Relationships and directors also currently serve other companiesRelated Party Transactions.”

Risks Related to this Offering and as such may present conflicts due to lack of full-time attention to the Company. We intend to diversify and/or expand our Board of Directors in the future.

NoneOwnership of our OfficersSecurities

An investment in our securities is speculative and Directors has any interest in any competitive business to ours or any service provider to our Company. The other businesses in which our officers and directors now participate have no relation to our business, do not compete with our business and do not supply services, materials, or technology to our business. We see the primary conflict as one of necessary time devoted to the Company business and internal controls and procedures for accounting for our quarterly and annual reports under Section 13(a) of the Securities Exchange Act of 1934, which must be filed timely under the section and quarterly reviews and annual audits by our auditors which require adequate record keeping.

WE HAVE AGREED TO INDEMNIFICATION OF OFFICERS AND DIRECTORS AS IS PROVIDED BY DELAWARE STATUTES.

Delaware General Corporation Laws provide for the indemnification of our directors, officers, employees, and agents, under certain circumstances, against attorney’s fees and other expenses incurred by them in any litigation to which they become a party arising from their association with or activities our behalf. We will also bear the expenses of such litigation for any of our directors, officers, employees, or agents, upon such person’s promise to repay us therefore if it is ultimately determined that any such person shall not have been entitled to indemnification. This indemnification policy could result in substantial expenditures by us that we will be unable to recoup.a loss of your entire investment.

OUR DIRECTORS’ LIABILITY TO US AND STOCKHOLDERS IS LIMITED

Delaware General Corporation Laws exclude personal liability of our directors and our stockholders for monetary damages for breach of fiduciary duty except in certain specified circumstances. Accordingly, we will have a much more limited right of action against our directors that otherwise would be the case. This provision does not affect the liability of any director under federal or applicable state securities laws.

We have no full-time employees which may impede our ability to carry on our business. Our officers are independent consultants who devote up to 10 hours per week to Company business. The lack of full-time employees may very well prevent the Company’s operations from being efficient, and may impair the business progress and growth, which is a risk to any investor.

REPORTING REQUIREMENTS UNDER THE EXCHANGE ACT AND COMPLIANCE WITH THE SARBANES-OXLEY ACT OF 2002, INCLUDING ESTABLISHING AND MAINTAINING ACCEPTABLE INTERNAL CONTROLS OVER FINANCIAL REPORTING, ARE COSTLY AND MAY INCREASE SUBSTANTIALLY.

The rules and regulations of the SEC require a public company to prepare and file periodic reports under the Exchange Act, which will require that the Company engage legal, accounting, auditing and other professional services. The engagement of such services is costly. Additionally, the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) requires, among other things, that we design, implement and maintain adequate internal controls and procedures over financial reporting. The costs of complying with the Sarbanes-Oxley Act and the limited technically qualified personnel we have may make it difficult for us to design, implement and maintain adequate internal controls over financial reporting. In the event that we fail to maintain an effective system of internal controls or discover material weaknessesAn investment in our internal controls, we may not be able to produce reliable financial reports or report fraud, which may harm our overall financial conditionsecurities is speculative and result in lossinvolves a high degree of investor confidence and a decline in our share price.

As a public company, we will be subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act, the Dodd-Frank Act of 2010 and other applicable securities rules and regulations. Despite recent reforms made possible by the JOBS Act, compliance with these rules and regulations will nonetheless increase our legal and financial compliance costs, make some activities more difficult, time-consuming or costly and increase demand on our systems and resources, particularly after we are no longer an “emerging growth company.” The Exchange Act requires, among other things, that we file annual, quarterly, and current reports with respect to our business and operating results.

Table of Contents

We are working with our legal, accounting and financial advisors to identify those areas in which changes should be made to our financial and management control systems to manage our growth and our obligations as a public company. These areas include corporate governance, corporate control, disclosure controls and procedures and financial reporting and accounting systems. We have made, and will continue to make, changes in these and other areas. However, we anticipate that the expenses that will be required in order to adequately prepare for being a public company could be material. We estimate that the aggregate cost of increased legal services; accounting and audit functions; personnel, such as a chief financial officer familiar with the obligations of public company reporting; consultants to design and implement internal controls; and financial printing alone will be a few hundred thousand dollars per year and could be several hundred thousand dollars per year. In addition, if and when we retain independent directors and/or additional members of senior management, we may incur additional expenses related to director compensation and/or premiums for directors’ and officers’ liability insurance, the costs of which we cannot estimate at this time. We may also incur additional expenses associated with investor relations and similar functions, the cost of which we also cannot estimate at this time. However, these additional expenses individually, or in the aggregate, may also be material.

In addition, being a public company could make it more difficult or more costly for us to obtain certain types of insurance, including directors’ and officers’ liability insurance, and we may be forced to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. The impact of these events could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees or as executive officers.

The increased costs associated with operating as a public company may decrease our net income or increase our net loss and may cause us to reduce costs in other areas of our business or increase the prices of our products or services to offset the effect of such increased costs. Additionally, if these requirements divert our management’s attention from other business concerns, they could have a material adverse effect on our business, financial condition and results of operations.

COMPETITION FROM SIMILAR SERVICE PROVIDERS.

We expect to encounter competition from other entities having similar business objectives, some of whom may have greater resources than us. Virtually all of our competitors will have a competitive advantage and are much larger. The need to compete for investment opportunities may make it necessary for us to offer clients attractive transaction terms than otherwise might be the case. We anticipate being a co-investor with other venture capital groups, and these relationships with other groups may expand our access to business opportunities.

WE HAVE INCURRED SIGNIFICANT LOSSES AND ANTICIPATE FUTURE LOSSES.

As of June 30, 2020, we had an accumulated deficit of $(35,319,671) and as of December 31, 2019, we had an accumulated deficit of $(35,168,060).

As a result of these, among other factors, we received from our registered independent public accountants in their report of the financial statements as of and for the period July 1, 2019 (Inception) through December 31, 2019, an explanatory paragraph stating that thererisk. There is substantial doubt about our ability to continue as a going concern.

OUR EXISTING FINANCIAL RESOURCES ARE INSUFFICIENT TO MEET OUR ONGOING OPERATING EXPENSES.

We have no sources of income at this time and insufficient assets to meet our ongoing operating expenses. In the short term, unless we are able to raise additional debt and/or equity, we shall be unable to meet our ongoing operating expenses. However, as noted elsewhere in the registration statement, we were able to sell equity in our Company during the second quarter of 2020 and receive proceeds in the amount of $262,000. On a longer-term basis, we may seek to merge with another entity with experienced management and opportunities for growth in return for shares of our common stock to create value for our shareholders. There can be no assurance that these eventsinvestors will be successfully completed.obtain any return on their investment. You should not purchase the securities if you cannot afford the loss of your entire investment.

BECAUSE INSIDERS CONTROL OUR ACTIVITIES, THAT MAY CAUSE US TO ACT IN A MANNER THAT IS MOST BENEFICIAL TO THEM AND NOT TO OUTSIDE SHAREHOLDERS WHICH COULD CAUSE US NOT TO TAKE ACTIONS THAT OUTSIDE INVESTORS MIGHT VIEW FAVORABLY

Our officers, directors, and holdersWe may in the future issue more shares of 5% or more of our issued and outstanding common stock beneficially own approximately 48%which could cause a loss of our issued and outstanding common stock and the Super Majority Voting Class A Preferred Stock votes 60% at all times until redeemed. As a result, they effectively control all matters requiring director and stockholder approval, including the election of directors, the approval of significant corporate transactions, such as mergers and related party transaction. These insiders also have the ability to delay

Table of Contents

or perhaps even block, by their ownership of our stock, an unsolicited tender offer. This concentration of ownership could have the effect of delaying, deterring or preventing a change in control of our Company that you might view favorably.

OUR TWO OFFICERS AND FOUR DIRECTORS HAVE THE ABILITY TO EFFECTIVELY CONTROL SUBSTANTIALLY ALL ACTIONS TAKEN BY STOCKHOLDERS.

Mr. Nichols and Mr. Avey, the officers, and Mr. Nichols, Mr. Avey, Mr. Smiley, Sr. and Mr. Ostler, directors of the Company control in excess of 5.00% of our issued and outstanding common stock and with the Class A Super Majority voting stock (held by Mr. Nichols, officer and director) are able to effectively control substantially all actions taken by our stockholders, including the election of directors. Such concentration of ownership could also have the effect of delaying, deterring or preventing a change in control that might otherwise be beneficial to stockholderspresent management and may also discourage the market for our stock due to the concentration.current shareholders.

WE MAY DEPEND UPON OUTSIDE ADVISORS, WHO MAY NOT BE AVAILABLE ON REASONABLE TERMS AND AS NEEDED.

To supplement the business experience of our officers and directors, we may be required to employ accountants, technical experts, appraisers, attorneys, or other consultants or advisors. Our Board without any input from stockholders will make the selection of any such advisors. Furthermore, it is anticipated that such persons may be engaged on an "as needed" basis without a continuing fiduciary or other obligation to us. In the event we consider it necessary to hire outside advisors, we may elect to hire persons who are affiliates, if they are able to provide the required services.

THE INABILITY OF OUR COMPANY TO ADEQUATELY EXECUTE OUR GROWTH OR EXPANSION STRATEGIES WOULD HAVE A NEGATIVE IMPACT ON OUR COMPANY VALUE.

The possibility that our Company will not be able to fully carry out or execute on its expansion or growth plans presents significant risk. Our success will ultimately depend on the success of our marketing. If our intended expansion or growth plan does not come to fruition or is otherwise impeded, or is unprofitable, we may not be able to stay in business or have any value.

 RISK FACTORS RELATED TO OUR STOCK

WE CAN GIVE NO ASSURANCE OF SUCCESS OR PROFITABILITY TO OUR INVESTORS.

Cash flows generated from operating activities were not enough to support all working capital requirements for the six months ended June 30, 2020 and the period July 1, 2019 (Inception) through December 31, 2019. Financing activities described below, have helped with working capital and other capital requirements. We incurred $(151,601) and $(1,909,107), respectively, in losses, and we used $123,896 and $25,000, respectively, in cash for operations for the six months ended June 30, 2020 and the period July 1, 2019 (Inception) through December 31, 2019, Cash flows from financing activities were $280,305 and $25,000, respectively for the same periods. These factors cause substantial doubt about our ability to continue as a going concern for a period of one year from the issuance of these financial statements.

In order for us to continue as a going concern, we will need to obtain additional debt or equity financing and look for companies with cash flow positive operations that we can acquire. There can be no assurance that we will be able to secure additional debt or equity financing, that we will be able to acquire cash flow positive operations, or that, if we are successful in any of those actions, those actions will produce adequate cash flow to enable us to meet all our future obligations. Most of our existing financing arrangements are short-term. If we are unable to obtain additional debt or equity financing, we may be required to significantly reduce or cease operations.

Our sources of capital are loans and sales of equity from common or preferred stock. We have no commitments for loans or equity sales at this date.

WE MAY IN THE FUTURE ISSUE MORE SHARES OF COMMON STOCK WHICH COULD CAUSE A LOSS OF CONTROL BY OUR PRESENT MANAGEMENT AND CURRENT STOCKHOLDERS.

We may issue further shares as consideration for the cash or assets or services out of our authorized but unissued common stock that would, upon issuance, represent a majority of theour voting power and equity of our Company.equity. The result of such an issuance would be those new stockholdersshareholders and management would have control our Company,of us, and persons unknown could replace our management at this time. Such an occurrence would result in a greatly reduced percentage of ownership of our Company by our current shareholders, which could present significant risks to investors.investors.

21
Table of Contents

WE CAN ISSUE FUTURE SERIES OF SHARES OF PREFERRED STOCK WITHOUT SHAREHOLDER APPROVAL, WHICH COULD ADVERSELY AFFECT THE RIGHTS OF COMMON SHAREHOLDERS.

 

We can issue future series of shares of preferred stock without shareholder approval, which could adversely affect the rights of common shareholders.

Our ArticlesCertificate of Incorporation, permitas amended, permits our Boardboard of Directorsdirectors to establish the rights, privileges, preferences, and restrictions, including voting rights, of future series of preferred stock and to issue such stock without approval from our shareholders. The rights of holders of common stock may suffer as a result of the rights granted to holders of preferred stock that may be issued in the future. In addition, we could issue preferred stock to prevent a change in control, of our Company, depriving common shareholders of an opportunity to sell their stock at a price in excess of the prevailing market price.

OUR OFFICERS AND DIRECTORS MAY HAVE CONFLICTS OF INTERESTS AS TO CORPORATE OPPORTUNITIES WHICH WE MAY NOT BE ABLE OR ALLOWED TO PARTICIPATE IN.Terms of subsequent financing, if any, may adversely impact your investment.

Presently there is no requirement containedWe may have to engage in common equity, debt, or preferred stock financings in the future. Your rights and the value of your investment in our Articles of Incorporation, Bylaws,common stock could be reduced by the dilution caused by future equity issuances, or minutes which requires officers and directorsconvertible debt issuances with conversion rates below the then fair market value of our businessstock at the time of conversion. Interest plus potential amortization of debt issuance costs on debt securities could increase costs and negatively impact operating results. As we are permitted to discloseissue preferred stock pursuant to us business opportunities which comethe terms of our governing documents, preferred stock could be issued in series from time to their attention. Our officerstime with such designation, rights, preferences, and directors do, however,limitations as needed to raise capital. The terms of preferred stock could be more advantageous to those investors than to the holders of our common stock.

We have a fiduciary dutybroad discretion in the use of loyalty to us to disclose to us any business opportunities which come to their attention, in their capacity as an officer and/or director or otherwise. Excludedthe net proceeds from this duty would be opportunities whichoffering and may not use them effectively.

Our management will have broad discretion in the person learns about through his involvement as an officer and directorapplication of another company. We have no intention of merging with or acquiring business opportunity from any affiliate or officer or director. (See “Conflicts of Interest” at page 38 )

WE HAVE AGREED TO INDEMNIFICATION OF OFFICERS AND DIRECTORS AS IS PROVIDED BY DELAWARE GENERAL CORPORATION LAW

Delaware General Corporation Laws provide for the indemnification of our directors, officers, employees, and agents, under certain circumstances, against attorney’s fees and other expenses incurred by them in any litigation to which they become a party arising from their association with or activities our behalf. We will also bear the expenses of such litigationnet proceeds, including for any of the purposes described in the section of this prospectus entitled “Use of Proceeds.” You will be relying on the judgment of our directors, officers, employees,management with regard to the use of these net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the net proceeds are being used appropriately. The failure by our management to apply these funds effectively could result in financial losses that could have a material adverse effect on our business, cause the price of our securities to decline and delay the development of our product candidates. Pending the application of these funds, we may invest the net proceeds from this offering in a manner that does not produce income or agents,that loses value.

If we are unable to implement and maintain effective internal control over financial reporting, investors may lose confidence in the accuracy and completeness of our financial reports, which could adversely affect the market price of our common stock.

We have identified material weaknesses in our internal control over financial reporting. These material weaknesses relate to the fact that we do not maintain a comprehensive policies and procedures manual designed to establish internal controls over financial reporting to reduce the risk of publishing materially misstated financial statements, as well as define responsibilities and segregate incompatible duties to reduce the risk of unauthorized transactions.

22

As a public company, we are required to maintain internal control over financial reporting and to report any material weaknesses in such internal controls. A material weakness is defined in the standards established by the Public Company Accounting Oversight Board (United States) as a deficiency, or an acquisition of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. The process of designing, implementing and testing the internal control over financial reporting required to comply with this obligation is time consuming, costly, and complex. If we fail to increase and maintain the number and expertise of our staff for our accounting and finance functions and to improve and maintain internal control over financial reporting adequate to meet the demand upon such person’s promiseus as a public company, including the requirements of the Sarbanes-Oxley Act, we may be unable to repay us therefore if it is ultimately determinedreport our financial results accurately and prevent fraud. In addition, we cannot be certain that any such person shallsteps we undertake will successfully remediate any material weaknesses or that other material weaknesses and control deficiencies will not have been entitled to indemnification. This indemnification policy could resultbe discovered in substantial expenditures by us thatthe future. If our remediation efforts are not successful or other material weaknesses or control deficiencies occur in the future, we willmay be unable to recoup.

OUR DIRECTORS’ LIABILITY TO US AND SHAREHOLDERS IS LIMITED.

Delaware General Corporation Laws exclude personal liabilityreport our financial results accurately or on a timely basis, which could cause our reported financial results to be materially misstated and result in the loss of investor confidence or delisting and cause our stock price to decline. As a result of such failures, we could also become subject to investigations by any over the counter market where our stock may trade, the SEC, or other regulatory authorities, and become subject to litigation from investors and shareholders, any of which could harm our reputation and financial condition, and divert financial and management resources. Even if we are able to report our consolidated financial statements accurately and timely, if we do not make all the necessary improvements to address the material weaknesses, continued disclosure of our directorsmaterial weaknesses will be required in future filings with the SEC, which could reduce investor confidence in our reported results and our stockholders for monetary damages for breachcause our stock price to decline.

Our stock price may be volatile and you could lose all or part of fiduciary duty except in certain specified circumstances. Accordingly, we will have a much more limited right of action against our directors than otherwise would be the case. This provision does not affect the liability of any director under federal or applicable state securities laws.your investment.

OUR STOCK PRICES IN THE MARKET MAY BE VOLATILE.

The valuetrading price of our Commoncommon stock following this offering is likely to be volatile, may fluctuate substantially, and may be highly volatile and couldhigher or lower than the public offering price. Our common stock may also be subject to fluctuationsrapid and substantial price volatility. There have been recent instances of extreme stock price run-ups followed by rapid price declines following initial public offerings, with stock price volatility seemingly unrelated to company performance, particularly among companies with relatively smaller public floats, and we expect that such instances may continue and/or increase in the future. Contributing to this risk of volatility are a number of factors. First, our shares of common stock are likely to be more sporadically and thinly traded than that of larger, more established companies. As a consequence of this lack of liquidity, the trade of relatively small quantities of shares by our shareholders may disproportionately influence the price of those shares in either direction. The price of our common stock could, for example, decline precipitously in the event that a large number of our shares are sold on the market without commensurate demand as compared to a seasoned issuer that could better absorb those sales without adverse impact on its stock price. Second, we are a speculative investment due to our limited operating history, not being profitable, and engaging in a new business strategy with no guarantee of its success. As a consequence of this enhanced risk, more risk-adverse investors may, under the fear of losing all or most of their investment in the event of negative news or lack of progress, be more inclined to sell their shares on the market more quickly and at greater discounts than would be the case with the stock of a larger, more established company that has a relatively large public float.

In addition, the market price of our common stock is also subject to significant fluctuations in response to, various factors, some of which are beyond our control. These factors include:among other factors:

quarterly variations in our results of operations or those of our competitors;
announcements by us or our competitors of acquisitions, new products, significant contracts, commercial relationships or capital commitments;
disruption to our operations or those of other sources critical to our operations;
the emergence of new competitors or new technologies;products;
our ability to develop and market new and enhanced products on a timely basis;
seasonal or other variations in our subscriber base;
commencement of, or our involvement in, litigation;

23

availability of additional spectrum;
dilutive issuances of our stock or the stock of our subsidiaries, or the incurrence of additional debt;
changes in our board or management;
adoption of new or different accounting standards;
changes in governmental regulations or in the status of our regulatory approvals;
changes in earnings estimates or recommendations by securities analysts; and
general economic conditions and slow or negative growth of related markets.
10 
Table of Contents

In addition,Many of these factors are beyond our control and may decrease the market price of our common stock. Such volatility, including any stock run-ups, may be unrelated or disproportionate to our actual or expected operating performance and financial condition or prospects, making it difficult for prospective investors to assess the rapidly changing value of our common stock.

Furthermore, the stock market in general, and the market for shares of event companies in particular, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies. We expectBroad market and industry factors, as well as general economic, political and market conditions such as recessions or interest rate changes, may seriously affect the valuemarket price of our common stock, willregardless of our actual operating performance. These fluctuations may be subject to such fluctuations.

WE MAY NOT BE ABLE TO SUCCESSFULLY IMPLEMENT OUR BUSINESS STRATEGY WITHOUT SUBSTANTIAL ADDITIONAL CAPITAL. ANY SUCH FAILURE MAY ADVERSELY AFFECT THE BUSINESS AND RESULTS OF OPERATIONS.

Unless we can generate revenues sufficient to implement our business plan, we will need to obtain additional financing through debt or bank financing, or through the sale of shareholder interests to execute our business plan. We expect to need $1,000,000even more pronounced in the next twelve months in capital or loans to expandtrading market for our plans and operations. Westock shortly following this offering. If the market price of our common stock after this offering does not exceed the per share public offering price, you may not be able to obtain this financing at all. We have not sought commitments for this financing,realize any return on your investment in us and we have no terms for either debtmay lose some or equity financing, and we realize that it may be difficult to obtain on favorable terms. Moreover, if we issue additional equity securities to support our operations, Investor holdings may be diluted. Our business plans are at risk if we cannot continually achieve additional capital raising to complete our plans.all of your investment.

WE MAY BE UNABLE TO COMPETE WITH LARGER, MORE ESTABLISHED COMPETITORS.

The market for providing large screen display and advertising services is competitive. We expect competition to intensifyFurther, in the future. Manypast, following periods of volatility in the overall market and the market prices of particular companies’ securities, securities class action litigations have often been instituted against these companies. Litigation of this type, if instituted against us, could result in substantial costs and a diversion of our potential competitors have longer operating histories, larger customer bases, greater recognitionmanagement’s attention and significantly greater resources. As a result, competitors may be ableAny adverse determination in any such litigation or any amounts paid to respond more quickly to emerging technologies, trends, and changes in customer requirements than we can. The continuous and timely introduction of competitively priced services offerings into the market is critical to our success, and there can be no assurancesettle any such actual or threatened litigation could require that we will be able to introduce such services offerings. We may not be able to compete successfully against competitors, and the competitive pressures we face may have an adverse effect on our business.make significant payments.

A LIMITED PUBLIC MARKET EXISTS FOR OUR COMMON STOCK AT THIS TIME, AND THERE IS NO ASSURANCE OF A FUTURE MARKET.

There ishas been a limited public market for our common stock and there is no assurance that a more active trading market will develop for our common stock and, as a result, it may be difficult for you to sell your shares of our common stock.

There has been a limited public market for shares of our common stock on the OTCQB. We do not yet meet the initial listing standards of the NYSE American, and, although we intend to apply to list our common stock on the NYSE American, no assurances can be given that a market will continue or that a shareholder everwe will be ablesuccessful. Until our common stock is listed on a stock exchange, we anticipate that it will remain quoted on the OTCQB. In that venue, investors may find it difficult to liquidate his investment without considerable delay,obtain accurate quotations as to the market value of our common stock. In addition, if at all.we fail to meet the criteria set forth in SEC regulations, various requirements would be imposed by law on broker-dealers who sell our securities to persons other than established customers and accredited investors. Consequently, such regulations may deter broker-dealers from recommending or selling our common stock, which may further affect liquidity. This could also make it more difficult to raise additional capital.

We cannot predict the extent to which investor interest in our Company will lead to the development of a more active trading market on the OTCQB, whether we can maintain the trading market for our common stock on the OTCQB, whether we will meet the initial listing standards of the NYSE American, or how liquid that market might become. If aan active trading market should continue, the price may be highly volatile. Factors such as those discussed in the “Risk Factors” sectiondoes not develop, you may have a significant impact upon the market pricedifficulty selling any of the shares offered hereby. Due to the low price of our securities, many brokerage firmscommon stock that you buy.

24

Our stock will, in all likelihood, be thinly traded and as a result you may not be willingunable to effect transactions in our securities. Evensell at or near ask prices or at all if a purchaser finds a broker willingyou need to affect a transaction in our shares, the combination of brokerage commissions, state transfer taxes, if any, and any other selling costs may exceed the selling price. Further, many lending institutions will not permit the use of our shares as collateral for any loans.liquidate your shares.

OUR STOCK WILL, IN ALL LIKELIHOOD, BE THINLY TRADED AND AS A RESULT YOU MAY BE UNABLE TO SELL AT OR NEAR ASK PRICES OR AT ALL IF YOU NEED TO LIQUIDATE YOUR SHARES.

The shares of our common stock may beare thinly-traded. We are a small Companycompany which is relatively unknown to stock analysts, stock brokers,stockbrokers, institutional stockholdersshareholders, and others in the investment community that generate or influence sales volume, and that even if we came to the attention of such persons, they tend to be risk-averse and would be reluctant to follow an unproven, early stage Companycompany such as ours or purchase or recommend the purchase of any of our securities until such time as we became more seasoned and viable. As a consequence, there may be periods of several days or more when trading activity in our securities is minimal or non-existent, as compared to a seasoned issuer which has a large and steady volume of trading activity that will generally support continuous sales without an adverse effect on Securities price.securities prices. We cannot give you any assurance that a broader or more active public trading market for our common securities will develop or be sustained, or that any trading levels will be sustained. Due to these conditions, we can give stockholdersshareholders no assurance that they will be able to sell their shares at or near ask prices or at all if they need money or otherwise desire to liquidate their securities.

THE REGULATION OF PENNY STOCKS BYOur securities are considered a penny stock, and therefore are subject to the penny stock rules, as such, U.S. broker-dealers may be discouraged from effecting transactions in our securities.

Our securities are subject to the penny stock rules under the Exchange Act. The SEC AND FINRA MAY DISCOURAGE THE TRADABILITY OF OUR SECURITIES.

We arerules define a “penny stock” company. Nonestock,” as any equity security that has a market price of our securities currently trade in any market and, if ever available for trading, will beless than $5.00 per share or with an exercise price of less than $5.00 per share, subject to certain exceptions. For any transaction involving a Securitiespenny stock, unless exempt, Rule 15g-9 requires broker-dealers that derive more than 5% of their customer transaction revenues from transactions in penny stocks to deliver a standardized risk disclosure document that provides information about penny stocks, and Exchange Commission rule that imposes special sales practice requirements upon broker-dealers who sell such securitiesthe nature and level of risks in the penny stock market, to persons other than established customers or accredited investors. For purposesany non-institutional customer to whom the broker-dealer recommends a penny stock transaction. The broker-dealer must also provide the customer with the current bid and offer quotations for the penny stock, the compensation of the rule,broker-dealer and its salesperson and monthly account statements showing the phrase “accredited investors” means,market value of each penny stock held in general terms, institutionsthe customer’s account. The bid and offer quotations and the broker-dealer and salesperson compensation information must be given to the customer orally or in writing before completing the transaction and must be given to the customer in writing before or with assets in excess of $5,000,000, the customer’s confirmation. In addition, the penny stock rules require that before a transaction, the broker and/or individuals having a net worth in excess of $1,000,000 or having an annual income that exceeds $200,000 (or that, when combined with a spouse’s income, exceeds $300,000). For transactions

11 
Table of Contents

covered by the rule, the broker-dealerdealer must make a special suitabilitywritten determination that the penny stock is a suitable investment for the purchaser and receive the purchaser’s written agreement to the transaction. The transaction priorcosts associated with penny stocks are high, reducing the number of broker-dealers who may be willing to engage in the trading of our securities. These additional penny stock disclosure requirements are burdensome and may reduce all the trading activity in the market for our securities. As long as our securities are subject to the sale. Effectively, this discourages broker-dealers from executing trades in penny stocks. Consequently, the rule will affect the abilitystock rules, holders of purchasers in this offeringour securities may find it more difficult to sell their securities in any market that might develop therefore because it imposes additional regulatory burdens on penny stock transactions.

In addition, the Securities and Exchange Commission has adoptedcause a number of rules to regulate “penny stocks". Such rules include Rules 3a51-1, 15g-1, 15g-2, 15g-3, 15g-4, 15g-5, 15g-6, 15g-7, and 15g-9 under the Securities and Exchange Act of 1934, as amended. Because our securities constitute “penny stocks” within the meaning of the rules, the rules would apply to us and to our securities. The rules will further affect the ability of owners of shares to sell our securities in any market that might develop for them because it imposes additional regulatory burdens on penny stock transactions.

Shareholders should be aware that, according to Securities and Exchange Commission, the market for penny stocks has suffered in recent years from patterns of fraud and abuse. Such patterns include (i) control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (ii) manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases; (iii) “boiler room” practices involving high-pressure sales tactics and unrealistic price projections by inexperienced sales persons; (iv) excessive and undisclosed bid-ask differentials and markups by selling broker-dealers; and (v) the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired consequent investor losses. Our management is aware of the abuses that have occurred historically in the penny stock market. Although we do not expect to be in a position to dictate the behavior of the market or of broker-dealers who participatedecline in the market management will strive within the confinesvalue of practical limitations to prevent the described patterns from being established with respect to our securities.stock.

Inventory in penny stocks have limited remediesRule 144 sales in the event of violations of penny stock rules. While the courts are always available to seek remedies for fraud against us, most, if not all, brokerages require their customers to sign mandatory arbitration agreements in conjunctions with opening trading accounts. Such arbitrationfuture may be through an independent arbiter. Investors may filehave a complaint with FINRA against the broker allegedly at fault, and FINRA may be the arbiter, under FINRA rules. Arbitration rules generally limit discovery and provide more expedient adjudication, but also provide limited remedies in damages usually only the actual economic loss in the account. Investors should understand that if a fraud case is filed against a company in the courts it may be vigorously defended and may take years and great legal expenses and costs to pursue, which may not be economically feasible for small investors.

That absent arbitration agreements, specific legal remedies available to investors of penny stocks include the following:

If a penny stock is sold to the investor in violation of the requirements listed above, or other federal or states securities laws, the investor may be able to cancel the purchase and receive a refund of the investment.

If a penny stock is sold to the investor in a fraudulent manner, the investor may be able to sue the persons and firms that committed the fraud for damages.

The fact that we are a penny stock company will cause many brokers to refuse to handle transactions in the stocks, and may discourage trading activity and volume, or result in wide disparities between bid and ask prices. These may cause investors significant illiquidity of the stock at a price at which they may wish to sell or in the opportunity to complete a sale. Investors will have no effective legal remedies for these illiquidity issues.

WE WILL PAY NO DIVIDENDS IN THE FORESEEABLE FUTURE.

We have not paid dividendsdepressive effect on our common stock and do not anticipate paying such dividends in the foreseeable future.price.

RULE 144 SALES IN THE FUTURE MAY HAVE A DEPRESSIVE EFFECT ON OUR STOCK PRICE.

All of the outstanding shares of common stock held by our present officers, directors, and affiliate stockholdersshareholders are “restricted securities” within the meaning of Rule 144 under the Securities Act of 1933, as amended.Act. As restricted Shares,securities, these shares may be resold only pursuant to an effective registration statement or under the requirements of Rule 144 or other applicable exemptions from registration under the Act and as required under applicable state securities laws. Rule 144 provides in essence that a person who has held restricted securities for six months, under certain conditions, sell every three months, in brokerage transactions, a number of shares that does not exceed the greater of 1.0% of a company’s outstanding common stock or the average weekly trading volume during the four calendar weeks prior to the sale. There is no limit on the amount of restricted securities that may be sold by a non-affiliate after the owner has held the restricted securities for a period of six months. A sale under Rule 144 or under any other exemption from the Act, if available, or pursuant to subsequent registration of shares of common stock of present stockholders,shareholders, may have a depressive effect upon the price of the common stock in any market that may develop.

12 25
Table of Contents

ANY SALES OF OUR COMMON STOCK, IF IN SIGNIFICANT AMOUNTS, ARE LIKELY TO DEPRESS THE FUTURE MARKET PRICE OF OUR SECURITIES.

 

Assuming all

Our shareholders may suffer future dilution due to issuances of shares for our convertible securities and various considerations in the future.

We currently have outstanding notes with the aggregate original principal amount of $9,675,000 with a 6% per annum interest rate, a maturity date of one year from issuance. The notes are convertible into shares of our common stock at any time at the option of the holders. Upon conversion of the notes and the potential issuance of 10,349,097 shares of common stock, held bythere will be substantial dilution of the selling security holders registered hereby are sold, we would have 9,690,999 new shares that are freely tradable and therefor available for sale, in market or private transactions.

Unrestricted sales of 9,690,999 shares of stock by our selling stockholders could have a huge negative impact on our share price, and the market for our shares.

OUR STOCKHOLDERS MAY SUFFER FUTURE DILUTION DUE TO ISSUANCES OF SHARES FOR VARIOUS CONSIDERATIONS IN THE FUTURE.

current shareholders. There may also be substantial dilution to Bio Lab Naturals, Inc. stockholdersour shareholders as a result of future decisions of the Boardboard of directors to issue shares without shareholder approval for cash, services, or acquisitions.

ANY NEW POTENTIAL INVESTORS WILL SUFFER A DISPROPORTIONATE RISK AND THERE WILL BE IMMEDIATE DILUTION OF EXISTING INVESTOR’S INVESTMENTS.

Our present shareholders have acquired their securities at a cost significantly less than that which the investors purchasing pursuant toIf you purchase our shares will pay for their stock holdings or at which future purchasersof Common Stock in this offering, you may incur immediate and substantial dilution in the marketbook value of your shares.

The public offering price per share of our Common Stock may pay. Therefore, any new potential investors will bear mostbe substantially higher than the net tangible book value per share of the risk of loss.

COVID-19 EFFECTS ON THE ECONOMY MAY NEGATIVELY AFFECT OUR COMPANY BUSINESS.

In December 2019, COVID-19 emerged and has subsequently spread worldwide. The World Health Organization has declared COVID-19 a pandemic resulting in federal, state and local governments and private entities mandating various restrictions, including travel restrictions, restrictions on public gatherings, stay at home orders and advisories and quarantining of people who may have been exposedour Common Stock immediately prior to the virus.

As the COVID-19 pandemic is complex and rapidly evolving, the Company's business has been and will be negatively affected for a sustained time frame. At this point, we cannot reasonably estimate the duration and severity of this pandemic, which could have a material adverse impact on our business, results of operations, financial position and cash flows.

The restrictions on crowds, gatherings, crowd sizes and travel have absolutely negatively impacted our business which relies upon social, sports and entertainment event gatherings to service. COVID-19 has impacted our revenue by 100% for approximately the last six months and has recently begun some recommencement of our services.

The continuation of COVID-19 related restriction or impacts on social, sports and entertainment gatherings has and will impact our revenues negatively and such lack of business raises substantial doubt about our ability to grow, maintain, and expand our busines and generate revenues sufficient to sustain our operations as planned (See expanded COVID-19 impact discussion under “Ongoing Assessment of the Impact of COVID-19” – Operations, Liquidity, and Capital Resources on pages 23-25).

WE CAN ISSUE SHARES OF PREFERRED STOCK WITHOUT SHAREHOLDER APPROVAL, WHICH COULD ADVERSELY AFFECT THE RIGHTS OF COMMON SHAREHOLDERS.

Our Articles of Incorporation permit our Board of Directors to establish the rights, privileges, preferences and restrictions, including voting rights, of future series of stock and to issue such stock without approval from our shareholders. The rights of holders of common stock may suffer as a result of the rights granted to holders of preferred stock that may be issued in the future. In addition, we could issue preferred stock to prevent a change in control of our Company, depriving common shareholders of an opportunity to sell their stock at a price in excess of the prevailing market price.

WE WILL BECOME A REPORTING COMPANY UPON THE EFFECTIVENESS OF THIS REGISTRATION STATEMENT.

We will become subjectoffering. After giving effect to the reporting requirements under the Securities and Exchange Act of 1934, Section 13a, after the effectiveness of this offering, pursuant to Section 15d of the Securities Act and we intend to be registered under Section 12(g). As a result, shareholders will have access to the information required to be reported by publicly held companies under the Exchange Act and the regulations

13 
Table of Contents

thereunder. As a result, we will be subject to legal and accounting expenses that private companies are not subject to and this could affect our ability to generate operating income.

ITEM 4. USE OF PROCEEDS

We will not receive any proceeds from theassumed sale of the shares being registered on behalf of our selling shareholders.

We may raise additional funds through a placement of shares of our common stock. AtCommon Stock in this time, there is no committed source for such funds and we cannot give any assurancesoffering, at an assumed public offering price of being able to raise such funds. We will require additional funds to carry out$[ ] per share (the last reported sale price of our business plan. The availability and terms of any future financing will depend on market and other conditions.

The monies we have raised thus far from private placements to our current shareholders as reflected in the attached financial statements is anticipated to be sufficient to pay all expenses of this registration statement, which is estimated to be $100,000.

ITEM 5. DETERMINATION OF OFFERING PRICE

We have a limited established market for our common stock as quoted on the OTC Pink under the symbol “BLAB.” We are in the process of uplisting to the OTCQB.

Our selling shareholders plan to sell shares at a fixed price until and unless we become listedCommon Stock on the OTCQB on [ ], 2024), and then such market prices as the market may dictate from time to time, or in private transactions.

TitlePer Share *
Common Stock$ 0.292

* 5 day average closing price (September 14, 2020 – September 21, 2020)

Our security holders may sell their securities on the OTC Pink at a fixed price as shown, unlessafter deducting underwriting discounts and until we achieve OTCQB listingcommissions and maintain such listing after which time our selling shareholders may sell at market prices or at any price in privately negotiated transactions. An amendment will be filed with the SEC at a later date if OTCQB listing is achieved .

As of September 22 , 2020, there were 10,753,504 shares of common stock issued and outstanding.

The market share price likely bears no relationship to any criteria of goodwill value, asset value, market price or any other measure of value.

ITEM 6. DILUTION

The following table sets forth with respect to existing shares being offered and under this registration, the numberestimated offering expenses payable by us, purchasers of our sharesCommon Stock in this offering will incur immediate dilution of common stock offered by shareholders, the percentage ownership of such shares, and the average price$[ ] per share. All percentages are computed based upon cumulative shares and consideration assuming sale of all sharesshare in the line item as compared to maximum in each previous line.

  Shares being offered for resale Net tangible book value
  Number Percent (1) /Share (2)
Existing Shareholders whose shares are being registered  9,690,999   90.12% ($0.033)

(1)Percentage relates to total percentage of shares to be registered for existing shareholders.

(2)Based upon net tangible book value at June 30, 2020.

“Net tangible book value” is the amount that results from subtracting the total liabilities and intangible assets from the total assets of an entity. Dilution occurs because we determined the offering price based on factors other than those used in computing book value of our stock. Dilution exists because the net tangible book value of shares held by existing stockholders is lower than the Common Stock they acquire. (For a further description of the dilution that investors in this offering price offeredmay experience, see “Dilution.”)

We have not paid dividends in the past and do not expect to resale investors.pay dividends in the foreseeable future.

As of June 30, 2020We have never paid cash dividends on our securities and December 31, 2019,do not anticipate paying cash dividends in the net tangible book valueforeseeable future. We currently intend to retain our future earnings, if any, to finance the development and expansion of our stock was ($0.033)business. The determination to pay dividends will be at the discretion of our board of directors and ($0.023) per share, respectively. 

14 
Table of Contents

ITEM 7. SELLING SECURITY HOLDERS

The selling shareholders obtained theirwill depend on our financial condition, results of operations, capital requirements, restrictions contained in any financing instruments, and such other factors as our board of directors deems relevant in its discretion. Accordingly, you may need to sell your shares of our common stock into realize a return on your investment, and you may not be able to sell your shares at or above the following transactions:

Number of SharesOriginal ConsiderationIssue Price Per Share
9,690,999Private Placements, Private Purchases, Services and Cash$0.0001 - $0.30

Other thanprice you paid for them, or at all for an indefinite period of time, except as permitted under the stock transactions discussed above, we have not entered into any transaction nor are there any proposed transactions in which any founder, director, executive officer, significant shareholder of our company or any member ofSecurities Act and the immediate familyapplicable securities laws of any ofother jurisdiction.

We will incur increased costs if we are listed on the foregoing had or is to have a direct or indirect material interest.NYSE American.

No person who may, in the future, be considered a promoter of this offering, will receive or expect to receive assets, services or other considerations from us except those persons who are our salaried employees or directors. No assets will be, nor expected to be, acquired from any promoter on behalf of us. We have and will incur significant legal, accounting, and other expenses that we would not entered into any agreements thatotherwise incur if we maintained listing on the OTCQB. Rules implemented by the NYSE American require disclosurechanges in corporate governance practices of public companies, some of which were not required by the OTCQB. We expect these rules and regulations to increase our legal and financial compliance costs and to make some activities more time-consuming and costly. We already have significant costs associated with our public company reporting requirements. We expect these rules and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the shareholders.same or similar coverage. As a result, it may be more difficult for us to attract and retain qualified people to serve on our board of directors, particularly to serve on our audit committee and when enacted, our compensation committee, or as executive officers.

(a)All of the securities listed below are being registered in this Registration Statement.

COMMON SHARES

NameCommon Shares Held by Each Shareholder Before OfferingCommon Shares to be RegisteredPercent Owned Before Offering (1)Shares Owned After Offering (5)Percent Owned After Offering (%) (5)
      
Kenneth Helfer (6)350,000350,0003.25%00%
Darrell Avey (2)(4)(6)270,000270,0002.51%00%
NextWave Development Group LLC (3)(6)395,000395,0003.67%00%
Bleu Ridge Consultants, Inc. (3)(6)205,000205,0001.91%00%
Dave Crowley30,00030,000.28%00%
Chad Stephens25,00025,000.23%00%
Gunslinger Capital Group, LLC (3)(6)50,00050,000.46%00%
Joe McShane Jr. (6)40,00040,000.37%00%
Village Partners, LLC (3)(6)100,000100,000.92%00%
Tyler J. Brasel (6)50,00050,000.46%00%
MJ Brasel, LLC (3)(6)500,000500,0004.64%00%
Brasel Family Holdings Trust (3)650,000650,0006.04%00%
Scott Owen55,00055,000.52%00%
Joe Logsdon (6)100,000100,000.92%00%
Joe Bruno (6)40,00040,000.37%00%
Michael B. Owens (6)200,000200,0001.85%00%
Paul Dragul or Paulette Dragul (6)50,00050,000.46%00%
William Bossung (6)1,805,0001,805,00016.78%00%
David Graham (6)90,00090,000.83%00%
Maurice W. Hansen Trust (3)(6)50,00050,000.46%00%
Jay Decker (6)100,000100,000.92%00%
Logan Decker (6)100,000100,000.92%00%
James Jenkens (6)15,00015,000.14%00%
Kyle Israel200,000200,0001.85%00%
Shelton Decker (6)100,000100,000.92%00%
Jeremy Ostler (2)(4)(6)80,00080,000.74%00%
David L. Hayes (6)70,00070,000.65%00%
Calvin D. Smiley Sr.  (2)(4)50,00050,000.46%00%
Ben Coates (6)100,000100,000.92%00%
Mike & Susan McShane (6)90,00090,000.83%00%
John & Loretta McShane (6)140,000140,0001.30%00%

15 26
Table of Contents

 

Jeffrey P. Ploen160,000160,0001.48%00%
Coronado Ventures Number One (3)80,00080,000.74%00%
Janet Brasel190,000190,0001.75%00%
First Capital Properties (3)200,000200,0001.85%00%
Causeway LLC (3)300,000300,0002.78%00%
Mathis Family Partners (3)25,00025,000.23%00%
Charitable Remainder Trust Of Susan Anne Brasel (3)100,000100,000.92%00%
La Mirage Trust (3)50,00050,000.46%00%
Justin T. Brasel50,00050,000.46%00%
Theodore Block (6)20,00020,000.18%00%
High Speed Aggregate, Inc. (3)800,000800,0007.43%00%
Zhuge Liang, LLC (3)116,000116,0001.06%00%
San Gabriel Fund, LLC (3)160,000160,0001.48%00%
JMW Fund, LLC (3)320,000320,0002.95%00%
Richland Fund, LLC (3)320,000320,0002.95%00%
Justin Yorke33,33333,333.30%00%
JPG Investments (3)33,33333,333.30%00%
Christopher Bragg33,33333,333.30%00%
W. Edward Nichols (2) (4) (7)200,000200,0001.85%00%
Michael A. Littman Atty Defined Benefit Plan (4) (7)400,000400,0003.72%00%
TOTAL9,690,9999,690,99990.12%00%

CAUTIONARY NOTE CONCERNING FORWARD-LOOKING STATEMENTS

Various statements contained in this prospectus, including those that express a belief, expectation, or intention, as well as those that are not statements of historical fact, are forward-looking statements. These forward-looking statements may include projections and estimates concerning the timing and success of specific projects and our future production, revenues, income, and capital spending. Our forward-looking statements are generally accompanied by words such as “estimate,” “project,” “predict,” “believe,” “expect,” “intend,” “anticipate,” “potential,” “plan,” “goal,” or other words that convey the uncertainty of future events or outcomes. The forward-looking statements in this prospectus speak only as of the date of this prospectus, and we disclaim any obligation to update these statements unless required by law, and we caution you not to rely on them unduly. We have based these forward-looking statements on our current expectations and assumptions about future events. While our management considers these expectations and assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory, and other risks, contingencies, and uncertainties, most of which are difficult to predict and many of which are beyond our control. The following factors, among others, may cause our actual results, performance, or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements:

(1)Based upon 10,753,504 shares of common stock issued and outstanding at September 22 , 2020. Certain shareholders not includedchanges adversely affecting the industry in total above are due to small amounts. Series A Preferred Convertible for 1,000,000 common shares are not included in the total shares of common stock.which we operate;
(2)Officer and/
our ability to achieve our business strategies or directorto manage our growth;
general economic condition;
changes in assumptions used to make industry forecasts;
our ability to retain our key employees and executives;
our future operating results and financial condition;
our business operations;
changes in our business and investment strategy;
availability, terms, and deployment of capital;
changes in, or the failure or inability to comply with, governmental laws and regulations;
the degree and nature of our Company.competition;
(3)The individuals have voting control for the entities noted in the list below (b).
(4)We are registering a total of 1,000,000 shares of common stock in which our officers/directorsleverage and control shareholders are considered to have beneficial ownership.debt service obligations; and
(5)Assumes resale of all shares registered for resale.
(6)Material Relationships (PTL). All shareholders marked with (6) were shareholdersadditional factors discussed under the sections captioned “Risk Factors,” “Management’s Discussion and Analysis of predecessor, Prime Time Live, Inc.
(7)Material Relationships (Bio Lab Naturals, Inc.). W. Edward Nichols has been CEOFinancial Condition and director (since 2015)Results of Bio Lab Naturals, Inc. Michael A. Littman has been a shareholderOperations” and legal counsel to Bio Lab Naturals, Inc. since 2013 and has owned shares since 2010.“Our Business.”

(b) The table below showsThese forward-looking statements reflect our management’s beliefs and views with respect to future events and are based on estimates and assumptions as of the person with voting controldate of this prospectus and are subject to risks and uncertainties. We discuss many of these risks in greater detail under “Risk Factors.” Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the entities listedimpact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in (a) above.any forward-looking statements we may make. Given these uncertainties, you should not place undue reliance on these forward-looking statements.

Name of the EntityPerson With Voting ControlNumber of Common Shares Being RegisteredAffiliate of Company?
NextWave Development Group LLCJustin T. Brasel395,000No
Bleu Ridge Consultants, Inc.Timothy J. Brasel205,000Yes
Gunslinger Capital Group, LLCMatt Gregarek50,000No
Village Partners, LLCGeorge Lee100,000No
MJ Brasel, LLCSusan A. Brasel500,000Yes
Brasel Family Holdings TrustSusan A. Brasel650,000Yes
Maurice W. Hansen TrustWayne Hanson50,000No
Coronado Ventures Number OneMatt Gregarek80,000No
First Capital PropertiesJim Sjoerdsma200,000No
Causeway LLCSusan A. Brasel300,000Yes
Mathis Family PartnersValerie Mathis25,000No
Charitable Remainder Trust Of Susan Anne BraselTimothy J. Brasel100,000Yes
La Mirage TrustTimothy J. Brasel50,000Yes
High Speed Aggregate, Inc.Jeffrey P. Ploen800,000Yes
Zhuge Liang, LLCAaron A. Grunfeld116,000No
San Gabriel Fund, LLCJustin W. Yorke160,000No
JMW Fund, LLCJustin W. Yorke320,000No
Richland Fund, LLCJustin W. Yorke320,000No
JPG InvestmentsJohn McGrain33,333No
Michael A. Littman Atty Defined Benefit PlanMichael A. Littman400,000Yes
TOTAL4,854,333

16 27
Table of Contents

 

ITEM 8. PLAN OF DISTRIBUTION

Upon effectiveness ofYou should read this amendmentprospectus and the documents that we reference in this prospectus and have filed as exhibits to the registration statement of which this prospectus isforms a part with the understanding that our existing selling shareholders may sell their securities at a fixed price as shown, unlessactual future results, levels of activity, performance and until we achieve OTCQB listing and maintain such listing after which time our selling shareholders may sell at market prices or at any price in privately negotiated transactions.

Our selling shareholdersachievements may be deemed underwritersmaterially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements.

The forward-looking statements made in this offering.

The selling shareholders are not paying any of the offering expenses and we will not receive any of the proceeds from the sale of the shares by the selling shareholders.

ITEM 9. DESCRIPTION OF SECURITIES

The securities being registered and/or offered by this Prospectus are common shares.

Common Stock

The Company is presently authorizedprospectus relate only to issue two hundred million (200,000,000) shares of its $0.0001 par value common shares. A total 10,753,504 common shares are issued and outstanding as of September 22 , 2020.

All shares, when issued, will be fully paid and non-assessable. All shares are equal to each other with respect to voting, liquidation, and dividend rights. Special Stockholders' meetings may be called by the Officers or Directors, or upon the request of holders of at least one-tenth (1/10th) of the outstanding shares. Holders of shares are entitled to one vote at any Stockholders' meeting for each share they ownevents as of the record date set by the Board of Directors. There ison which such statements are made. We undertake no quorum requirement for Stockholders’ meetings. Therefore, a vote of the majority of the shares represented at a meeting will govern even if this is substantially less than a majority of the shares outstanding. Holders of shares are entitledobligation to receive such dividends as may be declared by the Board of Directors out of funds legally available therefore, and upon liquidation are entitled to participate pro rata in a distribution of assets available for such a distribution to Stockholders. There are no conversion, pre-emptive or other subscription rights or privileges with respect toupdate any shares. Reference is made to the Company's Articles of Incorporation and its By-Laws as well as to the applicable statutes of the State of Delaware for a more complete description of the rights and liabilities of holders of shares. It should be noted that the Board of Directors without notice to the Stockholders may amend the By-Laws. The shares of the Company do not have cumulative voting rights, which mean that the holders of more than fifty percent (50%) of the shares voting for election of Directors may elect all the Directors if they choose to do so. In such event, the holders of the remaining shares aggregating less than fifty percent (50%) of the shares voting for election of Directors may not be able to elect any Director.

Preferred Stock

The Company is presently authorized to issue Five Million (5,000,000) shares of its $0.0001 par value Preferred Stock. A total of 500,000 shares of Class A Preferred Convertible Super Majority Voting Stock are issued and outstanding as of September 22 , 2020.

Class A Preferred Convertible Super Majority Voting Stock

The Certificate of Incorporation of the Company authorizes the issuance of up to five million (5,000,000) shares of Preferred Stock, $0.0001 par value per share (herein, “Preferred Stock” or “Preferred Shares”), and expressly vests in the Board of Directors of the Company the authority provided therein to issue any or all of the Preferred Shares in one (1) or more Class or classes and by resolution or resolutions to establish the designation and number and to fix the relative rights and preferences of each Class to be issued. The Board authorized Five Hundred Thousand (500,000) of the Five Million (5,000,000) authorized shares of Preferred Stock of the Company to be designated Class A Preferred Convertible Super Majority Voting Stock, $0.0001 par value per share (herein, “Class A Preferred” or “Class A Preferred Convertible Stock”), and shall possess the rights and preferences set forth below:

17 
Table of Contents

Rank. The Class A Preferred Convertible Stock shall rank: (i) senior to any other class or Class of outstanding Preferred Shares or Class of capital stock of the Company; (ii) prior to all of the Company's common stock, ("common stock"); and (iii) prior to any other class or Class of capital stock of the Company hereafter created "Junior Securities"); and in each case as to distributions of assets upon liquidation, dissolution or winding up of the Company, whether voluntary or involuntary (all such distributions being referred to collectively as "Distributions").

Dividends. The Class A Preferred Convertible Stock shall bear no dividends, except that in the event dividends are declared for common stock, the same rate of dividend per share shall be due and payable to the Class A Preferred shareholders on the same terms.

Liquidation / Merger Preference.

(a)       So long as a majority of the shares of Class A Preferred authorized are outstanding, the Company will not, without the written consent of the holders of at least 51% of the Company’s outstanding Class A Preferred, either directly or by amendment, merger, consolidation, or otherwise: (i) liquidate, dissolve or wind-up the affairs of the Company, or effect any Liquidation Event; (ii) amend, alter, or repeal any provision of the Certificate of Incorporation or Bylaws in a manner adverse to the Class A Preferred (iii) create or authorize the creation of, or issue any other security convertible into or exercisable for, any equity security, having rights, preferences or privileges senior to the Class A Preferred, or (iv) purchase or redeem or pay any dividend on any capital stock prior to the Class A Preferred, other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services.

(b)       In the event of any liquidation, merger, dissolution or winding up of the Company, either voluntary or involuntary, the holders of shares of Class A Preferred Convertible Stock (each a “Holder” and collectively the “Holders”) shall be entitled to receive, prior in preference to any distribution to Junior Securities, an amount per share equal to $1.00 plus any allocable and due dividends per share.

(c)       Upon the completion of the distribution required to Class A Preferred holders, if assets remain in the Company, they shall be distributed to holders of Junior Securities in accordance with the Company's Certificate of Incorporation including any duly adopted Certificate(s) of Designation.

Conversion Rights:

The Holders of the Class A Preferred Convertible Stock shall, individually and collectively, have the right to convert all of their Class A Preferred Convertible Stock, in one transaction, by electing, in writing, to convert the 500,000 shares of Class A Preferred into shares of common stock of the Company, on the basis of 2 common shares for each share of Class A Preferred, subject to

Adjustment to Conversion Rate. The conversion price will be subject to adjustments for stock dividends, splits, combinations and similar events and to Adjustment Due to Merger, Consolidation, Etc. If, prior to the conversion of all Class A Preferred Convertible Stock, there shall be any merger, consolidation, exchange of shares, recapitalization, reorganization, or other similar event, as a result of which shares of common stock of the Company shall be changed into the same or a different number of shares of the same or another class or classes of stock or securities of the Company or another entity or there is a sale of all or substantially all the Company’s assets, then the Holders of Class A Preferred Convertible Stock shall thereafter have the right to receive upon conversion of Class A Preferred Convertible Stock, upon the basis and upon the terms and conditions specified herein and in lieu of the shares of common stock immediately theretofore issuable upon conversion, such stock, securities and/or other assets (“New Assets”) which the Holder would have been entitled to receive in such transaction had the Class A Preferred Convertible Stock been convertible into New Assets fromforward-looking statements after the date hereof, at the market price of such New Assets on the date of conversion, and in any such case appropriate provisions shall be made with respect to the rights and interests of the Holders of the Class A Preferred Convertible Stock to the end that the provisions hereof (including, without limitation, provisions for the adjustment of the conversion price and of the number of shares of common stock issuable or New Assets deliverable upon conversion of the Class A Preferred Convertible Stock) shall thereafter be applicable, as nearly as may be practicable in relation to any securities thereafter deliverable upon the exercise here.

Redemption by Company. The Company may, at its sole discretion redeem all or any portion of the Class A Preferred Convertible Stock by paying in cash by wire transfer the stated value of US $1.00 per share, plus all accrued and unpaid dividends on the Class A Preferred Convertible Stock to be redeemed, to the Holder pursuant to the Holder’s written instructions. The Holders may convert Class A Preferred Convertible Stock into common stock of the Company until such cash has been transmitted to the Holder, at which time conversion rights shall cease and the Holder shall surrender all redeemed Class A Preferred Certificates to the Company for cancellation.

Super Majority Voting Rights. The record Holders of the Class A Preferred Convertible Stock shall have the right to vote on any matter with holders of common stock and may vote as required on any action, which Delaware law provides may or must be approved by vote or consent of the holders of the specific Class of voting preferred shares and the holders of common shares. The Record Holders of the Class A Preferred shall have the right to vote on any matter with holders of common stock voting together as one (1) class. The Record Holders of the Class A Preferred shall have that number of votes (identical in every other respect to the voting rights of the holders of other Class of voting preferred shares and the holders of common stock entitled to vote at any Regular or Special Meeting of the Shareholders) equal to that number of common shares which is not less than 60% of the vote required to approve any action, which Delaware law provides may or must be approved by vote or consent of the holders of other Class of voting preferred shares and the holders of common shares or the holders of other securities entitled to vote, if any. This Super Majority Voting Right continues until redemption, conversion or an exchange listing is approved. Our Company is not currently applying for an exchange listing.

18 
Table of Contents

Class B Preferred Convertible Stock

In November 2019, we designated 2,000,000 shares of Preferred Stock as Class B Preferred Convertible Stock (herein, “Class B Preferred Stock”).

The Class B Preferred Stock was designated in November 2019, has a par value of $0.0001, is senior to any other class or series of outstanding Preferred Stock, except the Class A Preferred, or common stock and does not bear dividends. The Class B Preferred Stock has a liquidation preference immediately after any Senior Securities, as defined and currently the Class A Preferred, and of an amount equal to $0.005 per share. Holders of the Class B Preferred Stock have a right to convert all or any part of the Class B Preferred Stock and will receive an equal number of common shares at the time of conversion. The Class B Preferred Stockholders have a right to vote on any matter with holders of common stock and shall have a number of votes equal to that number of Common Shares on a one to one basis. There are no shares of Class B Preferred Stock issued and outstanding as of September 22 , 2020.

Transfer Agent

The transfer agent and registrar for our common stock is Mountain Share Transfer, LLC. The transfer agent’s address is 2030 Powers Ferry Road, SE, Suite #212, Atlanta, GA 30339, and its telephone number is (404) 474-3110.

ITEM 10. INTEREST OF NAMED EXPERTS AND COUNSEL

Except as set forth at the end of this paragraph, no expert or counsel named in this prospectus as having prepared or certified any part of this prospectus or having givento conform such statements to actual results or revised expectations, except as required by law.

USE OF PROCEEDS

After deducting the estimated commissions and estimated offering expenses payable by us, we expect to receive net proceeds of approximately $[ ] from this offering , based on a public offering price of $[   ] per share.

We currently anticipate an opinion upon the validityapproximate allocation of the securities being registered or upon other legal matters in connection with the registration ornet proceeds from this offering of the Common Stock was employed on a contingency basis or had, or is to receive, in connection with the offering, a substantial interest, directly or indirectly, in the Registrant or any of its parents or subsidiaries. Nor was any such person connected with the Registrant or any of its parents, subsidiaries as a promoter, managing or principal underwriter, voting trustee, Director, officer, or employee. Michael A. Littman, as legal counsel to the company, had substantial participation in the preparation of the S-1, and owns both Series A Preferred shares and common shares, and is registering 400,000 common shares for resale for his Defined Benefit Plan, and has owned common shares in the Company since 2010.follows:

ITEM 11. INFORMATION WITH RESPECT TO THE REGISTRANT

a. DESCRIPTION of BUSINESS

BUSINESS SUMMARY

This prospectus contains various forward-looking statements that are based on our beliefs as well as assumptions made by and information currently available to us. When used in this prospectus, the words "believe," "expect," "anticipate," "estimate," and similar expressions are intended to identify forward-looking statements. These statements may include statements regarding seeking business opportunities, payment of operating expenses, and the like, and are subject to certain risks, uncertainties and assumptions which could cause actual results to differ materially from projections or estimates. Factors which could cause actual results to differ materially are discussed at length under the heading "Risk Factors". Should one or more of the enumerated risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. Investors should not place undue reliance on forward-looking statements, all of which speak only as of the date made.

In this prospectus, unless the context requires otherwise, references to “we,” “our,” or “us,” refer to Bio Lab Naturals, Inc. and our consolidated subsidiaries.

19 Development of new products and improvements to existing products
 Table of Contents

Company Overview

Business

Our predecessor,Vyta Corp, was incorporated in Nevada in June 1996. Until June 2009, Vyta Corp, through its wholly owned subsidiary BioAgra, LLC, was involved in the sale and manufacturing of a natural additive for use in the animal feed industry. On May 15, 2009, Vyta Corp ceased its operational activities. On June 30, 2009, Vyta Corp filed a Form 15-15D, with the Securities and Exchange Commission (“SEC”) to cease its filing obligations under the Securities Act of 1934. On August 20, 2010, it changed its state of incorporation to Delaware and on November 5, 2010, and through a holding company reorganization reorganized as Bio Lab Naturals, Inc. (the “Company or “Bio Lab”). Its predecessor was divested as a subsidiary.

The Company changed its year end from June 30th to December 31st and, therefore the consolidated financial statements represent a short year as of and for the period July 1, 2019 through December 31, 2019.

Reorganization Activities

On August 20, 2010, Vyta Corp (Nevada) executed a redomicile merger with its wholly owned subsidiary Vyta Corp (Delaware). As a result of the merger the Company’s corpo - rate domicile moved from Nevada to Delaware.

On September 16, 2010, Vyta Corp and its wholly owned subsidiaries, 10 Vyta, Inc., with Bio Lab Naturals, Inc. entered into a Holding Company Reorganization/Merger Transaction pursuant to Delaware Statute 251(g), whereby the Company was reorganized with 10 Vyta, Inc., with Bio Lab Naturals, Inc. being the survivor holding company, and 10 Vyta was divested thereafter. The shareholders of the Company became the shareholders of Bio Lab Naturals, Inc. (hereinafter the “Company”) with no change in the number of shares.

In 2010, the Company executed a merger with Bio Protein, Inc. As part of the merger, the Company exchanged 40 shares of its outstanding common stock for one share of Bio Protein, Inc. (Colorado.) This merger was rescinded April 10, 2013 and 6,868,260 shares were agreed to be cancelled. The name was changed back to Vyta Corp, but such was changed back to Bio Lab Naturals, Inc. when there failed to be shareholder approval.

The Company agreed to a merger with Set Net Global, Inc. in 2015 and changed its name, but the merger was never completed and the name was returned to Bio Lab Naturals, Inc.

On December 31, 2019, Bio Lab Naturals, Inc., PTL Acquisition Sub, Inc. (“PTL Acquisition Sub”), a wholly-owned subsidiary of Bio Lab Naturals, Inc., domiciled in Colorado and Prime Time Live, Inc. (“PTL”), a Colorado corporation entered into a Plan of Reorganization. PTL Acquisition Sub merged with PTL where PTL Acquisition Sub became the surviving entity in exchange for one share of the Company’s common stock being issued for each share of PTL’s 5,500,000 issued and outstanding shares of common stock. A total of 6,931,061 shares of the Company’s common stock were cancelled. PTL Acquisition Sub changed its name to Prime Time Live, Inc.

On September 17, 2019, PTL was incorporated in the State of Colorado and effective October 11, 2019, acquired all of the event services business of Prime Time Mobile Event Screens LLC (“PTMVES”) in exchange for PTL issuing 350,000 shares of its common stock to the owner of PTMVES. The transaction was accounted for by PTL as an acquisition of a business under ASC 805. Both PTL and PTMVES financial statements are included as part of this registration statement and they reflect the historical operations of the event services business that was acquired by the Company.

Our executive offices are located at 7400 E. Crestline Circle, Suite #130, Greenwood Village, CO 80111 and the telephone number is (720) 273-0433. We maintain a website at www.primetimeliveevents.com, and such website is not incorporated into or a part of this filing.

Our Business

Summary

Our subsidiary, Prime Time Live, Inc., is a Denver, CO based company that specializes in providing clients with high resolution mobile LED screens for entertainment, corporate, civic and sporting events. PTL, that included its predecessor PTMVES has been in the event services business since 2011. Its main operations are derived from its 30’ x 18’ LED mobile video display. This display is mounted in a 53 ft. trailer with an accompanying MQ Whisper Watt generator that can power the LED screen for 50 hours, and therefore, provides our clients with true portability.

20 
Table of Contents

For the six months ended June 30, 2020, PTL generated $0 in revenues. For the year 2019, PTL and its predecessor, PTMVES generated $139,562 in event screen rental fees from 16 events and for the years 2018 and 2017 PTMVES generated $195,276 in event screen rental fees from 22 events and $214,216 in event screen rental fees from 29 events.

As of August 31, 2020, PTL earned fees in the amount of $12,500 from the rental of a 30’ x 18’ screen and has no other commitments for screen rentals. There are yet any revenues or commitments from either its promotional offers for sponsors or fan villages.

Screens

Prime Time Live, Inc. owns two different screen sizes. The 30’ x 18’ mobile LED screen that is installed inside a 53 ft. trailer and an 8’ x 5’ mobile LED screen that is towed by a mid-size SUV. The 30’ x 18’ screen has a life time use of 50,000 hours of which 2,500 hours have been used and the 8’ x 5’ mobile LED screen is new with no hours.

Sponsors

Prime Time Live, Inc. will offer companies sponsorship opportunities by placing the sponsor’s name on the side of the semi-truck in addition to advertising on the LED screens. PTL is still determining the time frame of when this service will be offered and the fees charged for such services.

Fan Villages

Prime Time Live, Inc. offers event planners an opportunity to create a fan village. A fan village is the main place at the event where people can purchase refreshments, watch the entertainment, and interact with sponsors. Prime Time Live, Inc.’s fan village is created for each event to increase people’s desire to stay for longer periods of time. PTL is in the infancy stages of when this concept will be offered as well as the revenue generated.

Going Forward

Prime Time Live, Inc. plans to:

·Upgrade to a higher resolution 30’ x 18’ LED screen for its semi-truck during the first quarter of 2021 at a cost of $60,000;
$  
·Implement an enhancedSales and marketing and social media strategy to expose the brand of Prime Time Live, Inc. at a cost of $1,000 per month beginning in January of 2021 with such cost included in the selling, general and administrative expense.

We anticipate needing an estimated $120,000 in capital to continue our business operations and expansion. We do not have committed sources for these additional funds (except for a recent placement described below) and will need to be obtained through debt or equity placements or a combination of those. We have achieved a private placement of $262,000 for interim capital toward this capital requirement. 

Below is an overview of the Bio Lab’s corporate structure.

BIO LAB NATURALS, INC.

(a Delaware corporation)

capabilities    

Prime Time Live, Inc.

(a wholly-owned subsidiary)
(a Colorado corporation)

Working capital and general corporate purposes
TOTAL$

21 
Table of Contents

We may change the amount of net proceeds to be used specifically for any of the foregoing purposes. The amounts and timing of our actual expenditures will depend upon numerous factors, including our sales and marketing and commercialization efforts, demand for our products, our operating costs and the other factors described under “Risk Factors” in this prospectus. Accordingly, our management will have significant discretion and flexibility in applying the net proceeds from this offering. Pending any use, as described above, we intend to invest the net proceeds in high-quality, short-term, interest-bearing securities.

BudgetWe do not currently have any intention to use the net proceeds of this offering for any acquisitions nor do we have any verbal or written agreements with any third parties. However, the next 12 months

Our Budgetboard might decide to use some of the net proceeds for the next 12 months is as follows:

           
          Years
  Three Months Ending 2020-2021
  9/30/2020 12/31/2020 3/31/2021 6/30/2021 Total
           
 Revenues $39,000  $66,000  $40,000  $115,000  $260,000 
                     
 Cost of revenue  44,697   38,599   14,316   54,218   151,830 
 Selling, general and administrative expense  13,251   11,442   4,243   16,072   45,008 
Capital expenditures  0   0   60,000   0   60,000 
 Revenues excess of (short of) cost and expense $(18,948) $15,959  $(38,559) $44,710  $3,162 

Revenues were based upon events and fees thatan acquisition if the Company has historically experiencedbecomes aware of a suitable target company.

DIVIDEND POLICY

We currently intend to retain our future earnings, if any, to finance the development and are as follows:

Forexpansion of our business. We will continue to use that same plan. Any future determination related to our dividend policy will be made at the three months ending September 30, 2020, revenues were baseddiscretion of our board of directors, subject to applicable laws, and will depend upon, 2 outdoor sporting events at a feeamong other factors, our results of $6,500 per event, 1 special activity event at a feeoperations, financial condition, capital requirements, contractual restrictions, business prospects and other factors our board of $5,000directors may deem relevant, and 2 outdoor rodeo events at fees of $12,500 and $8,500 or total revenues of $39,000. A total of 4 events.

Forsubject to the three months ending December 31, 2020, revenues were based upon 8 outdoor sporting events at a fee of $6,500 per event and 1 outdoor concert event at a fee of $14,000 or total revenues of $66,000. A total of 9 events.

For the three months ending March 31, 2021, revenues were based upon 1 outdoor sporting event at a fee of $20,000, 1 outdoor sporting event at a fee of $6,500 and an indoor convention at a fee of $13,500 or total revenues of $40,000. A total of 3 events.

For the three months ending June 30, 2021, revenues were based upon 1 outdoor sporting event at a fee of $6,000, 1 indoor convention at a fee of $10,000, 1 outdoor rodeo at a fee of $15,000, 2 outdoor commencements at a fee of $27,000 and 5 special activity events at a fee of $42,000 or total revenues of $115,000. A total of 11 events.

The Companyrestrictions contained in any future financing instruments. Accordingly, you may change any or all the budget categories in the execution of its business plan. None of the line items are to be considered fixed or unchangeable. The Company currently has sufficient funds to satisfy its cash requirements during the six months ending December 31, 2020 based upon our current cash reserves of approximately $165,000 as of September 22 , 2020. 

If we are unable to generate enough revenue to cover our operational costs beginning the first quarter of 2021, we will need to seek additional sourcessell your shares of funds. Currently, we have no committed source for any funds as of date hereof.  No representation is made that any funds will be available when needed. In the event funds cannot be raised ifour common stock to realize a return on your investment, and when needed, weyou may not be able to carry out our business plansell your shares at or above the price you paid for them. (See “Risk Factors—Risks Related to this Offering and could fail in business as a result of these uncertainties.

The independent registered public accounting firm’s report on our financial statements as of December 31, 2019, includes a “going concern” explanatory paragraph that describes substantial doubt about our ability to continue as a going concern.

Liquidity and Capital Resource Needs & Plan of Operations

The Company currently has approximately $165,000 in cash for operations. Its capital resource is its common and preferred stock. We believe the cash is sufficient to conduct limited operations for six months.

COVID-19

In December 2019, COVID-19 emerged and has subsequently spread worldwide. The World Health Organization has declared COVID-19 a pandemic resulting in federal, state and local governments and private entities mandating various restrictions, including travel restrictions, restrictions on public gatherings, stay at home orders and advisories and quarantining of people who may have been exposed to the virus. The Company continues to monitor developments, including government requirements and recommendations at the national, state, and local level to evaluate possible extensions to all or part of such closures.

22 
Table of Contents

As the COVID-19 pandemic is complex and rapidly evolving, the Company's plans as described above may change. At this point, we cannot reasonably estimate the duration and severity of this pandemic, which could have a material adverse impact on our business, results of operations, financial position and cash flows.

Ongoing Assessment of the Impact of COVID-19

Operations, Liquidity, and Capital Resources

Companies have undertaken and are generally in the process of making a diverse range of operational adjustments in response to the effects of COVID-19. These adjustments are numerous and include a transition to telework; supply chain and distribution adjustments; and suspending or modifying certain operations to comply with health and safety guidelines to protect employees, contractors, and customers, including in connection with a transition back to the workplace. These types of adjustments may have an effect on a company that would be material to an investment or voting decision, and affected companies should carefully consider their obligations to disclose this information to investors. Companies also are undertaking a diverse and sometimes complex range of financing activities in response to the effects of COVID-19 on their businesses and markets. These activities may involve obtaining and utilizing credit facilities, accessing public and private markets, implementing supplier finance programs, and negotiating new or modified customer payment terms. The SEC has required a discussion of COVID-19 related considerations, specific facts and circumstances and make disclosures to address the following questions;

·What are the material operational challenges that management and the Board of Directors are monitoring and evaluating?
·How and to what extent have you altered your operations, such as implementing health and safety policies for employees, contractors, and customers, to deal with these challenges, including challenges related to employees returning to the workplace?
·How are the changes impacting or reasonably likely to impact your financial condition and short- and long-term liquidity?
·How is your overall liquidity position and outlook evolving?
·To the extent COVID-19 is adversely impacting your revenues, consider whether such impacts are material to your sources and uses of funds, as well as the materiality of any assumptions you make about the magnitude and duration of COVID-19’s impact on your revenues. Are any decreases in cash flow from operations having a material impact on your liquidity position and outlook?
·Have you accessed revolving lines of credit or raised capital in the public or private markets to address your liquidity needs?
·Have COVID-19 related impacts affected your ability to access your traditional funding sources on the same or reasonably similar terms as were available to you in recent periods?
·Have you provided additional collateral, guarantees, or equity to obtain funding?
·Have there been material changes in your cost of capital?

23 
Table of Contents

·How has a change, or a potential change, to your credit rating impacted your ability to access funding?
·Do your financing arrangements contain terms that limit your ability to obtain additional funding? If so, is the uncertainty of additional funding reasonably likely to result in your liquidity decreasing in a way that would result in you being unable to maintain current operations?
·Are you at material risk of not meeting covenants in your credit and other agreements?
·If you include metrics, such as cash burn rate or daily cash use, in your disclosures, are you providing a clear definition of the metric and explaining how management uses the metric in managing or monitoring liquidity?

·Are there estimates or assumptions underlying such metrics the disclosure of which is necessary for the metric not to be misleading?
·Have you reduced your capital expenditures and if so, how?
·Have you reduced or suspended share repurchase programs or dividend payments?
·Have you ceased any material business operations or disposed of a material asset or line of business?
·Have you materially reduced or increased your human capital resource expenditures?
·Are any of these measures temporary in nature, and if so, how long do you expect to maintain them?
·What factors will you consider in deciding to extend or curtail these measures?
·What is the short- and long-term impact of these reductions on your ability to generate revenues and meet existing and future financial obligations?
·Are you able to timely service your debt and other obligations?
·Have you taken advantage of available payment deferrals, forbearance periods, or other concessions? What are those concessions and how long will they last?

24 
Table of Contents

·Do you foresee any liquidity challenges once those accommodations end?
·Have you altered terms with your customers, such as extended payment terms or refund periods, and if so, how have those actions materially affected your financial condition or liquidity?
·Did you provide concessions or modify terms of arrangements as a landlord or lender that will have a material impact?
·Have you modified other contractual arrangements in response to COVID-19 in such a way that the revised terms may materially impact your financial condition, liquidity, and capital resources?

·Are you relying on supplier finance programs, otherwise referred to as supply chain financing, structured trade payables, reverse factoring, or vendor financing, to manage your cash flow?
·Have these arrangements had a material impact on your balance sheet, statement of cash flows, or short- and long-term liquidity and if so, how?
·What are the material terms of the arrangements?
·Did you or any of your subsidiaries provide guarantees related to these programs?
·Do you face a material risk if a party to the arrangement terminates it?
·What amounts payable at the end of the period relate to these arrangements, and what portion of these amounts has an intermediary already settled for you?
·Have you assessed the impact material events that occurred after the end of the reporting period, but before the financial statements were issued, have had or are reasonably likely to have on your liquidity and capital resources and considered whether disclosure of subsequent events in the financial statements and known trends or uncertainties in MD&A is required?

Government Assistance – The Coronavirus Aid, Relief, and Economic Security Act (CARES Act)

The CARES Act includes financial assistance for companies in the form of loans and tax relief in the form of deferred or reduced payments and potential refunds. Companies receiving federal assistance must consider the short- and long-term impact of that assistance on their financial condition, results of operations, liquidity, and capital resources, as well as the related disclosures and critical accounting estimates and assumptions. We have not received any financial assistance from the banks or any government agency.

25 
Table of Contents

·How does a loan impact your financial condition, liquidity and capital resources?
·What are the material terms and conditions of any assistance you received, and do you anticipate being able to comply with them?
·Do those terms and conditions limit your ability to seek other sources of financing or affect your cost of capital?
·Do you reasonably expect restrictions, such as maintaining certain employment levels, to have a material impact on your revenues or income from continuing operations or to cause a material change in the relationship between costs and revenues?
·Once any such restrictions lapse, do you expect to change your operations in a material way?

·Are you taking advantage of any recent tax relief, and if so, how does that relief impact your short- and long-term liquidity?
·Do you expect a material tax refund for prior periods?
·Does the assistance involve new material accounting estimates or judgments that should be disclosed or materially change a prior critical accounting estimate?
·What accounting estimates were made, such as the probability a loan will be forgiven, and what uncertainties are involved in applying the related accounting guidance?

A Company’s Ability to Continue as a Going Concern

The SEC has advised that Management should consider whether conditions and events, taken as a whole, raise substantial doubt about the company’s ability to meet its obligations as they become due within one year after the issuance of the financial statements. There is substantial doubt about a company’s ability to continue as a going concern due to continuation of the COVID-19 pandemic and we make the following disclosure:

·Are there conditions and events that give rise to the substantial doubt about the company’s ability to continue as a going concern?
·For example, have you defaulted on outstanding obligations?
·Have you faced labor challenges or a work stoppage?

26 
Table of Contents

·What are your plans to address these challenges?
·Have you implemented any portion of those plans?

 INDUSTRY ANALYSIS AND HISTORY

Barriers to Entry in the Event Production Industry

There is one major barrier to entry into the Event Production Industry which is capital. We have very limited capital with which to compete in this industry. Many other competitors have been in the business for many years and have very large capital resources and an established reputation. Our barriers to entry are, in addition to lack of capital, lack of reputation, lack of recognition, part-time management, lack of financial history to raise money, and lack of equity in our Company upon which to base a capital raise.

Competitive Factors Impacting Our Ability to Gain Market Share

Our competition enjoys advantages which may prevent us from achieving a market share due to our competitors’ known reputations, large funding abilities, competent management, and capital resources all of which will impede our abilities to achieve market share.

Competitive Factors in the Industry

There are numerous entities, large advertising companies, and private investors which will compete for the same business in which we intend to engage. We will be at a significant disadvantage to all of these other competitors for the foreseeable future. AllOwnership of our competitors should be considered to be far better capitalized than we are.

Registrant’s Competitive Position in the Industry

Registrant is an insignificant participant in the event production industry and cannot be expected to obtain a market share even discernable percentage wise. Without a large infusion of capital, it will remain a very small participant in the industry.

Historical Track Records

Our Company has no historical track record and we should be deemed a pure start-up of earning or operating with all of the risks of an unproven Company (see “Risk Factors”).

COMPETITION, MARKETS, REGULATION AND TAXATION

Competition

There are a large number of companies and individuals engaged in the event production industry; accordingly, there is a high degree of competition. Almost all of the companies and individuals so engaged have substantially greater technical and financial resources than we do.

Common Stock—We are an insignificant participant among the firms which engage in the funding of business opportunities. There are many established venture capital and financial concerns that have significantly greater financial and personnel resources and technical expertise than we have. In view of our limited financial resources and limited management availability, we will continue to be at a significant competitive disadvantage compared to our competitors.

Investment Company Act 1940

Although we will be subject to regulation under the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, we believe we will not be subject to regulation under the Investment Company Act of 1940 (the "1940 Act") insofar as we will not be engaged in the business of investing or trading in securities within the definitions and parameters which would make us subject to the “1940 Act.” In the event we engage in business activities that result in us holding investment interests in a number of entities, we might become subject to regulation under the 1940 Act. In such event, we would be required to register as an Investment Company and incur significant registration and compliance costs. Under no circumstances does the

27 
Table of Contents

Company intend to become an investment Company and its activities and its financial statement ratios of assets and cash will be carefully monitored and other activities reviewed by the Board to prevent being classified or inadvertently becoming an investment Company which would be subject to regulation under the Investment Company Act of 1940.

As a fundamental concept, the 1940 Act requires registration of companies that invest and manage funds to invest for others and trade in securities of other companies. Those companies that cross a threshold of 40% of assets in cash and stock in other companies may be required to register. Investment companies may issue face amount certificates, be a Unit Investment Trust, or be a mutual fund. We intend to do several things to remain outside of the 1940 Act: a) we will not trade in securities of other companies or manage investments for others, b) we intend to carefully monitor our ratios of cash and securities to total assets to avoid crossing the 1940 Act threshold, c) wecurrently do not intend to issue face amount certificates, d) we do not intend to distribute profits andpay dividends toon our shareholders on an annual or shorter basis, if ever, e) we do not pass through profits and losses to our shareholders on a tax basis, f) we will not issue Units in investment trusts, g) we will not act as a mutual fund, and h) we will not invest funds on behalf of others.common stock.”)

We have obtained no formal determination from the SEC as to our status under the 1940 Act and, consequently, any violation of the 1940 Act would subject us to material adverse consequences. We believe that, currently, we are exempt under Regulation 3(c)(4) and (5) of the 1940 Act.

Markets.

Our market is highly competitive and constantly changing. Commercial success is frequently dependent on capital availability, the effectiveness and sufficiency of which are very difficult to predict accurately.

Governmental Regulation.

Federal Regulations.

We are subject to regulations by securities laws as a public Company. We do not intend to become an investment Company under the Investment Company Act of 1940, but if we exceed certain thresholds of certain assets or our business operations cease to fall within certain exemptions, we might inadvertently become subject to the Act.

Compliance with Environmental Laws and Regulations.

We are not involved in operations with environmental considerations for our business.

State Regulations.

Certain states may require that we obtain a Local Business License. We intend to address this on an as needed basis. We know of no other regulations that would affect our business for temporary screen locations for events as the locations generally allow our screens.

For additional information about these matters, see “Risk Factors.”

LICENSES

None.

TITLE TO PROPERTIES

None.

BACKLOG OF ORDERS

We currently have no backlogs of orders for sales, at this time.

GOVERNMENT CONTRACTS

We have no government contracts.

28
Table of Contents

 

COMPANY SPONSORED RESEARCH AND DEVELOPMENT

We are not conducting any research.

NUMBER OF PERSONS EMPLOYED

We have 3 independent contractors who work approximately 20 hours per week. All officers and directors work approximately 10 hours per week under their appropriate responsibility.

b. DESCRIPTION OF PROPERTY

DESCRIPTION OF PROPERTIES/ASSETS

(a)Real Estate.None.
(b)Title to properties.None.
(c)Patents, Trade Names, Trademarks and CopyrightsNone.

Our executive offices are located in Denver, Colorado. We do not own any real property, but lease and office space consisting of approximately 1100 sq. ft. among all of our corporate and subsidiary locations. We believe that substantially all of our property and equipment is in good condition, subject to normal wear and tear, and that our facilities have sufficient capacity to meet the current needs of our business.

c. LEGAL PROCEEDINGS

We may be subject to various claims and legal actions arising in the ordinary course of business from time to time. We believe that the ultimate resolution of these matters, whether individually or in the aggregate, will not have a material adverse effect on our business, prospects, financial condition and results of operations.

We currently are not involved in any legal proceedings.

d. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

Market Information

Currently thereOur common stock is a limited publiccurrently trading market for our stock as quoted on the OTC PinkOTCQB under the symbol BLAB.“VYBE.”

The following table sets forth the high and low bid quotations ofListing

We intend to apply to list our common stock for the periods indicated:

Fiscal 2020 Low  High 
First Quarter – ended March 31, 2020 $0.30  $1.00 
Second Quarter – ended June 30, 2020 $0.40  $0.90 
       
Fiscal 2019 Low  High 
First Quarter – ended March 31, 2019 $0.005  $0.007 
Second Quarter – ended June 30, 2019 $0.007  $0.007 
Third Quarter – ended September 30, 2019 $0.07  $1.00 
Fourth Quarter – ended December 31, 2019 $0.20  $0.40 
         
Fiscal 2018 Low  High 
First Quarter – ended March 31, 2018 $0.035  $0.35 
Second Quarter – ended June 30, 2018 $0.035  $0.035 
Third Quarter – ended September 30, 2018 $0.005  $0.035 
Fourth Quarter – ended December 31, 2018 $0.005  $0.005 

29 
Table of Contents

Rules Governing Low-price Stocks That May Affect Our Shareholders' Ability to Resell Shares of Our Common Stock

Quotations on the OTC Pink reflect inter-dealer prices, without retail mark-up, markdown or commission and may not reflect actual transactions. Our common stockNYSE American. However, no assurance can be given that our application will be subject to certain rules adopted by the SEC that regulate broker-dealer practices in connection with transactions in “penny stocks.” Penny stocks generally are securities with a price of less than $5.00, other than securities registered on certain national exchangescompleted or quotedapproved. We will not consummate this offering unless our Common Stock is approved for listing on the NASDAQ system, provided that the exchangeNYSE American or system provides current price and volume information with respect to transaction in such securities. The additional sales practice and disclosure requirements imposed upon broker-dealers are and may discourage broker-dealers from effecting transactions in our shares which could severely limit the market liquidity of the shares and impede the sale of shares in the secondary market.another stock exchange.

The penny stock rules require broker-dealers, prior to a transaction in a penny stock not otherwise exempt from the rules, to make a special suitability determination for the purchaser to receive the purchaser’s written consent to the transaction prior to sale, to deliver standardized risk disclosure documents prepared by the SEC that provides information about penny stocks and the nature and level of risks in the penny stock market. The broker-dealer must also provide the customer with current bid and offer quotations for the penny stock. In addition, the penny stock regulations require the broker-dealer to deliver, prior to any transaction involving a penny stock, a disclosure schedule prepared by the SEC relating to the penny stock market, unless the broker-dealer or the transaction is otherwise exempt. A broker-dealer is also required to disclose commissions payable to the broker-dealer and the registered representative and current quotations for the securities. Finally, a broker-dealer is required to send monthly statements disclosing recent price information with respect to the penny stock held in a customer's account and information with respect to the limited market in penny stocks.Holders

Holders

As of the filing of this prospectus, we have 517 shareholders of record of our common stock. Sales under Rule 144 are also subject to manner of sale provisions and notice requirements and to the availability of current public information about us. Under Rule 144, a person who has not been an affiliate at any time during the three months preceding a sale, and who has beneficially owned the shares proposed to be sold for at least 6 months, is entitled to sell shares without complying with the manner of sale, volume limitation or notice provisions of Rule 144.

As of the date of this prospectus, our shareholders hold 10,753,504there are approximately 500 record holders of 3,977,497 shares of common stock andour Common Stock, one holder of 500,000 shares of Class A Preferred Stock and 13 holders of which 9,690,999 common10,349,097 shares may be sold pursuant to this Registration Statement.of Class B Preferred Stock.

DividendsOur transfer agent is Mountain Share Transfer, Inc., 2030 Powers Ferry Rd. SE, Suite # 212, Atlanta, Georgia 30339. Their telephone number is (404) 474-3110.

As of the filing of this prospectus, we have not paid any dividends to shareholders. There are no restrictions which would limit our ability to pay dividends on common equity or that are likely to do so in the future. The Delaware General Corporation Law, however, does prohibit us from declaring dividends where, after giving effect to the distribution of the dividend; we would not be able to pay our debts as they become due in the usual course of business; or our total assets would be less than the sum of the total liabilities plus the amount that would be needed to satisfy the rights of shareholders who have preferential rights superior to those receiving the distribution.

Securities Authorized for Issuance Under Equity Compensation Plans.

WeEffective August 9, 2022, we adopted aour 2022 Incentive and Nonstatutory Stock Option and Award Plan on January 15, 2020. We have authorized 2,000,000 shares of common stock to be available for the Plan. We have granted no options exercisable for shares of our common stock under the Plan.

e. FINANCIAL STATEMENTS

The following is a complete list of the financial statements filed as a part of this Report.

Bio Lab Naturals, Inc. and Subsidiary

Consolidated Financial Statements for the period July 1, 2019 (Inception) through December 31, 2019

(Audited)

Report of Independent Registered Public Accounting FirmF-2
Consolidated Balance SheetF-3
Consolidated Statement of OperationsF-4
Consolidated Statement of Changes in Stockholders’ Equity (Deficit)F-5
Consolidated Statement of Cash FlowsF-6
Notes to the Financial StatementsF-7

30 
Table of Contents

Bio Lab Naturals, Inc. and Subsidiary

Condensed Consolidated Financial Statements as of March 31, 2020

(Unaudited)

Condensed Consolidated Balance SheetsF-14
Condensed Consolidated Statements of Operations – three months ended March 21, 2020 and 2019F-15
Condensed Consolidated Statement of Changes in Stockholders’ EquityF-16
Condensed Consolidated Statements of Cash FlowsF-17
Notes to Condensed Consolidated Financial StatementsF-18

Bio Lab Naturals, Inc. and Subsidiary

Condensed Consolidated Financial Statements as of June 30, 2020

(Unaudited)

Condensed Consolidated Balance SheetsF-25
Condensed Consolidated Statements of Operations – three months ended June 30, 2020 and 2019F-26
Condensed Consolidated Statements of Operations – six months ended June 30, 2020 and 2019F-27
Condensed Consolidated Statement of Changes in Stockholders’ EquityF-28
Condensed Consolidated Statements of Cash FlowsF-29
Notes to Condensed Consolidated Financial StatementsF-30

Prime Time Live, Inc.

Financial Statements for the period September 17, 2019 (Inception) through December 30 , 2019

(Audited)

Report of Independent Registered Public Accounting FirmF-38
Balance SheetF-39
Statement of OperationsF-40
Statement of Changes in Stockholders’ Equity (Deficit)F-41
Statement of Cash FlowsF-42
Notes to the Financial StatementsF-43

Prime Time Mobile Video Event Screens, LLC

Financial Statements for the period January 1, 2019 (Inception) through October 11, 2019

(Audited)

Report of Independent Registered Public Accounting FirmF-49
Balance SheetF-50
Statement of OperationsF-51
Statement of Changes in Members’ CapitalF-52
Statement of Cash FlowsF-53
Notes to the Financial StatementsF-54

Prime Time Mobile Video Event Screens, LLC

Financial Statements for the year ended December 31, 2018

(Audited)

Report of Independent Registered Public Accounting FirmF-58
Balance SheetF-59
Statement of OperationsF-60
Statement of Changes in Members’ CapitalF-61
Statement of Cash FlowsF-62
Notes to the Financial StatementsF-63

Bio Lab Naturals, Inc.

Pro Forma Financial Statements for the period ended December 31, 2019

(Unaudited)

Pro Forma Combined Consolidated Balance SheetF-67
Pro Forma Combined Statement of OperationsF-68

31 
Table of Contents

Bio Lab Naturals, Inc.

Consolidated Financial Statements

For the period July 1, 2019 (Inception) through

December 31, 2019

Audited

F-1 
Table of Contents

Report of Independent Registered Public Accounting Firm

To the shareholders and the board of directors of Bio Lab Naturals, Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheet of Bio Lab Naturals, Inc. (the "Company") as of December 31, 2019, the related statement of operations, stockholders' equity (deficit), and cash flows for the period July 1, 2019 (Inception) through December 31, 2019 and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2019, and the results of its operations and its cash flows for the period July 1, 2019 (Inception) through December 31, 2019, in conformity with accounting principles generally accepted in the United States.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

Substantial Doubt about the Company’s Ability to Continue as a Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company’s significant operating losses raise substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s BF Borgers CPA PC

BF Borgers CPA PC

We have served as the Company's auditor since 2019

Lakewood, CO

July 2, 2020

F-2 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY
CONSOLIDATED BALANCE SHEET
DECEMBER 31, 2019
   
Assets  
Current assets  
 Cash $69,527 
 Accounts receivable, net  13,000 
    Total current assets  82,527 
    Equipment    
 Equipment, net  160,536 
     
 Total Assets $243,063 
     
 Liabilities and Stockholders' Equity    
    Current liabilities    
 Accounts payable $18,900 
 Due to related party  3,270 
 Total current liabilities  22,170 
    Total liabilities  22,170 
     
 Commitments and Contingencies  —   
     
 Stockholders' Equity    
 Preferred shares, $0.0001 par value, 5,000,000 shares authorized;    
    Class A Convertible, deemed par value $0.04 per share; 500,000    
      shares issued and outstanding at December 31, 2019  50 
 Common shares, $0.0001 par value, 200,000,000 shares authorized;    
    8,477,505 shares issued and outstanding at December 31, 2019  848 
 Additional paid in capital  35,388,065 
 Retained (deficit)  (35,168,070)
    Total stockholders' equity  220,893 
     
 Total Liabilities and Stockholders' Equity $243,063 
     
 The accompanying notes are an integral part of these financial statements.

F-3 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENT OF OPERATIONS
PERIOD JULY 1, 2019 THROUGH DECEMBER 31, 2019
   
   
   
Operating expenses  
 Consulting fees, related party $420,000 
 General and administrative expenses - other  25,000 
 Asset impairment  1,429,107 
    Total operating expenses  1,874,107 
     
 Loss from operations  (1,874,107)
     
 Other expenses    
 Loss on extinguishment of debt  34,103 
 Interest expense  897 
    Total other expenses  35,000 
     
 Loss before income taxes  (1,909,107)
     
 Income taxes  —   
     
 Net loss $(1,909,107)
     
 Net loss per common share - basic and diluted $(0.21)
     
 Weighted average number of common shares  9,240,816 
     
 The accompanying notes are an integral part of these financial statements.

F-4 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
           
           
           
  Preferred Shares $0.0001 Par Value  
  Class A Convertible   Series AA    
  Shares Amount Shares Amount  
 BALANCES, July 1, 2019  —    $—     2,000  $2     
    Issuance of shares for services, related party  500,000   50   —     —       
    Issuance of shares for debt  —     —     —     —       
    Issuance of shares to acquire subsidiary  —     —     —     —       
    Redemption of shares  —     —     (2,000)  (2)    
    Net loss for the period  —     —     —     —       
 BALANCES, December 31, 2019  500,000  $50   —    $—       
                     
                     
    Common Shares $0.0001 Par Value Shares    Amount    Additional Paid-in Capital    Accumulated (Deficit)    Total Stockholders’ Equity  
 BALANCES, July 1, 2019  9,308,566  $931  $33,258,030  $(33,258,963) $—   
    Issuance of shares for services, related party  400,000   40   419,910   —     420,000 
    Issuance of shares for debt  200,000   20   59,980   —     60,000 
    Issuance of shares to acquire subsidiary  5,500,000   550   1,649,450   —     1,650,000 
    Redemption of shares  (6,931,061)  (693)  695   —     —   
    Net loss for the period  —     —     —     (1,909,107)  (1,909,107)
 BALANCES, December 31, 2019  8,477,505  $848  $35,388,065  $(35,168,070) $220,893 
                     
 The accompanying notes are an integral part of these financial statements.

F-5 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENT OF CASH FLOWS
PERIOD JULY 1, 2019 THROUGH DECEMBER 31, 2019
   
   
OPERATING ACTIVITIES  
 Net loss $(1,909,107)
 Adjustment to reconcile net loss to net cash flows used    
 in operating activities    
 Issuance of common shares for services, related party  420,000 
 Asset impairment  1,429,107 
 Loss on extinguishment of debt  34,103 
 Changes in:    
 Accrued expenses  897 
 Net cash (used in) operating activities  (25,000)
     
 INVESTING ACTIVITIES    
 Cash acquired in purchase of subsidiary  69,527 
     
 FINANCING ACTIVITIES    
 Funds provided from short term loan  25,000 
     
 Net increase in cash  69,527 
 Cash at beginning of period  —   
 Cash at end of period $69,527 
     
 Supplemental Schedule of Cash Flow Information:    
 Interest paid $—   
 Income taxes paid $—   
     
 Supplemental Schedule of Non-Cash Flow Information:    
 Issuance of common shares for property $1,650,000 
 Issuance of common shares for debt $60,000 
     
 The accompanying notes are an integral part of these financial statements.

F-6 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

for the period July 1, 2019 (Inception) through December 31, 2019

Note 1 – Organization and History

Vyta Corp (the “Company”) was incorporated in Nevada in June 1996. On August 20, 2010, it changed its state of incorporation to Delaware and on November 5, 2010 it changed its name to Bio Lab Naturals, Inc. On August 20, 2010, the Company executed a redomicile merger with its wholly owned subsidiary Vyta Corp (Delaware), as result of the merger the Company’s corporate domicile moved from Nevada to Delaware.

Prior to 2011, the Company was involved in various business activities and since then the Company has been seeking a business opportunity.

Effective December 31, 2019, the Company entered into a Reorganization Agreement with Prime Time Live, Inc., a Colorado corporation (“PTL”), whereby PTL merged with a newly formed wholly owned subsidiary of the Company, and the subsidiary being the survivor in exchange for the Company issuing one share of its common stock for each share of PTL’s 5,500,000 issued and outstanding shares of common stock. See Note 5 – Significant Acquisition.

Note 2 – Summary of Significant Accounting Policies

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of Bio Lab Naturals, Inc. and its wholly owned subsidiary. All intercompany balances have been eliminated during consolidation.

The Company changed its year end from June 30th to December 31st and, therefore the consolidated financial statement represents a short year as of and for the period July 1, 2019 through December 31, 2019.

Use of Estimates in the Preparation of Consolidated Financial Statements

The preparation of consolidated financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Significant estimates include the fair value of assets and liabilities, income taxes and the valuation allowances related to accounts receivable, deferred tax assets and contingencies.

Cash and Cash Equivalents

The Company considers all liquid investments purchased with an initial maturity of three months or less to be cash equivalents. Cash and cash equivalents include demand deposits carried at cost which approximates fair value. The Company maintains its cash in institutions insured by the Federal Deposit Insurance Corporation (“FDIC”).

Concentration of Credit Risk

The Company offers its services to 2 clients. This risk of non-payment by these clients is considered minimal and the Company does not generally obtain collateral for sales. The Company continually monitors the credit standing of its clients.

Accounts Receivable

The Company records accounts receivable at net realizable value. This value includes an appropriate allowance for uncollectible accounts to reflect any loss anticipated on the accounts receivable balances and is charged to other income (expense) in the statements of operations. Management calculates this allowance based on its history of write-offs, the level of past-due accounts based on the contractual terms of the receivables, and the Company’s relationships with, and the economic status of, its clients. At December 31, 2019, there is no allowance for uncollectible accounts.

F-7 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

for the period July 1, 2019 (Inception) through December 31, 2019

Equipment

Equipment is recorded at cost and consists of video equipment. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation of video equipment is over the estimated useful life of five years using the straight-line method for consolidated financial statement purposes. At December 31, 2019 there were capitalized costs of $160,536 and depreciation for the period July 1, 2019 through December 31, 2019 was $0 due to the Company acquiring the equipment at December 31, 2019. See Note 4 – Fair Value Measurements.

Revenue recognition

The Company follows the provisions of Accounting Standards Update (“ASU”) No. 2014 - 09, Revenue from Contracts with Customers (Topic 606), using the full retrospective transition method. The Company’s adoption of ASU 2014 - 09 did not have a material impact on the amount and timing of revenue recognized in its consolidated financial statements.

Under ASU 2014 - 09, the Company recognizes revenue when control of the promised services is transferred to clients, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services.

The Company derives its revenues from the rendering of entertainment rental services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its contracts:

Identify the contract with a client;

Identify the performance obligations in the contract;

Determine the transaction price;

Allocate the transaction price to performance obligations in the contract; and

Recognize revenue as the performance obligation is satisfied.

Impairment of Long-Lived Assets

In accordance with authoritative guidance on accounting for the impairment or disposal of long-lived assets, as set forth in Topic 360 of the ASC, the Company assesses the recoverability of the carrying value of its long-lived assets when events occur that indicate an impairment in value may exist. An impairment loss is indicated if the sum of the expected undiscounted future net cash flows is less than the carrying amount of the assets. If this occurs, an impairment loss is recognized for the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets.

Other Comprehensive Loss

The Company has no material components of other comprehensive loss and accordingly, net loss is equal to comprehensive loss for the period.

F-8 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

for the period July 1, 2019 (Inception) through December 31, 2019

Income Taxes

The Company uses the liability method of accounting for income taxes under which deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the accounting bases and the tax bases of the Company’s assets and liabilities. The deferred tax assets and liabilities are computed using enacted tax rates in effect for the year in which the temporary differences are expected to reverse.

The Company's deferred income taxes include certain future tax benefits. The Company records a valuation allowance against any portion of those deferred income tax assets when it believes, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred income tax asset will not be realized.

The Company has adopted ASC guidance regarding accounting for uncertainty in income taxes. This guidance clarifies the accounting for income taxes by prescribing the minimum recognition threshold an income tax position is required to meet before being recognized in the consolidated financial statements and applies to all income tax positions. Each income tax position is assessed using a two-step process. A determination is first made as to whether it is more likely than not that the income tax position will be sustained, based upon technical merits, upon examination by the taxing authorities. If the income tax position is expected to meet the more likely than not criteria, the benefit recorded in the consolidated financial statements equals the largest amount that is greater than 50% likely to be realized upon its ultimate settlement. At December 31, 2019, there were no uncertain tax positions that required accrual.

Goodwill

In accordance with generally accepted accounting principles, goodwill cannot be amortized, however, it must be tested annually for impairment. This impairment test is calculated at the reporting unit level. The goodwill impairment test has two steps. The first identifies potential impairments by comparing the fair value of a reporting unit with its book value, including goodwill. If the fair value of the reporting unit exceeds the carrying amount, goodwill is not impaired and the second step is not necessary. If the carrying value exceeds the fair value, the second step calculates the possible impairment loss by comparing the implied fair value of goodwill with the carrying amount. If the implied goodwill is less than the carrying amount, a write-down is recorded. Management tests goodwill each year for impairment, or when facts or circumstances indicate impairment has occurred.

Net Loss per Share

Basic net loss per common share of stock is calculated by dividing net loss available to common stockholders by the weighted-average number of common shares outstanding during each period. Diluted net loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding, including the effect of other dilutive securities. The Company’s had no potentially dilutive securities issued as of and during the period July 1, 2019 through December 31, 2019.

Equity Based Payments

The Company recognizes compensation cost for equity based awards based on estimated fair value of the award and records capitalized cost or compensation expense over the requisite service period.  

Off-Balance Sheet Arrangements

As part of its ongoing business, the Company has not participated in transactions that generate relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities (SPEs), which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. For the period through December 31, 2019, the Company has not been involved in any unconsolidated SPE transactions.

F-9 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

for the period July 1, 2019 (Inception) through December 31, 2019

Subsequent Events

The Company evaluates events and transactions after the balance sheet date but before the consolidated financial statements are issued.

Note 3 – Going Concern and Managements’ Plan

The Company’s consolidated financial statements for the period July 1, 2019 through December 31, 2019 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The Company reported a net loss of $1,909,107 for the such period and an accumulated deficit of $35,158,070 at December 31, 2019.

The Company’s significant operating losses and the COVID-19 Pandemic raise substantial doubt about its ability to continue as a going concern within one year after the date of the issuance of these financial statements. The future success of the Company is dependent on its ability to attract additional capital and ultimately, upon its ability to develop future profitable operations. There can be no assurance that the Company will be successful in obtaining such financing, or that it will attain positive cash flow from operations. However, management believes that actions presently being taken to raise additional capital as more fully disclosed in Note 8 – Subsequent Events – provides the opportunity for the Company to continually continue as a going concern.

Note 4 – Fair Value Measurements

The Company applies the authoritative guidance applicable to all financial assets and liabilities required to be measured and reported on a fair value basis, as well as to non-financial assets and liabilities measured at fair value on a non-recurring basis, including impairments of long-lived assets. The fair value of an asset or liability is the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. Observable inputs are inputs that market participants would use in valuing the asset or liability based on market data obtained from sources independent of the Company. Unobservable input are inputs that reflect the Company’s assumptions of what market participants would use in valuing the asset or liability based on the information available in the circumstances.

Financial and non-financial assets and liabilities are classified within the valuation hierarchy based upon the lowest level of input that is significant to the fair value measurement. The Company’s policy is to recognize transfers in and out of the fair value hierarchy as of the end of the reporting period in which the event or change in circumstances caused the transfer. The Company has consistently applied the valuation techniques discussed below in all periods presented. The hierarchy is organized into three levels based on the reliability of the inputs as follows:

Level 1: Quoted prices in active markets for identical assets or liabilities; or

Level 2: Quoted prices in active markets for similar assets and liabilities and inputs, quoted prices for identical or similar assets or liabilities in markets that are not active and model-derived valuations whose inputs or significant value drivers are observable; or

Level 3: Unobservable pricing inputs in which there is little or no market data, which requires the reporting entity to develop its own assumptions.

The following table presents the Company’s non-financial assets and liabilities that were measured at fair value on a non-recurring basis at December 31, 2019 by level within the fair value hierarchy:

Description Level 1 Level 2 Level 3 Total
Assets        
  Equipment   $—    $—    $160,536  $160,536 
  Goodwill   $—    $—    $1,429,107  $1,429,107 

F-10 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

for the period July 1, 2019 (Inception) through December 31, 2019

Effective December 31 2019, the Company’s equipment was tested under ASC 360 as to its recoverability to determine if impairment is required under the accounting guidance. The Company used Level 3 inputs to measure the fair value of the assets. As such, there was no impairment during the period July 1, 2019 through December 31, 2019.

Effective December 31, 2019, the Company acquired Prime Time Live Inc. and as a result realized goodwill in the amount of $1,429,107. Thus, due to the significance of this event, goodwill was tested under ASC 360 as to its recoverability. Therefore, goodwill is recorded at fair value if impairment is required under the accounting guidance. The Company used Level 3 inputs to measure the fair value of the asset and management determined that there were no future undiscounted cash flows associated with goodwill. As such, the Company’s goodwill was fully impaired during the period July 1, 2019 through December 31, 2019 in the amount of $1,429,107 and reported in the consolidated statement of operations.

Note 5 – Significant Acquisition

Effective December 31, 2019, the Company acquired Prime Time Live, Inc., a company in the entertainment related industry in exchange for 5,500,000 shares of the Company’s common stock valued at $0.30 per share, based upon the stock price on the OTC markets at December 31, 2019, or a total value of $1,650,000.

The following table presents the allocation of the consideration given to the assets acquired and liabilities assumed, based on their fair values at December 31, 2019:

Consideration Given  
Shares of common stock $1,650,000 
     
Total purchase price $1,650,000 
     
     Allocation of Consideration Given    
Cash $69,527 
Accounts receivable, net  13,000 
Equipment  160,536 
Goodwill  1,429,107 
     
Total assets  1,672,170 
     
Current liabilities  22,170 
     
Net assets acquired $1,650,000 

Note 6 – Stockholders’ Equity

Preferred Shares

Class A Convertible

During the period July 1, 2019 through December 31, 2019, the Company issued 500,000 shares of its Class A Convertible shares of preferred stock (“Class A”) in exchange for services valued at $300,000. The Class A shares provide that when voting as a single class, the shares shall have the votes and the voting power at all times to be at least 60% of the voting power of the Company. Also, the holders of the Class A shares at their discretion and subject to a change of control and to the qualification by application to either NASQAD or NYSE Emerging Markets, convert their one share of Class A into two shares of the Company’s common stock, subject to adjustment. In addition, the holder of the shares of Class A is entitled to a liquidation preference of the Company senior to all other securities of the Company. See Note 7 – Related Party Transactions.

F-11 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

for the period July 1, 2019 (Inception) through December 31, 2019

Series AA

During the period July 1, 2019 through December 31, 2019, the Company cancelled its 2,000 Series AA shares of preferred stock and there were no holders of such shares.

Common Shares

The Company’s capital stock at December 31, 2019 consists of 200,000,000 authorized shares of $0.0001 par value common stock. At December 31, 2019, there are a total of 8,477,505 shares of common stock issued and outstanding.

During the period July 1, 2019 through December 31, 2019, the Company issued 400,000 shares of its common stock in exchange for services valued at $120,000. See Note 7 – Related Party Transactions.

In addition, the Company issued 200,000 shares of its common stock in exchange for payment of debt in the amount of $25,897 and realized a loss on extinguishment of debt in the amount of $34,103 that was reported in the consolidated statement of operations.

As part of the acquisition of Prime Time Live, Inc., the Company issued 5,500,000 shares of its common stock valued at $1,650,000. See Note 5 – Significant Acquisition.

Note 7 – Related Party Transactions

Due to Related Parties

At December 31, 2019, the Company owes affiliates of two of its officers $3,270.

Equity for Services

At December 31, 2019, the Company issued 500,000 shares of its Class A shares of preferred stock to an officer and more than five percent shareholder of the Company in exchange for consulting fees valued at $300,000.

During the period July 1, 2019 through December 31, 2019, the Company issued 400,000 shares of its common stock to a more than five percent shareholder of the Company and holder of 250,000 shares of Class A Preferred Super Majority Voting Stock in exchange for consulting fees valued at $120,000.

Note 8 – Subsequent Events

During the three months ended June 30, 2020, the Company sold 2,095,999 of its common stock as part of a private placement for $262,000 in cash or $0.125 per share and issued 100,000 shares of its common stock for services rendered in the amount of $12,500.

F-12 
Table of Contents

Bio Lab Naturals, Inc.

Consolidated Financial Statements

For the three-month period ended

March 31, 2020

Unaudited

F-13 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY
CONSOLIDATED BALANCE SHEETS
     
  March 31, December 31,
Assets 2020 2019
Current assets (Unaudited) (Audited)
 Cash $10,580  $69,527 
 Accounts receivable, net  —     13,000 
 Deposit  10,000   —   
    Total current assets  20,580   82,527 
    Equipment        
 Equipment, net of accumulated depreciation, $8,449  152,087   160,536 
         
 Total Assets $172,667  $243,063 
         
 Liabilities and Stockholders' Equity        
    Current liabilities        
 Accounts payable $30,829  $18,900 
 Due to related party  10,000   3,270 
 Note payable, related party  14,200   —   
 Total current liabilities  55,029   22,170 
    Total liabilities  55,029   22,170 
         
 Commitments and Contingencies  —       
         
 Stockholders' Equity        
 Preferred shares, $0.0001 par value, 5,000,000 shares authorized;        
    Class A Convertible, deemed par value $0.04 per share; 500,000        
      shares issued and outstanding at March 31, 2020 and        
      December 31, 2019  50   50 
 Common shares, $0.0001 par value, 200,000,000 shares authorized;        
    8,477,505 shares issued and outstanding at March 31, 2020        
      and December 31, 2019  848   848 
 Additional paid in capital  35,388,065   35,388,065 
 Retained (deficit)  (35,271,325)  (35,168,070)
    Total stockholders' equity  117,638   220,893 
         
 Total Liabilities and Stockholders' Equity $172,667  $243,063 
         
 The accompanying notes are an integral part of these financial statements. 

F-14 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
   
     
  Three Months Ended March 31,
  2020 2019
Sales $—    $—   
Cost of sales        
 Cost of sales - other  6,394   —   
 Depreciation  8,449   —   
    Total cost of sales  14,843   —   
         
 Gross profit  (14,843)  —   
         
 Operating expenses        
 Consulting fees, related party  27,000   —   
 Consulting fees  10,500   —   
 General and administrative expenses - other  10,134   —   
 Professional fees  40,778   —   
    Total operating expenses  88,412   —   
         
 Loss before income taxes  (103,255)  —   
         
 Income taxes  —     —   
         
 Net loss $(103,255) $—   
         
 Net loss per common share - basic and diluted $(0.01)   *  
         
 Weighted average number of common shares  9,308,566   9,308,566 
         
 * Net loss is less than $0.01 per share.        
         
 The accompanying notes are an integral part of these financial statements. 

F-15 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
(Unaudited)
               
               
               
  Class A Convertible Preferred Common Shares Additional   Total
  $0.0001 Par Value $0.0001 Par Value Paid-in Accumulated Stockholders'
  Shares Amount Shares Amount Capital (Deficit) Equity
 BALANCES, December 31, 2019  500,000  $50   8,477,505  $848  $35,388,065  $(35,168,070) $220,893 
    Net loss for the period  —     —     —     —     —     (103,255)  (103,255)
 BALANCES, March 31, 2020  500,000  $50   8,477,505  $848  $35,388,065  $(35,271,325) $117,638 
                             
 The accompanying notes are an integral part of these financial statements.

F-16 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
   
  Three Months Ended March 31,
  2020 2019
OPERATING ACTIVITIES    
 Net loss $(103,255) $—   
 Adjustment to reconcile net loss to net cash flows used        
 in operating activities        
 Depreciation  8,449   —   
 Changes in:        
 Accounts receivable - net  13,000   —   
 Deposit  (10,000)  —   
 Accounts payable  21,929   —   
 Net cash (used in) operating activities  (69,877)  —   
         
 INVESTING ACTIVITIES  —     —   
         
 FINANCING ACTIVITIES        
 Funds from related party, net of repayment  10,930   —   
         
 Net (decrease) in cash  (58,947)  —   
 Cash at beginning of period  69,527   —   
 Cash at end of period $10,580  $—   
         
 Supplemental Schedule of Cash Flow Information:        
 Interest paid $—    $—   
 Income taxes paid $—    $—   
         
 The accompanying notes are an integral part of these financial statements. 

F-17 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

March 31, 2020

Note 1 – Organization and History

Vyta Corp (the “Company”) was incorporated in Nevada in June 1996. On August 20, 2010, it changed its state of incorporation to Delaware and on November 5, 2010 it changed its name to Bio Lab Naturals, Inc. On August 20, 2010, the Company executed a redomicile merger with its wholly owned subsidiary Vyta Corp (Delaware), as result of the merger the Company’s corporate domicile moved from Nevada to Delaware.

Prior to 2011, the Company was involved in various business activities and since then the Company has been seeking a business opportunity.

Effective December 31, 2019, the Company entered into a Reorganization Agreement with Prime Time Live, Inc., a Colorado corporation (“PTL”), whereby PTL merged with a newly formed wholly owned subsidiary of the Company, and the subsidiary being the survivor in exchange for the Company issuing one share of its common stock for each share of PTL’s 5,500,000 issued and outstanding shares of common stock. See Note 5 – Significant Acquisition.

Note 2 – Summary of Significant Accounting Policies

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of Bio Lab Naturals, Inc. and its wholly owned subsidiary. All intercompany balances have been eliminated during consolidation.

Use of Estimates in the Preparation of Consolidated Financial Statements

The preparation of consolidated financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Significant estimates include the fair value of assets and liabilities, income taxes and the valuation allowances related to accounts receivable, deferred tax assets and contingencies.

Cash and Cash Equivalents

The Company considers all liquid investments purchased with an initial maturity of three months or less to be cash equivalents. Cash and cash equivalents include demand deposits carried at cost which approximates fair value. The Company maintains its cash in institutions insured by the Federal Deposit Insurance Corporation (“FDIC”).

Concentration of Credit Risk

The Company offers its services to 2 clients. This risk of non-payment by these clients is considered minimal and the Company does not generally obtain collateral for sales. The Company continually monitors the credit standing of its clients.

Accounts Receivable

The Company records accounts receivable at net realizable value. This value includes an appropriate allowance for uncollectible accounts to reflect any loss anticipated on the accounts receivable balances and is charged to other income (expense) in the statements of operations. Management calculates this allowance based on its history of write-offs, the level of past-due accounts based on the contractual terms of the receivables, and the Company’s relationships with, and the economic status of, its clients. At March 31, 2020 and December 31, 2019, there are no allowance for uncollectible accounts.

Equipment

Equipment is recorded at cost and consists of video equipment. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations

F-18 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

March 31, 2020

for the respective period. Depreciation of video equipment is over the estimated useful life of five years using the straight-line method for consolidated financial statement purposes. At March 31, 2020 and December 31, 2019 there were capitalized costs of $160,536 and $152,087, respectively. Depreciation for the three months ended March 31, 2020 and 2019 was $8,449 and $0, respectively due to the Company acquiring the equipment at December 31, 2019. See Note 4 – Fair Value Measurements.

Revenue recognition

The Company follows the provisions of Accounting Standards Update (“ASU”) No. 2014 – 09, Revenue from Contracts with Customers (Topic 606), using the full retrospective transition method. The Company’s adoption of ASU 2014 – 09 did not have a material impact on the amount and timing of revenue recognized in its consolidated financial statements.

Under ASU 2014 – 09, the Company recognizes revenue when control of the promised services is transferred to clients, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services.

The Company derives its revenues from the rendering of entertainment rental services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its contracts:

Identify the contract with a customer;

Identify the performance obligations in the contract;

Determine the transaction price;

Allocate the transaction price to performance obligations in the contract; and

Recognize revenue as the performance obligation is satisfied.

Impairment of Long-Lived Assets

In accordance with authoritative guidance on accounting for the impairment or disposal of long-lived assets, as set forth in Topic 360 of the ASC, the Company assesses the recoverability of the carrying value of its long-lived assets when events occur that indicate an impairment in value may exist. An impairment loss is indicated if the sum of the expected undiscounted future net cash flows is less than the carrying amount of the assets. If this occurs, an impairment loss is recognized for the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets.

Other Comprehensive Loss

The Company has no material components of other comprehensive loss and accordingly, net loss is equal to comprehensive loss for the period.

Income Taxes

The Company uses the liability method of accounting for income taxes under which deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the accounting bases and the tax bases of the Company’s assets and liabilities. The deferred tax assets and liabilities are computed using enacted tax rates in effect for the year in which the temporary differences are expected to reverse.

The Company’s deferred income taxes include certain future tax benefits. The Company records a valuation allowance against any portion of those deferred income tax assets when it believes, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred income tax asset will not be realized.

The Company has adopted ASC guidance regarding accounting for uncertainty in income taxes. This guidance clarifies the accounting for income taxes by prescribing the minimum recognition threshold an income tax position is required to meet before being recognized in the consolidated financial statements and applies to all income tax positions. Each income tax position is assessed using a two-step process. A determination is first made as to whether it is more likely than not that the income tax position will be sustained, based upon technical merits, upon examination by the taxing authorities. If the income tax position is expected to meet the more likely than not criteria, the benefit recorded in the consolidated financial statements equals the largest amount that is greater than 50% likely to be realized upon its ultimate settlement. At March 31, 2020 and December 31, 2019, there were no uncertain tax positions that required accrual.

F-19 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

March 31, 2020

Goodwill

In accordance with generally accepted accounting principles, goodwill cannot be amortized, however, it must be tested annually for impairment. This impairment test is calculated at the reporting unit level. The goodwill impairment test has two steps. The first identifies potential impairments by comparing the fair value of a reporting unit with its book value, including goodwill. If the fair value of the reporting unit exceeds the carrying amount, goodwill is not impaired and the second step is not necessary. If the carrying value exceeds the fair value, the second step calculates the possible impairment loss by comparing the implied fair value of goodwill with the carrying amount. If the implied goodwill is less than the carrying amount, a write-down is recorded. Management tests goodwill each year for impairment, or when facts or circumstances indicate impairment has occurred.

Net Loss per Share

Basic net loss per common share of stock is calculated by dividing net loss available to common stockholders by the weighted-average number of common shares outstanding during each period. Diluted net loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding, including the effect of other dilutive securities. The Company’s had no potentially dilutive securities issued as of and during the three months ended March 31, 2020 and 2019.

Equity Based Payments

The Company recognizes compensation cost for equity based awards based on estimated fair value of the award and records capitalized cost or compensation expense over the requisite service period.  

Off-Balance Sheet Arrangements

As part of its ongoing business, the Company has not participated in transactions that generate relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities (SPEs), which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. For the period through March 31, 2020, the Company has not been involved in any unconsolidated SPE transactions.

Subsequent Events

The Company evaluates events and transactions after the balance sheet date but before the consolidated financial statements are issued.

Note 3 – Going Concern and Managements’ Plan

The Company’s consolidated financial statements for the three months ended March 31, 2020 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The Company reported a net loss of $103,255 for the three months ended March 31, 2020 and an accumulated deficit of $35,271,325 at March 31, 2020.

The Company’s significant operating losses and the COVID-19 Pandemic raise substantial doubt about its ability to continue as a going concern within one year after the date of the issuance of these financial statements. The future success of the Company is dependent on its ability to attract additional capital and ultimately, upon its ability to develop future profitable operations. There can be no assurance that the Company will be successful in obtaining such financing, or that it will attain positive cash flow from operations. However, management believes that actions presently being taken to raise additional capital as more fully disclosed in Note 9 – Subsequent Events – provides the opportunity for the Company to possibly continue as a going concern.

Note 4 – Fair Value Measurements

The Company applies the authoritative guidance applicable to all financial assets and liabilities required to be measured and reported on a fair value basis, as well as to non-financial assets and liabilities measured at fair value on a non-recurring basis, including impairments of long-lived assets. The fair value of an asset or liability is the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair

F-20 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

March 31, 2020

value. Observable inputs are inputs that market participants would use in valuing the asset or liability based on market data obtained from sources independent of the Company. Unobservable input are inputs that reflect the Company’s assumptions of what market participants would use in valuing the asset or liability based on the information available in the circumstances.

Financial and non-financial assets and liabilities are classified within the valuation hierarchy based upon the lowest level of input that is significant to the fair value measurement. The Company’s policy is to recognize transfers in and out of the fair value hierarchy as of the end of the reporting period in which the event or change in circumstances caused the transfer. The Company has consistently applied the valuation techniques discussed below in all periods presented. The hierarchy is organized into three levels based on the reliability of the inputs as follows:

Level 1: Quoted prices in active markets for identical assets or liabilities; or

Level 2: Quoted prices in active markets for similar assets and liabilities and inputs, quoted prices for identical or similar assets or liabilities in markets that are not active and model-derived valuations whose inputs or significant value drivers are observable; or

Level 3: Unobservable pricing inputs in which there is little or no market data, which requires the reporting entity to develop its own assumptions.

The following table presents the Company’s non-financial assets and liabilities that were measured at fair value on a non-recurring basis at December 31, 2019 by level within the fair value hierarchy:

Description Level 1 Level 2 Level 3 Total
Assets        
  Equipment   $—    $—    $160,536  $160,536 
  Goodwill   $—    $—    $1,429,107  $1,429,107 

Effective December 31 2019, the Company’s equipment was tested under ASC 360 as to its recoverability to determine if impairment is required under the accounting guidance. The Company used Level 3 inputs to measure the fair value of the assets. As such, there was no impairment.

Effective December 31, 2019, the Company acquired Prime Time Live Inc. and as a result realized goodwill in the amount of $1,429,107. Thus, due to the significance of this event, goodwill was tested under ASC 360 as to its recoverability. Therefore, goodwill is recorded at fair value if impairment is required under the accounting guidance. The Company used Level 3 inputs to measure the fair value of the asset and management determined that there were no future undiscounted cash flows associated with goodwill. As such, the Company’s goodwill was fully impaired at December 31, 2019 in the amount of $1,429,107.

Note 5 – Significant Acquisition

Effective December 31, 2019, the Company acquired Prime Time Live, Inc., a company in the entertainment related industry in exchange for 5,500,000 shares of the Company’s common stock valued at $0.30 per share, based upon the stock price on the OTC markets at December 31, 2019, or a total value of $1,650,000.

The following table presents the allocation of the consideration given to the assets acquired and liabilities assumed, based on their fair values at December 31, 2019:

F-21 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

March 31, 2020

Consideration Given  
Shares of common stock $1,650,000 
     
Total purchase price $1,650,000 
     
     Allocation of Consideration Given    
Cash $69,527 
Accounts receivable, net  13,000 
Equipment  160,536 
Goodwill  1,429,107 
     
Total assets  1,672,170 
     
Current liabilities  22,170 
     
Net assets acquired $1,650,000 

Note 6 – Debt

Convertible Promissory Note

An affiliate of an officer of the Company, loaned the Company $14,200 in exchange for an unsecured convertible promissory note that includes interest at the rate of six percent (6%) per annum on the unpaid principal balance with any accrued and unpaid interest due on or before December 31, 2020 (the “Note”). The Note allows for the note holder to convert, at their discretion, any accrued and unpaid interest and principal balance due on the Note in whole or in part into shares of the Company’s common stock at a conversion price of $0.125 per share. At March 31, 2020, the Company owes $14,200 on the debt. – See Note 8 – Related Party Transactions.

Note 7 – Stockholders’ Equity

Preferred Shares

Class A Convertible

At March 31, 2020, there are a total of 500,000 shares of Class A Convertible shares of preferred stock (“Class A”) issued and outstanding. The Class A shares provide that when voting as a single class, the shares shall have the votes and the voting power at all times to be at least 60% of the voting power of the Company. Further, the holders of the Class A shares at their discretion and subject to a change of control and to the qualification by application to either NASQAD or NYSE Emerging Markets, can convert their one share of Class A into two shares of the Company’s common stock, subject to adjustment. In addition, the holder of the shares of Class A is entitled to a liquidation preference of the Company senior to all other securities of the Company.

Common Shares

The Company’s capital stock at March 31, 2020 consists of 200,000,000 authorized shares of $0.0001 par value common stock. At March 31, 2020, there are a total of 8,477,505 shares of common stock issued and outstanding.

Note 8 – Related Party Transactions

Due to Related Parties

During the three months ended March 31, 2020, the Company borrowed $14,200 from an affiliate of one of its officers in exchange for an unsecured convertible promissory note. See Note 9 – Subsequent Events.

F-22 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

March 31, 2020

During the three months ended March 31, 2020, the Company incurred consulting fees in the amount of $27,000 to an officer and an affiliate of one of its officers of which $9,800 is due by the Company as of March 31, 2020.

At March 31, 2020, the Company owes an affiliate of one of its officers $200 and at December 31, 2019 the Company owes affiliates of two of its officers $3,270.

Note 9 – Subsequent Events

During the three months ended June 30, 2020, the Company sold 2,095,999 of its common stock as part of a private placement for $262,000 in cash or $0.125 per share, issued 100,000 shares of its common stock for services rendered in the amount of $12,500 and issued 80,000 shares of its common stock to convert debt in the amount of $10,000.

F-23 
Table of Contents

Bio Lab Naturals, Inc.

Consolidated Financial Statements

For the three and six-month periods ended

June 30, 2020

(Unaudited)

F-24 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY
CONSOLIDATED BALANCE SHEETS
   
     
  June 30, December 31,
Assets 2020 2019
Current assets (Unaudited) (Audited)
 Cash $225,936  $69,527 
 Accounts receivable, net  —     13,000 
 Deposits  15,000   —   
    Total current assets  240,936   82,527 
    Equipment        
 Equipment, net of accumulated depreciation, $16,899  143,637   160,536 
         
 Total Assets $384,573  $243,063 
         
 Liabilities and Stockholders' Equity        
    Current liabilities        
 Accounts payable $19,206  $18,900 
 Earnest money deposit  6,250   —   
 Due to others  1,125   —   
 Due to related party  —     3,270 
 Note payable, related party  4,200   —   
 Total current liabilities  30,781   22,170 
    Total liabilities  30,781   22,170 
         
 Commitments and Contingencies  —       
         
 Stockholders' Equity        
 Preferred shares, $0.0001 par value, 5,000,000 shares authorized;        
    Class A Convertible, deemed par value $0.04 per share; 500,000        
      shares issued and outstanding at June 30, 2020 and        
      December 31, 2019  50   50 
 Common shares, $0.0001 par value, 200,000,000 shares authorized;        
    10,753,504 and 8,477,505 shares issued and outstanding at        
      June 30, 2020 and December 31, 2019, respectively  1,075   848 
 Additional paid in capital  35,672,338   35,388,065 
 Retained (deficit)  (35,319,671)  (35,168,070)
    Total stockholders' equity  353,792   220,893 
         
 Total Liabilities and Stockholders' Equity $384,573  $243,063 
         
 The accompanying notes are an integral part of these financial statements. 

F-25 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
     
     
  Three Months Ended June 30,
  2020 2019
Sales $—    $—   
         
Cost of sales        
Cost of sales - other  4,664   —   
Depreciation  8,449   —   
Total cost of sales  13,113   —   
         
Gross profit  (13,113)  —   
         
Operating expenses        
Consulting fees, related party  12,500   —   
Consulting fees  —     —   
General and administrative expenses - other  6,244   —   
Professional fees  16,237   —   
Total operating expenses  34,981   —   
         
Loss from operations  (48,094)  —   
         
Other (expense)        
Interest expense  (251)  —   
         
Loss before income taxes  (48,345)  —   
         
Income taxes  —     —   
         
Net loss $(48,345) $—   
         
Net loss per common share - basic and diluted  *   * 
         
Weighted average number of common shares  8,936,186   9,308,566 
         
* Net loss is less than $0.01 per share.        
         
The accompanying notes are an integral part of these financial statements. 

F-26 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
   
     
  Six Months Ended June 30,
  2020 2019
 Sales $—    $—   
         
 Cost of sales        
 Cost of sales - other  11,058   —   
 Depreciation  16,898   —   
    Total cost of sales  27,956   —   
         
 Gross profit  (27,956)  —   
         
 Operating expenses        
 Consulting fees, related party  39,500   —   
 Consulting fees  10,500   —   
 General and administrative expenses - other  16,379   —   
 Professional fees  57,015   —   
    Total operating expenses  123,394   —   
         
 Loss from operations  (151,350)  —   
         
 Other (expense)        
 Interest expense  (251)  —   
         
 Loss before income taxes  (151,601)  —   
         
 Income taxes  —     —   
         
 Net loss $(151,601) $—   
         
 Net loss per common share - basic and diluted $(0.02)   *  
         
 Weighted average number of common shares  8,706,846   9,308,566 
         
 * Net loss is less than $0.01 per share.        
         
 The accompanying notes are an integral part of these financial statements. 

F-27 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
(Unaudited)
               
               
  Class A Convertible Preferred Common Shares Additional   Total
  $0.0001 Par Value $0.0001 Par Value Paid-in Accumulated Stockholders'
  Shares Amount Shares Amount Capital (Deficit) Equity
 BALANCES, December 31, 2019  500,000  $50   8,477,505  $848  $35,388,065  $(35,168,070) $220,893 
    Issuance of shares for services  —     —     100,000   10   12,490   —     12,500 
    Issuance of shares for conversion of debt  —     —     80,000   8   9,992   —     10,000 
    Sale of shares for cash at $0.125 per share  —     —     2,095,999   209   261,791   —     262,000 
    Net loss for the period  —     —     —     —     —     (151,601)  (151,601)
 BALANCES, June 30, 2020  500,000  $50   10,753,504  $1,075  $35,672,338  $(35,319,671) $353,792 
                             
 The accompanying notes are an integral part of these financial statements.

F-28 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
   
     
  Six Months Ended June 30,
  2020 2019
OPERATING ACTIVITIES    
 Net loss $(151,601) $—   
 Adjustment to reconcile net loss to net cash flows used        
 in operating activities        
 Depreciation  16,898   —   
 Issuance of shares for services  12,500   —   
 Changes in:        
 Accounts receivable - net  13,000   —   
 Deposits  (15,000)  —   
 Accounts payable  307   —   
 Net cash (used in) operating activities  (123,896)  —   
         
 INVESTING ACTIVITIES  —     —   
         
 FINANCING ACTIVITIES        
 Funds from sale of common shares  262,000   —   
 Funds from over subscription  1,125   —   
 Funds from earnest money deposit  6,250     
 Funds from related party, net of repayment  10,930   —   
 Net cash provided by financing activities  280,305   —   
         
 Net increase in cash  156,409   —   
 Cash at beginning of period  69,527   —   
 Cash at end of period $225,936  $—   
         
 Supplemental Schedule of Cash Flow Information:        
 Interest paid $—    $—   
 Income taxes paid $—    $—   
         
 The accompanying notes are an integral part of these financial statements. 

F-29 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

June 30, 2020

Note 1 – Organization and History

Vyta Corp (the “Company”) was incorporated in Nevada in June 1996. On August 20, 2010, it changed its state of incorporation to Delaware and on November 5, 2010 it changed its name to Bio Lab Naturals, Inc. On August 20, 2010, the Company executed a redomicile merger with its wholly owned subsidiary Vyta Corp (Delaware), as result of the merger the Company’s corporate domicile moved from Nevada to Delaware.

Prior to 2011, the Company was involved in various business activities and since then the Company has been seeking a business opportunity.

Effective December 31, 2019, the Company entered into a Reorganization Agreement with Prime Time Live, Inc., a Colorado corporation (“PTL”), whereby PTL merged with a newly formed wholly owned subsidiary of the Company, and the subsidiary being the survivor in exchange for the Company issuing one share of its common stock for each share of PTL’s 5,500,000 issued and outstanding shares of common stock. See Note 5 – Significant Acquisition.

Note 2 – Summary of Significant Accounting Policies

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of Bio Lab Naturals, Inc. and its wholly owned subsidiary. All intercompany balances have been eliminated during consolidation.

Use of Estimates in the Preparation of Consolidated Financial Statements

The preparation of consolidated financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Significant estimates include the fair value of assets and liabilities, income taxes and the valuation allowances related to accounts receivable, deferred tax assets and contingencies.

Cash and Cash Equivalents

The Company considers all liquid investments purchased with an initial maturity of three months or less to be cash equivalents. Cash and cash equivalents include demand deposits carried at cost which approximates fair value. The Company maintains its cash in institutions insured by the Federal Deposit Insurance Corporation (“FDIC”).

Concentration of Credit Risk

The Company offers its services to a small number of customers. This risk of non-payment by these customers is considered minimal and the Company does not generally obtain collateral for sales. The Company continually monitors the credit standing of its customers.

Accounts Receivable

The Company records accounts receivable at net realizable value. This value includes an appropriate allowance for uncollectible accounts to reflect any loss anticipated on the accounts receivable balances and is charged to other income (expense) in the statements of operations. Management calculates this allowance based on its history of write-offs, the level of past-due accounts based on the contractual terms of the receivables, and the Company’s relationships with, and the economic status of, its customers. At June 30, 2020 and December 31, 2019, there are no allowance for uncollectible accounts.

F-30 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

June 30, 2020

Equipment

Equipment is recorded at cost and consists of video equipment. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation of video equipment is over the estimated useful life of five years using the straight-line method for consolidated financial statement purposes. At June 30, 2020 and December 31, 2019 there were capitalized costs of $160,536. Depreciation expense for the three and six months ended June 30, 2020 and 2019 was $8,449 and $0, respectively and for the six months ended June 30, 2020 and 2019 was $16,898 and $0, respectively. See Note 4 – Fair Value Measurements.

Revenue recognition

The Company follows the provisions of Accounting Standards Update (“ASU”) No. 2014 - 09, Revenue from Contracts with Customers (Topic 606), using the full retrospective transition method. The Company’s adoption of ASU 2014 - 09 did not have a material impact on the amount and timing of revenue recognized in its consolidated financial statements.

Under ASU 2014 - 09, the Company recognizes revenue when control of the promised services is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services.

The Company derives its revenues from the rendering of entertainment rental services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its contracts:

Identify the contract with a customer;

Identify the performance obligations in the contract;

Determine the transaction price;

Allocate the transaction price to performance obligations in the contract; and

Recognize revenue as the performance obligation is satisfied.

Impairment of Long-Lived Assets

In accordance with authoritative guidance on accounting for the impairment or disposal of long-lived assets, as set forth in Topic 360 of the ASC, the Company assesses the recoverability of the carrying value of its long-lived assets when events occur that indicate an impairment in value may exist. An impairment loss is indicated if the sum of the expected undiscounted future net cash flows is less than the carrying amount of the assets. If this occurs, an impairment loss is recognized for the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets.

Other Comprehensive Loss

The Company has no material components of other comprehensive loss and accordingly, net loss is equal to comprehensive loss for the period.

Income Taxes

The Company uses the liability method of accounting for income taxes under which deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the accounting bases and the tax bases of the Company’s assets and liabilities. The deferred tax assets and liabilities are computed using enacted tax rates in effect for the year in which the temporary differences are expected to reverse.

The Company's deferred income taxes include certain future tax benefits. The Company records a valuation allowance against any portion of those deferred income tax assets when it believes, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred income tax asset will not be realized.

F-31 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

June 30, 2020

The Company has adopted ASC guidance regarding accounting for uncertainty in income taxes. This guidance clarifies the accounting for income taxes by prescribing the minimum recognition threshold an income tax position is required to meet before being recognized in the consolidated financial statements and applies to all income tax positions. Each income tax position is assessed using a two-step process. A determination is first made as to whether it is more likely than not that the income tax position will be sustained, based upon technical merits, upon examination by the taxing authorities. If the income tax position is expected to meet the more likely than not criteria, the benefit recorded in the consolidated financial statements equals the largest amount that is greater than 50% likely to be realized upon its ultimate settlement. At June 30, 2020 and December 31, 2019, there were no uncertain tax positions that required accrual.

Goodwill

In accordance with generally accepted accounting principles, goodwill cannot be amortized, however, it must be tested annually for impairment. This impairment test is calculated at the reporting unit level. The goodwill impairment test has two steps. The first identifies potential impairments by comparing the fair value of a reporting unit with its book value, including goodwill. If the fair value of the reporting unit exceeds the carrying amount, goodwill is not impaired and the second step is not necessary. If the carrying value exceeds the fair value, the second step calculates the possible impairment loss by comparing the implied fair value of goodwill with the carrying amount. If the implied goodwill is less than the carrying amount, a write-down is recorded. Management tests goodwill each year for impairment, or when facts or circumstances indicate impairment has occurred.

Net Loss per Share

Basic net loss per common share of stock is calculated by dividing net loss available to common stockholders by the weighted-average number of common shares outstanding during each period. Diluted net loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding, including the effect of other dilutive securities. The Company’s had no potentially dilutive securities issued as of and during the three and six months ended June 30, 2020 and 2019.

Equity Based Payments

The Company recognizes compensation cost for equity-based awards based on estimated fair value of the award and records capitalized cost or compensation expense over the requisite service period.  

Off-Balance Sheet Arrangements

As part of its ongoing business, the Company has not participated in transactions that generate relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities (SPEs), which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. For the period through June 30, 2020, the Company has not been involved in any unconsolidated SPE transactions.

Subsequent Events

The Company evaluates events and transactions after the balance sheet date but before the consolidated financial statements are issued.

Note 3 – Going Concern and Managements’ Plan

The Company’s consolidated financial statements for the three and six months ended June 30, 2020 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The Company reported a net loss for the three and six months ended June 30, 2020 of $48,345 and $151,601, respectively and an accumulated deficit of $35,319,671 at June 30, 2020.

F-32 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

June 30, 2020

The Company’s significant operating losses raise substantial doubt about its ability to continue as a going concern within one year after the date of the issuance of these financial statements. The future success of the Company is dependent on its ability to attract additional capital and ultimately, upon its ability to develop future profitable operations. There can be no assurance that the Company will be successful in obtaining such financing, or that it will attain positive cash flow from operations. However, management believes that actions presently being taken to raise additional capital as more fully disclosed in these financial statements provides the opportunity for the Company to continue as a going concern.

Note 4 – Fair Value Measurements

The Company applies the authoritative guidance applicable to all financial assets and liabilities required to be measured and reported on a fair value basis, as well as to non-financial assets and liabilities measured at fair value on a non-recurring basis, including impairments of long-lived assets. The fair value of an asset or liability is the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. Observable inputs are inputs that market participants would use in valuing the asset or liability based on market data obtained from sources independent of the Company. Unobservable input are inputs that reflect the Company’s assumptions of what market participants would use in valuing the asset or liability based on the information available in the circumstances.

Financial and non-financial assets and liabilities are classified within the valuation hierarchy based upon the lowest level of input that is significant to the fair value measurement. The Company’s policy is to recognize transfers in and out of the fair value hierarchy as of the end of the reporting period in which the event or change in circumstances caused the transfer. The Company has consistently applied the valuation techniques discussed below in all periods presented. The hierarchy is organized into three levels based on the reliability of the inputs as follows:

Level 1: Quoted prices in active markets for identical assets or liabilities; or

Level 2: Quoted prices in active markets for similar assets and liabilities and inputs, quoted prices for identical or similar assets or liabilities in markets that are not active and model-derived valuations whose inputs or significant value drivers are observable; or

Level 3: Unobservable pricing inputs in which there is little or no market data, which requires the reporting entity to develop its own assumptions.

The following table presents the Company’s non-financial assets and liabilities that were measured at fair value on a non-recurring basis at December 31, 2019 by level within the fair value hierarchy:

Description Level 1 Level 2 Level 3 Total
Assets        
  Equipment   $—    $—    $160,536  $160,536 
  Goodwill   $—    $—    $1,429,107  $1,429,107 

Effective December 31 2019, the Company’s equipment was tested under ASC 360 as to its recoverability to determine if impairment is required under the accounting guidance. The Company used Level 3 inputs to measure the fair value of the assets. As such, there was no impairment.

Effective December 31, 2019, the Company acquired Prime Time Live Inc. and as a result realized goodwill in the amount of $1,429,107. Thus, due to the significance of this event, goodwill was tested under ASC 360 as to its recoverability. Therefore, goodwill is recorded at fair value if impairment is required under the accounting guidance. The Company used Level 3 inputs to measure the fair value of the asset and management determined that there were no future undiscounted cash flows associated with goodwill. As such, the Company’s goodwill was fully impaired at December 31, 2019 in the amount of $1,429,107.

F-33 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

June 30, 2020

Note 5 – Significant Acquisition

Effective December 31, 2019, the Company entered into a Reorganization Agreement with Prime Time Live, Inc., a Colorado corporation whereby PTL merged with a newly formed wholly owned subsidiary of the Company, and the subsidiary being the survivor in exchange for the Company issuing one share of its common stock for each share of PTL’s 5,500,000 issued and outstanding shares of common stock valued at $0.30 per share, based upon the stock price on the OTC markets at December 31, 2019, or a total value of $1,650,000.

The following table presents the allocation of the consideration given to the assets acquired and liabilities assumed, based on their fair values at December 31, 2019:

   
Consideration Given  
Shares of common stock $1,650,000 
     
Total purchase price $1,650,000 
     
     Allocation of Consideration Given    
Cash $69,527 
Accounts receivable, net  13,000 
Equipment  160,536 
Goodwill  1,429,107 
     
Total assets  1,672,170 
     
Current liabilities  22,170 
     
Net assets acquired $1,650,000 

Note 6 – Debt

Convertible Promissory Note

An affiliate of an officer of the Company, loaned the Company $14,200 in exchange for an unsecured convertible promissory note that includes interest at the rate of six percent (6%) per annum on the unpaid principal balance with any accrued and unpaid interest due on or before December 31, 2020 (the “Note”). The Note allows for the note holder to convert, at their discretion, any accrued and unpaid interest and principal balance due on the Note in whole or in part into shares of the Company’s common stock at a conversion price of $0.125 per share. On June 12, 2020, the note holder converted $10,000 of the Note into 80,000 shares of the Company’s common stock. At June 30, 2020, the Company owes $4,200 on the debt plus accrued interest in the amount of $251. See Note 9 - Related Party Transactions.

F-34 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

June 30, 2020

Note 7 – Stockholders’ Equity

Preferred Shares

Class A Convertible

At June 30, 2020, there are a total of 500,000 shares of Class A Convertible shares of preferred stock (“Class A”) issued and outstanding. The Class A shares provide that when voting as a single class, the shares shall have the votes and the voting power at all times to be at least 60% of the voting power of the Company. Further, the holders of the Class A shares at their discretion and subject to a change of control and to the qualification by application to either NASQAD or NYSE Emerging Markets, can convert their one share of Class A into two shares of the Company’s common stock, subject to adjustment. In addition, the holder of the shares of Class A is entitled to a liquidation preference of the Company senior to all other securities of the Company.

Common Shares

The Company’s capital stock at June 30, 2020 consists of 200,000,000 authorized shares of $0.0001 par value common stock. At June 30, 2020, there are a total of 10,753,504 shares of common stock issued and outstanding.

During the three months ended June 30, 2020, the Company sold 2,095,999 of its common stock as part of a private placement for $262,000 in cash or $0.125 per share, issued 100,000 shares of its common for services rendered in the amount of $12,500 and issued 80,000 shares of its common stock to convert debt in the amount of $10,000. See Note 9 – Related Party Transactions.

Note 8 – Equity Based Payments

The Company accounts for equity-based payment accruals under authoritative guidance as set forth in the Topics of the ASC. The guidance requires all equity-based payments to employees and non-employees, including grants of employee and non-employee stock options and warrants, to be recognized in the consolidated financial statements based at their fair values.

2014 Stock Incentive Plan

Effective January 15, 2020, the Company’s adopted its 2020“2022 Stock Option and Award Plan (the “2020 Stock Incentive Plan”). Under the 20202022 Stock IncentiveOption Plan, the Board of Directors may grant options or purchase rights to purchase common stock to officers, employees, and other persons who provide services to us. A total of 833,333 shares of common stock is reserved for the Company or any related company. The participants2022 Stock Option Plan. As of the date of this prospectus, there have been no options granted under the 2022 Stock Option Plan.

Effective August 9, 2022, we adopted our 2022 Restricted Stock Plan (the “2022 Restricted Stock Plan”). Under the 2022 Restricted Stock Plan, the Board of Directors may grant restricted stock to whom awards areofficers, directors, and key employees. A total of 833,333 shares of common stock is reserved for the 2022 Stock Option Plan. As of the date of this prospectus, there have been no shares of common stock granted under the type2022 Restricted Stock Plan.

Reverse Stock Split

On December 19, 2022, we filed a Certificate of awards granted,Amendment of Amended and Restated Certificate of Incorporation effecting a 1-for-30 reverse stock split (the “Reverse Stock Split”).

As a result of the Reverse Stock Split, the total number of shares of common stock held by each shareholder was converted automatically into the number of whole shares of common stock equal to (i) the number of shares coveredof common stock held by such shareholder immediately prior to the Reverse Split, divided by (ii) 30, and then rounded up to the nearest whole number. No fractional shares were issued, and no cash or other consideration was paid to any shareholder. Instead, we issued one whole share of the post-Reverse Stock Split common stock to any shareholder who otherwise would have received a fractional share as a result of the Reverse Stock Split.

Except for each award,our historical financial statements and unless otherwise stated, all option, share, and per share information gives effect to the Reverse Stock Split.

29

CAPITALIZATION

The following table sets forth our cash and cash equivalents, as well as our capitalization, as of September 30, 2023, as follows:

-on an actual basis; and

-on a pro forma as adjusted basis to give further effect to the sale by us of [ ] shares of Common Stock in this offering at an assumed public offering price of $[ ] per share of Common Stock, which is equal to the last reported bid price of our Common Stock on the OTCQB on [ ], 2024, after deducting the underwriting discounts and commissions and estimated offering expenses payable by us.

You should consider this table in conjunction with “Use of Proceeds” above as well as our “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our financial statements and the purchasenotes to those financial statements for the nine months ended September 30, 2023. The pro forma information set forth in the table below is illustrative only and will be adjusted based on the actual public offering price conditions and other terms of each award arethis offering determined at pricing.

  As of September 30, 2023 
  Actual  Pro Forma
As Adjusted(1)
 
       
Cash and cash equivalents $85,529  $[ ]
Stockholders’ equity:        
Common stock, par value $0.0001; 300,000,000 shares authorized; 3,976,998 shares issued and outstanding as of September 30, 2023  399   [ ] 
Preferred stock, par value $0.001; 5,000,000 shares authorized; 500,000 shares issued and outstanding as of September 30, 2023  50                
Additional paid-in capital  3,107,177   [ ] 
Accumulated deficit  (23,488,613)  [ ] 
Total stockholders’ equity  (20,380,987)  [ ] 
Total capitalization $(20,295,458) $[ ] 

(1)A $0.10 increase or decrease in the assumed public offering price of $[ ] per share of Common Stock a, which is equal to the last reported bid price of our Common Stock on the OTCQB on [ ], 2024, would increase or decrease by approximately $[ ] million our pro forma as adjusted cash and cash equivalents, additional paid-in capital, total stockholders’ equity and total capitalization, assuming the number of shares of Common Stock offered by us as set forth on the cover page of this prospectus remains the same, after deducting the underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, a 1,000,000 share increase or decrease in the number of shares of Common Stock offered by us would, based on the assumed public offering price of $[ ] per share of Common Stock, increase or decrease our pro forma as adjusted cash and cash equivalents, additional paid in capital, total stockholders’ equity and total capitalization by approximately $[ ] million, after deducting the underwriting discounts and commissions and estimated offering expenses payable by us.

The information above is based on 3,976,998 shares of our Common Stock outstanding as of September 30, 2023, and excludes:

33,334 shares of common stock issuable upon the conversion of our outstanding Class A Preferred Stock;
833,333 shares of common stock reserved for the future issuance of awards under our 2022 Incentive and Nonstatutory Stock Option Plan;
833,333 shares of common stock reserved for future issuance of awards under our 2022 Restricted Stock Plan; and
10,349,097 shares of our common stock issuable upon the conversion of outstanding convertible notes.

30

DILUTION

If you invest in our Common Stock shares in this offering, your ownership will be diluted immediately to the Board of Directors, except that the termextent of the options shall not exceed 10 years. A total of 2 million shares ofdifference between the Company’s common stock are subject to the 2020 Stock Incentive Plan. The shares issued for the 2020 Stock Incentive Plan may be either treasury or authorized and unissued shares. During the three and six months ended June 30, 2020, the Company granted no options under the 2020 Stock Incentive Plan.

Note 9 – Related Party Transactions

Due to Related Parties

During the three months ended June 30, 2020, the Company repaid an affiliate of one of its officers $10,000 toward an unsecured convertible promissory note by issuing 80,000 shares of its common stock value at $0.125public offering price per share and at June 30, 2020, owes $4,200 on the debt.

During the three months ended June 30, 2020, the Company repaid an affiliate of one of its officers $200 and at June 30, 2020 and December 31, 2019, the Company owes affiliates of two of its officers $0 and $3,270, respectively.

Equity for Services

During the three months ended June 30, 2020, the Company issued 100,000 shares of its common stockas adjusted net tangible book value per Common Stock immediately after this offering. Dilution in net tangible book value per share to two of its board members valued at $12,500 in exchange for services and expensed such services as consulting fees in the statement of operations.

F-35 
Table of Contents

BIO LAB NATURALS, INC. AND SUBSIDIARY

Notes to Consolidated Financial Statements

June 30, 2020

Consulting Fees

During the three and six months ended June 30, 2020, the Company incurred consulting fees in the amount of $0 and $27,000, respectively to an officer and an affiliate of one of its officers.

Note 9 – Subsequent Events

On July 2, 2020, the Company filed a Form S-1 Registration Statement with the Securities and Exchange Commission.

F-36 
Table of Contents

PRIME TIME LIVE, INC.

FINANCIAL STATEMENTS

DECEMBER 30, 2019

(Audited)

F-37 
Table of Contents

Report of Independent Registered Public Accounting Firm

To the shareholders and the board of directors of Prime Time Live, Inc.

Opinion on the Financial Statements

We have audited the accompanying balance sheet of Prime Time Live, Inc. (the "Company") as of December 30, 2019 , the related statement of operations, stockholders' equity (deficit), and cash flows for the period September 17, 2019 (Inception) through December 30, 2019 and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 30, 2019 , and the results of its operations and its cash flows for the period September 17, 2019 (Inception) through December 30, 2019 , in conformity with accounting principles generally accepted in the United States.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibilitynew investors is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

Substantial Doubt about the Company’s Ability to Continue as a Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company’s significant operating losses raise substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s BF Borgers CPA PC

BF Borgers CPA PC

We have served as the Company's auditor since 2019

Lakewood, CO

September 21, 2020

F-38 
Table of Contents

PRIME TIME LIVE, INC.
BALANCE SHEET
DECEMBER 30, 2019
   
Assets  
Current assets  
 Cash $69,527 
 Accounts receivable, net  13,000 
    Total current assets  82,527 
     
    Equipment    
 Video screen equipment  168,985 
    Total equipment  168,985 
 Less accumulated depreciation  8,449 
    Net equipment  160,536 
    Other assets    
 Intangible assets  50,000 
     
 Total Assets $293,063 
     
 Liabilities and Stockholders' Equity    
    Current liabilities    
 Accounts payable $18,900 
 Due to related party  3,270 
 Total current liabilities  22,170 
    Total liabilities  22,170 
     
 Commitments and Contingencies  —   
     
 Stockholders' Equity    
 Common shares, $0.001 par value, 100,000,000 shares authorized;    
    5,500,000 shares issued and outstanding at December 30, 2019  5,500 
 Additional paid in capital  294,060 
 Retained (deficit)  (28,667)
    Total stockholders' equity  270,893 
     
 Total Liabilities and Stockholders' Equity $293,063 
     
 The accompanying notes are an integral part of these financial statements.    
F-39 
Table of Contents

PRIME TIME LIVE, INC.
STATEMENT OF OPERATIONS
FOR THE PERIOD SEPTEMBER 17, 2019 (INCEPTION) THROUGH DECEMBER 30, 2019
   
   
 Sales $45,500 
     
 Cost of sales    
 Cost of sales - other  13,770 
 Depreciation  8,449 
    Total cost of sales  22,219 
     
 Gross profit  23,281 
     
 Operating expenses    
 Consulting fees, related party  26,075 
 General and administrative expenses - other  25,873 
    Total operating expenses  51,948 
     
 Loss before income taxes  (28,667)
     
 Income taxes  —   
     
 Net loss $(28,667)
     
 Net loss per common share - basic and diluted   *  
     
 Weighted average number of common shares  4,752,243 
     
 * Less than $.01 per share    
     
 The accompanying notes are an integral part of these financial statements.    

F-40 
Table of Contents

PRIME TIME LIVE, INC.
STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
           
           
           
           
  Common Shares Additional   Total
  $0.001 Par Value Paid-in Accumulated Stockholders'
  Shares Amount Capital (Deficit) Equity
BALANCES, September 17, 2019  —    $—    $—    $—    $—   
   Sale of shares for cash at $0.10 per share  925,000   925   91,575   —     92,500 
   Issuance of shares for services, related party  4,075,000   4,075   —     —     4,075 
   Issuance of shares for property  350,000   350   192,635       192,985 
   Issuance of shares for debt  150,000   150   9,850       10,000 
   Net loss for the period  —     —     —     (28,667)  (28,667)
BALANCES, December 30, 2019  5,500,000  $5,500  $294,060  $(28,667) $270,893 
                     

The accompanying notes are an integral part of these financial statements.

 

 

F-41 
Table of Contents

PRIME TIME LIVE, INC.
STATEMENT OF CASH FLOWS
FOR THE PERIOD SEPTEMBER 17, 2019 (INCEPTION) THROUGH DECEMBER 30, 2019
   
   
OPERATING ACTIVITIES  
 Net loss $(28,667)
 Adjustment to reconcile net loss to net cash flows used    
 in operating activities    
 Depreciation  8,449 
 Issuance of common shares for services, related party  4,075 
 Changes in:    
 Accounts receivable, trade  (13,000)
 Accounts payable  18,900 
 Net cash (used in) operating activities  (10,243)
     
 INVESTING ACTIVITIES    
 Net cash (used in) investing  activities  —   
     
 FINANCING ACTIVITIES    
 Proceeds from short term loans  7,270 
 Repayment of short term debt  (20,000)
 Sale of common shares  92,500 
 Net cash provided in financing activities  79,770 
     
 Net increase (decrease) in cash  69,527 
 Cash at beginning of period  —   
 Cash at end of period $69,527 
     
 Supplemental Schedule of Non-Cash Flow Information:    
 Interest paid $—   
 Income taxes paid $—   
 Issuance of common shares for property $192,985 
 Issuance of common shares for debt $10,000 
     
 The accompanying notes are an integral part of these financial statements.    

F-42 
Table of Contents

PRIME TIME LIVE, INC.

Notes to Financial Statements

December 30, 2019

Note 1 – Organization and History

Prime Time Live, Inc., a Colorado corporation (the “Company”) was incorporated on September 17, 2019. The Company specializes in providing clients with the largest, highest resolution Mobile LED screen for entertainment, corporate, civic and sporting events.

On October 11, 2019, the Company acquired the business of Prime Time Mobile Video Event Screens, LLC in exchange for 350,000 shares of the Company’s common stock. See Note 5 – Significant Acquisitions.

Note 2 – Summary of Significant Accounting Policies

Basis of Presentation

These financial statements are prepared in accordance with accounting principles generally accepted in the United States.

Use of Estimates in the Preparation of Financial Statements

The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Significant estimates include the fair value of assets and liabilities, income taxes and the valuation allowances related to accounts receivable and contingencies.

Cash and Cash Equivalents

The Company considers all liquid investments purchased with an initial maturity of three months or less to be cash equivalents. Cash and cash equivalents include demand deposits and money market funds carried at cost which approximates fair value. The Company maintains its cash in institutions insured by the Federal Deposit Insurance Corporation (“FDIC”).

Concentration of Credit Risk

The Company offers its services to 2 clients . This risk of non-payment by these customers is considered minimal and the Company does not generally obtain collateral for sales. The Company continually monitors the credit standing of its clients .

Accounts Receivable

The Company records accounts receivable at net realizable value. This value includes an appropriate allowance for uncollectible accounts to reflect any loss anticipated on the accounts receivable balances and is charged to other income (expense) in the statements of operations. Management calculates this allowance based on its history of write-offs, the level of past-due accounts based on the contractual terms of the receivables, and the Company’s relationships with, and the economic status of, its clients . At December 30, 2019 , there is no allowance for uncollectible accounts.

Equipment

Equipment is recorded at cost and consists of video equipment. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation of video equipment is provided over its estimated useful life of five years using the straight-line method for financial statement purposes. At December 30, 2019 there were capitalized costs of $168,985 and for the period September 17, 2019 (inception) through December 30, 2019 , there is depreciation expense of $8,449. See Note 4 – Fair Value Measurements.

F-43 
Table of Contents

PRIME TIME LIVE, INC.

Notes to Financial Statements

December 30, 2019

Revenue recognition

The Company follows the provisions of Accounting Standards Update (“ASU”) No. 2014 - 09, Revenue from Contracts with Customers (Topic 606), using the full retrospective transition method. The Company’s adoption of ASU 2014 - 09 did not have a material impact on the amount and timing of revenue recognized in its financial statements.

Under ASU 2014 - 09, the Company recognizes revenue when control of the promised services is transferred to clients , in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services.

The Company derives its revenues from the rendering of entertainment rental services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its contracts:

Identify the contract with a client ;

Identify the performance obligations in the contract;

Determine the transaction price;

Allocate the transaction price to performance obligations in the contract; and

Recognize revenue as the performance obligation is satisfied.

Impairment of Long-Lived Assets

In accordance with authoritative guidance on accounting for the impairment or disposal of long-lived assets, as set forth in Topic 360 of the ASC, the Company assesses the recoverability of the carrying value of its long-lived assets when events occur that indicate an impairment in value may exist. An impairment loss is indicated if the sum of the expected undiscounted future net cash flows is less than the carrying amount of the assets. If this occurs, an impairment loss is recognized for the amount by which the carryingoffering price paid by the purchasers of the shares sold in this offering exceeds the pro forma as adjusted net tangible book value per Common Stock after this offering. Net tangible book value per share is determined at any date by subtracting our total liabilities from the total book value of our tangible assets and dividing the difference by the number of shares of Common Stock deemed to be outstanding at that date.

The net tangible book value of our Common Stock as of September 30, 2023, was approximately $([    ]), or approximately $([  ]) per share of Common Stock. Net tangible book value per share represents the amount of our total tangible assets less total liabilities divided by the assets exceedstotal number of our shares of Common Stock outstanding as of September 30, 2023.

After giving effect to the estimated fair valuesale by us in this offering of the assets.

Other Comprehensive Loss

The Company has no material components[     ] shares of other comprehensive loss and accordingly, net lossCommon Stock in this offering at an assumed public offering price of $[    ] per share of Common Stock, which is equal to comprehensive loss for the period.

Income Taxes

The Company uses the liability methodlast reported bid price of accounting for income taxes under which deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the accounting bases and the tax bases of the Company’s assets and liabilities. The deferred tax assets and liabilities are computed using enacted tax rates in effect for the year in which the temporary differences are expected to reverse.

The Company's deferred income taxes include certain future tax benefits. The Company records a valuation allowance against any portion of those deferred income tax assets when it believes, basedour Common Stock on the weight of available evidence, it is more likely than not that some portion or all ofOTCQB on [    ], 2024, after deducting the deferred income tax asset will not be realized.

The Company has adopted ASC guidance regarding accounting for uncertainty in income taxes. This guidance clarifies the accounting for income taxesunderwriting discounts and commissions and estimated offering expenses payable by prescribing the minimum recognition threshold an income tax position is required to meet before being recognized in the consolidated financial statements and applies to all income tax positions. Each income tax position is assessed using a two-step process. A determination is first madeus, our as to whether it is more likely than not that the income tax position will be sustained, based upon technical merits, upon examination by the taxing authorities. If the income tax position is expected to meet the more likely than not criteria, the benefit recorded in the consolidated financial statements equals the largest amount that is greater than 50% likely to be realized upon its ultimate settlement. At December 30, 2019 , there were no uncertain tax positions that required accrual.

F-44 
Table of Contents

PRIME TIME LIVE, INC.

Notes to Financial Statements

December 30, 2019

Goodwill

In accordance with generally accepted accounting principles, goodwill cannot be amortized, however, it must be tested annually for impairment. This impairment test is calculated at the reporting unit level. The goodwill impairment test has two steps. The first identifies potential impairments by comparing the fair value of a reporting unit with itsadjusted net tangible book value including goodwill. If the fair valueas of the reporting unit exceeds the carrying amount, goodwill is not impaired and the second step is not necessary. If the carrying value exceeds the fair value, the second step calculates the possible impairment loss by comparing the implied fair value of goodwill with the carrying amount. If the implied goodwill is less than the carrying amount, a write-down is recorded. Management tests goodwill each year for impairment, or when facts or circumstances indicate impairment has occurred.

Net Loss per Share

Basic net loss per common share of stock is calculated by dividing net loss available to common stockholders by the weighted-average number of common shares outstanding during each period. Diluted net loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding, including the effect of other dilutive securities. The Company’s had no potentially dilutive securities issued during the period September 17, 2019 (inception) through December 30, 2019 .

Equity Based Payments

The Company recognizes compensation cost for equity based awards based on estimated fair value of the award and records capitalized cost or compensation expense over the requisite service period.  

Major Customers

During the period September 17, 2019 (inception) through December 30, 2019 , two purchasers accounted for all of the Company’s revenues.

Off-Balance Sheet Arrangements

As part of its ongoing business, the Company has not participated in transactions that generate relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities (SPEs), which2023 would have been established forapproximately $[   ] million, or approximately $[  ] per share of Common Stock. This represents an immediate increase in net tangible book value of approximately $[  ] per share of Common Stock to our existing security holders and an immediate dilution in as adjusted net tangible book value of approximately $[   ] per share of Common Stock to purchasers of Common Stock in this offering, as illustrated by the purposebelow table.

Dilution per share to new investors is determined by subtracting pro forma as adjusted net tangible book value per share after this offering from the initial public offering price per share paid by new investors. The information below is illustrative only and will change based on actual pricing and other terms of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. From its incorporation on September 17, 2019this offering determined at pricing. The final public offering price will be determined through December 30, 2019 , the Company has not been involved in any unconsolidated SPE transactions.

Subsequent Events

The Company evaluates events and transactions after the balance sheet date but before the financial statements are issued.

Note 3 – Going Concern and Managements’ Plan

The Company’s financial statements for the period September 17, 2019 through December 30, 2019 have been prepared on a going concern basis, which contemplates the realization of assetsnegotiation between us and the settlement of liabilitiesinvestors in the normal course of business. The Company reportedoffering and may be at a net loss of $28,667 fordiscount to the such period and an accumulated deficit of $28,667 at December 30, 2019.

The Company’s significant operating losses raise substantial doubt about its ability to continue as a going concern within one year aftercurrent market price. Therefore, the dateassumed public offering price used throughout this prospectus may not be indicative of the issuance of these financial statements. The future success of the Company is dependent on its ability to attract additional capital and ultimately, upon its ability to develop future profitable operations. There can be no assurance that the Company will be successful in obtaining such financing, or that it will attain positive cash flow from operations. However, management believes that actions presently being taken to raise additional capital as more fully disclosed in Note 8 – Subsequent Events – provides the opportunity for the Company to continually continue as a going concern.final public offering price.

F-45 Public offering price per share of Common Stock
 Table$[ ]
Historical net tangible book value per share as of ContentsSeptember 30, 2023$([ ])
Increase in net tangible book value per share attributable to this offering$[ ]
As adjusted net tangible book value per share after giving effect to this offering$[ ]
Dilution per share to new investors in this offering$[ ]

PRIME TIME LIVE, INC.

Notes to Financial Statements

December 30, 2019

Note 4– Fair Value Measurements

The Company appliesEach $0.10 increase or decrease in the authoritative guidance applicable to all financial assets and liabilities required to be measured andassumed public offering price of $[    ] per share, which was the last reported on a fair value basis, as well as to non-financial assets and liabilities measured at fair value on a non-recurring basis. The fair valuebid price of an asset or liability is the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. Observable inputs are inputs that market participants would use in valuing the asset or liability based on market data obtained from sources independent of the Company. Unobservable input are inputs that reflect the Company’s assumptions of what market participants would use in valuing the asset or liability basedour Common Stock on the information available inOTCQB on [    ], 2024, would increase or decrease the circumstances.

Financial and non-financial assets and liabilities are classified within the valuation hierarchy based upon the lowest level of input that is significant to the fairas adjusted net tangible book value measurement. The Company’s policy is to recognize transfers in and out of the fair value hierarchy as of the end of the reporting period in which the event or change in circumstances caused the transfer. The Company has consistently applied the valuation techniques discussed below in all periods presented. The hierarchy is organized into three levels based on the reliability of the inputs as follows:

Level 1: Quoted prices in active markets for identical assets or liabilities; or

Level 2: Quoted prices in active markets for similar assets and liabilities and inputs, quoted prices for identical or similar assets or liabilities in markets that are not active and model-derived valuations whose inputs or significant value drivers are observable; or

Level 3: Unobservable pricing inputs in which there is little or no market data, which requires the reporting entity to develop its own assumptions.

The following table presents the Company’s non-financial assets and liabilities that were measured at fair value on a non-recurring basis at December 30, 2019per share by level within the fair value hierarchy:

Description Level 1 Level 2 Level 3 Total
Assets        
 Equipment $—    $—    $168,985  $168,985 
 Intangible assets $—    $—    $50,000  $50,000 

Effective October 11 2019, the Company’s equipment and intangible assets were tested under ASC 360 as to their recoverability to determine if impairment is required under the accounting guidance. The Company used Level 3 inputs to measure the fair value of the assets. As such, there was no impairment during the period September 17, 2019 (inception) through December 30, 2019 .

Note 5 – Significant Acquisitions

At October 11, 2019, the Company acquired the business of a company in the entertainment related industry.

The following table presents the allocation of the consideration given to the assets acquired and liabilities assumed, based on their fair values at October 11, 2019:

Consideration Given  
Shares of common stock $192,985 
     
Total purchase price $192,985 
     
     Allocation of Consideration Given    
Equipment $168,985 
Intangible assets  50,000 
     
Total assets  218,985 
     
Current liabilities  26,000 
     
Net assets acquired $192,985 

F-46 
Table of Contents

PRIME TIME LIVE, INC.

Notes to Financial Statements

December 30, 2019

Note 6 – Stockholders’ Equity

The Company’s capital stock at December 30, 2019 consists of 100,000,000 authorized shares of $0.001 par value common stock.

Common Shares

At December 30, 2019 there are a total of 5,500,000 shares of common stock issued and outstanding.

During the period September 17, 2019 (inception) through December 30, 2019 , the Company sold 925,000 shares of its common stock for $92,500 in cash. Also, the Company issued 4,075,000 shares of its common stock for services valued at $4,075. See Note 7 – Related Party Transactions.

Further, and as part of the Company entering into an acquisition of a business, the Company issued 350,000 shares of its common stock valued at $192,985. In addition, and a part of this acquisition, the Company issued 150,000 shares of its common stock in connection with the conversion of debt assumed by the Company in the amount of $10,000.

Note 7 – Related Party Transactions

Due to Related Parties

During the period September 17, 2019 (inception) through December 30, 2019 , the Company borrowed $3,270 in funds from affiliates of two of its officers and at December 30, 2019 owes $3,270.

Equity for Services

During the period September 17, 2019 (inception) through December 30, 2019 , officers and directors of the Company and a related party were issued 4,075,000 shares of the Company’s common stock in exchange for services valued at $4,075 that were expensed.

Consulting Services

During the period September 17, 2019 (inception) through December 30, 2019 , the Company paid its officers $26,075 in consulting fees that were expensed and these services are performed on a month-month basis.

Note 8 – Subsequent Events

Effective December 31, 2019, the Company entered into a Merger Agreement with Bio Lab Naturals Inc. (“BLAB”) whereby the Company’s shareholders received 5,500,000 shares of BLAB’s common stock valued at $1,650,000. As a result, all of the Company’s assets and liabilities were transferred to a wholly owned subsidiary of BLAB$[    ] per share and the Company ceaseddilution per share to exist.

F-47 
Table of Contents

PRIME TIME MOBILE VIDEO EVENT SCREENS, LLC

FINANCIAL STATEMENT

OCTOBER 11, 2019

(Audited)

F-48 
Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the shareholders and the board of directors of Prime Time Mobile Video Event Screens, LLC

Opinion on the Financial Statements

We have audited the accompanying balance sheet of Prime Time Mobile Video Event Screens, LLC (the "Company") as of October 11, 2019, the related statement of operations, stockholders' equity (deficit), and cash flows for the year then ended, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly,investors participating in all material respects, the financial position of the Company as of October 11, 2019, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates madethis offering by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

Substantial Doubt about the Company’s Ability to Continue as a Going Concern

The accompanying financial statements have been prepared$[    ] per share, assuming that the Company will continuenumber of shares, as a going concern. As discussed in Note 2 toset forth on the financial statements, the Company’s significant operating losses raise substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcomecover page of this uncertainty.prospectus, remains the same and after deducting underwriting discounts and commissions and estimated offering expenses payable by us.

/s BF Borgers CPA PC

BF Borgers CPA PC

We have served asmay also increase or decrease the Company's auditor since 2019

Lakewood, CO

September 21, 2020

F-49 
Table of Contents

PRIME TIME MOBILE VIDEO EVENT SCREENS, LLC
BALANCE SHEET
OCTOBER 11, 2019
   
   
Assets  
Current assets  
 Cash $3,553 
 Accounts receivable, net  13,000 
    Total current assets  16,553 
     
 Total Assets $16,553 
     
 Liabilities and Members' Equity    
    Current liabilities    
 Accounts payable $800 
 Notes payable  10,000 
    Total current liabilities  10,800 
     
    Total liabilities  10,800 
     
 Members' Equity    
 Equity  5,753 
     
 Total Liabilities and Members' Equity $16,553 
     
  The accompanying notes are an integral part of these financial statements.    

F-50 
Table of Contents

PRIME TIME MOBILE VIDEO EVENT SCREENS, LLC
STATEMENT OF OPERATIONS
PERIOD JANUARY 1, 2019 THROUGH OCTOBER 11, 2019
   
   
   
 Sales $94,062 
     
 Cost of sales    
 Cost of sales - other  67,669 
 Depreciation  1,573 
    Total cost of sales  69,242 
     
 Gross profit  24,820 
     
 Operating expenses    
 Guaranteed payments  37,460 
 General and administrative expenses - other  23,292 
    Total operating expenses  60,752 
     
 Loss from operations  (35,932)
     
 Other income (expense)    
 Gain on disposition of assets  212,149 
 Gain on forgiveness of debt  15,000 
 Interest expense  (2,207)
    Total other income  224,942 
     
 Net income $189,010 
     
  The accompanying notes are an integral part of these financial statements.    

F-51 
Table of Contents

PRIME TIME MOBILE VIDEO EVENT SCREENS, LLC
STATEMENT OF CHANGES IN MEMBERS' CAPITAL
   
   
   
 Balance December 31, 2018 $(12,422)
 Contributions  32,000 
 Distributions  (202,835)
 Net loss for the year  189,010 
 Balance October 11, 2019 $5,753 
     
  The accompanying notes are an integral part of these financial statements.    

F-52 
Table of Contents

PRIME TIME MOBILE VIDEO EVENT SCREENS, LLC
STATEMENT OF CASH FLOWS
PERIOD JANUARY 1, 2019 THROUGH OCTOBER 11, 2019
   
   
   
OPERATING ACTIVITIES  
 Net income $189,010 
 Adjustment to reconcile net income to net cash flows used    
 in operating activities    
 Depreciation  1,573 
 Gain on disposition of assets  (212,149)
 Gain on forgiveness of debt  (15,000)
 Changes in:    
 Accounts receivable, trade  —   
 Accounts payable and accrued liabilities  (490)
 Net cash (used in) operating activities  (37,056)
     
 INVESTING ACTIVITIES    
 Net cash (used in) investing  activities  —   
     
 FINANCING ACTIVITIES    
 Proceeds from debt obligations  44,000 
 Repayment of debt  (27,039)
 Contributions from partner  32,000 
 Distributions to partner  (9,850)
 Net cash provided by financing activities  39,111 
     
 Net increase (decrease) in cash  2,055 
 Cash at beginning of period  1,498 
 Cash at end of period $3,553 
     
 Supplemental Schedule of Cash Flow Information:    
 Interest paid $1,207 
     
 Supplemental Schedule of Non Cash Flow Information    
 Disposition of assets for property $192,985 
 Disposition of assets for debt assumed $26,000 
     
  The accompanying notes are an integral part of these financial statements.    
     
F-53 
Table of Contents

PRIME TIME MOBILE VIDEO EVENT SCREENS, LLC

Notes to Financial Statements

October 11, 2019

NOTE 1 – ORGANIZATION AND HISTORY

Prime Time Mobile Video Event Screens, LLC, a Colorado limited liability company (the “Company”) was formed on September 4, 2010. The Company specializes in providing clients with the largest, highest resolution Mobile LED screen for entertainment, corporate, civic and sporting events (the “Business”).

On October 11, 2019, the Company sold its Business, including equipment to Prime Time Live, Inc. See Note 4 – Dispositionnumber of Assets.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

These financial statementsshares we are prepared in accordance with accounting principles generally acceptedoffering. A 1,000,000 share increase in the United Statesnumber of America.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of equipment.

Income Taxes

Income taxes have not been providedshares, as each member is individually liable for the taxes, if any, on its share of the Company’s income and expenses.

Concentration of Credit Risk

No single customer amounts to greater than 20% of sales. For the period January 1 2019 through October 11, 2019 approximately 40% of the company’s revenue was generated in the form of rentals provided to sporting events.

Cash and Cash Equivalents

The Company considers all liquid investments purchased with an initial maturity of three months or less to be cash equivalents. Cash and cash equivalents include demand deposits carried at cost which approximates fair value. The Company maintains its cash in institutions insured by the Federal Deposit Insurance Corporation (“FDIC”).

Accounts Receivable

The Company records accounts receivable at net realizable value. This value includes an appropriate allowance for uncollectible accounts to reflect any loss anticipatedset forth on the accounts receivable balances and is chargedcover page of this prospectus, would not materially change the as adjusted net tangible book value per share or the dilution per share to other income (expense)new investors participating in the statements of operations. Management calculates this allowanceoffering, based on its historyan assumed public offering price of write-offs,$[    ] per share, which was the levellast reported bid price of past-due accountsour Common Stock on the OTCQB on [    ], 2024, remaining the same and after deducting underwriting discounts and commissions and estimated offering expenses payable by us.

The information above is based on the contractual terms of the receivables, and the Company’s relationships with, and the economic status of, its customers. At October 11, 2019, there is no allowance for uncollectible accounts.

F-54 
Table of Contents

PRIME TIME MOBILE VIDEO EVENT SCREENS, LLC

Notes to Financial Statements

October 11, 2019

Equipment

Equipment is recorded at cost and consisted of video equipment. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation of video equipment is provided over its useful life of seven years using the straight-line method for financial statement purposes. At October 11, 2019, the Company had $0 of capitalized costs and for the period January 1, 2019 through October 11, 2019 there is depreciation expense of $1,573. See Note 4 – Disposition of Assets.

Revenue recognition

On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) No. 2014 - 09, Revenue from Contracts with Customers (Topic 606), using the full retrospective transition method. The Company’s adoption of ASU 2014 - 09 did not have a material impact on the amount and timing of revenue recognized in its financial statements.

Under ASU 2014 - 09, the Company recognizes revenue when control of the promised services is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services.

The Company derives its revenues from the rendering of entertainment rental services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its contracts:

Identify the contract with a customer;

Identify the performance obligations in the contract;

Determine the transaction price;

Allocate the transaction price to performance obligations in the contract; and

Recognize revenue as the performance obligation is satisfied.

Subsequent Events

The Company evaluates events and transactions after the balance sheet date but before the financial statements are issued.

NOTE 3 – GOING CONCERN AND MANAGEMENTS’ PLAN

The Company’s financial statements for the period January 1, 2019 through October 11, 2019 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The Company reported a net loss from operations of $35,932 for the such period.

The Company’s significant operating losses raise substantial doubt about its ability to continue as a going concern within one year after the date of the issuance of these financial statements. The future success of the Company is dependent on its ability to attract additional capital and ultimately, upon its ability to develop future profitable operations. There can be no assurance that the Company will be successful in obtaining such financing, or that it will attain positive cash flow from operations. However, management believes that actions presently being taken to raise additional capital as more fully disclosed in Note 4 – Disposition of Assets – provides the opportunity for the Company to continually continue as a going concern.

NOTE 4 – DISPOSITION OF ASSETS

On October 11, 2019, the Company sold its Business, comprised of equipment and goodwill with a carrying amount of $6,836 to Prime Time Live, Inc. (PTL) in exchange for 350,0003,976,998 shares of PTL’s common stock valued at $192,985 plus assumptionour Common Stock outstanding as of the Company’s debt in the amount of $26,000 or a total of $218,985 and recognized a gain on disposition of assets in the amount of $212,149.

F-55 
Table of Contents

PRIME TIME MOBILE VIDEO EVENT SCREENS, LLC

Notes to Financial Statements

October 11, 2019

NOTE 5 – DEBT

During the years ended December 31, 2018 and 2017, the Company borrowed $15,000 from an entity in exchange for unsecured promissory notes at an interest rate of twenty percent (20%) per annum with accrued and unpaid interest and principal due on or before September 30, 2018. In addition, the Company agreed to pay the holder of promissory notes ten percent (10%) of all advertising dollars of a certain sporting event as well as grant the holder a first right of refusal to fund all future Company events. All promissory notes maturity dates were extended to September 30, 2019.2023, and excludes:

In addition, during the period January 1, 2019 through October 11, 2019, the Company borrowed $10,000 from an individual in exchange for an unsecured promissory note at an interest rate of eighteen percent (18%) per annum with accrued and unpaid interest and principal due on or before September 30, 2019. As part of the Company selling its assets to PTL on October 11, 2019, this debt in the amount of $25,000 plus accrued and unpaid interest in the amount of $1,000 was assumed by PTL.

During the period January 1, 2019 through October 11, 2019, the Company borrowed $9,000 from entities and repaid in full these loans plus interest in the amount of $600. 

During the period January 1, 2019 through October 11, 2019, the Company borrowed $15,000 from an individual and on October 9, 2019 the debt was forgiven by the note holder. As a result, the Company recognized a gain on the forgiveness of debt in the amount of $15,000.

On September 9, 2014, the Company issued a secure promissory note in the amount of $100,734 as part of the refinancing of previous debt at an interest rate of eight percent (8%) per annum payable over sixty (60) monthly payments of $2,072. The promissory note is collateralized by the Company’s equipment with accrued and unpaid interest and principal due the earlier of September 9, 2019 or the sale of the Company’s equipment. At October 11, 2019, the debt was paid in full and during the period January 1, 2019 through October 11, 2019, the Company paid interest in the amount of $607.

NOTE 6 – MEMBERS’ CAPITAL

During the period January 1, 2019 through October 11, 2019, the Company’s member contributed cash in the amount of $32,000 and during the same period, the Company distributed cash of $9,850 plus 350,000 shares of PTL’s common stock valued at $192,985 to the member. See Note 4 – Disposition of Assets.

NOTE 7 – COMMITMENTS AND CONTINGENCIES

The Company has no long-term commitments or contingencies.

NOTE 8 – SUBSEQUENT EVENTS

The Company evaluated events and transactions after the balance sheet date and before the issuance of its financial statements and no subsequent events need to be disclosed.

F-56 
Table of Contents

PRIME TIME MOBILE VIDEO EVENT SCREENS, LLC

FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2018

(Audited)

F-57 
Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the shareholders and the board of directors of Prime Time Mobile Video Event Screens, LLC

Opinion on the Financial Statements

We have audited the accompanying balance sheet of Prime Time Mobile Video Event Screens, LLC (the "Company") as of December 31, 2018, the related statement of operations, stockholders' equity (deficit), and cash flows for the year then ended, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2018, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

Substantial Doubt about the Company’s Ability to Continue as a Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company’s significant operating losses raise substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s BF Borgers CPA PC

BF Borgers CPA PC

We have served as the Company's auditor since 2019

Lakewood, CO

September 21, 2020

F-58 
Table of Contents

PRIME TIME MOBILE VIDEO EVENT SCREENS, LLC
BALANCE SHEET
DECEMBER 31, 2018
   
   
Assets  
Current assets  
 Cash $1,498 
 Accounts receivable, net  13,000 
 Prepaid expense  —   
    Total current assets  14,498 
     
    Equipment    
 Video screen equipment  618,877 
 Computers, furniture and equipment  15,484 
    Total equipment  634,361 
 Less accumulated depreciation  625,952 
    Net equipment  8,409 
     
 Total Assets $22,907 
     
 Liabilities and Members' Equity    
    Current liabilities    
 Accounts payable and accrued liabilities $2,290 
 Notes payable  33,039 
 Total current liabilities  35,329 
    Long term liabilities    
 Note payable  —   
    Total liabilities  35,329 
     
 Members' Equity    
 Members' capital - (deficit)  (12,422)
     
 Total Liabilities and Equity $22,907 
     
  The accompanying notes are an integral part of these financial statements.

F-59 
Table of Contents

PRIME TIME MOBILE VIDEO EVENT SCREENS, LLC
STATEMENT OF OPERATIONS
YEAR ENDED DECEMBER 31, 2018
   
   
   
 Sales $195,276 
     
 Cost of sales    
 Cost of sales - other  94,423 
 Depreciation  43,131 
    Total cost of sales  137,554 
     
 Gross profit  57,722 
     
 Operating expenses    
 Guaranteed payments  53,050 
 General and administrative expenses - other  42,675 
    Total operating expenses  95,725 
     
 Loss from operations  (38,003)
     
 Other expenses    
 Interest expense  6,427 
     
 Net loss $(44,430)
     
  The accompanying notes are an integral part of these financial statements.

F-60 
Table of Contents

PRIME TIME MOBILE VIDEO EVENT SCREENS, LLC
STATEMENT OF CHANGES IN MEMBERS' CAPITAL
   
   
     
 Balance December 31, 2017 $20,842 
 Contributions  11,166 
 Net loss for the year  (44,430)
 Balance December 31, 2018 $(12,422)
     
  The accompanying notes are an integral part of these financial statements.

F-61 
Table of Contents

PRIME TIME MOBILE VIDEO EVENT SCREENS, LLC
STATEMENTS OF CASH FLOWS
YEAR ENDED DECEMBER 31, 2018
   
   
 OPERATING ACTIVITIES    
 Net loss $(44,430)
 Adjustment to reconcile net loss to net cash flows used    
 in operating activities    
 Depreciation  43,131 
 Changes in:    
 Accounts receivable, trade  1,000 
 Prepaid expense  429 
 Accounts payable and accrued liabilities  (3,117)
 Net cash provided by (used in) operating activities  (2,987)
     
 INVESTING ACTIVITIES    
 Acquisition of equipment  (3,046)
 Net cash (used in) investing  activities  (3,046)
     
 FINANCING ACTIVITIES    
 Proceeds from notes payable  5,000 
 Repayment of debt  (22,435)
 Contributions from partner  11,166 
 Net cash (used in) financing activities  (6,269)
     
 Net increase (decrease) in cash  (12,302)
 Cash at beginning of period  13,800 
 Cash at end of period $1,498 
     
 Supplemental Schedule of Cash Flow Information:    
 Interest paid $6,427 
     
  The accompanying notes are an integral part of these financial statements.

F-62 
Table of Contents

PRIME TIME MOBILE VIDEO EVENT SCREENS, LLC

Notes to Financial Statements

December 31, 2018

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS

Prime Time Mobile Video Event Screens, LLC, a Colorado limited liability company (the “Company”) was formed on September 4, 2010. The Company specializes in providing clients with the largest, highest resolution Mobile LED screen for entertainment, corporate, civic and sporting events.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

These financial statements are prepared in accordance with accounting principles generally accepted in the United States of America.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of equipment.

Income Taxes

Income taxes have not been provided as each member is individually liable for the taxes, if any, on its share of the Company’s income and expenses.

Concentration of Credit Risk

No single customer amounts to greater than 10% of sales. For the year ended December 31, 2018, approximately 70% of the company’s revenue was generated in the form of rentals provided to sporting events.

Cash and Cash Equivalents

The Company considers all liquid investments purchased with an initial maturity of three months or less to be cash equivalents. Cash and cash equivalents include demand deposits carried at cost which approximates fair value. The Company maintains its cash in institutions insured by the Federal Deposit Insurance Corporation (“FDIC”).

Accounts Receivable

The Company records accounts receivable at net realizable value. This value includes an appropriate allowance for uncollectible accounts to reflect any loss anticipated on the accounts receivable balances and is charged to other income (expense) in the statements of operations. Management calculates this allowance based on its history of write-offs, the level of past-due accounts based on the contractual terms of the receivables, and the Company’s relationships with, and the economic status of, its customers. At December 31, 2018 , there is no allowance for uncollectible accounts.

Equipment

Equipment is recorded at cost. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation is provided over the estimated useful lives of the related assets ranging between five to seven years using the straight-line method for financial statement purposes. The Company uses accelerated methods of depreciation for income tax purposes, where appropriate. At December 31, 2018, there were capitalized costs of $634,361 and for the year ended December 31, 2018, there is depreciation expense of $43,131.

F-63 
Table of Contents

PRIME TIME MOBILE VIDEO EVENT SCREENS, LLC

Notes to Financial Statements

December 31, 2018

Revenue recognition

On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) No. 2014 - 09, Revenue from Contracts with Customers (Topic 606), using the full retrospective transition method. The Company’s adoption of ASU 2014 - 09 did not have a material impact on the amount and timing of revenue recognized in its financial statements.

Under ASU 2014 - 09, the Company recognizes revenue when control of the promised services is transferred to clients , in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services.

The Company derives its revenues from the rendering of entertainment rental services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its contracts:

Identify the contract with a client ;

Identify the performance obligations in the contract;

Determine the transaction price;

Allocate the transaction price to performance obligations in the contract; and

Recognize revenue as the performance obligation is satisfied.

Subsequent Events

The Company evaluates events and transactions after the balance sheet date but before the financial statements are issued.

NOTE 3 – GOING CONCERN AND MANAGEMENTS’ PLAN

The Company’s financial statements for the year ended December 31, 2018 has been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The Company reported a net loss of $44,430 for the year end and a members’ deficit of $12,422 at December 31, 2018.

The Company’s significant operating losses raise substantial doubt about its ability to continue as a going concern within one year after the date of the issuance of these financial statements. The future success of the Company is dependent on its ability to attract additional capital and ultimately, upon its ability to develop future profitable operations. There can be no assurance that the Company will be successful in obtaining such financing, or that it will attain positive cash flow from operations. However, management believes that actions presently being taken to raise additional capital as more fully disclosed in Note 8 – Subsequent Events – provides the opportunity for the Company to continually continue as a going concern.

NOTE 4 – RELATED PARTY TRANSACTION

On September 1, 2011, a member of the Company provided a line of credit with a maximum limit of $700,000 and the Company issued an unsecured promissory note at an interest rate of 4.26% per annum. In December of 2016, the holder of the promissory note agreed to the balance of the loan in the amount of $690,874 becoming contributed capital to the Company. See Note 6 – Members’ Capital

NOTE 5 – NOTES PAYABLE

During the year December 31, 2018, the Company borrowed $10,000 from an entity in exchange for unsecured promissory notes at an interest rate of twenty percent (20%) per annum with accrued and unpaid interest and principal due on or before September 30, 2018. In addition, the Company agrees to pay the holder of promissory notes ten percent (10%) of all advertising dollars of a certain sporting event as well as grant the holder a first right of refusal to fund all future Company events. With similar provisions, during the year December 31, 2017, the Company borrowed $10,000 in exchange for promissory notes with the accrued and unpaid interest and principal due on or before September 30, 2017. All promissory notes maturity dates were extended to September 30, 2019. During the year December 31, 2018, the Company repaid $5,000 on the debt plus interest in the amount of $4,000. At December 31 2018, the Company owes $15,000 on the debt.

F-64 
Table of Contents

PRIME TIME MOBILE VIDEO EVENT SCREENS, LLC

Notes to Financial Statements

December 31, 2018

On September 9, 2014, the Company issued a secure promissory note in the amount of $100,734 as part of the refinancing of previous debt at an interest rate of eight percent (8%) per annum payable over sixty (60) monthly payments of $2,072. The promissory note is collateralized by the Company’s equipment with accrued and unpaid interest and principal due the earlier of September 9, 2019 or the sale of the Company’s equipment.

NOTE 6 – MEMBERS’ CAPITAL

At December 31, 2016 the members’ capital was a deficit of $603,552. On January 1, 2017, a member of the Company agreed to recharacterize their loan due from the Company in the amount of $690,874 as contributed capital. During the year ended December 31, 2018, a member of the Company contributed cash of $11,166.

NOTE 7 – COMMITMENTS AND CONTINGENCIES

The Company has no long-term commitments or contingencies.

NOTE 8 – SUBSEQUENT EVENTS

On October 11, 2019, the Company sold its business, including equipment to Prime Time Live, Inc. (“PTL”) in exchange for 350,000 shares of PTL’s common stock.

F-65 
Table of Contents

BIO LAB NATURALS, INC. PRO FORMA COMBINED FINANCIAL STATEMENTS

DECEMBER 31, 2019

(UNAUDITED)

F-66 
Table of Contents

The summary unaudited pro forma combined balance sheet as1,000,000 shares of December 31, 2019 representscommon stock issuable upon the effectconversion of the acquisition of Prime Time Live, Inc. as if the transaction occurred on December 31, 2019 and the statement of operations were effective as of the beginning of the latest fiscal year, July 1, 2019. The acquisition of Prime Time Live, Inc. was effective as of December 31, 2019 and, therefore, the effect of the acquisition is included in the historical financial statements of Bio Lab Naturals, Inc. as of December 31, 2019.our outstanding Class A Preferred Stock;
   
833,333 shares of common stock reserved for the future issuance of awards under our 2022 Incentive and Nonstatutory Stock Option Plan;
   
The summary unaudited pro forma statement833,333 shares of operationscommon stock reserved for the period July 1, 2019 (Inception) through December 31, 2019 reflects the acquisitionfuture issuance of Prime Time Live, Inc. as if the transaction occurred on July 1, 2019, the beginning of the latest fiscal year, including the issuanceawards under our 2022 Restricted Stock Plan; and cancellation of Bio Lab Naturals Inc.'s common shares as well as the historical operations of Prime Time Live, Inc. for the period September 17, 2019 through December 30, 2019 and Prime Time Mobile Event Screens, LLC for the period July 1, 2019 through October 11, 2019 [the date Prime Time Mobile Video Event Screens, LLC ceased business]. NOTE 1
   
The unaudited pro forma combined financial statements are presented for illustrative purposes only and are not necessarily indicative10,349,097 shares of our common stock issuable upon the financial condition or resultsconversion of operations of future periods or the financial condition or results of operations that actually would have been realized had the entities been combined during the periods presented. outstanding convertible notes.

Unaudited Pro forma Combined Balance Sheet as of December 31, 2019
         
  Historical      
  Bio Lab Naturals Inc Pro forma Adjustments Notes Pro forma Combined
         
ASSETS        
Current assets        
Cash $69,527  $—        $69,527 
Accounts receivable, net  13,000   —         13,000 
     Total current assets  82,527   —         82,527 
                 
Equipment                
Equipment, net  160,536   —         160,536 
                 
     Total assets $243,063  $—        $243,063 
                 
          LIABILITIES AND STOCKHOLDERS' EQUITY                
Total current liabilities $22,170  $—         22,170 
     Total liabilities  22,170   —         22,170 
                 
Stockholders' equity:                
Preferred shares, par value of $0.0001  50   —         50 
Common shares, par value of $0.0001  848   —         848 
Additional paid-in capital  35,388,065   39,483   1   35,427,548 
Accumulated deficit  (35,168,070)  (39,483)  1   (35,207,553)
Total Stockholders' equity  220,893   —         220,893 
                 
     Total liabilities and stockholders' equity $243,063  $—        $243,063 

F-67 31
Table of Contents

 

Unaudited Pro forma Combined Statement of Operations for the period July 1, 2019 (Inception) through December 31, 2019
             
             
  Historical      
  Bio Lab Naturals Inc. Prime Time Live, Inc. Prime Time Mobile Video Event Screens, LLC Pro forma Adjustments Notes Pro forma Combined
             
Revenue            
 Sales $—    $45,500  $65,050  $—        $110,550 
 Total revenue  —     45,500   65,050   —         110,550 
                         
 Cost of sales                        
         Cost of sales - other  —     13,770   52,901   —         66,671 
         Depreciation  —     8,449   1,573   —         10,022 
     Total cost of sales  —     22,219   54,474   —         76,693 
                         
 Gross profit  —     23,281   10,576   —         33,857 
                         
 Operating expenses                        
 Consulting fees, related party  420,000   26,075   15,375   —         461,450 
 General and administrative expenses - other  25,000   25,873   3,735   —         54,608 
 Asset impairment  1,429,107   —     —     —         1,429,107 
 Total operating expenses  1,874,107   51,948   19,110   —         1,945,165 
                         
 Loss from operations  (1,874,107)  (28,667)  (8,534)  —         (1,911,308)
                         
 Other expenses                        
 Loss on extinguishment of debt  34,103   —     —     —         34,103 
 Interest expense  897   —     2,282   —         3,179 
 Total other expense  35,000   —     2,282   —         37,282 
                         
 Net loss before income taxes  (1,909,107)  (28,667)  (10,816)  —  ��      (1,948,590)
                         
 Income taxes  —     —     —     —         —   
                         
 Net loss $(1,909,107) $(28,667) $(10,816) $—     1  $(1,948,590)
                         
Net (Loss) per Common Share                        
Basic and Diluted $(0.21)   *     N/A     N/A       $(0.24)
                         
Weighted Average Number of Shares Outstanding                        
Basic and Diluted  9,240,816   4,752,243    N/A    (5,801,424)  1   8,191,635 

F-68 
Table of Contents

f. SELECTED FINANCIAL INFORMATION

Not applicable.

g. SUPPLEMENTARY FINANCIAL INFORMATION

Not applicable.

h. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

TheYou should read the following discussion should be readand analysis in conjunction with our unaudited condensed consolidated financial statements and the notes to those financial statements for the three and nine months ended September 30, 2023 and September 30, 2022 and our audited consolidated financial statements and notes thereto included herein. In connection with, and because we desire to take advantage of, the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, we caution readers regarding certain forward-looking statements in the following discussion and elsewhere in this report and in any other statement made by, or on our behalf, whether or not in future filings with the Securities and Exchange Commission. Forward-looking statements are statements not based on historical information and which relate to future operations, strategies, financial results or other developments. Forward looking statements are necessarily based upon estimates and assumptions that are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control and many of which, with respect to future business decisions, are subject to change. These uncertainties and contingencies can affect actual results and could cause actual results to differ materially from those expressed in any forward-looking statements made by, or on our behalf. We disclaim any obligation to update forward-looking statements.

Our plan of operations for the next 12 months is as follows:

As reported elsewhere in this registration statement and the herein financial statements the event services business acquired from Prime Time Live, Inc. and its predecessor, Prime Time Mobile Video Event Services LLC realized historical revenues and operations for the years ended December 31, 2019, 20182022 and 2017.the Period from September 27, 2021 (Date of Formation of LimitlessX) through December 31, 2021, in each case, included elsewhere in this prospectus. This discussion contains forward-looking statements based upon current expectations that involve risks and uncertainties. See “Special Note Regarding Forward-Looking Statements.” Our actual results may differ materially from those contained in or implied by any forward-looking statements.

INTRODUCTION

On May 11, 2022, Bio Lab Naturals, Inc., a Delaware corporation (“Bio Lab”), entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with Limitless X, Inc., a Nevada corporation (“LimitlessX”), and its 11 shareholders (the “LimitlessX Acquisition”). The Company has been continuing this business but experienced duringparties completed and closed the LimitlessX Acquisition on May 20, 2022 by issuing an aggregate of 3,233,334 shares of common stock of Bio Lab to the LimitlessX shareholders (the “Acquisition Closing”). According to the terms of the Share Exchange Agreement, Bio Lab then issued an additional 300,000 shares of common stock to the LimitlessX shareholders pro rata to their interests in approximately six months ended June 30, 2020 no revenues,from the Acquisition Closing as part of the Limitless Acquisition. Concurrently with the LimitlessX Acquisition, Jaspreet Mathur, the founder and principal shareholder of LimitlessX, also purchased from Helion Holdings LLC, 500,000 shares of Bio Lab’s Class A Preferred Convertible Stock, which at all times have a number of votes equal to 60% of all of the issued and outstanding shares of common stock of Bio Lab.

For accounting purposes, the LimitlessX Acquisition was accounted for as a result of“reverse merger” with LimitlessX as the COVID-19 impactaccounting acquiror (legal acquiree) and Bio Lab as well as no events during the winter months. However, management has now been able to reconnect with event services business relationshipsaccounting acquiree (legal acquiror). and, consequently, the transaction was treated as a resultrecapitalization of the impact from COVID-19 lessening and the normal demand for the event services business. Therefore, the Company now expects, without any new or additional steps, revenuesBio Lab. Since LimitlessX was deemed to be generated during the third quarteraccounting acquiror in the LimitlessX Acquisition, the historical financial information for periods prior to the LimitlessX Acquisition reflect the financial information and activities solely of 2020, forwardLimitlessX and not of Bio Lab. No step-up in basis or intangible assets or goodwill was recorded in this transaction.

On June 10, 2022, Bio Lab changed its name to reach operational status by the end of 2020.Limitless X Holdings Inc. (“we,” “us,” or “our”).

32

 

3rd Quarter 2020Marketing and Operations $57,948
4th Quarter 2020 Marketing and Operations$50,041
1st Quarter 2021 Marketing and Operations$18,559
2nd Quarter 2021Marketing and Operations$70,290

RESULTS OF OPERATION

Results of HISTORICAL Operations

For the Three Months Ended JuneSeptember 30, 20202023 Compared to the Three Months Ended JuneSeptember 30, 20202022

  For the three months ended September 30,    
  2023  2022  Changes 
  Amount  % of Sales  Amount  % of Sales  Amount  % 
Revenue                  
Product sales $1,005,924   44% $12,114,278   56% $(11,108,354)  -92%
Service revenue  1,261,814   56%  9,378,900   44%  (8,117,086)  -87%
Rentals  -   0%  2,500   0%  (2,500)  -100%
Total revenue  2,267,738   100%  21,495,678   100%  (19,227,940)  -89%
                         
Cost of sales                        
Cost of sales  644,365   28%  3,037,997   14%  (2,393,632)  -79%
Total cost of sales  644,365   28%  3,037,997   14%  (2,393,632)  -79%
                         
Gross profit  1,623,373   72%  18,457,681   86%  (16,834,308)  -91%
                         
Operating expenses:                        
General and administrative  (1,129)  0%  660,068   3%  (661,197)  -100%
Advertising and marketing  1,873,612   83%  17,163,099   80%  (15,289,487)  -89%
Transaction fees  75,050   3%  1,401,892   7%  (1,326,842)  -95%
Merchant fees  41,370   2%  917,427   4%  (876,057)  -95%
Royalty fees  18,324   1%  472,082   2%  (453,758)  -96%
Professional fees  91,642   4%  272,963   1%  (181,321)  -66%
Payroll and payroll taxes  859,512   38%  258,934   1%  600,578   232%
Rent  37,609   2%  41,177   0%  (3,568)  -9%
Consulting fees, related party  -   0%  6,000   0%  (6,000)  -100%
Total operating expenses  2,995,990   132%  21,193,642   99%  (18,197,652)  -86%
                         
Loss from operations  (1,372,617)  -61%  (2,735,961)  -13%  1,363,344   -50%
                         
Other income (expense)                        
Interest expense  (275,856)  -12%  (68,286)  0%  (207,570)  304%
Other expense  (132,000)  -6%  -   0%  (132,000)  N/A 
Total other income (expense), net  (407,856)  -18%  (68,286)  0%  (339,570)  497%
                         
Loss before income taxes  (1,780,473)  -79%  (2,804,247)  -13%  1,023,774   -37%
                         
Income tax provision  (48)  0%  -   0%  (48)  N/A 
                         
Loss $(1,780,425)  -79% $(2,804,247)  -13% $1,023,822   -37%

During the three months ended June 30, 2020 and 2019 we recognized total revenues of $0. This Company expectsProduct Sales - Our product sales decreased by $11.1 million to generate revenues in the third quarter of 2020 as reflected in the above budget for the next 12 months.

Gross profit loss$1.0 million for the three months ended JuneSeptember 30, 2020 was $(48,345)2023 as compared to $0 for the prior period. The decrease of $48,345 pertained primarily to increase in cost of sales of $48,345.

During the three months ended June 30, 2020, we recognized $34,981 in operating expenses compared to $0 for the prior period. The change results primarily from $34,981 increase in consulting fees, professional fees and general and administrative expenses for the current period.

For the Six Months Ended June 30, 2020 Compared to the Six Months Ended June 30, 2020

During the six months ended June 30, 2020 and 2019 we recognized total revenues of $0. This Company expects to generate revenues in the third quarter of 2020 as reflected in the above budget for the next 12 months.

32 
Table of Contents

Gross profit loss for the six months ended June 30, 2020 was $(27,956) compared to $0 for the prior period. The decrease of $27,956 pertained primarily to increase in cost of sales of $27,956.

During the six months ended June 30, 2020, we recognized $123,394 in operating expenses compared to $0 for the prior period. The change results primarily from $123,394 increase in consulting fees, professional fees and general and administrative expenses for the current period.

For the Three Months Ended March 31, 2020 Compared to the Three Months Ended March 31, 2019

During the three months ended March 31, 2020 and 2019, we recognized total revenues of $0. This low or no revenues is expected to continue until the Company has sufficient access to capital or loans to properly execute marketing activities.

Gross profit loss$12.1 million for the three months ended March 31, 2020September 30, 2022. In 2023, there was $(14,843) compared to $0 fora shift in our marketing and selling strategies, including a change in performance marketers and platforms, which resulted in the prior period. The decrease of $14,843 pertained primarily to increase in cost of sales of $14,843.product sales.

During the three months ended March 31, 2020, we recognized $88,412 in operating expenses compared to $0 for the prior period. The change results primarily

Service Revenue - Our service revenue decreased by $8.1 million from $88,412 increase in consulting fees, professional fees and general and administrative expenses for the current period.

During the three months ended March 31, 2020, we recognized a net loss of $(103,255) compared to $0 for the prior period. The increase in the net loss of $103,255 was a result of an increase in cost of sales and operating expenses of $103,255 during the current period.

For the Period July 1, 2019 (Inception) through December 31, 2019 (The Company has no operations prior to July 1, 2019).

During the period July 1, 2019 (Inception) through December 31, 2019, we recognized total revenues of $0. We acquired an operating at December 31, 2019 and therefore had yet to realize any revenues.

During the period July 1, 2019 (Inception) through December 31, 2019, we recognized $1,874,107 in operating expenses comprised of $420,000 in consulting fees to an officer and an affiliate of the Company, $25,000 in other general and administrative expenses and $1,429,107 in asset impairment related to the write off of goodwill.

During the period July 1, 2019 (Inception) through December 31, 2019, we recognized $35,000 in other expenses comprised of $34,103 in the loss on the extinguishment of debt that was converted into shares of common stock and interest expense of $897.

During the period July 1, 2019 (Inception) through December 31, 2019, we recognized a net loss of $(1,909,017).

RESULTS OF COMBINED OPERATIONS

The following Management, Discussion and Analysis is presented for purposes of more meaningful comparison of operations and is based upon the unaudited historical operations of the Company$9.4 million for the three months ended March 31, 2020 and for the three and six months ended JuneSeptember 30, 2020 as compared2023 to the unaudited combined historical operations of Prime Time Live, Inc. and Prime Time Mobile Video Event Screens, LLC (predecessors of the Company’s business operations )$1.3 million for the three months ended March 31, 2019September 30, 2022. Our service revenue decrease was primarily due to a shift in our marketing and for the three and six months ended June 30, 2019 and the years ended December 31, 2019 and 2018.selling strategies.

For the Three Months Ended March 31, 2020 Compared to the Three Months Ended March 31, 2019Cost of Sales -

During Our cost of sales decreased from $3.0 million, or 14% of sales, in the three months ended March 31, 2020 and 2019 we recognized total revenuesSeptember 30, 2022, to $644,365, or 28% of $0 and $8,000, respectively. The decreasesales, in revenues of $8,000 was due to the COVID-19 pandemic and the lower event activitythree months ended September 30, 2023. As operations decreased during the 2020 winter months.period, so did our costs for freight, inventory, and other supplies.

Gross Profit - Gross profit loss for the three months ended March 31, 2020September 30, 2023 was $(14,843)$1.6 million compared to $(1,959) for the prior period. The increase of $12,884 was due to an increase in cost of sales of $4,884 and the decrease in revenues of $8,000.

During the three months ended March 31, 2020, we recognized $88,412 in operating expenses compared to $20,529 for the prior period. The increase of $67,883 was due to an increase in consulting and professional fees as a result of the Company’s audits and the use of consultants by the Company.

33 
Table of Contents

For the Three Months Ended June 30, 2020 Compared to the Three Months Ended June 30, 2019

During the three months ended June 30, 2020 and 2019 we recognized total revenues of $0 and $16,250, respectively. The decrease in revenues of $16,250 was due to the COVID-19 pandemic.

Gross profit loss$18.5 million for the three months ended JuneSeptember 30, 2020 was $(13,113) compared to gross profit of $5,746 for the prior period.2022. The decrease in gross profit of $18,859$16.8 million was primarily due to an increasea shift in cost of sales of $2,609our marketing and the decreaseselling strategies, including a change in revenues of $16,250 as a result of the COVID- 19 pandemic.performance marketers and platforms.

 

33

Operating Expenses - During the three months ended JuneSeptember 30, 2020,2023, we recognized $34,981$3.0 million in operating expenses compared to $12,278$21.2 million for the prior period.three months ended September 30, 2022. The increasedecrease of $22,703$18.2 million in operating expenses was primarily due to an increasethe decrease in consultingour advertising, marketing, and professional fees of $18,037payroll expenses, as well as a result of the Company’s auditsdecrease in transaction fees, merchant fees, and filings with the OTC Markets and an increase in general & administrative expense of $4,666 as the result of new corporate office and accounting system.royalty fees.

Our advertising and marketing expenses decreased by $15.3 million due to a shift in marketing strategies from relying on performance marketers and celebrity endorsements.
The increase in transaction payroll is related to accruals of unpaid salaries.
The increase in transaction fees and merchant fees are directly related to the increased number of transactions during the three months ended September 30, 2023.
Beginning on April 1, 2022, we began accruing royalties of 4.0% of gross sales (excluding returns, chargebacks, and other such allowances) pursuant to certain manufacturing and distributorship license agreements. During the three months ended September 30, 2023, the royalty fees decreased by $480,648 from the three months ended September 30, 2022.

For the SixNine Months Ended JuneSeptember 30, 20202023 Compared to the SixNine Months Ended JuneSeptember 30, 20192022

  For the nine months ended September 30,    
  2023  2022  Changes 
  Amount  % of Sales  Amount  % of Sales  Amount  % 
Revenue                  
Product sales $13,852,451   77% $27,382,335   153% $(13,529,884)  -49%
Service revenue  4,058,818   23%  12,344,100   69%  (8,285,282)  -67%
Rentals  15,000   0%  7,500   0%  7,500   100%
Total revenue  17,926,269   100%  39,733,935   222%  (21,807,666)  -55%
                         
Cost of sales                        
Cost of sales  3,717,216   21%  5,837,994   33%  (2,120,778)  -36%
Cost of sales - other  -   0%  358   0%  (358)  -100%
Total cost of sales  3,717,216   21%  5,838,352   33%  (2,121,136)  -36%
                         
Gross profit  14,209,053   79%  33,895,583   189%  (19,686,530)  -58%
                         
Operating expenses:                        
General and administrative  1,051,630   6%  1,089,109   6%  (37,479)  -3%
Advertising and marketing  18,525,288   103%  34,376,380   192%  (15,851,092)  -46%
Stock compensation for services  141,020   1%  1,117,782   6%  (976,762)  -87%
Transaction fees  1,159,896   6%  1,988,718   11%  (828,822)  -42%
Merchant fees  1,098,648   6%  1,656,920   9%  (558,272)  -34%
Royalty fees  398,149   2%  704,203   4%  (306,054)  -43%
Professional fees  1,211,759   7%  940,945   5%  270,814   29%
Payroll and payroll taxes  2,931,357   16%  392,605   2%  2,538,752   647%
Rent  123,401   1%  121,570   1%  1,831   2%
Bad debt expense  232,374   1%  -   0%  232,374   N/A 
Consulting fees, related party  10,000   0%  38,500   0%  (28,500)  -74%
Total operating expenses  26,883,522   150%  42,426,732   237%  (15,543,210)  -37%
                         
Loss from operations  (12,674,469)  -71%  (8,531,149)  -48%  (4,143,320)  49%
                         
 Other income (expense)                        
Interest expense  (731,616)  -4%  (81,394)  0%  (650,222)  799%
Loss on debt settlement  (142,551)  -1%  -   0%  (142,551)  N/A 
Other income  -   0%  57,756   0%  (57,756)  -100%
Other expense  (162,000)  -1%  -   0%  (162,000)  N/A 
Gain on disposal of assets  -   0%  28,397   0%  (28,397)  -100%
Total other income (expense), net  (1,036,167)  -6%  4,759   0%  (1,040,926)  -21873%
                         
Loss before income taxes  (13,710,636)  -76%  (8,526,390)  -48%  (5,184,246)  61%
                         
Income tax provision  -   0%  6,402   0%  (6,402)  N/A 
                         
Gain on deconsolidation of subsidiary  241,365   1%  -   0%  241,365   N/A 
                         
Net loss $(13,469,271)  -75% $(8,532,792)  -48% $(4,936,479)  58%

34

 

During

Product Sales - Our product sales decreased by $13.5 million to $13.9 million for the sixnine months ended JuneSeptember 30, 20202023 as compared from $27.4 million for the nine months ended September 30, 2022. In 2023, there was a shift in our marketing and 2019 we recognized total revenuesselling strategies, including a change in performance marketers and platforms, which resulted in the decrease of $0 and $24,250, respectively. Theproduct sales.

Service Revenue - Our service revenue decreased by $8.3 million to $4.1 million for the nine months ended September 30, 2023 as compared to $12.3 million for the nine months ended September 30, 2022. Our service revenue decrease in revenues of $24,250 was primarily due to a shift in our marketing strategies.

Cost of Sales - Our cost of sales decreased from $5.8 million, or 33% of sales, for the COVID-19 pandemic andnine months ended September 30, 2022, to $3.7 million, or 21% of sales, for the lower event activitynine months ended September 30, 2023. As operations decreased during the 2020 winter months.period, so did our costs for freight, inventory, and other supplies.

For the nine months ended September 30, 2023, the average rate of return was 17%. Historically, the average return period is about two weeks from the sale of a product for the current period. For the nine months ended September 30, 2023, we determined the refund reserve to be $0 as there were no sales during the last two weeks of the period.
For the nine months ended September 30, 2023, the average rate of chargebacks was 48%. Historically, the average chargeback period coincided with the return period and is about two weeks. For the nine months ended September 30, 2023, we determined the chargeback reserve to be $0 as there were no sales during the last two weeks of the period.

Gross Profit - Gross profit loss for the sixnine months ended JuneSeptember 30, 20202023 was $(27,956)$14.2 million compared to gross profit of $3,787$33.9 million for the prior period.nine months ended September 30, 2022. The decrease in gross profit of $31,743$19.7 million was primarily due to an increasea shift in cost of sales of $7,493, asour marketing and selling strategies, including a result of increasechange in depreciation of $11,886performance marketers and a decrease in cost of sales – other of $4,393, and the decrease in revenues of $24,250 as a result of the COVID- 19 pandemic and the lower event activity during the 2020 winter months.platforms.

Operating Expenses - During the sixnine months ended JuneSeptember 30, 2020,2023, we recognized $123,394$26.9 million in operating expenses compared to $32,807$42.4 million for the prior period.nine months ended September 30, 2022. The increase of $90,587$15.5 million in operating expenses was primarily due to an increase in consultingadvertising and professionalmarketing, payroll, transaction fees, of $78,130 as a result of the Company’s audits, use of consultantsmerchant fees, royalty fees, and filings with the OTC Markets and an increase in general & administrative expense - other of $12,457 as a result of the establishment of new accounting system and a corporate office.bad debt expense.

Our advertising and marketing expense decreased by $15.9 million due to a shift in marketing strategies from relying on performance marketers.
The increase in transaction payroll is related to accruals of unpaid salaries.
The increase in transaction fees and merchant fees are directly related to the increased number of transactions during the nine months ended September 30, 2023.
The increase of $232,374 in bad debt expense was due to accounts receivable being deemed uncollectible.
Beginning on April 1, 2022, we began accruing royalties of 4.0% of gross sales (excluding returns, chargebacks, and other such allowances) pursuant to manufacturing and distributorship license agreements. During the nine months ended September 30, 2023, the royalty fees decreased by $332,944 from the nine months ended September 30, 2022.

35

 

RESULTS OF OPERATION

For the Year Ended December 31, 20192022 Compared to the Year EndedPeriod from September 27, 2021 (Date of Formation of LimitlessX) through December 31, 20182021

  

For the

year ended

December 31, 2022

  

For the period from

September 27, 2021

(Date of formation)

through

December 31, 2021

  Changes 
  Amount  % of Sales  Amount  % of Sales  Amount  % 
Revenue                        
Product sales $40,364,955   69% $302,371   100% $40,062,584   13,249%
Service revenue  18,308,341   31%  -   0%  18,308,341   N/A 
Rentals  15,000  

 

0%  -   0%  15,000   N/A 
Total revenue  58,688,296   100%  302,371   100%  58,385,925   19,309%
                         
Cost of sales                        
Cost of sales  6,942,680   12%  3,258   1%  6,939,422   212,996%
Cost of sales - other  358   0%  -   0%  358   N/A 
Total cost of sales  6,943,038   12%  3,258   1%  6,939,780   213,007%
                         
Gross profit  51,745,258   88%  299,113   99%  51,446,145   17,200%
                         
Operating expenses:                        
General and administrative  1,938,640   3%  12,054   4%  1,926,586   15,983%
Advertising and marketing  47,164,700   80%  194,679   64%  46,970,021   24,127%
Stock compensation for services  1,117,782   2%  -   0%  1,117,782   N/A 
Transaction fees  3,201,599   5%  1,416   0%  3,200,183   226,002%
Merchant fees  2,459,670   4%  20,092   7%  2,439,578   12,142%
Royalty fees  1,114,403   2%  -   0%  1,114,403   N/A 
Professional fees  1,647,787   3%  14,000   5%  1,633,787   11,670%
Payroll and payroll taxes  1,306,565   2%  17,794   6%  1,288,771   7,243%
Rent  205,497   0%  11,508   4%  193,989   1,686%
Dad debt expense  1,300,855   2%  -   0%  1,300,855   N/A 
Consulting fees, related party  43,500   0%  -   0%  43,500   N/A 
Total operating expenses  61,500,998   105%  271,543   90%  61,229,455   22,549%
                         
Income (loss) from operations  (9,755,740)  -17%  27,570   9%  (9,783,310)  -35,485%
                         
Other income (expense)                        
Interest expense  (348,017)  -1%  -   0%  (348,017)  N/A 
Other income  57,756   0%  -   0%  57,756   N/A 
Gain on disposal of assets  28,397   0%  -   0%  28,397   N/A 
Total other income (expense), net  (261,864)  0%  -   0%  (261,864)  N/A 
                         
Income (loss) before income taxes  (10,017,604)  -17%  27,570   9%  (10,045,174)  -36,435%
                         
Income tax provision  6,402   0%  22,906   8%  (16,504)  -72%
                         
Net income (loss) $(10,024,006)  -17% $4,664   2% $(10,028,670)  -215,023%

 

During

Product Sales - Our product sales increased by 13,249% to $40.4 million for the year ended December 31, 2019 and 2018 we recognized total revenues of $139,562 and $195,276, respectively. The decrease in revenues of $55,7142022 as compared to $302,371 for the period from September 27, 2021 through December 31, 2021. Sales increase was primarily due to us being in operation for 12 months in 2022 compared to one month in 2021. In 2022, there was a decreaseshift in our marketing strategies, including strategic advertisement placements with celebrities and more effective product placement.

Service Revenue - Our service revenue increased by $18.3 million to $18.3 million for the year ended December 31, 2022 as compared to $0 for the period from September 27, 2021 through December 31, 2021. Our service revenue increase was primarily due to us being in operation for 12 months in 2022 compared to one month in 2021. In 2022, we began our digital marketing services.

Cost of 8 eventsSales - Our cost of sales increased from $3,258, 1% of sales, to $76.9 million, 12% of sales. This increase was primarily due to us being in operations for 12 months in 2022 compared to one month in 2021. As operations increased during the year 2019 as a result of the business being sold during the last quarter of 2019period, so did our costs for freight, inventory, and thus a lack of operations.other supplies.

Gross Profit - Gross profit for the year ended December 31, 20192022 was $48,101$51.7 million compared to gross profit of $57,722$299,113 for the year endedperiod from September 27, 2021 through December 31, 2018.2021, 2022. The decreaseincrease in gross profit of $9,621$51.4 million was primarily due to a decreaseus being in cost of sales of $7,493 and a decreaseoperations for 12 months in depreciation of $33,109 from the disposition of assets during the year 2019 and the decrease2022 compared to one month in revenues of $55,714 as a result of the lower event activity during the year 2019.2021 .

 

36

Operating Expenses - During the year ended December 31, 2019,2022, we recognized $112,700$61.5 million in operating expenses compared to $95,725$271,543 for the year endedperiod from September 27, 2021 through December 31, 2018.2021. The increase of $16,975$61.2 million was due to an increaseus being in consulting fees of $26,075 as a result of the use of consultants and a decrease in guaranteed payments to a partner of $15,590 and an increase in general & administrative expense - other of $6,490.

During the year ended December 31, 2019, we recognized other income, net of $224,942operations for 12 months compared to $(6,427) for the year ended December 31, 2018. Thisone month in 2021. The increase of $231,369 wasour operating expenses were primarily due to a gain on the disposition of the business assets of $212,149advertising and a gain on the forgiveness ofmarketing, transaction fees, merchant fees, royalty fees, and bad debt in the amount of $15,000 during the year 2019 along with a decrease in interest expense of $4,220 during the year 2019 as a result of lower debt.expense.

Our advertising and marketing expense increased by $47.0 million due to a shift in marketing strategies to heavily push our related products by using performance marketers and celebrity endorsements. $42.7 million of our advertising and marketing expenses are commission fees to performance marketers.
The increase in transaction fees and merchant fees are directly related to the increased number of transactions during the year.
Beginning on April 1, 2022, we began accruing royalties per the manufacturing and distributorship license agreements of 4.00% of gross sales, excluding returns, chargebacks, and other such allowances. Thus, the royalty fees increased during the period.
The increase in bad debt expense was due to management providing a reserve based on aging of the holdback receivables that they determine should be uncollectible.

LIQUIDITY AND CAPITAL RESOURCES

OperationalOperating Activities

During the nine months ended September 30, 2023, net cash used in operating activities was $7.7 million. The cash used in operating activities was primarily due to net loss, timing of settlement of assets and liabilities, loss on settlement of debt, and was off-set by a gain in deconsolidation of a subsidiary.

Investing Activities

Net cash flows of $123,896used in investing activities for the sixnine months ended JuneSeptember 30, 2020 as compared to $0 for the six months ended June 30, 2019. Cash flows from2023 was $1,604.

Financing Activities

Net cash used in financing activities for the sixnine months ended JuneSeptember 30, 2020 were $280,3052023 was $1,988,817. This amount was incurred by increased borrowings from investors and borrowings from a stockholder.

Off Balance Sheet Arrangements

None.

37

BUSINESS

OVERVIEW

Limitless X is a multinational consumer packaged goods company that helpedspecializes in developing and offering ‘Look Good, Feel Great’ products, specifically within the nutrition and beauty industry, through direct response advertising and our distinctive and highly successful celebrity-backed brand awareness strategies. We possess unique capabilities to greatly enhance the reputation and impact of brands, due to our extensive knowledge and expertise in digital marketing and our successful track record in launching new consumer products.

Leadership

Jas Mathur, our Chairman and Chief Executive Officer, is an entrepreneur with over 14 years of experience within the health, wellness, and dietary supplements industry and 25 years of experience as a webmaster and internet marketer. He is the owner of Emblaze One, a global interactive and web development agency with a staff of 100+. Mr. Mathur founded Limitless X in 2021, drawing upon his own personal battles with health and his transformative journey that resulted in a remarkable weight loss of over 250 lbs. His extraordinary achievements in the business world serve as a powerful source of motivation, inspiration, and empowerment for all those who cross paths with him, igniting their dreams, fostering belief, and empowering them to achieve greatness.

Our Services

Leveraging our top-notch business know-how, deep insights in the health and nutrition industry and a broad network in the industry to identify and boost unique investment opportunities, we help design, build, and grow successful e-commerce brands that have unique capabilities in each of their respective markets while enriching people’s lives. We empower founders by fostering connections with customers, strategic partners, and investors, using our unique direct-to-consumer model to maximize profits.

Product Development

We help create and grow strong, memorable brands. We help our partners at all stages of product development level, including with market research and product, label and packaging design. On the market research side, we examine the competitive landscape of industries by analyzing competitors’ products, conducting surveys, finding relevant partners, and researching resources. We then create an actionable plan to break into the relevant market. We also facilitate key introductions to strategic partners in the PR, IT, finance and legal industries and we help design and implement the product fulfillment process.

Product Manufacturing

We maintain complete control over the manufacturing process, from start to finish, including with the sourcing of high-quality ingredients, identifying reliable supply chain, distribution and manufacturers networks, and the designing of quality assurance and compliance processes.

Product Distribution and Fulfillment

Our streamlined omni-channel approach to product distribution prioritizes consumer interests to help deliver better conversion rates. It includes e-commerce websites, social media, shipping, distributed warehousing, payment processing and product returns. Reliable fulfillment and logistics process allows a fast delivery. Product orders are fulfilled via online, direct to consumer, retail, wholesale and big box retail channels.

38

Marketing, Advertising, and Consumer Outreach

In 2023, we shifted our business model from working capital needs as comparedwith third-party affiliates and affiliate networks to $0now include an in-house, full service digital marketing team to decrease our customer acquisition costs, increase customer retention, satisfaction and build brand trust and loyalty. This shift allows us to control the content and marketing creatives, mitigate chargebacks, decrease refunds, lower customer acquisition costs, impact average order values, and create direct relationships with advertisement platforms.

Our marketing efforts are designed to increase consumer awareness of and demand for the prior period.brands we work with or own. Our marketing team helps design, form and generate the right content for each brand, and devises the best strategy for its distribution. We employ a broad mix of traditional marketing strategies, from: product sampling to exhibiting at consumer trade events and hosting celebrity-rich events where our company and brand(s) are prominently highlighted. Our primary driver is the use of social media platforms to communicate with consumers and build interest in the respective brand(s) and product(s). Our advertising and use of online resources are aimed at increasing consumer preference and usage of our products. Operating as an integrated marketing agency, we plan to offer global marketing services across all areas of the sales process in the near future.

Our Competitive Strengths

 

Operating activities used cash flowsWe constantly strive to find gaps in the relevant marketplace and help develop products that fill those gaps and meet or exceed the needs of $69,877 for the three months ended March 31, 2020 as comparedconsumers. Because of our turnkey solution, we are able to $0 forlaunch products quickly and efficiently to meet consumer needs and cater to new advances in the three months ended March 31, 2019. Cash flows from financing activities for the three months ended March 31, 2020 were $10,930 that helped with working capital needs as compared to $0 for the prior period. 

34 
Table of Contents

Operating activities used cash flows of $25,000 for the period from July 1, 2019 (Inception) through December 31, 2019. Cash flows from financing activities were $25,000 for the same period. health and wellness industry.

 

In order forWe believe that our experience has uniquely positioned us to continue as a going concern,scale and maintain an ecosystem of opinion leaders following wellness-focused brands. We believe we will need to obtain additional debt or equity financingwork with an “A-list” group of influencers who promote the products and look forservices that are offered on our platform.

Our Clients

Currently, all of the brands in our portfolio are with affiliated companies with cash flow positive operations that we can acquire. There can be no assurance that we will be able to secure additional debt or equity financing, that we will be able to acquire cash flow positive operations, or that, if we are successful in anyowned 100% by our Chief Executive Officer, Jas Mathur.

Our Network of those actions, those actions will produce adequate cash flow to enable us to meet all our future obligations. Most of our existing financing arrangements are short-term. If we are unable to obtain additional debt or equity financing, we may be required to significantly reduce or cease operations.Influencers

 

We have approximately $165,000brought together a network of high profile and influential individuals who have all have two things in cashcommon: Look Good and Feel Great. This includes: music artists, movie stars, professional athletes, popular social media influencers, fitness experts, and nutrition coaches. We utilize our network of influencers on an “as needed” basis and compensation terms vary depending on the influencer and product, as of September 22 , 2020 and therefore, have sufficient resources to funddecided upon by our business plan for the next 6 months.

CRITICAL ACCOUNTING POLICIES

management. We changed our year end from June 30th to December 31st and, therefore the consolidated financial statement represents a short year as of and for the period July 1, 2019 (Inception) through December 31, 2019.

Revenue Recognition

We follow the provisions of Accounting Standards Update (“ASU”) No. 2014 – 09, Revenue from Contracts with Customers (Topic 606), using the full retrospective transition method. The adoption of ASU 2014 – 09 diddo not have a material impact onany formal long-term contracts with any one influencer. Our marketing team works with the amount and timing of revenue recognized in our consolidated financial statements.

Under ASU 2014 – 09, we recognize revenues when control of the promised services is transferred to clients, in an amount that reflects the consideration we expect to be entitled to in exchange for those services.

We derive revenues from the rendering of entertainment rental services. We apply the following five steps in orderbrands to determine the appropriate amountaudience for any given brand and reaches out to those persons in our network, who are then engaged to publicize on their media platforms a pre-approved post provided by our marketing team, and in turn, they receive commissions for sales of revenue to be recognized as it fulfills our obligations under each of our contracts:

Identify the contract with a client;

Identify the performance obligations in the contract;

Determine the transaction price;

Allocate the transaction price to performance obligations in the contract; and

Recognize revenue as the performance obligation is satisfied.

Share-based Compensation

We are required to measure and recognize compensation expense for all share-based payment awards (including stock options) made to employees and directors based on estimated fair value. Compensation expense for equity-classified awards is measured at the grant date based on the fair valueproducts they publicize. All of the award and is recognized as an expense in earnings over the requisite service period.

We record compensation expense relatedproducts promoted are offered to non-employees that are awarded stock in conjunction with selling goods or services and recognize compensation expenses over the vesting period of such awards.

In June 2018, the FASB issued ASU No. 2018-07, Improvements to Nonemployee Share-Based Payment Accounting, which amends ASC 718, Compensation – Stock Compensation. This ASU requires that most of the guidance related to stock compensation granted to employees be followed for non-employees, including the measurement date, valuation approach, and performance conditions. The expense is recognized in the same period as though cash were paid for the good or service. The effective date is the first quarter of fiscal year 2020, with early adoption permitted, including in interim periods. The ASU has been adopted using a modified-retrospective transition approach. The adoption is not considered to have a material effect on the consolidated financial statements.

Income Taxes

We use the liability method of accounting for income taxes under which deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the accounting bases and the tax bases ofconsumers through our assets and liabilities. The deferred tax assets and liabilities are computed using enacted tax rates in effect for the year in which the temporary differences are expected to reverse.website.

35 
Table of Contents

 

Our deferred income taxes include certain future tax benefits. We record a valuation allowance against any portion of those deferred income tax assets when we believe, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred income tax asset will not be realized.Compliance Team

 

All of our compliance matters are managed in house by our Chief Operating Officer and our VP of Legal Affairs, including our data security, privacy rights, and ensuring that the products that we offer are in compliance with applicable government regulations. (See “Government Regulation” below.)

39

Our Strategy

We have adopted ASC guidance regarding accounting for uncertainty in income taxes. This guidance clarifiesmanufacturing and distribution licensing agreements to market, manufacture, sell, and distribute the accounting for income taxes by prescribingbranded products on behalf of our licensors. The licensor retains the minimum recognition threshold an income tax position is requiredrights to meet before being recognized in the consolidated financial statements and applies to all income tax positions. Each income tax position is assessed using a two-step process. A determination is first made as to whether it is more likely than not that the income tax position will be sustained, based upon technical merits, upon examination by the taxing authorities. If the income tax position is expected to meet the more likely than not criteria, the benefit recorded in the consolidated financial statements equals the largest amount that is greater than 50% likely to be realized uponcontinue its ultimate settlement. At December 31, 2019, there were no uncertain tax positions that required accrual.

Goodwill

In accordance with generally accepted accounting principles, goodwill cannot be amortized, however, it must be tested annually for impairment. This impairment test is calculated at the reporting unit level. The goodwill impairment test has two steps. The first identifies potential impairments by comparing the fair value of a reporting unit with its book value, including goodwill. If the fair value of the reporting unit exceeds the carrying amount, goodwill is not impaired and the second step is not necessary. If the carrying value exceeds the fair value, the second step calculates the possible impairment loss by comparing the implied fair value of goodwill with the carrying amount. If the implied goodwill is less than the carrying amount, a write-down is recorded. Management tests goodwill each year for impairment, or when facts or circumstances indicate impairment has occurred.

Impairment of Long-Lived Assets

In accordance with authoritative guidance on accounting for the impairment or disposal of long-lived assets, as set forth in Topic 360 of the ASC, we assess the recoverability of the carrying value of its long-lived assets when events occur that indicate an impairment in value may exist. An impairment loss is indicated if the sum of the expected undiscounted future net cash flows is less than the carrying amount of the assets. If this occurs, an impairment loss is recognized for the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets.

Fair Value Measurements

We apply the authoritative guidance applicable to all financial assets and liabilities required to be measured and reported on a fair value basis, as well as to non-financial assets and liabilities measured at fair value on a non-recurring basis, including impairments of long-lived assets. The fair value of an asset or liability is the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. We maximize theown use of observable inputsthese items under existing or new contracts in its discretion, and minimizesto develop new products. Our typical manufacturing and distribution licensing agreements allows us to:

(a)Design or redesign the products;
(b)Manufacture the products under such design specifications as may be mutually agreed upon by the licensor and us from time to time;
(c)Promote, sell, and distribute the products in the United States and its territories;
(d)Use the existing designs of the products and all intellectual property rights associated with or for such products, including all trademarks and patent rights, with the sale, promotion, and distribution of the products in the territory, including the display of any trademarks, and all other designs or marks which could be or that are actually later registered with the federal Patent and Trademark Office, on our vehicles and other merchandising equipment, and on stationery, packaging, and other advertising and promotional materials;
(e)Use the existing domain names, web addresses, telephone lines, third-party vendors, and any other operational element currently in use by the licensor that can be transferred to us; and
(f)Manufacture, promote, sell, and distribute new products designed or created by us that we deem preferable to sell under the licensor’s name; and in such case, we negotiate in good faith to agree on a royalty commission percentage or flat rate amount for the sale of new products using the licensor’s name.

Market Data and Research of Our Verticals

Health and Wellness

According to Zion Market Research, the use of unobservable inputs when measuring fair value. Observable inputs are inputs thatglobal health and wellness market participants would use in valuing the asset or liability based on market data obtained from sources independent of us. Unobservable input are inputs that reflect our assumption of what market participants would use in valuing the asset or liability based on the information available in the circumstances.

Financial and non-financial assets and liabilities are classified within the valuation hierarchy based upon the lowest level of input thatsize is significantprojected to the fair value measurement. Our policy is to recognize transfers in and out of the fair value hierarchy as ofreach $8,946 billion by the end of 2030, with a compound annual growth rate of approximately 6.9% between 2023 and 2030. In 2022, the reporting period in which the event or change in circumstances caused the transfer. We have consistently applied the valuation techniques discussed below in all periods presented. The hierarchy is organized into three levels basedmarket size was estimated to be $5,244 billion.

Intellectual Property

Currently, we do not own any registered trademarks, but we intend on the reliabilityacquiring some of the inputs as follows:

Level 1: Quoted prices in active markets for identical assets or liabilities; or

Level 2: Quoted prices in active markets for similar assets and liabilities and inputs, quoted prices for identical or similar assets or liabilities in markets that are not active and model-derived valuations whose inputs or significant value drivers are observable; or

Level 3: Unobservable pricing inputs in which there is little or no market data, which requires the reporting entity to develop its own assumptions.

i. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURES

Not applicable.

36 
Table of Contents

j. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

k. DIRECTORS and EXECUTIVE OFFICERS

The Company currently has no employees that it identifies as significant employees. The directors and executive officers are set forthlicenses we have worked with in the chart below.past and/or are working with today.

NamePositionAgeTerm of Office (if indefinite, give date appointed)Approximate hours per week (if part-time)/full-time
W. Edward NicholsChief Executive Officer and Director78Annual10
     
Darrell AveyChief Financial Officer, Vice President and Director64Annual10
     
Jeremy OstlerDirector45Annual5
     
Calvin D. Smiley, Sr.Director67Annual2

Our officers are elected bySeasonality

We do not experience seasonal variations in our quarterly operating results and capital requirements.

Human Capital

As of the boarddate of directors at the first meeting after each annual meetingthis prospectus, we have 12 full-time employees and no part-time employees. None of our stockholdersemployees are members of a labor union or covered by a collective bargaining agreement.

Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing and hold office until their successors are duly electedintegrating our existing and qualified under our bylaws.

new employees, advisors, and consultants. The directors named above will serve until the next annual meetingprincipal purposes of our stockholders. Thereafter, directors will be elected for one-year terms atequity incentive plans are to attract, retain and reward personnel through the annual stockholders’ meeting. Officers will holdgranting of equity-based compensation awards in order to increase shareholder value and the success of our business by motivating such individuals to perform to the best of their positions at the pleasure of the board of directors absent any employment agreement. abilities and achieve our objectives.

Legal Proceedings

There isare no arrangement or understanding between our directors and officers and any other person pursuantmaterial proceedings to which any director or officer, was or any associate of any such director or officer, is a party that is adverse to be selected asour Company or any of our subsidiaries or has a material interest adverse to our Company or any of our subsidiaries. No director or executive officer has been a director or officer.

BIOGRAPHICAL INFORMATION

W. Edward Nichols, Chief Executive Officer and Director since 2015

Mr. Nichols is an attorney located in Littleton, Colorado. He is authorized to practice in the Statesexecutive officer of Colorado and Kansas, United States Federal Courts, and the Supreme Court of the United States. Mr. Nichols is in house counsel and consultant for Columbine Valley Resources, Inc. (fka T-Rex Oil, Inc.) since September 1, 2014 to present. He also serves as a Director of ECO2 Source, Inc. (fka NexFuels, Inc.) from July 20, 2016 to present. Mr. Nichols served as a Director and Chairman of Audit Commission of Bakken Resources, Inc. from 2012 until March 2015. He is also Managing Director of Nichols & Company LLC, a management consulting firm since May 25, 2000. Prior to Nichols & Company, Mr. Nichols practiced with Nichols and Wolfe where he specialized in municipal bonds. After 16 years he sold his interest in the firm and moved to Denver. He was instrumental in structuring and providing approving legal opinions for several hundred million dollars of General Obligation Bonds, Tax Anticipation Notes and Revenue Bonds.

Mr. Nichols holds a Bachelor of Business Administration from Washburn University and a Juris Doctorate degree from Washburn University School of Law in Topeka, Kansas. Mr. Nichols is a member of the Board of Governors of the Law School and an Advisor to the Transaction Law Center at the University.

Darrell Avey, Chief Financial Officer, Vice President and Director since February 2020

Mr. Avey started his career in the Video Display Business in 1985. For the last 19 years, Mr. Avey has been involved in the building and rentals of video displays for special events around the United States. In that time, he has been involved in the manufacturing and sales of video displays to learning and participating in all aspects of a publicly owned company. He has been a Manager of Prime Time Mobile Video Event Screens from May 2010 through present. He is responsible for building the largest highest mobile video screen in the country as well as startup and daily operations of the mobile video screen rental company.

Jeremy Ostler, Director since February, 2020

Mr. Ostler has been an owner of several businesses in the Audio, Music and Production industry since 1996. He has managed installation and Live production crews on over 1000 installations and 1500 events.

37 
Table of Contents

From 2016 until present, he has been Owner and Manager of Rezolution AV, an Audio Visual Production Company, where he handles large scale concerts, festivals, corporate conferences such as Utah Department of Transportation Annual Conference, Deer Valley Music Festival, Video for Mackenzie Exhibit Tradeshow Booths.

From 2005 to 2016, he was Owner and Manager of Trax AV, an Audio Visual Production Company, where he handled installations and all Live Productions across USA. Productions included Video for 2 NFL Super Bowl Events, Jeep King of the Mountain, Deer Valley Music Festival, Chive Tour, Park City & SLC Jazz Festivals. Telluride Blues Festival, PGA Champions Tournament, Nitro Circus, University of Idaho, Utah, Montana, and Washington commencements, Stadium of Fire and many more events. Installations included All Utah and some southern Idaho Kohls Department store audio systems, Canyons School District, Weber School District High School Auditorium upgrades.

Mr. Ostler is also a present Partner and Owner of Warehouse 22 overseeing all technology in a Visually stunning event center that uses Projection Mapping to add video and scenic elements to any type of event. He is also a current Partner in BD Catering Company which provides a broad range of Catering options for Events inside and outside the venue.

Mr. Ostler was an Apprentice with Jeffrey Ostler. He obtained a BS in Audio from BYU.

Calvin D. Smiley, Sr., Director since February, 2020

Mr. Smiley has more than 30 years in the broadcasting and cable television industries. He was appointed the Chief Executive Officer, President and a Director of the Nexhorizon, Inc. in October 2006. He previously had co-founded Sunrise Broadband Group, Inc. from 2004 through 2006. From 2001 to 2003, he was a telecommunications consultant and began work to develop the Sunrise business strategy. Mr. Smiley held various executive positions with TCOM Ventures Corporation headquartered in Englewood, Colorado. From 2000 to 2001 he served as a director, President and CEO of TCOM Ventures, with a business focus to use a digital wireless platform to provide broadband services to customers of acquired rural ISP’s and competitive local exchange carriers (“CLEC’s”). From 1998 to 1999, he co-founded and served as President of Communicast, Inc., a successful turn-key marketing and advertising sales company which developed revenues for rural cable television systems, wireless providers and independent television stations. Mr. Smiley attended Geneva College in Beaver Falls, Pennsylvania. He completed strategic management courses of study at the University of Pittsburgh.

CONFLICTS OF INTEREST – GENERAL

There can be no assurance that management will resolve all conflicts of interest in favor of the Company.

Our directors and officers are, or may become, in their individual capacities, officers, directors, controlling shareholder and/or partners of other entities engaged in a variety of businesses. Thus, there exist potential conflicts of interest including, among other things, time, efforts and corporation opportunity, involved in participation with such other entities. Consequently, there are potential inherent conflicts of interest in their acting as officers and directors of the Company. Insofar as the officers and directors are engaged in other business activities, officer-management anticipates it will devote only up to approximately 10 hours per week to the Company’s affairs.

None of our Officers and Directors has any interest in any competitive business to ours or any service provider to our Company. The other businesses in which our officers and directors now participate have no relation to our business, do not compete with our business and do not supply services, materials, or technology to our business. We see the primary conflict as one of necessary time devoted to the Company business and internal controls and procedures for accounting for our quarterly and annual reports under Section 13(a) of the Securities Exchange Act of 1934, which must be filed timely under the section and quarterly reviews and annual audits by our auditors which require adequate record keeping.

CONFLICTS OF INTEREST – CORPORATE OPPORTUNITIES

Presently no requirement contained in our Articles of Incorporation, Bylaws, or minutes which requires officers and directors of our Company to disclose business opportunities which come to their attention. Our officers and directors do, however, have a fiduciary duty of loyalty to our Company to disclose to it any business opportunities which come to their attention, in their capacity as an officer and/has filed a bankruptcy petition or had a bankruptcy petition filed against it during the past ten years. No current director or otherwise. Excluded from this duty would be opportunities which the person learns about through his involvement as anexecutive officer and director of another Company. We have no intention of merging with or acquiring an affiliate, associate person or business opportunity from any affiliate or any client of any such person.

38 
Table of Contents

Our Board of Directors has adopted a policy that the Company will not do business with any entity in which any officer or director serves as an officer or director or in which they or their family members own or hold a controlling ownership interest. Although the Board of Directors could elect to change this policy, the Board of Directors has no present intention to do so.

COMMITTEES OF THE BOARD OF DIRECTORS

We are managed under the direction of its board of directors.

EXECUTIVE COMMITTEE

We do not have an executive committee, at this time.

AUDIT COMMITTEE

We have formed a non-independent audit committee in May 2020 to assist the Board in monitoring (1) the integrity of the financial statements of the Company, (2) the compliance by the Company with legal and regulatory requirements and (3) the independence and performance of the Company’s internal and external auditors. Ed Nichols, as Chairman, and Calvin D. Smiley, Sr. act as the initial members of the Audit Committee.

The functions of the audit committee are to review the scope of the audit procedures employed by our independent auditors, to review with the independent auditors our accounting practices and policies and recommend to whom reports should be submitted, to review with the independent auditors their final audit reports, to review with our internal and independent auditors our overall accounting and financial controls, to be available to the independent auditors during the year for consultation, to approve the audit fee charged by the independent auditors, to report to the board of directors with respect to such matters and to recommend the selection of the independent auditors.

In the absence of a separate audit committee our board of directors functions as audit committee and performs some of the same functions of an audit committee, such as recommending a firm of independent certified public accountants to audit the annual financial statements; reviewing the independent auditors independence, the financial statements and their audit report; and reviewing management’s administration of the system of internal accounting control We expect that the selection of a business opportunity will be complex. Due to general economic conditions, rapid technological advances being made in some industries and shortages of available capital, we believe that there are numerous firms seeking the benefits of an issuer who has complied with the 1934 Act. Such benefits may include facilitating or improving the terms on which additional equity financing may be sought, providing liquidity for incentive stock options or similar benefits to key employees, providing liquidity (subject to restrictions of applicable statutes) for all stockholders and other factors. Potentially, available business opportunities may occur in many different industries and at various stages of development, all of which will make the task of comparative investigation and analysis of such business opportunities extremely difficult and complex. We have, and will continue to have, essentially no assets to provide the owners of business opportunities. However, we will be able to offer owners of acquisition candidates the opportunity to acquire a controlling ownership interest in an issuer who has complied with the 1934 Act without incurring the cost and time required to conduct an initial public offering.

ANNUAL MEETING

The annual meeting of stockholders is anticipated in the 4th Quarter of 2020 and will include the election of directors. The annual meeting will be held at our principal office or at such other place as permitted by the laws of the State of Delaware and on such date as may be fixed from time to time by resolution of our board of directors.

PREVIOUS “BLANK CHECK” OR “SHELL” COMPANY INVOLVEMENT

No members of our management have been involved in previous “blank-check” or “shell” companies, except Ed Nichols. He has been officer and director of the Company while it has been a “shell” since 2015.

INVOLVEMENT IN LEGAL PROCEEDINGS

No executive Officer or Director of our Company has been convicted in anyof a criminal proceeding (excluding traffic violations)offense or is the subject of a pending criminal proceeding that is currently pending.

during the past ten years. No current director or executive Officer or Director of our Company isofficer has been the subject of any pending legal proceedings.order, judgment or decree of any court permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities or banking activities during the past ten years. No current director or officer has been found by a court to have violated a federal or state securities or commodities law during the past ten years. From time to time, we may be named in claims arising in the ordinary course of business.

However, we may from time to time after the date of this prospectus become subject to claims and litigation arising in the ordinary course of business. One or more unfavorable outcomes in any claim or litigation against us could have a material adverse effect for the period in which such claim or litigation is resolved. In addition, regardless of their merits or their ultimate outcomes, such matters are costly, divert management’s attention, and may materially adversely affect our reputation, even if resolved in our favor.

Properties

We own no property.

Corporate History and Background

The Company was formed in the State of Nevada on June 3, 1996, as Vyta Corp. On November 5, 2010, the Company changed its name to Bio Lab Naturals, Inc. On May 11, 2022, Bio Lab Naturals, Inc., a Delaware corporation (“Bio Lab”), entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with Limitless X, Inc., a Nevada corporation (“LimitlessX”), and its 11 shareholders (the “LimitlessX Acquisition”). The parties completed and closed the LimitlessX Acquisition on May 20, 2022. Concurrently with the LimitlessX Acquisition, Jaspreet Mathur, the founder and principal shareholder of LimitlessX, also purchased from Helion Holdings LLC, shares of Bio Lab’s Class A Preferred Convertible Stock, which at all times have a number of votes equal to 60% of all of the issued and outstanding shares of common stock of Bio Lab. On June 10, 2022, the Company changed its name to Limitless X Holdings Inc.

Subsidiaries

We have 2 subsidiaries, Limitless X, Inc, a Nevada corporation and Prime Time Live, Inc., a Colorado corporation.

Corporate Information

We are a Delaware corporation. Our corporate headquarters are located at 9454 Wilshire Blvd., #300, Beverly Hills, CA 90212. Our telephone number is (833) 888-8923. We maintain a website at www. https://www.limitlessx.com/.

39 40
Table of Contents

 

 

No

MANAGEMENT

Directors and Executive Officer or Director of our Company is involved in any bankruptcy petition by or against any business in which they are a general partner or executive officer at this time or within two years of any involvement as a general partner, executive officer, or Director of any business.Officers

l. EXECUTIVE AND DIRECTORS COMPENSATION

COMPENSATION

The following table sets forth the compensation paid toinformation about our current executive officers and board members during the three months ended March 31, 2020 and the period July 1, 2019 (Inception) throughdirectors, including their ages as of December 31, 2019 and for2023. With respect to our directors, each biography includes information regarding the years ended June 30, 2019 and 2018. The table sets forth this information for Bio Lab Naturals, Inc. including salary, bonus, and certain other compensationexperience, qualifications, attributes, or skills that caused our board of directors to the Board members and named executive officers for the three months ended March 31, 2020 and for the period July 1, 2019 (Inception) through December 31, 2019 and for the years ended June 30, 2019 and 2018. 

SUMMARY EXECUTIVE COMPENSATION TABLE

Name & Position Year Salary
($)
 Bonus
($)
 Stock awards Option awards
($)
 Non-equity incentive plan compensation
($)
 Non-qualified deferred compensation earnings
($)
 All other compensation ($) Total
($)
W. Edward Nichols, CEO and President  2020(1)  0   0   0   0   0   0   0   0 
   2019(2)  0   0   250,000   0   0   0   0  $150,000 
   2019   0   0   0   0   0   0   0   0 
   2018   0   0   0   0   0   0   0   0 
Darrell Avey, CFO and Vice President (3) and (4)  2020(1)  0   0   0   0   0   0  $15,000  $15,000 
TOTAL      0   0   250,000   0   0   0  $15,000  $165,000 

(1)Represents three months ended March 31, 2020.

(2) Represents period July 1, 2019 (Inception) through December 31, 2019.

(3) Engaged in February 2020.

(4) Represents $15,000 in consulting fees paid ondetermine that such person should serve as a month to month basis at the rate of $5,000 per month.

OPTION/WARRANT GRANTS IN THE LAST FISCAL YEAR

On January 15, 2020, the Board of Directors and majority stockholders of Bio Lab Naturals, Inc. approved the 2020 Bio Lab Naturals, Inc. Stock Option and Award Incentive Plan (“the 2020 Plan.”) There are 2,000,000 sharesdirector of our common stock reserved undercompany.

Set forth below are the 2020 Plan.

The numbernames, ages, and positions of options, exercise priceour directors and expiration date of these options are as follows:

Stock OptionShareExpire
GrantedPriceDate
None

40 
Table of Contents

OUTSTANDING EQUITY AWARDS AT FISCAL YEAR END

The following table sets forth certain information concerning outstanding equity awards held by our appointed executive officers as of December 31, 2019 (the “Named Executive Officers”):the date of this prospectus.

NameOption AwardsStock awardsAgePosition with the CompanyDate Joined the Company
NameJaspreet Mathur

Number of securities underlying unexercised options (#) exercisable

Number of securities underlying unexercised options (#) unexercisable

37

Equity incentive plan awards: Number of securities underlying unexercised unearned options

(#)

Option exercise price

($)

Chief Executive Officer and Chairman

Option expiration date

Number of shares or units of stock that have not vested

(#)

Market value of shares of units of stock that have not vested

($)

Equity incentive plan awards: Number of unearned shares, units or other rights that have not vested (#)

Equity incentive plan awards: Market or payout value of unearned shares, units or others rights that have not vested

($)

May 20, 2022
W. Edward Nichols, CEOKenneth Haller36President and ChairmanDirector------------------May 20, 2022
Benjamin Chung46Chief Financial OfficerMay 20, 2022
Darrell Avey, CFO and Vice PresidentDanielle Young----35----Chief Operating Officer----May 20, 2022
Rob Cucher----46--VP of Legal AffairsMay 20, 2022
Bharat Raj Mathur67DirectorMay 20, 2022
Amanda Saccomanno31DirectorMay 20, 2022
Dov Konetz40DirectorMay 20, 2022
Dan Fleyshman40DirectorOctober 3, 2022
Leon Anderson36DirectorOctober 3, 2022
Michael Braun38DirectorJanuary 11, 2023
Hassan Iddrissu45DirectorJanuary 11, 2023

DIRECTOR COMPENSATION

41

 

Director Independence

For a director to be considered “independent,” the Board must affirmatively determine that the director has no material relationship with the Company (directly or as a partner, stockholder or officer of an organization that has a relationship with the Company). In each case, the Board considers all relevant factsBiographical Information

Directors and circumstances. We currently have no independent directors.Executive Officers

All of our officers and/or directors will continue to be active in other companies. All officers and directors have retained the right to conduct their own independent business interests.

The following table sets forth certain information concerning compensation paid to our directors during the period July 1, 2019 (Inception) through December 31, 2019:

    Name

 Fees earned or paid in cash

($)

Stock awards ($)

Option awards ($)

Non-equity incentive plan compensation ($)

Non-qualified deferred compensation earnings

($)

All other compensation ($)

Total

($)

W. Edward Nichols—  —  —  —  —  —  —  
Darrell Avey—  —  —  —  —  —  —  
Jeremy Ostler—  —  —  —  —  —  —  
Calvin D. Smiley, Sr.—  —  —  —  —  —  —  

The termis a brief biography of office for each Director is until March 1, 2022, or until their successor is duly elected or appointed. The term of office for each of our Officers is at the pleasure of the Board of Directors.current executive officers and directors:

41 Jaspreet Mathur– Chief Executive Officer and Chairman of the Board of Directors
Table of Contents

The Board of Directors has no nominating, auditing committee or a compensation committee. Therefore, the selection of person or election to the Board of Directors was neither independently made nor negotiated at arm’s length.

At this time,On May 20, 2022, Jaspreet Mathur became our Director does not receive cash compensation for serving asChairman, Chief Executive Officer, and a member of our Board of Directors. In January 2011, Mr. Mathur launched Kore Fit Living, a chain of retail stores across Canada specializing in sales of vitamins and supplements, sports nutrition, athletic apparel and fitness/MMA training equipment. In 2013, he launched a web agency, Emblaze One, as a full-service interactive agency with global offices to accommodate a consumer market shift from brick and mortar to e-commerce. In November 2018, Mr. Mathur launched the Limitless brand, which manufactures and distributes health and wellness products and offers B2B services for brand development and digital marketing. In January 2022, he teamed up with Dr. Mehmet Oz and a nonprofit organization called HealthCorps to jumpstart health and wellness programs that are targeted to teens and young adults.

Kenneth Haller– President and Director

On May 20, 2022 Kenneth Haller was appointed our President and a Director of our Board. From January 2021 until April 2022, Mr. Haller was Vice President of Payments at RYVYL Inc. (formerly Greenbox POS) (Nasdaq: RYVL), a software company that designs and develops mobile applications for cash-free e-wallet payments. From May 2013 through May 2022, Mr. Haller was Managing Partner of SKY MIDS, a strategic merchant services company that focuses on high risk and international credit card processing. During this same period until 2021, he was Chief Executive Officer of ChargeSavvy, LLC, a table-side checkout POS system that streamlines information gathering and payment processing.

Benjamin Chung- Chief Financial Officer

On May 20, 2022, Benjamin Chung was appointed as our Chief Financial Officer. Mr. Chung has been in public accounting for over 24 years. From 1999 through 2004, Mr. Chung was an Audit Manager at PricewaterhouseCoopers. From May 2004 through June 2007, Mr. Chung was an audit manager at Ernst & Young. He then went on to become the Director of Internal Audit for Big 5 Sporting Goods. In January 2012, Mr. Chung was the founder and managing partner at Benjamin & Ko, a public accounting and consulting firm. In May 2021, Mr. Chung became the CFO of RYVYL Inc. (formerly Greenbox POS) (Nasdaq: RYVL). Additionally, over the last five years, Mr. Chung has also served on the board for multiple public companies, the most recent being Franklin Wireless, which trades on Nasdaq. Mr. Chung resigned from that board in December 2019 and currently does not serve on the board of directors of any publicly traded company.

Danielle Young- Chief Operating Officer

On May 20, 2022, Danielle Young was appointed our Chief Operating Officer. Mrs. Young has been in public accounting for over twelve years. In January 2015, she was hired by Benjamin & Young, LLP, a mid-size CPA firm in Orange County, California as part of their tax department. In May 2019, she left Benjamin & Young and joined Benjamin & Ko, as the Director of Internal Audit, spearheading their operations as well as working with major public companies such as The Habit Burger, Aerovironment, and Ducommun Aerospace. After leaving Benjamin & Ko in July 2021, she started her own consulting firm, Irvine Advisory Services which focuses on IPO readiness preparation, internal audit, Sarbanes-Oxley and corporate management. In June 2022, she was elected to the board of trustees of The Miss America Foundation.

42

Rob Cucher-VP of Legal Affairs

On May 20,2022 Rob Cucher was appointed as our VP of Legal Affairs. Mr. Cucher is a seasoned attorney with 20 years of courtroom practice and experience representing clients on a wide range of legal matters including civil litigation, corporate governance, labor and employment, and commercial transactions, with a concentration in business law and health care. Since April 2017, Mr. Cucher has served as an officer and director of a technology company finding solutions to tracking chronic care and behavioral health conditions for patients throughout California. In February 2010, Mr. Cucher co-founded Sports for All Children, a non-profit providing athletic opportunities for children with special needs. Additionally, Mr. Cucher became a director in May 2019 of Better Housing Solutions, an affordable housing non-profit currently servicing Palmdale, California. Mr. Cucher graduated cum laude from UCLA and Loyola Law School in Los Angeles and is a current member of the California State Bar and United States District Courts.

Bharat Raj Mathur- Director

Bharat Raj Mathur joined our board of directors on May 20, 2022. Since July 2016, he has been a columnist and featured contributor at www.bizcatalyst360.com. From March 2014 to April 2016, he was chief operating officer at KORE Fit Living. From August 2004 through April 2016, Mr. Mathur was Vice President, Distribution Channel Management at Incredible Entertainment.

Amanda Saccomanno- Director

Amanda Saccomanno joined our board of directors on May 20, 2022. Ms. Saccomanno is an American professional wrestler, television personality, and fitness and figure competitor. In 2015, Ms. Saccomanno gained major attention from World Wrestling Entertainment (WWE) after scoring second place in its Tough Enough reality show – a competition of contenders vying for a WWE wrestling contract. In May 2015, she signed with the WWE as a Sports Entertainer and starring in their E! Hit Reality Series, Total Divas. Since May 2017, Ms. Saccomanno has developed multiple health platforms and launched an iOS application called “Fit with Mandy.” In 2020, Ms. Saccomanno co-founded and continues to help market and develop a skin care line, with our CEO, Jaspreet Mathur, called Amarose.

Dov Konetz- Director

For more than the past five years, Dov Konetz has been the Managing Director of DMK Capital, a company engaged in providing valuations in commercial real estate, intangibles and movable assets. Since 2008, Mr. Konetz has served as a Director of Mount Sinai Hospital in Miami, Florida. Mr. Konetz also served on the Miami Beach Police Relations Committee from 2010 through 2012. Mr. Konetz is a valued supporter of The Dream Catcher Foundation, a non-profit that is dedicated to combating human trafficking.

Dan Fleyshman- Director

Dan Fleyshman is the CIO and a director of Blockchain Consulting Group, Inc. He founded Elevator Studios in 2015 and is currently its CEO. From 2012 through 2015, he was the CEO of One Penny Ad Agency. Between 2010 and 2012, Mr. Fleyshman consulted for a casino in Nevada. He was the CEO of Victory Poker from 2009 through April 2010. From 1999 through 2009, he was the president of WYD, Inc. located in San Diego, California.

Leon Starino Anderson- Director

From 2002 through 2012, Mr. Anderson became a partner in a London based night club. Mr. Anderson went on to develop public relations and marketing services for major brand deals while in the U.K. for a number of celebrities. Mr. Anderson was recognized for a “first of its kind” buyout on a brand that had no previous history but secured a buyout by ASOS. Since September 2021, Mr. Anderson has continued to run his company, Due Diligence Apparel Ltd.

Michael Braun- Director

Since 2010, Michael Braun has been the Director of Marketing and Sales of Westbank Pacific Realty Corp., a mixed-use real estate development company. Prior to Westbank, Mr. Braun worked for Rennie, a real estate marketing and sales firm in Vancouver. He graduated from the University of British Columbia in 2007 with a Science Major and Commerce Minor. Mr. Braun holds a real estate license in Vancouver, British Columbia.

Hassan Iddrissu- Director

Since 2014, Mr. Iddrissu has been the CFO of First Pinnacle Capital Group, Inc., a real estate company in West Los Angeles. Since 2003, Mr. Iddrissu has also been the co-Founder, Chairman, and CEO of RoadStarr Motorsports, a market leader in the auto boutique with various entities across the luxury car industry including an exotic car rental company Starr Auto Rentals. Mr. Iddrissu is also an active mentor and motivational speaker for various inner-city youth, including the Los Angeles Sheriff Foundation. Mr. Iddrissu has his Bachelor of Business Administration from Loyola Marymount University.

43

Family Relationships

Except for Bharat Raj Mathur, who is the father of our CEO, Jaspreet Mathur, there are no family relationships with any of the executive officers or directors of the Company and the above referenced individuals. Other than as may be contemplated by the Share Exchange Agreement there are no arrangements or understandings between the above referenced individuals and any other persons pursuant to which he or she was selected as a director.

Board Composition

Our board of directors currently consists of nine persons.

Our board of directors believes its members collectively have the experience, qualifications, attributes and skills to effectively oversee our management, including a high degree of personal and professional integrity, an ability to exercise sound business judgment on a broad range of issues, sufficient experience and background to have an appreciation of the issues facing us, a willingness to devote the necessary time to board duties, a commitment to representing our best interests and the best interests of our shareholders, and a dedication to enhancing shareholder value.

We held no board of directors meetings in 2023 and two board of directors meetings in 2022. All other board actions were taken by unanimous written consent of the directors.

Director Independence

We adhere to the rules of NYSE American in determining whether a director is independent. The NYSE American listing standards generally define an “independent director” as a person, other than an executive officer of a company or any other individual having a relationship which, in the opinion of the issuer’s board of directors, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director.

Our board of directors has undertaken a review of the independence of each director and will review the independence of any new directors based on information provided by each director concerning his background, employment, and affiliations, in order to make a determination of independence. Our board of directors has determined that there are five independent directors on our board of directors.

Role of Our Board of Directors in Risk Oversight

One of the key functions of our board of directors is informed oversight of our risk management process. Our board of directors administers this oversight function directly, and has or will have supporting committees, including the audit committee, compensation committee, and the nominating and corporate governance committee, who each then support the board of directors by addressing risks specific to its respective areas of oversight. In particular, our audit committee has the responsibility to consider and discuss our major financial risk exposures and the steps our management takes to monitor and control these exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken. The audit committee also monitors compliance with legal and regulatory requirements, in addition to oversight of the performance of our internal audit function. Once formed, our compensation committee will be responsible for assessing and monitoring whether any of our compensation policies and programs has the potential to encourage excessive risk-taking. Once formed, our nominating and corporate governance committee will be responsible for providing oversight with respect to corporate governance and ethical conduct and monitors the effectiveness of our corporate governance guidelines, including whether such guidelines are successful in preventing illegal or improper liability-creating conduct.

Committees of the Board of Directors

Our board of directors will establish an audit committee, a compensation committee, and a nominating and corporate governance committee prior to the completion of this offering. The functions of these committees are described below. Members will serve on these committees until their resignation or until otherwise determined by our board of directors. Our board of directors may establish other committees as it deems necessary or appropriate from time to time.

Audit Committee

Our board of directors will establish an audit committee, and we anticipate that [  ] will be the members of the committee, with [  ] serving as the chair of the audit committee. Each member of the committee will meet the requirements for independence under the listing standards of NYSE and SEC rules and regulations, including Rule 10A-3(b)(1) under the Exchange Act. Each member of our audit committee will also meet the financial literacy requirements of the listing standards of NYSE. In addition, our board of directors has determined that [  ] is an audit committee financial expert within the meaning of Item 407(d) of Regulation S-K under the Securities Act.

The audit committee’s main purpose is to oversee our corporate accounting and financial reporting process. Our audit committee will be responsible for, among other things:

selecting a qualified firm to serve as the independent registered public accounting firm to audit our financial statements;
helping to ensure the independence and performance of the independent registered public accounting firm;
discussing the scope and results of the audit with the independent registered public accounting firm, and reviewing, with management and the independent registered public accounting firm, our interim and year-end results of operations;
developing procedures for employees to submit concerns anonymously about questionable accounting or audit matters;
reviewing our policies on risk assessment and risk management;
reviewing related party transactions;
reviewing and pre-approving, as required, all audit and all permissible non-audit services to be performed by the independent registered public accounting firm; and
assisting our board of directors in monitoring the performance of our internal audit function.

Our audit committee will operate under a written charter that satisfies the applicable rules and regulations of the SEC and the listing standards of NYSE, a copy of which will be available on our website at https://limitlessx.com/.

44

Compensation Committee

Our board of directors will establish a compensation committee and we anticipate that [  ] will be the members of this committee, with [  ] serving as the chair of the compensation committee. Each member of the committee will meet the requirements for independence under the listing standards of NYSE and SEC rules and regulations. Each member of our compensation committee will also be a non-employee director, as defined pursuant to Rule 16b-3 promulgated under the Exchange Act, or Rule 16b-3. In arriving at these determinations, our board of directors will examine all factors relevant to determining whether any compensation committee member has a relationship to us that is material to that member’s ability to be independent from management in connection with carrying out such member’s duties as a compensation committee member.

The compensation committee’s main purpose is to review and recommend policies relating to compensation and benefits of our officers and employees. Our compensation committee will be responsible for, among other things:

reviewing, approving, and determining, or making recommendations to our board of directors regarding, the compensation and compensation arrangements of our executive officers;
administering our equity compensation plans;
reviewing and approving, or making recommendations to our board of directors regarding, incentive compensation and equity compensation plans; and
establishing and reviewing general policies relating to compensation and benefits of our employees.

Our compensation committee will operate under a written charter that satisfies the applicable rules and regulations of the SEC and the listing standards of NYSE, a copy of which will be available on our website.

Nominating and Corporate Governance Committee

Our board of directors will establish a nominating and corporate governance committee, and we anticipate that [  ] will be the members of this committee, with [  ] serving as the chair of the nominating and corporate governance committee. Each member of the committee will meet the requirements for independence under the listing standards of NYSE and SEC rules and regulations.

Our nominating and corporate governance committee will be responsible for, among other things:

identifying, evaluating, and selecting, or making recommendations to our board of directors regarding, nominees for election to our board of directors and its committees;
developing and overseeing the annual evaluation of our board of directors and of its committees;
considering and making recommendations to our board of directors regarding the composition of our board of directors and its committees;
overseeing our corporate governance practices; and
making recommendations to our board of directors regarding corporate governance guidelines.

45

Our nominating and corporate governance committee will operate under a written charter that satisfies the applicable listing standards of NYSE, a copy of which will be available on our website.

Compensation Committee Interlocks and Insider Participation

None of the members of our compensation committee is a current or former executive officer or employee of our company. None of our executive officers serves as a member of the compensation committee of any entity that has one or more executive officers serving on our compensation committee.

Code of Business Conduct and Ethics

Our Board has adopted a Code of Business Conduct and Ethics that applies to all of our employees, including our executive officers and directors. Code of Business Conduct and Ethics will be available on our website at www.limitlessx.comat the closing of this offering. If we amend or grant a waiver of one or more of the provisions of our Code of Ethics and Business Conduct, we intend to satisfy the requirements under Item 5.05 of Form 8-K regarding the disclosure of amendments to or waivers from provisions of our Code of Ethics and Business Conduct that apply to our principal executive officer, financial and accounting officers by posting the required information on our website at the above address within four business days of such amendment or waiver. The information on our website is not part of this prospectus.

Our Board, management and all employees of our Company are committed to implementing and adhering to the Code of Business Conduct and Ethics. Therefore, it is up to each individual to comply with the Code of Business Conduct and Ethics and to be in compliance of the Code of Business Conduct and Ethics. If an individual is concerned that there has been a violation of the Code of Business Conduct and Ethics, he or she will be able to report such violation in good faith to his or her superior. While a record of such reports will be kept confidential by our Company for the purposes of investigation, the report may be made anonymously and no individual making such a report will be subject to any form of retribution.

Risk Oversight

One of the key functions of our board of directors is informed oversight of our risk management process. Our board of directors administers this oversight function directly through our board of directors as a whole, and through various standing committees of our board of directors that address risks inherent in their respective areas of oversight. In particular, our board of directors is responsible for monitoring and assessing strategic risk exposure, including risks associated with cybersecurity and data protection, and our audit committee has the responsibility to consider our major financial risk exposures and the steps our management has taken to monitor and control these exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken. Our audit committee will review legal, regulatory, and compliance matters that could have a significant impact on our financial statements. Our nominating and corporate governance committee will monitor the effectiveness of our corporate governance practices, including whether they are successful in preventing illegal or improper liability-creating conduct. Our compensation committee will assess and monitor whether any of our compensation policies and programs has the potential to encourage excessive risk taking. While each committee is responsible for evaluating certain risks and overseeing the management of such risks, our entire board of directors will be regularly informed through committee reports about such risks.

Limitations on Liabilities and Indemnification of Directors and Officers

There are limitations of liability and indemnification and advancement rights applicable to our directors and officers. See “Description of Capital Stock.”

Director Compensation

We did not provide any cash or equity compensation to any of our directors during the year ended December 31, 2023, in their capacity as directors, and we have not yet adopted a compensation program for our directors.

46

EXECUTIVE AND DIRECTOR COMPENSATION

Executive Compensation

This section discusses the material components of the executive compensation program for the following persons: (i) all persons serving as our principal executive officers during 2023 and (ii) the most highly compensated of our other executive officers who received compensation during 2023 of at least $100,000 and who were executive officers on December 31, 2023. We refer to these persons as our “named executive officers” elsewhere in this prospectus. Our “named executive officers” and their positions are as follows:

Jaspreet Mathur, Chief Executive Officer and Chairman of the Board of Directors  

Summary Compensation

The following table summarizes information regarding the compensation for fiscal years 2022 and 2021 for our named executive officers.

Name and Principal Position Year  

Salary

($)

  

Stock

Awards

($)

  

Option

Awards

($)

  

All Other

Compensation

($)

  

Total

($)

 
Jaspreet Mathur, Chief Executive Officer  2022   291,667   -   -   417   292,084 
and Chairman of the Board of Directors(1)  2021   -   -   -   -   - 
Kenneth Haller,  2022   145,833   -   -   5,624   151,457 
President and Director(2)  2021   -   -   -   -   - 
Benjamin Chung,  2022   113,750   -   -   5,112   118,862 
Chief Financial Officer(3)  2021   -   -   -   -   - 
Danielle Young,  2022   91,000   -   -   667   91,667 
Chief Operating Officer(4)  2021   -   -   -   -   - 
Rob Cucher,  2022   116,667   -   -   7,924   124,591 
VP of Legal Affairs(5)  2021   -   -   -   -   - 
W. Edward Nichols,  2022   -   -   -   -   - 
Former CEO and President(6)  2021   -   77,500   -   -   77,500 
Darrell Avey,  2022   -   -   -   -   - 
Former CFO and Vice President(7)  2021   -   -   -   17,500   17,500 

(1)Mr. Mathur was appointed as CEO on May 20, 2022.
(2)Mr. Haller was appointed as President on May 20, 2022.
(3)Mr. Chung was appointed as CFO on May 20, 2022.
(4)Ms. Young was appointed as COO on May 20, 2022.
(5)Mr. Cucher was appointed VP of Legal Affairs on August 1, 2022.
(6)Mr. Nichols resigned all of his officer and director positions on May 20, 2022. Mr. Nichols was issued 50,000 shares of common stock in exchange for his services in 2021, valued at $1.55 per share to Helion Holdings, LLC, an entity beneficially owned by Mr. Nichols.
(7)Mr. Avey resigned all of his officer and director positions on May 20, 2022. Represents consulting fees paid to Mr. Avey during the year 2021.

Executive Compensation

We believe that the primary goal of executive compensation is to align the interests of our executive officers with those of our shareholders in a way that allows us to attract and retain the best executive talent.

47

Annual Base Salary. Base salary will be designed to compensate our named executive officers at a fixed level of compensation that will be designed to serve as a retention tool throughout the executive’s career. In determining base salaries, our board of directors (or, when enacted, our compensation committee) considers each executive’s role and responsibility, unique skills, future potential with us, salary levels for similar positions in our market and internal pay equity.

Option Plan. We plan to offer option awards to executives and other employees, in the discretion of the board of directors, considering the executive’s role and other compensation.

Health/Welfare Plans. All of our full-time employees are eligible to participate in health and welfare plans, including medical, dental and vision benefits, maintained by the Company. The Company pays 100% of health and welfare plans for all executives and 50% of health and welfare plans for all full-time employees.

PTO Plan. We offer paid-time off, which can be used for may be used for vacations, rest and relaxation and personal business, and sick days. The PTO varies amongst type of employee and is between two and three weeks.

Employment Agreements

Jaspreet Mathur, Chief Executive Officer

We entered into an employment agreement with Jaspreet Mathur, effective as of May 1, 2022, pursuant to which Mr. Mathur will serve as our Chief Executive Officer. Under his employment agreement, Mr. Mathur has agreed to devote his full business time and effort to the business affairs of the Company. Mr. Mathur employment agreement provides that his employment will be on an at-will basis and can be terminated by either Mr. Mathur or the Company at any time for cause. Under the agreement, Mr. Mathur will receive an initial base salary of $500,000 per year. Thereafter, effective as of January 1, 2023 , the Company agreed to increase Mr. Mathur’s annual salary to $1,000,000. In the event that Mr. Mathur’s employment is terminated by our company without “Cause” or is terminated by Mr. Mathur for “Good Reason”, Mr. Mathur will be entitled to a predetermined severance compensation package which will be negotiated in good faith and be incompliance with all SEC regulations. “Cause” is defined to include dishonesty, misappropriation, willful misconduct, breach of the agreement, and other customary matters. “Good Reason” is defined to include a material adverse change in Mr. Mathur’s compensation or duties and level of responsibility. Mr. Mathur will be eligible to participate in Stock Option plans or other incentive plans the Company will offer. The employment agreement also contains customary confidentiality and invention-assignment covenants to which Mr. Mathur is subject.

Kenneth Haller, President

We entered into an employment agreement with Kenneth Haller, effective as of May 1, 2022, pursuant to which Mr. Haller will serve as our President. Under his employment agreement, Mr. Haller has agreed to devote his full business time and effort to the business affairs of the Company. Mr. Mathur employment agreement provides that his employment will be on an at-will basis and can be terminated by either Mr. Mathur or the Company at any time for cause. Under the agreement, Mr. Mathur will receive an initial base salary of $250,000 per year. Mr. Haller’s employment may be terminated by our company for “Good Reason” or without “Cause.” “Cause” is defined to include dishonesty, misappropriation, willful misconduct, breach of the agreement, and other customary matters. “Good Reason” is defined to include a material adverse change in Mr. Haller’s compensation or duties and level of responsibility. Mr. Haller will be eligible to participate in Stock Option plans or other incentive plans the Company will offer. The employment agreement also contains customary confidentiality and invention-assignment covenants to which Mr. Haller is subject.

Rob D. Cucher, Esq., President

We entered into an employment agreement with Rob D. Cucher, Esq., effective as of May 1, 2022, pursuant to which Mr. Cucher will serve as our Vice President – Legal Affairs. Under his employment agreement, Mr. Cucher has agreed to devote his full business time and effort to the business affairs of the Company. Mr. Cucher’s employment agreement provides that his employment will be on an at-will basis and can be terminated by either Mr. Cucher or the Company at any time for cause. Under the agreement, Mr. Cucher will receive an initial base salary of $250,000 per year. Mr. Cucher’s employment may be terminated by our company for “Good Reason” or without “Cause.” “Cause” is defined to include dishonesty, misappropriation, willful misconduct, breach of the agreement, and other customary matters. “Good Reason” is defined to include a material adverse change in Mr. Cucher’s compensation or duties and level of responsibility. Mr. Cucher will be eligible to participate in Stock Option plans or other incentive plans the Company will offer. The employment agreement also contains customary confidentiality and invention-assignment covenants to which Mr. Cucher is subject.

Karmandeep Munder, Operations Manager

We entered into an employment agreement with Karmandeep Munder, effective as of May 1, 2022, pursuant to which Mr. Munder will serve as our Operations Manager. Under his employment agreement, Mr. Munder has agreed to devote his full business time and effort to the business affairs of the Company. Mr. Munder employment agreement provides that his employment will be on an at-will basis and can be terminated by either Mr. Cucher or the Company at any time for cause. Under the agreement, Mr. Munder will receive an initial base salary of $150,000 per year. Mr. Munder’s employment may be terminated by our company for “Good Reason” or without “Cause.” “Cause” is defined to include dishonesty, misappropriation, willful misconduct, breach of the agreement, and other customary matters. “Good Reason” is defined to include a material adverse change in Mr. Munder’s compensation or duties and level of responsibility. Mr. Munder will be eligible to participate in Stock Option plans or other incentive plans the Company will offer. The employment agreement also contains customary confidentiality and invention-assignment covenants to which Mr. Munder is subject.

 

48

Benjamin Chung, Chief Financial Officer

We entered into an employment agreement with Benjamin Chung, effective as of July 27, 2022, pursuant to which Mr. Chung will serve as our Chief Financial officer. Under his employment agreement, Mr. Chung has agreed to devote his full business time and effort to the business affairs of the Company. Mr. Chung employment agreement provides that his employment will be on an at-will basis and can be terminated by either Mr. Chung or the Company at any time for cause. Under the agreement, Mr. Chung will receive an initial base salary of $250,000 per year. Mr. Chung’s employment may be terminated by our company for “Good Reason” or without “Cause.” “Cause” is defined to include dishonesty, misappropriation, willful misconduct, breach of the agreement, and other customary matters. “Good Reason” is defined to include a material adverse change in Mr. Chung’s compensation or duties and level of responsibility. Mr. Chung will be eligible to participate in Stock Option plans or other incentive plans the Company will offer. The employment agreement also contains customary confidentiality and invention-assignment covenants to which Mr. Chung is subject. 

Danielle Young, Chief Operating Officer 

We entered into an employment agreement with Danielle Young, effective as of May 1, 2022, pursuant to which Ms. Young will serve as our Chief Operating Officer. Under her employment agreement, Ms. Young has agreed to devote her full business time and effort to the business affairs of the Company. Ms. Young’s employment agreement provides that her employment will be on an at-will basis and can be terminated by either Ms. Young or the Company at any time for cause. Under the agreement, Ms. Young will receive an initial base salary of $200,000 per year. Ms. Young’s employment may be terminated by our company for “Good Reason” or without “Cause.” “Cause” is defined to include dishonesty, misappropriation, willful misconduct, breach of the agreement, and other customary matters. “Good Reason” is defined to include a material adverse change in Ms. Young’s compensation or duties and level of responsibility. Ms. Young will be eligible to participate in Stock Option plans or other incentive plans the Company will offer. The employment agreement also contains customary confidentiality and invention-assignment covenants to which Ms. Young is subject.

Base Salaries

The base salaries of our employed executive officers are specified in their respective employment agreements, as summarized above.

Bonuses

We did not pay any bonuses to any of our named executive officers during 2022 or 2023.

Equity Compensation

Through the date of this prospectus, none of our officers, directors, or employees have received any equity compensation.

Retirement Plans

We do not currently maintain any retirement plans for our employees.

Director Compensation

The following table sets forth a summary of compensation for the fiscal year ended December 31, 2022, that we paid to each director. We reimburse directors for expenses incurred in attending meetings required in person. No other or additional compensation for services were paid to any of the directors.

Name Fees Earned or
Paid in Cash
($)
  Option Awards ($)  Stock Awards ($)  Total ($) 
Jaspreet Mathur  0   0   0   0 
Kenneth Haller  0   0   0   0 
Bharat Raj Mathur  0   0   0   0 
Amanda Saccomanno  0   0   0   0 
Dov Konetz  0   0   0   0 
Dan Fleyshman  0   0   0   0 
Leon Anderson  0   0   0   0 
Michael Braun  0   0   0   0 
Hassan Iddrissu  0   0   0   0 
W. Edward Nichols(1)  0   0   0   0 
Darrell Avey(1)  0   0   0   0 
Jeremy Ostler(1)  0   0   0   0 
Calvin D. Smiley(1)  0   0   0   0 

(1)Resigned as Directors on May 20, 2022.

Director Agreements

We do not have any written agreements with our directors. However, we have agreed to reimburse the directors for any Company-related expenses.

Outstanding Equity Awards at Fiscal Year End

There were no equity awards held by any of our appointed executive officers and directors as of December 31, 2022.

49

2022 Stock Option Plan

Effective August 9, 2022, we adopted our 2022 Incentive and Nonstatutory Stock Option Plan (the “2022 Stock Option Plan”). Under the 2022 Stock Option Plan, the Board of Directors may grant options to purchase common stock to officers, employees, and other persons who provide services to us. A total of 833,333 shares of common stock is reserved for the 2022 Stock Option Plan. As of the date of this Annual Report, there have been no options granted under the 2022 Stock Option Plan.

2022 Restricted Stock Plan

Effective August 9, 2022, we adopted our 2022 Restricted Stock Plan (the “2022 Restricted Stock Plan”). Under the 2022 Restricted Stock Plan, the Board of Directors may grant restricted stock to officers, directors, and key employees. A total of 833,333 shares of common stock is reserved for the 2022 Stock Option Plan. As of the date of this Annual Report, there have been no shares of common stock granted under the 2022 Restricted Stock Plan.

Limitation on Liability and Indemnification

We are a Delaware corporation. The Delaware General Corporation Laws (DGCL) provides that the articles of incorporation of a Delaware corporation may contain a provision eliminating or limiting the personal liability of a director to the corporation or our stockholdersshareholders for monetary damages for breach of fiduciary duty as a director, except that any such provision may not eliminate or limit the liability of a director (i) for any breach of the director’s duty of loyalty to the corporation or our stockholders,shareholders, (ii) acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) acts specified in Section 78 (concerning unlawful distributions), or (iv) any transaction from which a director directly or indirectly derived an improper personal benefit. Our articles of incorporation contain a provision eliminating the personal liability of directors to our Company’company’ or our stockholdersshareholders for monetary damages to the fullest extent provided by the DGCL.

The DGCL provides that a Delaware corporation must indemnify a person who was wholly successful, on the merits or otherwise, in defense of any threatened, pending, or completed action, suit, or proceeding, whether civil, criminal, administrative, or investigative and whether formal or informal (a “Proceeding”), in which he or she was a party because the person is or was a director, against reasonable expenses incurred by him or her in connection with the Proceeding, unless such indemnity is limited by the corporation’s articles of incorporation. Our articles of incorporation do not contain any such limitation.

The DGCL provides that a Delaware corporation may indemnify a person made a party to a Proceeding because the person is or was a director against any obligation incurred with respect to a Proceeding to pay a judgment, settlement, penalty, fine (including an excise tax assessed with respect to an employee benefit plan) or reasonable expenses incurred in the Proceeding if the person conducted himself or herself in good faith and the person reasonably believed, in the case of conduct in an official capacity with the corporation, that the person’s conduct was in the corporation’s best interests and, in all other cases, his or her conduct was at least not opposed to the corporation’s best interests and, with respect to any criminal proceedings, the person had no reasonable cause to believe that his or her conduct was unlawful. Our articles of incorporation and bylaws allow for such indemnification. A corporation may not indemnify a director in connection with any Proceeding by or in the right of the corporation in which the director was adjudged liable to the corporation or, in connection with any other Proceeding charging that the director derived an improper personal benefit, whether or not involving actions in an official capacity, in which Proceeding the director was judged liable on the basis that he or she derived an improper personal benefit. Any indemnification permitted in connection with a Proceeding by or in the right of the corporation is limited to reasonable expenses incurred in connection with such Proceeding.

The DGCL, unless otherwise provided in the articles of incorporation, a Delaware corporation may indemnify an officer, employee, fiduciary, or agent of the corporation to the same extent as a director and may indemnify such a person who is not a director to a greater extent, if not inconsistent with public policy and if provided for by our bylaws, general or specific action of our board of directors or stockholders,shareholders, or contract. Our articles of incorporation provide for indemnification of our directors, officers, employees, fiduciaries, and agents to the full extent permitted by Delaware law.

Our articles of incorporation also provide that we may purchase and maintain insurance on behalf of any person who is or was a director or officer of our Companycompany or who is or was serving at our request as a director, officer, or agent of another enterprise against any liability asserted against him or her and incurred by him or her in any such capacity or arising out of his or her status as such, whether or not we would have the power to indemnify him or her against such liability.

50

 

Employment Agreements

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

The following is a description of transactions within the last three years to which we have been a party, in which the amount involved exceeded or will exceed $120,000, and in which any of our executive officers, directors or holders of more than 5% of our voting securities, or an immediate family member thereof, had or will have a direct or indirect material interest. We believe the terms obtained or consideration that we paid or received, as applicable, in connection with Officersthe transactions described below were comparable to terms available or amounts that would be paid or received, as applicable, in arm’s-length transactions with unrelated third parties.

We had the following transactions with related parties during the last two fiscal years:

Sale of Class A Preferred Convertible Stock

Concurrently with the LimitlessX Acquisition, Jaspreet Mathur, our current Chief Executive Officer purchased from Helion Holdings, LLC, a company beneficially owned by our former Chief Executive Officer, 500,000 shares of our Class A Preferred Convertible Stock for consideration of $400,000.

Royalty Payables

Limitless Performance Inc. (“LPI”), SMILZ INC. (“Smiles”), and DIVATRIM INC. (“Divatrim”), are all companies owned by Jas Mathur, our Chief Executive Officer, Director, and majority shareholder. AMAROSE INC. (“Amarose”) is owned 50% by Mr. Mathur and 50% by Amanda Saccomanno, one of our directors.

On December 1, 2021, we entered into a manufacturing and distributorship license agreement with LPI for us to distribute LPI products and for payments to LPI for its product designs and distribution rights. We pay to LPI from time-to-time royalty payments equal to 4.00% of gross sales, excluding returns, chargebacks, and other such allowances.
On December 1, 2021, we entered into a manufacturing and distributorship license agreement with Smiles for us to distribute Smiles products and for payments to Smiles for its product designs and distribution rights. We pay to Smiles from time-to-time royalty payments equal to 4.00% of gross sales, excluding returns, chargebacks, and other such allowances.
On December 1, 2021, we entered into a manufacturing and distributorship license agreement with Divatrim for us to distribute Divatrim products and for payments to Smiles for its product designs and distribution rights. We pay to Divatrim from time-to-time royalty payments equal to 4.00% of gross sales, excluding returns, chargebacks, and other such allowances.
On December 1, 2021, we entered into a manufacturing and distributorship license agreement with Amarose for us to distribute Amarose products and for payments to Smiles for its product designs and distribution rights. We pay to Amarose from time-to-time royalty payments equal to 4.00% of gross sales, excluding returns, chargebacks, and other such allowances.

We started paying all earned royalties to LPI, Smiles, Divatrim, and Amarose beginning on June 15, 2022. As of December 31, 2022, the royalty payable is in the amount of $1,114,403.

As of November 1, 2023, we terminated our licensing agreement with Limitless Performance, Inc., Amarose, Inc., Divatrim, Inc., and SMILZ, Inc

Notes Payable to Shareholder as of September 30, 2023

Notes payable to shareholder consisted of the following:

  September 30, 
  2023 
    
December 6, 2021 ($50,000) $50,000 
February 11, 2022 ($150,000)  150,000 
May 8, 2022 ($550,000)  550,000 
May 9, 2022 ($1,100,000)  1,100,000 
May 16, 2022 ($450,000)  450,000 
June 1, 2022 ($500,000)  500,000 
June 30, 2022 ($922,028)  922,028 
August 25, 2022 ($290,000)  290,000 
November 15, 2022 ($450,000)  450,000 
May 16, 2023 ($150,000)  150,000 
May 18, 2023 ($50,000)  50,000 
June 5, 2023 ($150,000)  150,000 
June 20, 2023 ($50,000) – Funding Commitment  50,000 
July 13, 2023 ($50,000) – Funding Commitment  50,000 
August 1, 2023 ($190,000) – Funding Commitment  190,000 
August 7, 2023 ($50,000) – Funding Commitment  50,000 
September 30, 2023 ($660,000) – Funding Commitment  660,000 
September 30, 2023 ($138,817)  138,817 
Total notes payable to stockholder (current) $5,950,845 

51

December 6, 2021 – $50,000

On December 6, 2021, the Company entered into a Loan Authorization and Agreement for a loan of $50,000 from a shareholder, the proceeds of which were used to be used for working capital purposes. As of September 30, 2023 and December 31, 2022, the principal balance was $50,000 and $50,000, respectively. Beginning on June 1, 2022, the loan required a payment of $4,303 per month, which included principal and interest with an interest rate of 6 % per annum. The total balance of principal and interest of $51,640 was due on May 1, 2023.

February 11, 2022 – $150,000

On February 11, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $150,000 from a shareholder, the proceeds of which were to be used for working capital purposes. As of September 30, 2023 and December 31, 2022, the principal balance was $150,000 and $150,000, respectively. Beginning on June 1, 2022, the loan required a payment of $12,910 per month, which included principal and interest with an interest rate of 6% per annum. The total balance of principal and interest of $154,920 was due on May 1, 2023.

May 8, 2022 – $550,000

On May 8, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $550,000 from a shareholder, the proceeds of which were to be used for working capital purposes. As of September 30, 2023 and December 31, 2022, the principal balance was $550,000 and $550,000, respectively. Beginning on June 1, 2022, the loan required a payment of $47,337 per month, which included principal and interest with an interest rate of 6% per annum. The total balance of principal and interest of $568,038 was due on May 1, 2023.

May 16, 2022 – $1,100,000

On May 16, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $1,100,000 from a shareholder, the proceeds of which were to be used for working capital purposes. As of September 30, 2023 and December 31, 2022, the principal balance was $1,100,000 and $1,100,000, respectively. Interest began accruing at the rate of 8.5% per annum on June 17, 2022 and was due on May 16, 2023.

May 18, 2022 – $450,000

On May 18, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $450,000 from a shareholder, the proceeds of which were to be used for working capital purposes. As of September 30, 2023 and December 31, 2022, the principal balance was $450,000 and $450,000, respectively. Interest began accruing at the rate of 8.5% per annum on June 19, 2022 and was due on May 18, 2023.

June 1, 2022 – $500,000

On June 1, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $500,000 from a shareholder, the proceeds of which were to be used for working capital purposes. As of September 30, 2023 and December 31, 2022, the principal balance was $500,000 and $500,000, respectively. Beginning on August 1, 2022, the loan required a payment of $43,494 per month, which included principal and interest with an interest rate of 8% per annum. The total balance of principal and interest of $521,931 was due on July 1, 2023.

September 30, 2022 – $922,028

On June 30, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $922,028 from a shareholder, the proceeds of which were to be used for working capital purposes. As of September 30, 2023 and December 31, 2022, the principal balance was $922,028 and $922,028, respectively. Beginning on August 1, 2022, the loan required a payment of $80,206 per month, which included principal and interest with an interest rate of 8% per annum. The total balance of principal and interest of $962,469 was due on August 1, 2023.

52

August 25, 2022 – $290,000

On August 25, 2022, the Company entered into a Loan Authorization Agreement for a loan of $290,000 from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of 10% per annum and is due on demand. As of September 30, 2023 and December 31, 2022, the principal balance was $290,000 and $290,000, respectively.

November 15, 2022 – $450,000

On November 15, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $450,000 from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of 10% per annum and is due on demand. As of September 30, 2023 and December 31, 2022, the principal balance was $450,000 and $450,000, respectively.

May 16, 2023 – $150,000

On May 16, 2023, the Company entered into a Loan Authorization and Agreement for a loan of $150,000 from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of 10% per annum and is due on demand. As of September 30, 2023, the principal balance was $150,000.

May 18, 2023 – $50,000

On May 18, 2023, the Company entered into a Loan Authorization and Agreement for a loan of $50,000 from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of 10% per annum and is due on demand. As of September 30, 2023, the principal balance was $50,000.

June 5, 2023 – $150,000

On June 5, 2023, the Company entered into a Loan Authorization and Agreement for a loan of $150,000 from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of 10% per annum and is due on demand. As of September 30, 2023, the principal balance was $150,000.

September 30, 2023 – $138,817

On September 30, 2023, the Company entered into a Loan Authorization and Agreement for a loan of $138,817 from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of 10% per annum and is due on demand. As of September 30, 2023, the principal balance was $138,817.

Funding Commitment Agreement

On June 3, 2023, the Company entered into a Funding Commitment Agreement (the “Funding Commitment”) with its Chief Executive Officer and Chairman of the Board of Directors, Jaspreet Mathur, wherein Mr. Mathur committed to provide up to $1,000,000 of Bio Lab Naturals, Inc.

Weworking capital to the Company over the next six months. Mr. Mathur agreed to the Funding Commitment in exchange for a one year convertible promissory note for each drawdown amount advanced to the Company with an annual interest rate of 10% and a balloon payment of principal and interest due at maturity, unless Mr. Mathur elects to convert the outstanding principal and interest into Class B Preferred Stock of the Company at the conversion price of $1.50 per share; provided, however, Mr. Mathur may only covert each note within the term of the Funding Commitment, in the event of the occurrence of the earlier of a public offering of securities of the Company pursuant to a registration statement filed with the SEC and declared effective pursuant to the Securities Act of 1933, upon completion of which the Company has a class of stock registered under the Securities Exchange Act of 1934 and that stock is listed on a national stock exchange, or a liquidation, merger, acquisition, sale of voting control or sale of substantially all of the assets of the Company in which the shareholders of the Company do not have employment/consultant agreementsown a majority of the outstanding shares of the surviving corporation. For the avoidance of doubt, a national stock exchange includes Nasdaq, NYSE, and NYSE American, but excludes any over-the-counter quotation systems or trading platforms. The balance of the Funding Commitment are as follows:

  September 30, 2023 
    
June 20, 2023 ($50,000) $50,000 
July 13, 2023 ($50,000)  50,000 
August 1, 2023 ($190,000)  190,000 
August 7, 2023 ($50,000)  50,000 
September 30, 2023 ($660,000)  660,000 
Total Funding Commitment $1,000,000 

As of September 30, 2023, the balance of the Funding Commitment was $1,000,000.

53

Notes Payable to Related Party as of September 30, 2023

Notes payable to related party consisted of the following:

  September 30,  December 31, 
  2023  2022 
       
May 10, 2022 ($12,500) $12,500  $12,500 
May 10, 2022 ($12,500)  12,500   12,500 
May 10, 2022 ($20,000)  20,000   20,000 
May 31, 2022 ($5,000)  5,000   5,000 
May 31, 2022 ($15,000)  15,000   15,000 
June 9, 2022 ($15,000)  15,000   15,000 
December 31, 2022 ($929,401)  -   929,401 
         
Total notes payable to related parties (current) $80,000  $1,247,011 

May 10, 2022 - $12,500

On May 10, 2022, a related party of the Company loaned Prime Time Live, Inc. $12,500 in exchange for a promissory note that includes interest at the rate of 10% per annum on the unpaid principal balance, with all unpaid principal and interest due on or before May 10, 2023. Interest began accruing on May 10, 2022. As of September 30, 2023 and December 31, 2022, the principal balance was $12,500 and $12,500, respectively.

May 10, 2022 - $12,500

On May 10, 2022, a related party of the Company loaned Prime Time Live, Inc. $12,500 in exchange for a promissory note that includes interest at the rate of 10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 10, 2023. Interest began accruing on May 10, 2022. As of September 30, 2023 and December 31, 2022, the principal balance was $12,500 and $12,500, respectively.

May 10, 2022 - $20,000

On May 10, 2022, a related party of the Company loaned Prime Time Live, Inc. $20,000 in exchange for a promissory note that included interest at the rate of 10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 10, 2023. Interest began accruing on May 10, 2022. As of September 30, 2023 and December 31, 2022, the principal balance was $20,000 and $20,000, respectively.

54

May 31, 2022 - $5,000

On May 31, 2022, a related party of the Company loaned Prime Time Live, Inc. $5,000 in exchange for a promissory note that included interest at the rate of 10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 31, 2023. Interest began accruing on May 31, 2022. As of September 30, 2023 and December 31, 2022, the principal balance was $5,000 and $5,000, respectively.

May 31, 2022 - $15,000

On May 31, 2022, a related party of the Company loaned Prime Time Live, Inc. $15,000 in exchange for a promissory note that included interest at the rate of 10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 31, 2023. Interest began accruing on May 31, 2022. As of September 30, 2023 and December 31, 2022, the principal balance was $15,000 and $15,000, respectively.

June 9, 2022 - $15,000

On May 10, 2022, a related party of the Company loaned Prime Time Live, Inc. $15,000 in exchange for a promissory note that included interest at the rate of 10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 10, 2023. Interest began accruing on May 10, 2022. As of September 30, 2023 and December 31, 2022, the principal balance was $15,000 and $15,000, respectively.

December 31, 2022 - $929,401

On December 31, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $929,401 from Emblaze, the proceeds of which were to be used for working capital purposes. The loan had an interest rate of 8% per annum and was due on December 1, 2023. As of September 30, 2023 and December 31, 2022, the balance was $0 and $929,401, respectively.

On June 1, 2023, the Company entered into an Agreement for Purchase and Sale of Stock with Emblaze wherein the Company sold all 5,000 of its shares of common stock of Vybe Labs, as full payment and settlement of a debt in the in the principal amount of $929,401 owed by the Company to Emblaze.

Policies and Procedures for Transactions with Related Persons

All future related party transactions will be voted upon by the disinterested board of directors. The audit committee of the board of directors is responsible for evaluating each related party transaction and making a recommendation to the disinterested members of the board of directors as to whether the transaction at issue is fair, reasonable and within our policy and whether it should be ratified and approved. If there is no Audit Committee at such time, then the evaluation will also be done by the disinterested board of directors. The board of directors or the audit committee, as applicable, in making its recommendation, will consider various factors, including the benefit of the transaction to us, the terms of the transaction and whether they are at arm’s-length and in the ordinary course of our business, the direct or indirect nature of the related person’s interest in the transaction, the size and expected term of the transaction and other facts and circumstances that bear on the materiality of the related party transaction under applicable law and listing standards. The board of directors or the audit committee will review, at least annually, a summary of our transactions with our officers. We use month to month consulting.directors and officers and with firms that employ our directors, as well as any other related person transactions.

55

 

m.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AS OF SEPTEMBER 22 , 2020

As of the date of this Annual Report, there are 3,977,497 shares of our common stock outstanding. The following table sets forth information with respect to the beneficial ownership of our outstanding common stock immediately prior to the completion of this offering by:

·each of our directors;
each of our named executive officers;
all of our directors and executive officers as a group; and
each person who is known by us to be the beneficial owner of five percent (5%)5% or more of our outstanding common stock;stock.

·our executive officers, and each director as identified in the “Management — Executive Compensation” section; and

·all of our directors and executive officers as a group.
42 
Table of Contents

Beneficial ownership is determined in accordance withaccording to the rules of the Securities and Exchange Commission and generally includesSEC. Generally, it means that a person has beneficial ownership of a security if he or she possesses sole or shared voting or investment power with respect to securities. Sharesof that security and includes options, warrants, and other securities convertible or exercisable into shares of common stock, and options, warrants andprovided that such securities are currently exercisable or convertible securities that are currentlyor exercisable or convertible within 60 days of the date hereof. Each director or officer, as the case may be, has furnished us with information with respect to their beneficial ownership. Except as otherwise indicated, all persons listed below have (i) sole voting power and investment power with respect to their stock, except to the extent that authority is shared by spouses under applicable law, and (ii) record and beneficial ownership with respect to their securities.

Name and Address (1) Office Shares Owned  

Percent of

Class (2)

 
Class A Preferred Stock          
           
Jaspreet Mathur Chief Executive Officer and Chairman  500,000   100%
           
Common Stock          
           
Jaspreet Mathur Chief Executive Officer and Chairman  2,632,334   66.18%
           
Bharat Raj Mathur Director  141,334   3.55%
           
Kenneth Haller President and Director  141,334   3.55%
           
Amanda Saccomanno Director  106,000   2.67%
           
Benjamin Chung Chief Financial Officer  35,334   * 
           
Rob Cucher VP of Legal Affairs  17,667   * 
           
Danielle Young Chief Operating Officer  -   - 
           
Dov Konetz Director  -   - 
           
Dan Fleyshman Director  -   - 
           
Leon Anderson Director  -   - 
           
Michael Braun Director  -   - 
           
Hassan Iddrissu Director  -   - 
           
All executive officers and directors    3,074,003   78.29%

*Less than 1%.
(1)The mailing address of each of the officers and directors as set forth above is c/o Limitless X Holdings Inc., 9454 Wilshire Blvd. #300, Beverly Hills, California 90212.
(2)As of the date hereof, there were 3,977,497 shares of our common stock issued and outstanding and 500,000 shares of our Class A Preferred Stock issued and outstanding.

56

DESCRIPTION OF CAPITAL STOCK

The following is a description of the material terms of our amended and restated certificate of incorporation and our amended and restated bylaws to be in effect upon the completion of this documentoffering. The following description is a summary, does not purport to be complete and is qualified in its entirety by reference to our amended and restated certificate of incorporation and amended and restated bylaws, which are filed as exhibits to the registration statement of which this prospectus is a part and are incorporated by reference into this prospectus.

General

Limitless X Holdings, Inc. is a Delaware corporation governed by the laws of the State of Delaware, our amended and restated certificate of incorporation and our amended and restated bylaws. We have authorized 300,000,000 shares of common stock par value $0.0001 per share and 30,000,000 shares of preferred stock, 500,000 of which are designated as Class A Preferred Convertible Stock.

Common Stock

Holders of shares of our common stock are deemedentitled to be outstanding andone vote for each share held on all matters submitted to be beneficially owned by the person holding the options, warrants or convertible securities for the purposea vote of computing the percentage ownershipshareholders. Accordingly, holders of a majority of the person, but are not treated as outstandingshares of our common stock entitled to vote in any election of directors may elect all of the directors standing for the purpose of computing the percentage ownership of any other person.

The information below is based on the numberelection. Holders of shares of our common stock that we believe was beneficially ownedare entitled to receive proportionately any dividends if and when such dividends are declared by each personour board of directors, subject to any preferential dividend rights of outstanding preferred stock. Upon the liquidation, dissolution or entity aswinding up of September 22 , 2020.

OFFICERS AND DIRECTORS

Title of ClassName of Beneficial Owner (1)Amount and Nature of Beneficial OwnerPercent of Class Outstanding before offering (2)Percent of Class Outstanding after offering (3)
Common StockW. Edward Nichols, Chief Executive Officer and Director200,0001.86%0%
     
Class A Preferred Convertible Stock 500,000 (4)100.00%100.00%
     
Common StockDarrell Avey, Chief Financial Officer, Vice President and Director270,0002.51%0%
     
Class A Preferred Convertible Stock 00.00%0%
     
Common StockJeremy Ostler, Director80,000.74%0%
     
Class A Preferred Convertible Stock 00.00%0%
     
Common StockCalvin D. Smiley, Sr., Director50,000.46%0%
     
Class A Preferred Convertible Stock 00.00%0%
     
Common StockAll Directors and Executive Officers as a Group (4 persons)600,0005.57%0%
     
Class A Preferred Convertible StockAll Directors and Executive Officers as a Group (1 person)500,000100.00%100.00%

(1)The address of each person listed above, unless otherwise indicated, is c/o Bio Lab Naturals, Inc., 7400 E. Crestline Circle, Suite #130, Greenwood Village, CO 80111 .
(2)Based upon 10,753,504 common shares issued and outstanding on a fully diluted basis. (Does not include conversion of 500,000 shares held of Class A Preferred Convertible Stock).  
(3)Assumes maximum sale of all registered shares and 10,753,504 shares issued and outstanding after resales.
(4)Helion Holdings, LLC (beneficially W. Edward Nichols) holds 250,000 shares of Class A Preferred Convertible Stock. Together with Mr. Nichols individual holdings of 250,000 shares of Class A Preferred Convertible Stock, he has beneficial ownership of 500,000 shares of Class A Preferred Convertible Stock (100%)

43 
Table of Contents

GREATER THAN 5% STOCKHOLDERS

Title of ClassName of Beneficial Owner (1)Amount and Nature of Beneficial OwnerPercent of Class Outstanding before offering (2)Percent of Class Outstanding after offering (3)
Common StockWilliam Bossung1,805,00016.78%0%
     
Common StockHigh Speed Aggregate, Inc. (4)960,0008.92%0%
     
Common StockTimothy J. Brasel and Janet M. Brasel (6)545,0005.07%0%
     
Common StockSusan A. Brasel (7)1,450,00013.48%0%
     
Common StockM.A. Littman (8)550,0005.11%1.4%
     
Class A Preferred Convertible StockW. Edward Nichols, CEO and Director250,00050.00%50.00% (5)
     
Class A Preferred Convertible Stock

Helion Holdings, LLC (beneficially W. Edward Nichols, CEO and Director)

250,00050.00%50.00% (5)

(1)The address of each person listed above, unless otherwise indicated, is c/o Bio Lab Naturals, Inc., 7400 E. Crestline Circle, Suite #130, Greenwood Village, CO 80111 .

(2)Based upon 10,753,504 shares of common stock issued and outstanding on a fully diluted basis. (Does not include conversion of 500,000 shares held of Class A Preferred Convertible Stock).  
(3)Assumes maximum sale of all registered shares and 10,753,504 shares of common stock issued and outstanding after resales.
(4)Jeffrey Ploen has indirect beneficial ownership of 800,000 common shares of High Speed Aggregate, Inc. Mr. Ploen also has direct beneficial ownership of 160,000 common shares.
(5)Class A Preferred Convertible Stock together votes 60% of common stock at all votes of shareholders until conversion.
(6)Timothy J. Brasel and Janet M. Brasel are married. They have indirect beneficial ownership of 205,000 common shares of Bleu Ridge Consultants, Inc., 50,000 common shares of La Mirage Trust and 100,000 common shares of the Charitable Remainder Trust of Susan Anne Brasel. Janet M. Brasel also has direct beneficial ownership of 190,000 common shares.
(7)Susan A. Brasel has indirect beneficial ownership of 500,000 common shares of M.J. Brasel, LLC, 300,000 common shares        of Causeway, LLC and 600,000 common shares of Brasel Family Holdings Trust.
(8)Through his Atty Defined Benefit Plan.

Rule 13d-3 under the Securities Exchange Actcompany, the holders of 1934 governsour common stock are entitled to receive ratably net assets available after the determinationpayment of beneficial ownershipall debts and other liabilities and subject to the prior rights of securities. That rule provides that a beneficial owner of a security includes any person who directly or indirectly has or shares voting power and/or investment power with respect to such security. Rule 13d-3 also provides that a beneficial owner of a security includes any person who has the right to acquire beneficial ownership of such security within sixty days, including through the exerciseholders of any option, warrant or conversionoutstanding preferred stock. The rights, preferences, and privileges of a security. Any securities not outstanding whichholders of our common stock are subject to, such options, warrants or conversion privileges are deemed toand may be outstanding foradversely affected by, the purpose of computing the percentage of outstanding securitiesrights of the class owned by such person. Those securities are not deemed to be outstanding for the purposeholders of computing the percentageshares of the class owned by any other person. Included in this table are only those derivative securities with exercise pricesseries of preferred stock that we believe have a reasonable likelihoodmay designate and issue in the future.

A total of being “in the money” within the next sixty days.

OUTSTANDING EQUITY AWARDS AT FISCAL YEAR END

We adopted a Stock Option and Award Plan on January 15, 2020. We have authorized 2,000,0003,977,497 shares of common stock are issued and outstanding as of the date hereof.

Preferred Stock

Our Certificate of Incorporation authorize our board of directors to establish one or more series of preferred stock. Unless required by law or any stock exchange, the authorized but unissued shares of preferred stock will be available for issuance without further action by our shareholders. Our board of directors is authorized to divide the Plan. We have granted no options exercisablepreferred stock into series and, with respect to each series, to fix and determine the designation, terms, preferences, limitations, and relative rights thereof, including dividend rights, dividend rates, conversion rights, voting rights, redemption rights and terms, liquidation preferences, sinking fund provisions and the number of shares constituting the series. Without shareholder approval, we could issue preferred stock that could impede or discourage an acquisition attempt or other transaction that some, or a majority, of our shareholders may believe is in their best interests or in which they may receive a premium for their common stock over the market price of the common stock.

It is not possible to state the actual effect of the issuance of any shares of preferred stock upon the rights of holders of our common stock underuntil the Plan.

44 
Table of Contents

n. CERTAIN RELATIONSHIPS, RELATED TRANSACTIONS, PROMOTERS AND CONTROL PERSONS

Other thanboard of directors determines the transactions discussed below, we have not entered into any transaction in past two years, nor are there any proposed transactions in which anyspecific rights of the founders, directors, executive officers, shareholders or any membersholders of the immediate family of any of the foregoing had or is to have a direct or indirect material interest:preferred stock. However, these effects might include:

restricting dividends on the common stock;

diluting the voting power of the common stock;

impairing the liquidation rights of the common stock; and

delaying or preventing a change in control of the company.

W. Edward Nichols is our CEO and director and holds 500,000 Class A Preferred Shares.Convertible Stock

A total of 500,000 shares of Class A Preferred Convertible Stock are issued and outstanding as of the date of this prospectus, all of which are owned by our Chief Executive Officer and Chairperson, Jaspreet Mathur.

Rank. The Class A Preferred SharesConvertible Stock shall rank: (i) senior to any other class or class of outstanding preferred shares or class of capital stock; (ii) prior to all of our common stock; and (iii) prior to any other class or class of capital stock hereafter created “Junior Securities”); and in each case as to distributions of assets upon liquidation, dissolution or winding up of the Company, whether voluntary or involuntary (all such distributions being referred to collectively as “Distributions”).

Dividends. The Class A Preferred Convertible Stock shall bear no dividends, except that in the event dividends are declared for common stock, the same rate of dividend per share shall be due and payable to the Class A Preferred shareholders on the same terms.

Liquidation / Merger Preference.

(a) So long as a majority of the shares of Class A Convertible Preferred Stock authorized are outstanding, we will not, without the written consent of the holders of at least 51% of our outstanding Class A Preferred Convertible Stock, either directly or by amendment, merger, consolidation, or otherwise: (i) liquidate, dissolve or wind-up the affairs of the Company, or effect any Liquidation Event; (ii) amend, alter, or repeal any provision of the Certificate of Incorporation or bylaws in a manner adverse to the Class A Preferred Convertible Stock; (iii) create or authorize the creation of, or issue any other security convertible into or exercisable for, any equity security, having rights, preferences or privileges senior to the Class A Preferred Convertible Stock; or (iv) purchase or redeem or pay any dividend on any capital stock prior to the Class A Preferred Convertible Stock, other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services.

(b) In the event of any liquidation, merger, dissolution or winding up of the Company, either voluntary or involuntary, the holders of shares of Class A Preferred Convertible Stock shall be entitled to receive, prior in preference to any distribution to Junior Securities, an amount per share equal to $1.00 plus any allocable and due dividends per share.

57

(c) Upon the completion of the distribution required to holders of Class A Preferred Convertible Stock, if assets remain in the Company, they shall be distributed to holders of Junior Securities in accordance with our Certificate of Incorporation including any duly adopted Certificate(s) of Designation.

Conversion Rights. The holders of the Class A Preferred Convertible Stock may convert, or be converted, to shares of common stock as follows: Upon a Liquidation Event, or at the option of the Holder, in the Holder’s sole discretion, any Holder of Class A Preferred Convertible Stock is entitled to convert their shares of Class A Preferred Convertible Stock into common stock on a one share of Class A Preferred Convertible Stock for two shares of Common Stock basis, subject to adjustment. As a result of the Reverse Stock Split, the Conversion Rate was adjusted so that every one share of Class A Preferred Stock is now convertible into .0667 shares of common stock. Therefore, 500,000 shares of Class A Preferred Stock is convertible to 33,334 shares of common stock.

Adjustment to Conversion Rate. The conversion price will be subject to adjustments for stock dividends, splits, combinations. The holders of Class A Preferred Convertible Stock may also receive, pursuant to any merger, consolidation exchange of shares, recapitalization, reorganization, or similar event, the same number of shares or consideration that the Class A Preferred Convertible Stock would have received on an as-converted basis.

Super Majority Voting Rights. The holders of the Class A Preferred Convertible Stock have the right to vote on any matter together with holders of common stock and may vote as required on any action which Delaware law provides may or must be approved by vote or consent of the holders of the specific classes of voting preferred shares and the holders of shares of common stock. The Holders of the Class A Preferred Convertible Stock have the right to vote on any matter with holders of common stock voting together as one class. The Holders of the Class A Preferred Convertible Stock have a number of votes equal to 60% of all of the issued and outstanding shares of common stock. For purposes of determining a quorum for any Regular or Special Meeting of the Shareholders, the Class A Preferred Shares shall be deemed as the equivalent of 60% of all issued and outstanding shares.

Class B Preferred Convertible Stock

A total of 1,000,000 common11,000,000 shares and have super majority voting rights until an exchange listing may be achieved.of Class B Preferred Convertible Stock are authorized as of the date of this prospectus, having been amended from the original issue of 5,000,000, on November 8, 2023.

Darrell Avey and Jeremy Ostler, twoRank. The Class B Convertible Preferred Stock shall rank: (i) junior to the Class A Stock; (ii) senior to any other class or series of our officers and directors, were principals in Prime Time Live, Inc. (“PTL”) which entered into a merger agreement in which 5,500,000 sharesoutstanding Preferred Stock or Classes of capital stock of the Company; (iii) prior to all of the Company’s common stock were distributed(“Common Stock”); and (iv) prior to PTL shareholders effective December 31, 2019. Mr. Avey received 250,000 common shares and Jeremy Ostler received 30,000 common shares in the exchange.

W. Edward Nichols (Officer and Director) received 250,000 Class A Preferred shares for services valued in the amountany other class or series of $150,000. Helion Holdings, LLC (beneficially W. Edward Nichols) received 250,000 Class A Preferred shares for services valued in the amount of $150,000. Such shares together vote equivalent of 60% of common at all times and convert to common on a two for one basis.

Michael A. Littman received 400,000 common shares for services valued in the amount of $120,000 during the period July 1, 2019 (Inception) through December 31, 2019 (owned by his Atty Defined Benefit Plan).

Timothy J. Brasel and Janet M. Brasel, husband and wife, personally and through various entities received beneficially a total of 545,000 common sharescapital stock of the Company hereafter created (“Junior Securities”); and in each case as partto distributions of the PTL merger.

William Bossung personally received a totally of 1,725,000 common sharesassets upon liquidation, dissolution or winding up of the Company, as partwhether voluntary or involuntary.

Dividends. The Class B Convertible Preferred Stock shall bear no dividends, except that in the event dividends or other distribution of its assets (or rights to acquire assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Class B Convertible Preferred Stock, then, in each such case, the holder of the PTL merger.

Shares Issued for Asset Acquisition Agreement

Persons and/or EntitiesNature
Prime Time Live, Inc.5,500,000 sharesClass B Convertible Preferred Stock (each a “Holder” and collectively the “Holders”) shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of common stock issued for founders and for services

Shares or Warrants Issued for Compensation or Services

Since January 1, 2018 through September 22 , 2020, we have issued shares of our common stockCommon Stock acquirable upon complete Conversion of this Class B Convertible Preferred Stock (without regard to any limitations on Conversion hereof, including without limitation, the Beneficial Ownership Limitation) (as defined below) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in exchange for servicessuch Distribution (provided, however, to the individuals and/or entitiesextent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the amounts set forth below:portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

Persons and/or EntitiesNature
M.A. Littman400,000 shares of common stock for legal services
Helion Holdings, LLC (beneficially W. Edward Nichols)250,000 shares of Class A Preferred stock for services
W. Edward Nichols250,000 shares of Class A Preferred stock for services
Jeremy Ostler50,000 shares of common stock for Director services
Calvin D. Smiley, Sr.50,000 shares of common stock for Director services

Liquidation / Merger Preference.

45 
Table of Contents

ITEM 11A. MATERIAL CHANGES

None.

ITEM 12. INCORPORATION OF CERTAIN INFORMATION BY REFERENCE

WHERE YOU CAN FIND MORE INFORMATION

We have filed with(a) So long as a majority of the SECshares of Class B Convertible Preferred Stock are outstanding, the Company will not, without the written consent of the holders of at least 51% of the Company’s outstanding Class B Convertible Preferred Stock, either directly or by amendment, merger, consolidation, or otherwise: (i) amend, alter, or repeal any provision of the A&R Certificate or Amended and Restated Bylaws, as amended (the “A&R Bylaws”), in a registration statement on Form S-1 under the Securities Act of 1933 with respectmanner adverse to the securities offered by this prospectus. This prospectus does not containClass B Convertible Preferred Stock; (ii) create or authorize the creation of, or issue any other new security convertible into or exercisable for, any equity security, having rights, preferences or privileges senior to the Class B Convertible Preferred Stock.

(b) In the event of any Liquidation Event. either voluntary or involuntary, the Holders of shares of Class B Convertible Preferred Stock shall be entitled to receive, prior in preference to any distribution to Common Stock or other Junior Securities, but after distribution to the Class A Stock, an amount per share equal to $3.00 plus any allocable and due dividends per share. A “Liquidation Event” shall include (A) the closing of the sale, transfer or other disposition of all or substantially all of the information included inCompany’s assets; (B) the registration statement. For further information pertaining to us and our common stock, you should refer to the registration statement and the exhibits filed with the registration statement. Whenever we make reference in this prospectus to any of our contracts, agreements or other documents, the references are not necessarily complete, and you should refer to the exhibits attached to the registration statement for copiesconsummation of the actual contract, agreementmerger or other document.

Upon effectivenessconsolidation of our S-1 Registration Statement, we will be subjectthe Company with or into another entity (except a merger or consolidation in which the holders of capital stock of the Company immediately prior to such merger or consolidation continue to hold more than 50% of the informational requirementsvoting or economic power of the outstanding capital stock of the Company (or the surviving or acquiring entity); (C) the closing of the transfer (whether by merger, consolidation or otherwise), in one transaction or a series of related transactions, to a Person or “group” (within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, and will file reportsthe rules and other information with the SEC. You can read our SEC filings, including the registration statement, over the internet at the SEC’s website at http://www.sec.gov. You may also read and copy any document we file with the SEC at its Public Reference Room at 100 F Street N.E., Washington, D.C. 20549. Additionally, you can obtain copiesregulations promulgated thereunder (the “Exchange Act”)) (other than an underwriter of the documents at prescribed rates by writing to the Public Reference SectionCompany’s securities), of the SEC at 100 F Street N.E., Washington, D.C. 20549. Please callCompany’s securities if, after such closing, such Person or “group” (within the SEC at 1-800-SEC-0330 for further information onmeaning of Section 13(d)(3) of the operationExchange Act) would own more than 50% of its Public Reference Room.

EXPERTS

The financial statementsvoting or economic power of the outstanding capital stock of the Company (or the surviving or acquiring entity); or (D) a liquidation, dissolution or winding up of the Company; provided that a transaction shall not constitute a Liquidation Event if its sole purpose is to change the jurisdiction of the Company’s incorporation or to create a holding company that will be owned in the same proportions by the persons who held the Company’s securities immediately prior to such transaction.

(c) Upon the completion of the distribution, if assets remain in the Company, they shall be distributed to holders of Junior Securities or Common Stock, as applicable, in accordance with the Company’s A&R Certificate including any duly adopted Certificate(s) of Designation.

Conversion Rights. The holders of the Class B Convertible Preferred Stock may convert, or be converted, to shares of Common Stock as follows: Subject to the Beneficial Ownership Limitation, upon a Liquidation Event or at the option of the Holder, in the Holder’s sole discretion, any Holder of Class B Convertible Preferred Stock shall be entitled at the office of the Company or any transfer agent for the Class B Convertible Preferred Stock designated by the Company to the Holder in writing (the “Transfer Agent”), to convert the shares of Class B Convertible Preferred Stock into Common Stock by electing, in writing, to convert the shares of Class B Convertible Preferred Stock then outstanding and held by the Holder into shares of Common Stock of the Company, on a one share of Class B Convertible Preferred Stock for two shares of Common Stock basis subject to adjustment upon tender of a Notice of Conversion.

Adjustment to Conversion Rate. The conversion price will be subject to adjustments for stock dividends, splits, combinations. The holders of Class B Preferred Convertible Stock may also receive, pursuant to any merger, consolidation exchange of shares, recapitalization, reorganization, or similar event, the same number of shares or consideration that the Class B Preferred Convertible Stock would have received on an as-converted basis.

Voting Rights. The holders of the Class B Preferred Convertible Stock shall have no voting rights except as otherwise set forth in the Company’s Certificate of Designation of Class B Convertible Preferred Stock or otherwise from time to time as required by law. The holders of the Class B Preferred Convertible Stock shall be entitled to notice of any Regular or Special Meeting of the Shareholders for meetings which require the vote of the holders of the Class B Convertible Preferred Stock.

58

Transfer Agent

Our transfer agent and registrar for our common stock is Mountain Share Transfer, LLC. The transfer agent’s address is 2030 Powers Ferry Road SE, Suite #212, Atlanta, Georgia 30339, and its telephone number is (404) 474-3110.

2022 Stock Option Plan

On August 9, 2022, we adopted the 2022 Incentive and Non-statutory Stock Option Plan which provides for the grant of incentive stock options within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), to our employees and the employees of any future subsidiary corporation, and for the grant of non-statutory stock options to non-employees, including directors and other service providers (the “2022 Stock Option Plan”).

Authorized Shares. A total of 833,333 shares of our common stock have been reserved for issuance pursuant to the exercise of options issued from the 2022 Stock Option Plan.

Plan Administration. Our board of directors administers our 2022 Stock Option Plan.

Stock Options. Stock options may be granted under our 2022 Stock Option Plan. The exercise price of options granted under our 2022 Stock Option Plan must at least be equal to the fair market value of our common stock on the date of grant. The term of an incentive stock option may not exceed ten years, except that with respect to any participant who owns more than 10% of the voting power of all classes of our outstanding stock, the term must not exceed five years and the exercise price must equal at least 110% of the fair market value on the grant date. The administrator will determine the methods of payment of the exercise price of an option, which may include cash, shares, or other property acceptable to the administrator, as well as other types of consideration permitted by applicable law. After the termination of service of an employee, director, or consultant, he or she may exercise his or her option for the period from July 1, 2019 (Inception) through December 31, 2019 appearing elsewhereof time stated in this Offering Circular have been included herein in reliance upon the report of BF Borgers CPA PC, an independent registered public accounting firm, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, and upon the authority of BF Borgers CPA PC as experts in accounting and auditing.

INCORPORATION OF DOCUMENTS BY REFERENCE

The SEC allows us to “incorporate by reference” into this prospectus information we have filed with it. The information incorporated by reference is an important part of this prospectus and is considered to be part of this prospectus. We incorporate by reference the documents listed as exhibits to the document in Item 16.

ITEM 12A. DISCLOSURE OF COMMISSION POSITION OF INDEMNIFICATION FOR SECURITIES ACT LIABILITIES

The Delaware General Corporation Law requires us to indemnify officers and directors for any expenses incurred by any officer or director in connection with any actions or proceedings, whether civil, criminal, administrative, or investigative, brought against such officer or director because of his or her status asoption agreement. Generally, if termination is due to death or disability, the option will remain exercisable for 12 months. In all other cases, the option will generally remain exercisable for three months following the termination of service. However, in no event may an officer or director,option be exercised later than the expiration of its term. Subject to the extent thatprovisions of our 2022 Stock Option Plan, the directoradministrator determines the other terms of options.

Non-transferability of Awards. Unless the administrator provides otherwise, our 2022 Stock Option Plan generally does not allow for the transfer of awards and only the recipient of an award may exercise an award during his or officer has been successful onher lifetime.

Certain Adjustments. In the meritsevent of certain changes in our capitalization, to prevent diminution or otherwise in defenseenlargement of the actionbenefits or proceeding. The Delaware General Corporation Law permits a corporation to indemnify an officer potential benefits available under our 2022 Stock Option Plan, the administrator will adjust the number and class of shares that may be delivered under our 2022 Stock Option Plan and/or director, eventhe number, class and price of shares covered by each outstanding award and the numerical share limits set forth in our 2022 Stock Option Plan. In the absenceevent of an agreement to do so, for expenses incurred in connection with any actionour proposed liquidation or proceeding if such officer or director acted in good faithdissolution, the administrator will notify participants as soon as practicable, and in a manner in which he or she reasonably believed to be in or not opposedall awards will terminate immediately prior to the best interestsconsummation of us and such indemnification is authorized by the stockholders, by a quorum of disinterested directors, by independent legal counselproposed transaction.

Merger or Change in a written opinion authorized by a majority vote of a quorum of directors consisting of disinterested directors, or by independent legal counsel in a written opinion if a quorum of disinterested directors cannot be obtained.

The Delaware General Corporation Law prohibits indemnification of a director or officer if a final adjudication establishes that the officer’s or director’s acts or omissions involved intentional misconduct, fraud, or a knowing violation of the law and were material to the cause of action. Despite the foregoing limitations on indemnification, the Florida Statutes may permit an officer or director to apply to the court for approval of indemnification even if the officer or director is adjudged to have committed intentional misconduct, fraud, or a knowing violation of the law.

The Delaware General Corporation Law alsoControl. Our 2022 Stock Option Plan provides that indemnification of directors is not permitted for the unlawful payment of distributions, except for those directors registering their dissent to the payment of the distribution.

46 
Table of Contents

According to our bylaws, we are authorized to indemnify our directors to the fullest extent authorized under Delaware General Corporation Law subject to certain specified limitations.

Insofar as indemnification for liabilities arising under the Securities Act of 1933 (the “Act”) may be permitted to directors, officers and persons controlling us pursuant to the foregoing provisions or otherwise, we are advised that in the opinionevent of a merger or change in control, as defined under the 2022 Stock Option Plan, each outstanding award will be treated as the administrator determines, except that if a successor corporation or its parent or subsidiary does not assume or substitute an equivalent award for any outstanding award, then such award will fully vest, all restrictions on the shares subject to such award will lapse, all performance goals or other vesting criteria applicable to the shares subject to such award will be deemed achieved at 100% of target levels and all of the Securitiesshares subject to such award will become fully exercisable, if applicable, for a specified period prior to the transaction. The award will then terminate upon the expiration of the specified period of time.

Amendment; Termination. The administrator has the authority to amend, suspend, or terminate the 2022 Stock Option Plan provided such action will not impair the existing rights of any participant. Our 2022 Stock Option Plan will automatically terminate in 2032, unless we terminate it sooner.

Options Granted. To date, we have not issued any options pursuant to our 2022 Stock Option Plan.

2022 Restricted Stock Plan

On August 9, 2022, the board of directors adopted the 2022 Restricted Stock Plan (the “2022 Restricted Stock Plan”) which provides for the grant of common stock awards and Exchange Commission, such indemnification is against public policy as expressed in the Actperformance awards to our officers, directors, and is, therefore, unenforceable.key employees or of any subsidiary corporation.

47 59
Table of Contents

 

[OUTSIDE BACK COVER PAGE OF PROSPECTUS]

Dealer Prospectus Delivery RequirementsPurpose of the Plan. The 2022 Restricted Stock Plan is intended to provide incentives which will attract, retain, motivate, and reward our officers, directors, and key employees or any of our Affiliates (“Participants”), by providing them opportunities to acquire shares of our common stock.

PART II. INFORMATION NOT REQUIRED IN PROSPECTUSStock Subject to the Plan. The aggregate number of shares of common stock that may be subject to Awards granted under the 2022 Restricted Stock Plan is 833,333 shares of common stock. If any shares of common stock are forfeited, retained by us as payment of tax withholding obligations with respect to an Award, or surrendered to us to satisfy tax withholding obligations, such shares of common stock will be added back to the shares available for Awards. The 2022 Restricted Stock Plan contains certain adjustment provisions relating to stock dividends, stock splits, and the like.

ITEM 13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION

We have expended, orAdministration of the Plan. The 2022 Restricted Stock Plan will expend fees in relation to this registration statement as detailed below:

Expenditure Item Amount
Attorney Fees $25,000 
Audit Fees $50,000 
Transfer Agent Fees $2,000 
SEC Registration and Blue Sky Registration fees (estimated) $5,000 
Printing Costs and Miscellaneous Expenses (estimated) $18,000 
Total $100,000 

ITEM 14. INDEMNIFICATION OF DIRECTORS AND OFFICERS

Our officers and directors are indemnified as providedbe administered by the Delaware General Corporation Lawsboard of directors. The board of directors will have the full power and authority to grant Awards to the bylaws.persons eligible to receive such Awards and to determine the amount, type, terms, and conditions of each such Award.

Under the Delaware General Corporation Laws, director immunity from liability to a company or its shareholders for monetary liabilities applies automatically unless it is specifically limited by a company’s ArticlesEligibility. Participants consist of Incorporation. Our Articlessuch officers, directors, and key employees of Incorporation do not specifically limit the directors’ immunity. Excepted from that immunity are: (a) a willful failure to deal fairly with us or any of our shareholdersAffiliates as the board of directors, in connection with a matter in which the director has a material conflict of interest; (b) a violation of criminal law, unless the director had reasonable cause to believe that his or her conduct was lawful or no reasonable cause to believe that his or her conduct was unlawful; (c) a transaction from which the director derived an improper personal profit; and (d) willful misconduct.

Our bylaws provide that it will indemnify the directors to the fullest extent not prohibited by Delaware law; provided, however, that we may modify the extent of such indemnification by individual contracts with the directors and officers; and, provided, further, that we shall not be required to indemnify any director or officer in connection with any proceeding, or part thereof, initiated by such person unless such indemnification: (a) is expressly requiredits sole discretion, determines to be made by law, (b)significantly responsible for our success and future growth and profitability and whom the proceeding was authorizedboard of directors may designate from time to time to receive Awards under the 2022 Restricted Stock Plan.

Types of Awards. Stock Awards and Performance Awards may, as determined by the board of directors, (c)in its discretion, constitute Performance-Based Awards.

Stock Awards. The board of directors is provided by us,authorized to grant Stock Awards and will, in its sole discretion, pursuantdetermine the recipients and the number of shares of common stock underlying each Stock Award. Each Stock Award will be subject to such terms and conditions consistent with the 2022 Restricted Stock Plan as determined by the board of directors and as set forth in an Award agreement, including, without limitation, restrictions on the sale or other disposition of such shares and our right to reacquire such shares for no consideration upon termination of the Participant’s employment or membership on the board of directors, as applicable, within specified periods.

Performance Awards. The board of directors is authorized to grant Performance Awards and will, in its sole discretion, determine the recipients and the number of shares of common stock that may be subject to each Performance Award. Each Performance Award will be subject to such terms and conditions consistent with the 2022 Restricted Stock Plan as determined by the board of directors and as set forth in an Award agreement. The board of directors will set performance targets at its discretion which, depending on the extent to which they are met, will determine the number of Performance Awards that will be paid out to the powersParticipants and may attach to such Performance Awards one or more restrictions. Performance targets may be based upon, without limitation, Company-wide, divisional and/or individual performance.

The board of directors has the authority to adjust performance targets. The board of directors also has the authority to permit a Participant to elect to defer the receipt of any Performance Award, subject to the 2022 Restricted Stock Plan.

Performance-Based Awards. Certain Stock Awards and Performance Awards granted under the 2022 Restricted Stock Plan and the compensation attributable to such Awards are intended to (i) qualify as Performance-Based Awards or (ii) be otherwise exempt from the deduction limitation imposed by Section 162(m) of the Code.

The board of directors determines whether Stock Awards and Performance Awards granted under the 2022 Restricted Stock Plan qualify as Performance-Based Awards. The board of directors will establish in writing the performance goals, the vesting period, the performance targets, and any other terms and conditions of the Award in its sole discretion.

Vesting. Awards granted to Participants under the 2022 Restricted Stock Plan may be subject to a graded vesting schedule with a minimum vesting period of two years, unless otherwise determined by the board of directors.

60

If there is a Change in Control, all unvested Awards granted under the 2022 Restricted Stock Plan will become fully vested immediately upon the occurrence of the Change in Control and such vested Awards will be paid out or settled, as applicable, within 60 days upon the occurrence of the Change in Control, subject to requirements of applicable laws and regulations.

Subject to the discretion of the board of directors, if a Participant’s employment or membership on the board of directors is terminated due to death or Disability, then all unvested and/or unearned Awards will be forfeited as of such date.

Section 409A of the Code. Awards under Delaware law or (d) is requiredthe 2022 Restricted Stock Plan are intended either to be exempt from the rules of Section 409A of the Code or to satisfy those rules and shall be construed accordingly. However, we will not be liable to any Participant or other holder of an Award with respect to any Award-related adverse tax consequences arising under Section 409A or other provision of the Code.

Transferability. Each Award granted under the 2022 Restricted Stock Plan will not be transferable otherwise than by a will or the laws of decent and distribution or as otherwise decided by the board of directors.

Fair Market Value. For purposes of the 2022 Restricted Stock Plan, “Fair Market Value” means, as of any given date, the closing price of a share of common stock on any such other public trading market on which shares of common stock are listed or quoted on that date.

Withholding. All payments or distributions of Awards made pursuant to the bylaws.2022 Restricted Stock Plan will be net of any amounts required to be withheld pursuant to applicable federal, state, and local tax withholding requirements.

Amendments. The board of directors may amend the 2022 Restricted Stock Plan from time to time or suspend or terminate it at any time. However, no amendment will be made, without approval of our shareholders to (i) increase the total number of shares which may be issued under the 2022 Restricted Stock Plan; (ii) modify the requirements as to eligibility for Awards under the 2022 Restricted Stock Plan; or (iii) otherwise materially amend the 2022 Restricted Stock Plan as provided in Nasdaq Marketplace Rules.

Term of the Plan. The 2022 Restricted Stock Plan will terminate on the tenth anniversary of its Effective Date.

Current Issuance. As of the date of this prospectus, there have been no shares issued under the 2022 Restricted Stock Plan.

61

Anti-Takeover Provisions

Delaware Law

We are subject to Section 203 of the Delaware General Corporation Law. This provision generally prohibits a Delaware corporation from engaging in any business combination with any interested shareholder for a period of three years following the date the shareholder became an interested shareholder, unless:

-prior to such date, the board of directors approved either the business combination or the transaction that resulted in the shareholder becoming an interested shareholder;
-upon consummation of the transaction that resulted in the shareholder becoming an interested shareholder, the interested shareholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding those shares owned by persons who are directors and also officers and by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or
-on or subsequent to such date, the business combination is approved by the board of directors and authorized at an annual or special meeting of shareholders and not by written consent, by the affirmative vote of at least 662/3% of the outstanding voting stock that is not owned by the interested shareholder.

Section 203 defines a business combination to include:

-any merger or consolidation involving the corporation and the interested shareholder;
-any sale, transfer, pledge, or other disposition of 10% or more of the assets of the corporation involving the interested shareholder;
-subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested shareholder;
-any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested shareholder; or
-the receipt by the interested shareholder of the benefit of any loans, advances, guarantees, pledges, or other financial benefits provided by or through the corporation.

In general, Section 203 defines an “interested shareholder” as any entity or person beneficially owning 15% or more of the outstanding voting stock of a corporation, or an affiliate or associate of the corporation and was the owner of 15% or more of the outstanding voting stock of a corporation at any time within three years prior to the time of determination of interested shareholder status; and any entity or person affiliated with or controlling or controlled by such entity or person.

These statutory provisions could delay or frustrate the removal of incumbent directors or a change in control of our company. They could also discourage, impede, or prevent a merger, tender offer, or proxy contest, even if such event would be favorable to the interests of shareholders.

 

62

Certificate of Incorporation and Bylaw Provisions

Our certificate of incorporation and bylaws contain provisions that could have the effect of discouraging potential acquisition proposals or making a tender offer or delaying or preventing a change in control, including changes a shareholder might consider favorable. In particular, the charter documents, as applicable, among other things:

-provide our board of directors with the ability to amend our bylaws by majority vote of the directors; and shareholders may amend the bylaws with a 75% vote of the shares present at a meeting, provided that if the board recommends that the shareholders approve an amendment, such amendment shall only require a majority vote of shares present;
-provide that vacancies on our board of directors may be filled by a majority of directors in office, although less than a quorum;
-provide that our board of directors has exclusive authority to call special shareholder meetings;
-sets the quorum at all meetings of shareholders at 33 1/3% of the stock issued and outstanding and entitled to vote, except as otherwise provided by statute;
-provide for shareholder advance notice provisions for any proposed business a shareholder desires to put forth at the Annual Shareholder Meeting; and
-provides an exclusive forum in the Court of Chancery of the State of Delaware.

63

Such provisions may have the effect of discouraging a third-party from acquiring us, even if doing so would be beneficial to our shareholders. These provisions are intended to enhance the likelihood of continuity and stability in the composition of our board of directors and in the policies formulated by them, and to discourage some types of transactions that may involve an actual or threatened change in control of our company. These provisions are designed to reduce our vulnerability to an unsolicited acquisition proposal and to discourage some tactics that may be used in proxy fights. We believe that the benefits of increased protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure our company outweigh the disadvantages of discouraging such proposals because, among other things, negotiation of such proposals could result in an improvement of their terms.

However, these provisions could have the effect of discouraging others from making tender offers for our shares that could result from actual or rumored takeover attempts. These provisions also may have the effect of preventing changes in our management.

Limitation on Liability and Indemnification of Directors and Officers

Our charter documents limit the liability of our directors and officers. Our bylaws providestate that it will advance towe shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending, or completed action, suit, or proceeding, whether civil, criminal, administrative, or investigative by reason of the fact that he isthey are or was aare our director or officer, of us, or is or was serving at theour request of us as a director or executive officer of another company, partnership, joint venture, trust or other enterprise, prior to the final disposition of the proceeding, promptly following request therefore, allagainst expenses (including attorneys’ fees), judgments, fines, and amounts paid in settlement actually and reasonably incurred by any director or officerthem in connection with such action, suit, or proceeding upon receipt of an undertakingif they 1) acted in good faith and in a manner they reasonably believed to be in or not opposed to our best interests; and 2) with respect to any criminal action or proceeding, had no reasonable cause to believe their conduct was unlawful.

We shall also indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending, or completed action or suit by or on behalf of such personin our right to repay said amounts if it should be determined ultimately that such person is not entitled to be indemnified under the bylaws or otherwise.

Our bylaws provide that no advance shall be made by us to an officer exceptprocure a judgment in our favor by reason of the fact that suchthey are or were our director, officer, employee, or agent, or is or was serving at our directorrequest against expenses (including attorneys’ fees) actually and reasonably incurred by him or her in connection with the defense or settlement of such action or suit, if they acted in good faith and in a manner they reasonably believed to be in or not opposed to our best interests, except that no indemnification shall be made in respect of any claim, issue, or matter as to which such person shall have been adjudged to be liable to us unless and only to the extent that the Delaware Court of Chancery or the court in which event this paragraphsuch action or suit was brought shall not apply,determine such person is fairly and reasonably entitled to indemnity for such expenses.

We shall also indemnify against expenses (including attorneys’ fees) actually and reasonably incurred by any of our directors, officers, employees, or agents who has been successful on the merits or otherwise in defense of any action, suit, or proceeding whether civil, criminal, administrative or investigative, ifin defense of any claim, issue, or matter therein.

Any indemnification by us (unless ordered by a court) shall be made only as authorized in the specific case upon a determination that the indemnification of the person is reasonably and promptly made: (a)proper in the circumstances because they have met the applicable standard of conduct set forth. Such determination shall be made (i) by the board of directors by a majority vote of a quorum consisting of directors who were not parties to thesuch action, suit, or proceeding or (b)(ii) if such quorum is not obtainable or, even if obtainable, as a quorum of disinterested directors so directs, by independent legal counsel in a written opinion, or (iii) by the shareholders.

We will pay expenses incurred in defending a civil or criminal action, suit, or proceeding, by an individual who may be entitled to indemnification in advance of the final disposition of such action, suit, or proceeding upon receipt of an undertaking by or on behalf of the person to repay such amount if it shall ultimately be determined that they are not entitled to be indemnified.

Insofar as the above described indemnification provisions permit indemnification of directors, officers, or persons controlling us for liability arising under the Securities Act, we understand that in the opinion of the SEC, this indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

There is no pending litigation or proceeding involving any of our directors or officers as to which indemnification is required or permitted, and we are not aware of any threatened litigation or proceeding that may result in a claim for indemnification.

Authorized but Unissued Shares

Our authorized but unissued shares of common stock will be available for future issuance without your approval. We may use additional shares for a variety of purposes, including future offerings to raise additional capital, to fund acquisitions and as employee compensation. The existence of authorized but unissued shares of common stock could render it more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.

64

UNDERWRITING

We entered into an underwriting agreement with the underwriters named below on [  ], 2024. [  ] is acting as representative of the underwriters.

The underwriting agreement provides for the purchase of a specific number of shares of Common Stock by each of the underwriters. The underwriters’ obligations are several, which means that each underwriter is required to purchase a specified number of shares of Common Stock, but is not responsible for the commitment of any other underwriter to purchase shares of Common Stock. Subject to the terms and conditions of the underwriting agreement, each underwriter has severally agreed to purchase the number of shares of Common Stock set forth opposite its name below:

Underwriter

Number of

Units

Total

The underwriters have agreed to purchase all of the shares of Common Stock offered by this prospectus, if any are purchased.

The shares of Common Stock offered hereby are expected to be ready for delivery on or about [ ], 2024 against payment in immediately available funds.

The underwriters are offering the shares of Common Stock subject to various conditions and may reject all or part of any order. The representative of the underwriters has advised us that the facts knownunderwriters propose to offer the shares of Common Stock to the decision-making partypublic at the public offering price set forth on the cover page of this prospectus and to dealers at a price less a concession not in excess of $   per share. After the shares of Common Stock are released for sale to the public, the representative may change the offering price, the concession, and other selling terms at various times.

The following table provides information regarding the amount of the discounts and commissions to be paid to the underwriters by us, before expenses:

Total Per Unit

Public offering price$
Underwriting discounts and commissions(1)$
Proceeds, before expenses, to us$

(1)We have agreed to pay the underwriters a commission of [ ]% of the gross proceeds of this offering.

We estimate that our total expenses of the offering, excluding the estimated underwriting discounts and commissions, will be approximately $[  ], which includes the fees and expenses for which we have agreed to reimburse the underwriters, provided that any such fees and expenses in excess of an aggregate of $[  ] will be subject to our prior written approval (which shall not be unreasonably withheld).

Insider Participation

Certain affiliates of our directors and other existing stockholders have indicated an interest in purchasing an aggregate of approximately $[  ] of shares of Common Stock in this offering at the initial public offering price per share and on the same terms as other purchasers in this offering. However, because indications of interest are not binding agreements or commitments to purchase, the underwriters may determine to sell more, fewer or no shares in this offering to any of these stockholders, or any of these stockholders may determine to purchase more, fewer or no shares in this offering. The underwriters will receive the same underwriting discount on any shares of Common Stock purchased by these stockholders as they will on any other shares sold to the public in this offering.

65

We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act.

In connection with this offering, we, our directors, executive officers, and certain stockholders have agreed not to offer, issue, sell, contract to sell, encumber, grant any option for the sale of or otherwise dispose of any of our Common Stock or securities convertible into or exchangeable for, or that represent the right to receive, shares of Common Stock, for a period of 1 year  following the closing of the offering of the shares. This means that, subject to certain exceptions, for a period of 1 year following the date of this prospectus, we and such persons may not offer, sell, pledge or otherwise dispose of these securities without the prior written consent of [  ].

Subject to certain conditions, we granted [  ], for a period of twelve months after the date of the closing of this offering, a right of first refusal to act as lead bookrunning underwriter, lead initial purchaser, lead placement agent or lead selling agent, as the case may be in connection with any financing for the company.

Our Common Stock is presently quoted on the OTCQB marketplace under the symbol “VYBE” We intend to apply to have our Common Stock listed on NYSE under the symbol “VYBE” No assurance can be given that our application will be approved. Trading quotes of securities on an over-the-counter marketplace may not be indicative of the market price of those securities on a national securities exchange.

Rules of the SEC may limit the ability of the underwriters to bid for or purchase shares of Common Stock before the distribution of the shares of Common Stock is completed. However, the underwriters may engage in the following activities in accordance with the rules:

Stabilizing transactions - The representative may make bids or purchases for the purpose of pegging, fixing or maintaining the price of the shares of Common Stock, so long as stabilizing bids do not exceed a specified maximum.
Penalty bids - If the representative purchases shares of Common Stock in the open market in a stabilizing transaction or syndicate covering transaction, it may reclaim a selling concession from the underwriters and selling group members who sold those shares of Common Stock as part of the offering.

Passive market making - Market makers in the shares of Common Stock who are underwriters or prospective underwriters may make bids for or purchases of shares of Common Stock, subject to limitations, until the time, if ever, at which a stabilizing bid is made.

Similar to other purchase transactions, the underwriters’ purchases to cover the syndicate short sales or to stabilize the market price of the shares of Common Stock may have the effect of raising or maintaining the market price of the shares of Common Stock or preventing or mitigating a decline in the market price of the shares of Common Stock. As a result, the price of the shares of Common Stock may be higher than the price that might otherwise exist in the open market. The imposition of a penalty bid might also have an effect on the price of the shares of Common Stock if it discourages resales of the shares of Common Stock.

Neither we nor the underwriters make any representation or prediction as to the effect that the transactions described above may have on the price of the shares of Common Stock. These transactions may occur on the NYSE or otherwise. If such transactions are commenced, they may be discontinued without notice at any time.

Electronic Delivery of Preliminary Prospectus

A prospectus in electronic format may be delivered to potential investors by one or more of the underwriters participating in the offering. The prospectus in electronic format will be identical to the paper version of such prospectus. Other than the prospectus in electronic format, the information on any underwriter’s website and any information contained in any other website maintained by an underwriter is not part of this prospectus or the registration statement of which this prospectus forms a part.

66

Notice to Non-U.S. Investors

Belgium

The offering is exclusively conducted under applicable private placement exemptions and therefore it has not been and will not be notified to, and this document or any other offering material relating to the shares of Common Stock has not been and will not be approved by, the Belgian Banking, Finance and Insurance Commission (“Commission bancaire, financière et des assurances/Commissie voor het Bank, Financie en Assurantiewezen”). Any representation to the contrary is unlawful.

Each underwriter has undertaken not to offer sell, resell, transfer or deliver directly or indirectly, any shares of Common Stock, or to take any steps relating/ancillary thereto, and not to distribute or publish this document or any other material relating to the shares of Common Stock or to the offering in a manner which would be construed as: (a) a public offering under the Belgian Royal Decree of 7 July 1999 on the public character of financial transactions; or (b) an offering of securities to the public under Directive 2003/71/EC which triggers an obligation to publish a prospectus in Belgium. Any action contrary to these restrictions will cause the recipient and the company to be in violation of the Belgian securities laws.

Canada

This document constitutes an “exempt offering document” as defined in and for the purposes of applicable Canadian securities laws. No prospectus has been filed with any securities commission or similar regulatory authority in Canada in connection with the offer and sale of the securities described herein, or the Securities. No securities commission or similar regulatory authority in Canada has reviewed or in any way passed upon this document or on the merits of the Securities and any representation to the contrary is an offence.

Canadian investors are advised that this document has been prepared in reliance on section 3A.3 of National Instrument 33-105 Underwriting Conflicts (“NI 33-105”). Pursuant to section 3A.3 of NI 33-105, this document is exempt from the requirement to provide investors with certain conflicts of interest disclosure pertaining to “connected issuer” and/or “related issuer” relationships as would otherwise be required pursuant to subsection 2.1(1) of NI 33-105.

Resale Restrictions

The offer and sale of the securities in Canada is being made on a private placement basis only and is exempt from the requirement to prepare and file a prospectus under applicable Canadian securities laws. Any resale of Securities acquired by a Canadian investor in the offering must be made in accordance with applicable Canadian securities laws, which may vary depending on the relevant jurisdiction, and which may require resales to be made in accordance with Canadian prospectus requirements, a statutory exemption from the prospectus requirements, in a transaction exempt from the prospectus requirements or otherwise under a discretionary exemption from the prospectus requirements granted by the applicable local Canadian securities regulatory authority. These resale restrictions may under certain circumstances apply to resales of the securities outside of Canada.

Representations of Purchasers

Each Canadian investor who purchases the securities will be deemed to have represented to the issuer and to each dealer from whom a purchase confirmation is received, as applicable, that the investor (i) is purchasing as principal, or is deemed to be purchasing as principal in accordance with applicable Canadian securities laws, for investment only and not with a view to resale or redistribution; (ii) is an “accredited investor” as such term is defined in section 1.1 of National Instrument 45-106 Prospectus Exemptions, or NI-45-106 or, in Ontario, as such term is defined in section 73.3(1) of the Securities Act (Ontario); and (iii) is a “permitted client” as such term is defined in section 1.1 of National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations.

67

Taxation and Eligibility for Investment

Any discussion of taxation and related matters contained in this document does not purport to be a comprehensive description of all of the tax considerations that may be relevant to a Canadian investor when deciding to purchase the securities and, in particular, does not address any Canadian tax considerations. No representation or warranty is hereby made as to the tax consequences to a resident, or deemed resident, of Canada of an investment in the securities or with respect to the eligibility of the securities for investment by such investor under relevant Canadian federal and provincial legislation and regulations.

Rights of Action for Damages or Rescission

Securities legislation in certain of the Canadian jurisdictions provides certain purchasers of securities pursuant to an offering memorandum, including where the distribution involves an “eligible foreign security” as such term is defined in Ontario Securities Commission Rule 45-501 Ontario Prospectus and Registration Exemptions and in Multilateral Instrument 45-107 Listing Representation and Statutory Rights of Action Disclosure Exemptions, as applicable, with a remedy for damages or rescission, or both, in addition to any other rights they may have at law, where the offering memorandum, or other offering document that constitutes an offering memorandum, and any amendment thereto, contains a “misrepresentation” as defined under applicable Canadian securities laws. These remedies, or notice with respect to these remedies, must be exercised or delivered, as the case may be, by the purchaser within the time limits prescribed under, and are subject to limitations and defences under, applicable Canadian securities legislation. In addition, these remedies are in addition to and without derogation from any other right or remedy available at law to the investor.

Language of Documents

Upon receipt of this document, each Canadian investor hereby confirms that it has expressly requested that all documents evidencing or relating in any way to the sale of the securities described herein (including for greater certainty any purchase confirmation or any notice) be drawn up in the English language only. Par la réception de ce document, chaque investisseur canadien confirme par les présentes qu’il a expressément exigé que tous les documents faisant foi ou se rapportant de quelque manière que ce soit à la vente des valeurs mobilières décrites aux présentes (incluant, pour plus de certitude, toute confirmation d’achat ou tout avis) soient rédigés en anglais seulement.

France

Neither this prospectus nor any other offering material relating to the shares of Common Stock has been submitted to the clearance procedures of the Autorité des marchés financiers in France. The shares of Common Stock have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in France. Neither this prospectus nor any other offering material relating to the shares of Common Stock has been or will be: (a) released, issued, distributed or caused to be released, issued or distributed to the public in France; or (b) used in connection with any offer for subscription or sale of the shares of Common Stock to the public in France. Such offers, sales and distributions will be made in France only: (i) to qualified investors (investisseurs qualifiés) and/or to a restricted circle of investors (cercle restreint d’investisseurs), in each case investing for their own account, all as defined in and in accordance with Articles L.411-2, D.411-1, D.411-2, D.734-1, D.744-1, D.754-1 and D.764-1 of the French Code monétaire et financier; (ii) to investment services providers authorised to engage in portfolio management on behalf of third parties; or (iii) in a transaction that, in accordance with article L.411-2-II-1°-or-2°-or 3° of the French Code monétaire et financier and article 211-2 of the General Regulations (Règlement Général) of the Autorité des marchés financiers, does not constitute a public offer (appel public à l’épargne). Such shares of Common Stock may be resold only in compliance with Articles L.411-1, L.411-2, L.412-1 and L.621-8 through L.621-8-3 of the French Code monétaire et financier.

Israel

This prospectus does not constitute a prospectus under the Israeli Securities Law, 5728-1968, or the Securities Law, and has not been filed with or approved by the Israel Securities Authority. In the State of Israel, this document is being distributed only to, and is directed only at, and any offer of the shares of Common Stock is directed only at, investors listed in the first addendum to the Israeli Securities Law, or the Addendum, consisting primarily of joint investment in trust funds, provident funds, insurance companies, banks, portfolio managers, investment advisors, members of the Tel Aviv Stock Exchange, underwriters, venture capital funds, entities with equity in excess of NIS 50 million and “qualified individuals”, each as defined in the Addendum (as it may be amended from time to time), collectively referred to as qualified investors (in each case purchasing for their own account or, where permitted under the Addendum, for the accounts of their clients who are investors listed in the Addendum). Qualified investors will be required to submit written confirmation that they fall within the scope of the Addendum, are aware of the meaning of same and agree to it.

68

Italy

The offering of the shares of Common Stock offered hereby in Italy has not been registered with the Commissione Nazionale per la Società e la Borsa, or CONSOB, pursuant to Italian securities legislation and, accordingly, the shares of Common Stock offered hereby cannot be offered, sold or delivered in the Republic of Italy, or Italy, nor may any copy of this prospectus or any other document relating to the shares of Common Stock offered hereby be distributed in Italy other than to professional investors (operatori qualificati) as defined in Article 31, second paragraph, of CONSOB Regulation No. 11522 of 1 July, 1998 as subsequently amended. Any offer, sale or delivery of the shares of Common Stock offered hereby or distribution of copies of this prospectus or any other document relating to the shares of Common Stock offered hereby in Italy must be made:

(a)by an investment firm, bank or intermediary permitted to conduct such activities in Italy in accordance with Legislative Decree No. 58 of 24 February 1998 and Legislative Decree No. 385 of 1 September 1993, or the Banking Act;
(b)in compliance with Article 129 of the Banking Act and the implementing guidelines of the Bank of Italy; and
(c)in compliance with any other applicable laws and regulations and other possible requirements or limitations which may be imposed by Italian authorities.

Sweden

This prospectus has not been nor will it be registered with or approved by Finansinspektionen (the Swedish Financial Supervisory Authority). Accordingly, this prospectus may not be made available, nor may the shares of Common Stock offered hereunder be marketed and offered for sale in Sweden, other than under circumstances which are deemed not to require a prospectus under the Financial Instruments Trading Act (1991: 980).

Switzerland

The shares of Common Stock offered pursuant to this prospectus will not be offered, directly or indirectly, to the public in Switzerland and this prospectus does not constitute a public offering prospectus as that term is understood pursuant to art. 652a or art. 1156 of the Swiss Federal Code of Obligations. The company has not applied for a listing of the shares of Common Stock being offered pursuant to this prospectus on the SWX Swiss Exchange or on any other regulated securities market, and consequently, the information presented in this prospectus does not necessarily comply with the information standards set out in the relevant listing rules. The shares of Common Stock being offered pursuant to this prospectus have not been registered with the Swiss Federal Banking Commission as foreign investment funds, and the investor protection afforded to acquirers of investment fund certificates does not extend to acquirers of shares of Common Stock.

Investors are advised to contact their legal, financial or tax advisers to obtain an independent assessment of the financial and tax consequences of an investment in shares of Common Stock.

European Economic Area and the United Kingdom

In relation to each Member State of the European Economic Area and the United Kingdom, each referred to as a Relevant State, no shares of Common Stock have been offered or will be offered pursuant to the offering to the public in that Relevant State prior to the publication of a prospectus in relation to the shares of Common Stock which has been approved by the competent authority in that Relevant State or, where appropriate, approved in another Relevant State and notified to the competent authority in that Relevant State, all in accordance with the Prospectus Regulation), except that offers of shares of Common Stock may be made to the public in that Relevant State at any time under the following exemptions under the Prospectus Regulation:

(a)to any legal entity which is a qualified investor as defined under the Prospectus Regulation;

69

(b)to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus Regulation), subject to obtaining the prior consent of the underwriters for any such offer; or

(c)in any other circumstances falling within Article 1(4) of the Prospectus Regulation,

provided that no such offer of shares of Common Stock shall require us or any of underwriters to publish a prospectus pursuant to Article 3 of the Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation.

Each person in a Relevant State who initially acquires any shares of Common Stock or to whom any offer is made will be deemed to have represented, acknowledged and agreed to and with us and the underwriters that it is a qualified investor within the meaning of the Prospectus Regulation.

In the case of any shares of Common Stock being offered to a financial intermediary as that term is used in Article 5(1) of the Prospectus Regulation, each such financial intermediary will be deemed to have represented, acknowledged and agreed that the shares of Common Stock acquired by it in the offer have not been acquired on a non-discretionary basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an offer to the public other than their offer or resale in a Relevant State to qualified investors, in circumstances in which the prior consent of the underwriters has been obtained to each such proposed offer or resale.

We, the underwriters and their affiliates, will rely upon the truth and accuracy of the foregoing representations, acknowledgements and agreements.

For the purposes of this provision, the expression an “offer to the public” in relation to any shares of Common Stock in any Relevant State means the communication in any form and by any means of sufficient information on the terms of the offer and any shares of Common Stock to be offered so as to enable an investor to decide to purchase or subscribe for any shares of Common Stock, and the expression “Prospectus Regulation” means Regulation (EU) 2017/1129.

References to the Prospectus Regulation includes, in relation to the United Kingdom, the Prospectus Regulation as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018.

The above selling restriction is in addition to any other selling restrictions set out below.

United Kingdom

This document is for distribution only to persons who (i) have professional experience in matters relating to investments and who qualify as investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the Financial Promotion Order), (ii) are persons falling within Article 49(2)(a) to (d), or high net worth companies, unincorporated associations etc., of the Financial Promotion Order, (iii) are outside the United Kingdom, or (iv) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Act 2000, as amended, or FSMA,) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as “relevant persons”). This document is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this document relates is available only to relevant persons and will be engaged in only with relevant persons.

70

CERTAIN MATERIAL FEDERAL INCOME TAX CONSIDERATIONS

The following is a summary of certain material United States federal income tax consequences to you of the acquisition, ownership, and disposition of shares of our common stock offered pursuant to this prospectus. This discussion is not a complete analysis of all of the potential United States federal income tax consequences relating thereto, and, except as otherwise specifically provided herein, it does not address any estate and gift tax consequences or any tax consequences arising under any state, local or foreign tax laws, or any other United States federal tax laws. This discussion is based on the Code, Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the Internal Revenue Service (the “IRS”), all as in effect as of the date of this prospectus. These authorities may change, possibly retroactively, resulting in United States federal income tax consequences different from those discussed below. No ruling has been or will be sought from the IRS with respect to the matters discussed below, and there can be no assurance that the IRS will not take a contrary position regarding the tax consequences of the acquisition, ownership, or disposition of the shares of our common stock, or that any such contrary position would not be sustained by a court.

This discussion is limited to holders who purchase shares of our common stock pursuant to this prospectus and who hold the shares of our common stock as a “capital asset” within the meaning of Section 1221 of the Code (generally, property held for investment). This discussion does not consider any specific facts or circumstances that may be relevant to holders subject to special rules under the United States federal income tax laws, including, without limitation:

financial institutions, banks, and thrifts;
insurance companies;
tax-exempt organizations;
“S” corporations, partnerships, or other pass-through entities;
traders in securities that elect to mark to market;
regulated investment companies and real estate investment trusts;
broker-dealers or dealers in securities or currencies;
United States expatriates;
persons subject to the alternative minimum tax;
persons holding our stock as a hedge against currency risks or as a position in a straddle;
persons that are former citizens or former long-term residents of the U.S.;
persons that are subject to special tax accounting rules;
controlled foreign corporations and passive foreign investment companies; or
U.S. holders (as defined below) whose functional currency is not the United States dollar.

If a partnership (or other entity taxed as a partnership for United States federal income tax purposes) holds shares of our common stock, the tax treatment of a partner in the partnership will depend on the status of the partner, upon the activities of the partnership, and upon certain determinations made at the partner level. Accordingly, partnerships holding our common stock and the partners in such partnerships should consult their own tax advisors regarding the specific United States federal income tax consequences to them.

71

Prospective investors should consult their own tax advisors regarding the particular United States federal income tax consequences to them of acquiring, owning, and disposing of shares of our common stock, as well as any tax consequences arising under any state, local or foreign tax laws and any other United States federal tax laws.

For purposes of this discussion, a “U.S. holder” is any beneficial owner of shares of our common stock who, for United States federal income tax purposes, is:

an individual who is a citizen or resident of the United States;
a corporation (or other entity treated as a corporation for United States federal income tax purposes) created or organized in or under the laws of the United States or of any state or in the District of Columbia;
an estate the income of which is subject to United States federal income taxation regardless of its source; or
a trust, if a United States court can exercise primary supervision over the administration of the trust and one or more United States persons have the authority to control all substantial decisions of the trust, or if the trust has a valid election in place to be treated as a United States person.

A “non-U.S. holder” is any beneficial owner of our common stock that is neither a “U.S. holder” nor an entity treated as a partnership for United States federal income tax purposes.

Taxation of U.S. Holders

Distributions on Shares of Our Common Stock. If we make cash or other property distributions on shares of our common stock, such distributions generally will constitute dividends for United States federal income tax purposes to the extent of our current and accumulated earnings and profits, as determined under United States federal income tax principles. Subject to certain limitations, these distributions may be eligible for the dividends-received deduction in the case of U.S. holders that are corporations. Dividends paid to non-corporate U.S. holders generally will qualify for taxation at special rates as “qualified dividends” if such U.S. holder meets certain holding period and other applicable requirements. The special rate will not, however, apply to dividends received to the extent that the U.S. holder elects to treat dividends as “investment income,” which may be offset by investment expense.

Amounts not treated as dividends for United States federal income tax purposes will constitute a return of capital and will first be applied against and reduce a U.S. holder’s tax basis in the shares of our common stock, but not below zero. Distributions in excess of our current and accumulated earnings and profits and in excess of a U.S. holder’s tax basis in its shares of our common stock will be taxable as capital gain realized on the sale or other disposition of the shares of our common stock and will be treated as described under “—Sales or Other Taxable Dispositions of Shares of Our Common Stock” below.

Sale or Other Taxable Dispositions of Shares of Our Common Stock. If a U.S. holder sells or disposes of shares of our common stock, such U.S. holder generally will recognize gain or loss for United States federal income tax purposes in an amount equal to the difference between the amount of cash and the fair market value of any property received on the sale or other disposition and the U.S. holder’s adjusted basis in the shares of our common stock for United States federal income tax purposes. This gain or loss generally will be long-term capital gain or loss if the U.S. holder has held the shares of our common stock for more than one year. The deductibility of capital losses is subject to limitations.

Backup Withholding and Information Reporting. Information reporting will generally apply to U.S. holders with respect to payments of dividends on shares of our common stock and to certain payments of proceeds on the sale or other disposition of shares of our common stock. Certain U.S. holders may be subject to U.S. backup withholding on payments of dividends on shares of our common stock and certain payments of proceeds on the sale or other disposition of shares of our common stock unless the beneficial owner of shares of our common stock furnishes the payor or its agent with a taxpayer identification number, certified under penalties of perjury, and certain other information, or otherwise establishes, in the manner prescribed by law, an exemption from backup withholding.

U.S. backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a credit against a U.S. holder’s United States federal income tax liability, which may entitle the U.S. holder to a refund, provided the U.S. holder timely furnishes the required information to the IRS.

72

Medicare Tax. A U.S. person that is an individual or estate, or a trust that does not fall into a special class of trusts that is exempt from such tax, will be subject to an additional tax on the lesser of (1) the U.S. person’s “net investment income” for the relevant taxable year and (2) the excess of the U.S. person’s modified adjusted gross income for the taxable year over a certain threshold. Net investment income generally includes dividends, and net gains from the disposition of common stock, unless such income or gains are derived in the ordinary course of the conduct of a trade or business (other than a trade or business that consists of certain passive or trading activities). A U.S. holder that is an individual, estate or trust should consult its own tax advisor regarding the applicability of the Medicare tax to its income and gains in respect of its investment in our common stock.

Taxation of Non-U.S. Holders

Distributions on Shares of Our Common Stock. Distributions that are treated as dividends (see “Taxation of U.S. Holders—Distributions on Shares of Our Common Stock”) generally will be subject to United States federal withholding tax at a rate of 30% of the gross amount of the dividends, or such lower rate specified by an applicable income tax treaty. If we cannot determine at the time such determinationa distribution is made demonstrate clearlywhether or not the distribution will exceed current and convincinglyaccumulated earnings and profits (and therefore whether the distribution will be treated as a dividend), we intend to withhold from the distribution at the rate applicable to dividends. A non-U.S. holder may seek a refund from the IRS of any amounts withheld if it is subsequently determined that the distribution was, in fact, in excess of our current and accumulated earnings and profits. To receive the benefit of a reduced treaty rate, a non-U.S. holder must furnish to us or our paying agent a valid IRS Form W-8BEN (or applicable successor form) certifying such non-U.S. holder’s qualification for the reduced rate. This certification must be provided to us or our paying agent prior to the payment of dividends and must be updated as required by law. Non-U.S. holders that do not timely provide us or our paying agent with the required certification, but that qualify for a reduced treaty rate, may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS.

If a non-U.S. holder holds shares of our common stock in connection with the conduct of a trade or business in the United States, and dividends paid on the shares of our common stock are effectively connected with such non-U.S. holder’s United States trade or business (and if required by an applicable income tax treaty, attributable to a permanent establishment maintained by the non-U.S. holder in the United States), the non-U.S. holder will be exempt from United States federal withholding tax. To claim the exemption, the non-U.S. holder must generally furnish to us or our paying agent a properly executed IRS Form W-8ECI (or applicable successor form).

Any dividends paid on shares of our common stock that are effectively connected with a non-U.S. holder’s United States trade or business (and if required by an applicable income tax treaty, attributable to a permanent establishment maintained by the non-U.S. holder in the United States) generally will be subject to United States federal income tax on a net income basis at the regular graduated United States federal income tax rates in much the same manner as if such non-U.S. holder were a resident of the United States. A non-U.S. holder that is a foreign corporation also may be subject to an additional branch profits tax equal to 30% (or such lower rate specified by an applicable income tax treaty) of its effectively connected earnings and profits for the taxable year, as adjusted for certain items. Non-U.S. holders should consult their own tax advisors regarding any applicable income tax treaties that may provide for different rules.

Distributions that we determine are in excess of our current and accumulated earnings and profits and that are in excess of a non-U.S. holder’s tax basis in its shares of our common stock will be treated as gain from the sale of common stock as described under “—Sales or Other Taxable Dispositions of Shares of Our Common Stock” below. If we are a USRPHC (as defined below) and we do not qualify for the Regularly Traded Exception (as defined below), distributions which constitute a return of capital will be subject to withholding tax unless an application for a withholding certificate is filed to reduce or eliminate such withholding. (See “— Sales or Other Taxable Dispositions of Shares of our Common Stock” below for a discussion of the treatment of USRPHCs.)

Sales or Other Taxable Dispositions of Shares of Our Common Stock. Subject to the discussion of backup withholding and withholding tax relating to foreign accounts below, a non-U.S. holder generally will not be subject to United States federal income tax for gain recognized on a sale or other disposition of common stock unless one of the following conditions is satisfied:

the gain is effectively connected with a trade or business conducted by the non-U.S. holder in the United States (and, if an income tax treaty applies, is attributable to a permanent establishment maintained in the United States by such non-U.S. holder). The non-U.S. holder will, unless an applicable treaty provides otherwise, be taxed on its net gain derived from the sale or other disposition under regular graduated United States federal income tax rates. Effectively connected gains realized by a corporate non-U.S. holder may also, under certain circumstances, be subject to an additional “branch profits tax” at a 30% rate or a lower rate as may be specified by an applicable income tax treaty;

73

in the case of a non-U.S. holder who is an individual and holds the common stock as a capital asset, the holder is present in the United States for 183 or more days in the taxable year of the sale or other disposition and certain other conditions exist. Such gain will be subject to United States federal income tax at a flat 30% rate (or such lower rate specified by an applicable income tax treaty), but may be offset by United States source capital losses (even though the individual is not considered a resident of the United States); or
our common stock constitutes a USRPI within the meaning FIRPTA by reason of our status as a USRPHC for United States federal income tax purposes.

With respect to the third bullet point above, because of our holdings of United States real property interests, we believe that we are a USRPHC for United States federal income tax purposes. Because the determination of whether we are a USRPHC depends on the fair market value of our United States real property interests relative to the fair market value of our other trade or business assets and any foreign real property interests, it is possible that we may not remain a USRPHC in the future. As a USRPHC, if a class of our stock is regularly traded on an established securities market as determined under the Treasury Regulations (the “Regularly Traded Exception”), such stock will be treated as a USRPI only with respect to a non-U.S. holder that actually or constructively holds more than 5% of such class of stock at any time during the shorter of the five-year period preceding the date of disposition or the holder’s holding period for such stock. We anticipate that our common stock will be regularly traded on an established securities market following this offering. However, no assurance can be given in this regard and no assurance can be given that our common stock will remain regularly traded in the future. If gain on the sale or other taxable disposition of shares of our common stock were subject to taxation under FIRPTA as a sale of a USRPI, the non-U.S. holder would be subject to regular United States federal income tax with respect to such gain in the same manner as a taxable U.S. holder (subject to any applicable alternative minimum tax and a special alternative minimum tax in the case of non-resident alien individuals). In addition, if the sale or other taxable disposition of shares of our common stock is subject to tax under FIRPTA, the purchaser of the stock would be required to withhold and remit to the IRS 15% of the purchase price unless an exception applies. A non-U.S. holder also will be required to file a United States federal income tax return for any taxable year in which it realizes a gain from the disposition of our common stock that is subject to United States federal income tax.

Non-U.S. holders should consult their own tax advisors concerning the consequences of selling or otherwise disposing of shares of our common stock.

Backup Withholding Tax and Information Reporting. We must report annually to each non-U.S. holder of shares of our common stock and to the IRS the amount of payments on the shares of our common stock paid to such non-U.S. holder and the amount of any tax withheld with respect to those payments. These information reporting requirements apply even if no withholding was required because the payments were effectively connected with the non-U.S. holder’s conduct of a United States trade or business, or withholding was reduced or eliminated by an applicable income tax treaty. This information also may be made available under a specific treaty or agreement with the tax authorities in the country in which the non-U.S. holder resides or is established. Backup withholding, however, generally will not apply to distribution payments to a non-U.S. holder of shares of our common stock provided the non-U.S. holder furnishes to us or our paying agent the required certification as to its non-U.S. status, such as by providing a valid IRS Form W-8BEN or IRS Form W-8ECI, or certain other requirements are met. Notwithstanding the foregoing, backup withholding may apply if either we or our paying agent has actual knowledge, or reason to know, that the holder is a U.S. person that is not an exempt recipient.

Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or a credit against a non-U.S. holder’s United States federal income tax liability, provided the required information is timely furnished to the IRS.

74

Additional Withholding Tax Relating to Foreign Accounts. Withholding taxes may be imposed under Sections 1471 to 1474 of the Code, the Treasury Regulations promulgated thereunder and other official guidance (commonly referred to as “FATCA”) on certain types of payments made to non-U.S. financial institutions and certain other non-U.S. entities. Specifically, a 30% withholding tax may be imposed on dividends on shares of our common stock paid to a “foreign financial institution” or a “non-financial foreign entity” (each as defined in the Code), unless (1) the foreign financial institution undertakes certain diligence, reporting and withholding obligations, (2) the non- financial foreign entity either certifies it does not have any “substantial United States owners” (as defined in the Code) or furnishes identifying information regarding each substantial United States owner, or (3) the foreign financial institution or non-financial foreign entity otherwise qualifies for an exemption from these rules. If the payee is a foreign financial institution and is subject to the diligence, reporting and withholding requirements in (1) above, it must enter into an agreement with the U.S. Department of the Treasury requiring, among other things, that it undertake to identify accounts held by certain “specified United States persons” or “United States-owned foreign entities” (each as defined in the Code), annually report certain information about such accounts, and withhold 30% on certain payments to non-compliant foreign financial institutions and certain other account holders. Accordingly, the entity through which shares of our common stock is held will affect the determination of whether such withholding is required. Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States governing FATCA may be subject to different rules. Future Treasury Regulations or other official guidance may modify these requirements.

Under the applicable Treasury Regulations, withholding under FATCA generally applies to payments of dividends on shares of our common stock. While withholding under FATCA would have also applied to payments of gross proceeds from the sale or other disposition of shares of our common stock on or after January 1, 2019, recently proposed Treasury Regulations eliminate FATCA withholding on payments of gross proceeds. The preamble to these proposed regulations indicates that taxpayers may rely on them pending their finalization. The FATCA withholding tax will apply to all withholdable payments without regard to whether the beneficial owner of the payment would otherwise be entitled to an exemption from imposition of withholding tax pursuant to an applicable income tax treaty with the United States or U.S. domestic law. We will not pay additional amounts to holders of shares of our common stock in respect of amounts withheld.

Prospective investors should consult their own tax advisors regarding the potential application of withholding under FATCA to their investment in shares of our common stock.

75

LEGAL MATTERS

Certain legal matters in connection with this offering, including the validity of the securities offered hereby, will be passed upon for us by Lucosky Brookman LLP, Iselin, New Jersey. Certain legal matters in connection with this offering will be passed upon for the underwriters by [  ].

EXPERTS

The financial statements of Limitless X Holdings, Inc., a Delaware corporation, as of December 31, 2022 and 2021, and for the years then ended have been included herein and in the registration statement in reliance upon the report of BF Borgers CPA PC, independent registered public accounting firm, appearing elsewhere herein, and upon the authority of said firm as experts in accounting and auditing.

WHERE YOU CAN FIND MORE INFORMATION

We have filed with the SEC a registration statement on Form S-1 under the Securities Act, with respect to the securities being offered by this prospectus. This prospectus, which constitutes part of that registration statement, does not contain all of the information set forth in the registration statement or the exhibits and schedules which are part of the registration statement. Some items included in the registration statement are omitted from the prospectus in accordance with the rules and regulations of the SEC. For further information with respect to us and the securities offered in this prospectus, we refer you to the registration statement and the accompanying exhibits.

A copy of the registration statement and the accompanying exhibits and any other document we file may be inspected without charge at the public reference facilities maintained by the SEC at 100 F Street, N.E., Washington, D.C. 20549, and copies of all or any part of the registration statement may be obtained from this office upon the payment of the fees prescribed by the SEC. The public may obtain information on the operation of the public reference facilities in Washington, D.C. by calling the SEC at 1-800-SEC-0330. Our filings with the SEC are available to the public from the SEC’s website at www.sec.gov.

Upon the completion of this offering, we will be subject to the information and periodic reporting requirements of the Exchange Act, applicable to a company with securities registered pursuant to Section 12 of the Exchange Act. In accordance therewith, we will file proxy statements, periodic information, and other information with the SEC. All documents filed with the SEC are available for inspection and copying at the public reference room and website of the SEC referred to above. We maintain a website at https://limitlessx.com/. You may access our reports, proxy statements and other information free of charge at this website as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. The information contained in, or that can be accessed through, our website is not incorporated by reference and is not a part of this prospectus.

76

LIMITLESS X HOLDINGS INC.

INDEX TO CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS

Financial StatementsF-1
Unaudited Condensed Consolidated Balance SheetsF-1
Unaudited Condensed Consolidated Statements of OperationsF-2
Unaudited Condensed Consolidated Statement of Changes in Stockholders’ DeficitF-3
Unaudited Condensed Consolidated Statements of Cash FlowsF-5
Notes to the Unaudited Condensed Consolidated Financial StatementsF-6

LIMITLESS X HOLDINGS, INC.

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

Report of Independent Registered Public Accounting Firm (PCAOB ID No. 5041)F-22
Consolidated Balance SheetsF-23
Consolidated Statements of OperationsF-24
Consolidated Statement of Changes in Stockholders’ EquityF-25
Consolidated Statements of Cash FlowsF-26
Notes to the Consolidated Financial StatementsF-27

77

Up to [    ] Shares of Common Stock

LIMITLESS X HOLDINGS, INC.

PROSPECTUS

[      ]

The date of this prospectus is , 2024

PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

Item 13. Other Expenses of Issuance and Distribution.

The following table sets forth the costs and expenses, other than the underwriting discounts and commissions, payable in connection with the sale of common stock being registered. All amounts shown are estimates, except the U.S. Securities and Exchange Commission registration fee, the NYSE American filing fee, and the FINRA filing fee.

DescriptionAmount
U.S. Securities and Exchange Commission registration fee$
FINRA filing fee
NYSE American filing fee
Accounting fees and expenses$
Legal fees and expenses$
Transfer agent and registrar fees and expenses$
Printing expenses$
Miscellaneous$
Total$

Item 14. Indemnification of Directors and Officers.

Section 145 of the Delaware General Corporation Law provides that a corporation may indemnify directors and officers as well as other employees and individuals against expenses including attorneys’ fees, judgments, fines and amounts paid in settlement in connection with various actions, suits or proceedings, whether civil, criminal, administrative or investigative other than an action by or in the right of the corporation, a derivative action, if they acted in badgood faith orand in a manner that such person did not believethey reasonably believed to be in or not opposed to the best interests of us.the corporation, and, with respect to any criminal action or proceeding, if they had no reasonable cause to believe their conduct was unlawful. A similar standard is applicable in the case of derivative actions, except that indemnification only extends to expenses including attorneys’ fees incurred in connection with the defense or settlement of such actions, and the statute requires court approval before there can be any indemnification where the person seeking indemnification has been found liable to the corporation. The statute provides that it is not exclusive of other indemnification that may be granted by a corporation’s certificate of incorporation, bylaws, agreement, a vote of shareholders or disinterested directors or otherwise.

Our charter documents provide that we will indemnify and hold harmless, to the fullest extent permitted by Section 145 of the Delaware General Corporation Law, as amended from time to time, each person that such section grants us the power to indemnify.

The Delaware General Corporation Law permits a corporation to provide in its certificate of incorporation that a director of the corporation shall not be personally liable to the corporation or its shareholders for monetary damages for breach of fiduciary duty as a director, except for liability for:

Any breach of the director’s duty of loyalty to the corporation or its shareholders;
Acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law;
Payments of unlawful dividends or unlawful stock repurchases or redemptions; or
Any transaction from which the director derived an improper personal benefit.

Our charter documents provide that, to the fullest extent permitted by applicable law, none of our directors will be personally liable to us or our shareholders for monetary damages for breach of fiduciary duty as a director. Any repeal or modification of this provision will be prospective only and will not adversely affect any limitation, right, or protection of a director of our company existing at the time of such repeal or modification.

48 II-1
Table of Contents

 

ITEMItem 15. RECENT SALES OF UNREGISTERED SECURITIESRecent Sales of Unregistered Securities.

Issuer PurchasesOn May 11, 2022, Bio Lab Naturals, Inc. entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with Limitless X, Inc., a Nevada corporation (“LimitlessX”), and its 11 shareholders (the “LimitlessX Acquisition”). The parties completed and closed the LimitlessX Acquisition on May 20, 2022 by issuing an aggregate of Equity Securities

We did not repurchase any97,000,000 shares to the LimitlessX shareholders (the “Acquisition Closing”). Subsequently and according to the terms of the Share Exchange Agreement, Bio Lab Naturals, Inc. issued an additional 300,000 shares of our common stock duringto the period January 1, 2018 through ended September 22 , 2020.

Shares Issued for AssetLimitlessX shareholders pro rata to their interests after the Acquisition Agreement

Persons and/or EntitiesNatureDate
Prime Time Live, Inc.5,500,000 shares of common stock issued for founders and for servicesDecember 2019

Shares or Warrants Issued for Compensation or Services

Since January 1, 2018 through September 22 , 2020, we have issuedClosing and as part of the LimitlessX Acquisition. Concurrently with the LimitlessX Acquisition, Jaspreet Mathur, the founder and principal shareholder of LimitlessX, also purchased from Helion Holdings LLC, 500,000 shares of ourBio Lab Naturals, Inc.’s Class A Preferred Convertible Stock, which at all times have a number of votes equal to 60% of all the issued and outstanding shares of common stock in exchangeof Bio Lab Naturals, Inc. All the shares are registered from this transaction except for services300,000 shares that are unregistered which is issuable to CEO of the individuals and/or entities andCompany as part of the amounts set forth below:Share Exchange Agreement. The Company recorded the 300,000 shares as common stock issuable as of June 30, 2022.

Persons and/or EntitiesNatureDate
M.A. Littman400,000 shares of common stock for legal servicesDecember 2019
Helion Holdings, LLC (beneficially W. Edward Nichols)250,000 shares of Class A Preferred stock for servicesDecember 2019
W. Edward Nichols250,000 shares of Class A Preferred stock for servicesDecember 2019
Jeremy Ostler50,000 shares of common stock for Director servicesApril 2020
Calvin D. Smiley, Sr.50,000 shares of common stock for Director servicesApril 2020

Shares Issued in Private Placement Offering

The saleFrom July to December 2022, we issued $9,175,000 of 2,095,999 common shares for cash during the monthsconvertible notes that have a conversion rate of April 2020 through June 2020 was based upon subscription agreements at $0.125$0.25 per share for a total of $262,000.common stock. The private placement was terminated asnotes have maturity dates of one year from issuance. The interest rate of the datenotes is 6% per annum. The notes are convertible into shares of this prospectus.

Exemption From Registration Claimed

Allcommon stock at the option of the aboveholder.

In connection with each of the following unregistered sales by usand issuances of our unregistered securities, were madeexcept as otherwise provided below, the Company relied upon the exemption from registration provided by us in reliance upon Rule 506 of Regulation D or Section 4(a)2(2) of the Securities Act for transactions not involving a public offering.

Item 16. Exhibits and Financial Statement Schedules.

(a) The following exhibits are filed as part of 1933, as amended (the "1933 Act").this Registration Statement and are numbered in accordance with Item 601 of Regulation S-K:

See the Exhibit Index immediately preceding the Signature Page.

(b) Financial Statement Schedules:

See our Financial Statements starting on page F-1. All other schedules for which provision is made in the applicable accounting regulations of the individuals and/SEC are not required, are inapplicable or entities that purchased the unregistered securities were known to usinformation is included in the financial statements, and our management, through pre-existing business relationships, or long-standing business associates or were shareholders of Prime Time Live, Inc. who received exchange shares for Prime Time Live, Inc. assets. All purchasers were provided access to all material information, which they requested, and all information necessary to verify such information and were afforded access to our management in connection with their purchases. All purchasers of the unregistered securities acquired such securities for investment and not with a view toward distribution, acknowledging such intent to us. All certificates or agreements representing such securities that were issued contained restrictive legends, prohibiting further transfer of the certificates or agreements representing such securities, without such securities either being first registered or otherwise exempt from registration in any further resale or disposition.have therefore been omitted.

Item 17. Undertakings.

49 
��Table of Contents

ITEM 16. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

Exhibit NumberDescription 
   
 3(i).1Certificate of Merger to Delaware -8.20.10(1)
   
 3(i).2Certificate of Incorporation – Vyta Corp. – Delaware -6.3.2010(1)
   
 3(i).3Certificate of Amendment of Certificate of Incorporation – Vyta Corp.  - DE – 8.26.10(1)
   
 3(i).4Certificate of Incorporation – Bio Lab Naturals, Inc. – DE – 8.26.10(1)
   
 3(i).5Certificate of Incorporation – 10 Vyta, Inc. DE – 8.26.10(1)
   
3(i).6Certificate of Amendment of Certificate of Incorporation – Bio Lab Naturals, Inc. – DE – 10.1.10(1)
   
3(i).7Certificate of Amendment of Certificate of Incorporation – Name Change to Vyta Corp. – DE – 4.18.13(1)
   
3(i).8Certificate of Correction – Voiding Name Change – DE – 3.27.15(1)
   
 3(i).9Certificate of Amendment of Certificate of Incorporation - Name change to Set Net Global, Inc. – DE – 4.1.15 (1)
   
 3(i).10Certificate of Amendment of Certificate of Incorporation - Name change back to Bio Lab Naturals, Inc. – DE – 7.16.19(1)
   
 3(i).11Articles of Amendment - HPI Equipment Corp. Name Change to PTL Acquisition Sub, Inc. - 1.28.20(1) 
   
3(i).12Certification of Amendment of Certificate of Incorporation (Article 4) – 2/3/20(1)
   
3(i).13Articles of Incorporation - PrimeTime Live(1)
   
3(i).14Statement of Correction – Prime Time Live(1)
   
3(i).15Articles of Amendment to Articles of Incorporation – Name Change Prime Time Live, Inc.(1)
   
3(ii).16Bylaws of Bio Lab Naturals, Inc.(1)
   
3(ii).17Bylaws of PTL Acquisition Sub, Inc.(1)
   
4.12020 Stock Option and Award Plan(1)
   
4.2Series A Preferred Certification of Designation – Bio Lab Naturals, Inc. DE – 8.31.10(1)
   
4.3Class A Super Majority Convertible Preferred Shares Designation – Bio Lab Naturals, Inc. – DE – 2.5.20(1)
   
4.4Class B Convertible Preferred Shares Designation(1)
   
4.5Certificate of Designation of Series AA Preferred Stock – Bio Lab Naturals, Inc. – DE – 5.3.12(1)
   
10.1Agreement and Plan of Reorganization with Prime Time Live, Inc.(1)
   
21.1List of Subsidiaries(1)
50 
Table of Contents

(a)
23.1Legal Opinion of Christen Lambert, Attorney at LawFiled Herewith
23.2Consent of Independent Certified Public AccountantsFiled Herewith
The undersigned registrant hereby undertakes:

(1)Incorporated by reference(1)To file, during any period in which offers or sales are being made, a post-effective amendment to the Exhibits to the Registrant’s Registration Statement on Form S-1 (File No. 333-239640) filed with the Securities and Exchange Commission on July 2, 2020.this registration statement:

ITEM 17. UNDERTAKINGS

We hereby undertake the following:

To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

a.(i)To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;Act;

b.(ii)To reflect in the prospectus any facts or events arising after the effective date of thisthe registration statement or(or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in thisthe registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

c.(iii)To include any material information with respect to the plan of distribution not previously disclosed in thisthe registration statement or any material change to such information in the registration statement.statement

That, for the purpose of determining any liability under the Securities Act, each post-effective amendment shall be deemed to be a new registration statement relating to the securities offered herein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

To remove from registration by means of a post-effective amendment any of the securities being registered hereby which remain unsold at the termination of the Offering.

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to the directors, officers and controlling persons pursuant to the provisions above, or otherwise, we have been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable.

In the event that a claim for indemnification against such liabilities, other than the payment by us of expenses incurred or paid by one of the directors, officers, or controlling persons in the successful defense of any action, suit or proceeding, is asserted by one of the directors, officers, or controlling persons in connection with the securities being registered, we will unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification is against public policy as expressed in the Securities Act, and we will be governed by the final adjudication of such issue.

For determining liability under the Securities Act, to treat the information omitted from the form of prospectus filed as part of this Registration Statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant under Rule 424(b) (1) or (4) or 497(h) under the Securities Act as part of this Registration Statement as of the time the Commission declared it effective.

51 II-2

Table(2)That, for the purpose of Contentsdetermining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(3)To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

(4)That, for the purpose of determining liability under the Securities Act to any purchaser, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

(5)For the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

(i)Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

(ii)Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

(iii)The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

(iv)Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

(b)Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions hereof, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

II-3

 

EXHIBIT INDEX

Exhibit Number Description Form Exhibit Filing Date Filed Herewith
3.1 Amended and Restated Certificate of Incorporation filed October 31, 2022 8-K 3.1 11/01/2022  
3.2 Amended and Restated Bylaws       X
3.3 Certificate of Amendment of Amended and Restated Certificate of Incorporation filed December 19, 2022 8-K 3.1 12/21/2022  
3.4 Class A Super Majority Convertible Preferred Shares Designation filed February 5, 2020 S-1 4.3 07/02/2020  
3.5 Amended Certificate of Designation of Class A Preferred Convertible Stock 8-K 3.1 05/26/2022  
3.6 Certificate of Designation of Class B Convertible Preferred Stock filed October 23, 2023 8-K 3.1 10/26/2023  
3.7 Amended Certificate of Designation of Class B Preferred Convertible Stock    X
4.2 2022 Restricted Stock Plan       X
4.3 2022 Stock Option Plan       X
5.1* Opinion of Lucosky Brookman LLP        
10.1 Manufacturing & Distributorship License Agreement between Limitless X Inc. and Divatrim Inc., dated December 1, 2021 8-K 10.3 05/26/2022  
10.2 Manufacturing & Distributorship License Agreement between Limitless X Inc. and Smilz Inc., dated December 1, 2021 8-K 10.4 05/26/2022  
10.3 Manufacturing & Distributorship License Agreement between Limitless X Inc. and Limitless Performance Inc., dated December 1, 2021 8-K 10.5 05/26/2022  
10.4 Manufacturing & Distributorship License Agreement between Limitless X Inc. and Amarose Inc., dated December 1, 2021 8-K 10.6 05/26/2022  
10.5 Promissory Note between Limitless X, Inc. and Jaspreet Mathur, dated December 6, 2021 8-K 10.7 05/26/2022  
10.6 Promissory Note between Limitless X, Inc. and Jaspreet Mathur, dated February 11, 2022 8-K 10.8 05/26/2022  
10.7 Promissory Note between Limitless X, Inc. and Jaspreet Mathur, dated May 8, 2022 8-K 10.9 05/26/2022  
10.8 Share Exchange Agreement among Bio Lab Naturals, Inc., Limitless X, Inc., and Certain Shareholders, dated May 11, 2022 8-K 2.1 05/26/2022  
10.9 Promissory Note between Limitless X, Inc. and Jaspreet Mathur, dated May 16, 2022 8-K 10.10 05/26/2022  
10.10 Promissory Note between Limitless X, Inc. and Jaspreet Mathur, dated May 18, 2022 8-K 10.11 05/26/2022  
10.11 Amendment to Share Exchange Agreement, dated August 2, 2022 8-K 10.1 08/05/2022  
21.1 List of Subsidiaries       X
23.1 Consent of BF Borgers CPA PC       X
23.2* Consent of Lucosky Brookman LLP (included in Exhibit 5)        
24.1 Power of attorney (see signature page)       X
101.1 Interactive Data File        
107 Calculation of Filing Fee Tables       X

*To be filed by amendment

II-4

 

SIGNATURES

In accordance withPursuant to the requirements of the Securities Act of 1933, the registrant certifies that itRegistrant has reasonable grounds to believe that it meets all of the requirements for filing on Form S-1/A and authorizedduly caused this Registration Statement to be signed on ourits behalf by the undersigned, thereunto duly authorized, in the City of Denver,Beverly Hills, State of Colorado,California, on September 22 , 2020.February 14, 2024.

BIO LAB NATURALS, INC.

/s/ W. Edward NicholsSeptember 22 , 2020LIMITLESS X HOLDINGS, INC.
W. Edward Nichols
(By:/s/ Jaspreet Mathur
Jaspreet Mathur
Chief Executive Officer and Principal Executive Officer)
/s/Darrell AveySeptember 22 , 2020
Darrell Avey
(Chief Financial Officer and Principal Accounting Officer)
Chairman of the Board of Directors

In accordanceKNOW ALL MEN BY THESE PRESENTS, that each of the undersigned constitutes and appoints Jaspreet Mathur his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for such person and in his name, place and stead, in any and all capacities, to sign this Registration Statement on Form S-1 (including all pre-effective and post-effective amendments and registration statements filed pursuant to Rule 462 under the Securities Act of 1933), and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming that any such attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement on Form S-1 has been signed by the following persons in the capacities and on the dates stated.indicated.

SignatureTitleDate
/s/ Jaspreet MathurChief Executive Officer and Chairman of the Board of DirectorFebruary 14, 2024
Jaspreet Mathur(Principal Executive Officer)
/s/ Benjamin ChungChief Financial OfficerFebruary 14, 2024
Benjamin Chung(Principal Financial Officer and Principal Accounting Officer)
/s/ Bharat Raj MathurDirectorFebruary 14, 2024
Bharat Raj Mathur
/s/ Amanda SaccomannoDirectorFebruary 14, 2024
Amanda Saccomanno
/s/ Dov KonetzDirectorFebruary 14, 2024
Dov Konetz
/s/ Leon AndersonDirectorFebruary 14, 2024
Leon Anderson
/s/ Dan FleyshmanDirectorFebruary 14, 2024
Dan Fleyshman
/s/ Michael BraunDirectorFebruary 14, 2024
Michael Braun
/s/ Hassan IddrissuDirectorFebruary 14, 2024
Hassan Iddrissu

II-5

LIMITLESS X HOLDINGS INC.

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

LIMITLESS X HOLDINGS INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

  September 30,
2023
  December 31,
2022
 
  (unaudited)  (audited) 
ASSETS        
         
Current Assets:        
Cash $85,529  $5,843,323 
Accounts receivables, net of allowance for doubtful accounts of $232,374 and $0, respectively  225,484   895,713 
Holdback receivables, net of allowance for doubtful accounts of $0 and $1,300,855, respectively  2,350,060   1,043,991 
Inventories  2,391,451   3,855,946 
Due from related party  2,514   - 
Total current assets  5,055,038   11,638,973 
         
Non-Current Assets:        
Operating lease right-of-use asset, net  -   91,032 
Property and equipment, net  30,526   32,256 
Other assets  57,182   78,965 
Total non-current assets  87,708   202,253 
         
Total assets $5,142,746  $11,841,226 
         
LIABILITIES AND STOCKHOLDERS’ DEFICIT        
         
Current Liabilities:        
Accounts payable and accrued expenses $7,836,967  $2,419,051 
Current portion of operating lease liabilities  -   92,195 
Royalty payable  1,512,552   1,114,403 
Refunds payable  34,673   213,930 
Chargebacks payable  381,640   118,288 
Income tax payable  17,056   17,056 
Note payable  35,000   35,000 
Convertible notes payable  9,675,000   9,175,000 
Current portion of loan payables to shareholder  5,950,845   4,462,028 
Notes payable to stockholder  

5,950,845

   4,462,028 
Notes payable to related parties  80,000   1,247,011 
Notes payable  80,000   1,247,011 
         
Total current liabilities  

25,523,733

   18,893,962 
Operating lease liabilities, less current portion        
Loan payables to shareholder, less current portion        
Total liabilities  25,523,733   18,893,962 
         
Commitments and contingencies  -   - 
         
Stockholders’ deficit        
Preferred Stock - $0.0001 par value; 30,000,000 authorized shares; 500,000 shares issued and outstanding at September 30, 2023 and December 31, 2022  50   50 
Common Stock- $0.0001 par value; 300,000,000 authorized shares; 3,976,998 shares and 3,929,834 issued at September 30, 2023 and December 31, 2022, respectively  399   394 
Additional paid-in-capital  3,107,177   2,966,162 
Retained earnings  

(23,488,613

)  (10,019,342)
Total stockholders’ deficit  

(20,380,987

)  (7,052,736)
         
Total liabilities and stockholders’ deficit $5,142,746  $11,841,226 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

F-1

LIMITLESS X HOLDINGS INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

             
  For the three months ended
September 30,
  For the nine months ended
September 30,
 
  2023  2022  2023  2022 
             
Revenue                
Product sales $1,005,924  $12,114,278  $13,852,451  $27,382,335 
Service revenue  1,261,814   9,378,900   4,058,818   12,344,100 
Rentals  -   2,500   15,000   7,500 
Total revenue  2,267,738   21,495,678   17,926,269   39,733,935 
                 
Cost of sales                
Cost of sales  644,365   3,037,997   3,717,216   5,837,994 
Cost of sales - other  -   -   -   358 
Total cost of sales  644,365   3,037,997   3,717,216   5,838,352 
                 
Gross profit  1,623,373   18,457,681   14,209,053   33,895,583 
                 
Operating expenses:                
General and administrative  (1,129)  660,068   1,051,630   1,089,109 
Advertising and marketing  1,873,612   17,163,099   18,525,288   34,376,380 
Stock compensation for services  -   -   141,020   1,117,782 
Transaction fees  75,050   1,401,892   1,159,896   1,988,718 
Merchant fees  41,370   917,427   1,098,648   1,656,920 
Royalty fees  18,324   472,082   398,149   704,203 
Professional fees  91,642   272,963   1,211,759   940,945 
Payroll and payroll taxes  859,512   258,934   2,931,357   392,605 
Rent  37,609   41,177   123,401   121,570 
Bad debt expense  -   -   232,374   - 
Consulting fees, related party  -   6,000   10,000   38,500 
Total operating expenses  2,995,990   21,193,642   26,883,522   42,426,732 
                 
Loss from operations  (1,372,617)  (2,735,961)  (12,674,469)  (8,531,149)
                 
Other income (expense)                
Interest expense  

(275,856

)  (68,286)  

(731,616

)  (81,394)
Loss on debt settlement  -   -   (142,551)  - 
Other income  -   -   -   57,756 
Other expense  (132,000)  -   (162,000)  - 
Gain on disposal of assets  -   -   -   28,397 
Total other income (expense), net  

(407,856

)  (68,286)  

(1,036,167

)  4,759 
                 
Loss before income taxes  

(1,780,473

)  (2,804,247)  (13,710,636)  (8,526,390)
                 
Income tax provision  (48)  -   -   6,402 
                 
Gain on deconsolidation of subsidiary  -   -   241,365   - 
                 
Net loss $(1,780,425) $(2,804,247) $(13,469,271) $(8,532,792)
                 
Net loss per common share - basic and diluted $(0.45) $(0.74) $(3.41) $(4.28)
                 
Weighted average number of common shares  3,977,497   3,789,565   3,950,911   1,995,073 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

F-2

LIMITLESS X HOLDINGS INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

                             
  Preferred Stock  Common Stock  Additional
Paid-In
  Retained  Total
Stockholders’
 
  Shares  Amount  Shares  Amount  Capital  Earnings  Equity 
                      
Balance at December 31, 2022  500,000  $50   3,929,834  $394 -$2,966,162  $(10,019,342) $(7,052,736)
                             
Issuance of common stock for services  -   -   47,164   5   141,015   -   141,020 
                             
Net loss  -   -   -   - - -   (13,469,271)  (13,469,271)
                             
Balance at September 30, 2023 (unaudited)  500,000  $50   3,976,998  $399 -$3,107,177  $(23,488,613) $(20,380,987)

                             
  Preferred Stock  Common Stock  Additional
Paid-In
  Retained  Total
Stockholders’
 
  Shares  Amount  Shares  Amount  Capital  Earnings  Equity 
                      
Balance at June 30, 2023 (unaudited)  500,000  $50   3,976,998  $399 -$3,107,177  $(21,708,188) $(18,600,562)
                             
Net loss  -   -   -   - - -   (1,780,425)  (1,780,425)
                             
Balance at September 30, 2023 (unaudited)  500,000  $50   3,976,998  $399 -$3,107,177  $(23,488,613) $(20,380,987)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

F-3

LIMITLESS X HOLDINGS INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

                                     
  Preferred Stock  Common Stock  Common Stock
Issuable
  Additional
Paid-In
  Retained  Total
Stockholders’
 
  Shares  Amount  Shares  Amount  Shares  Amount  Capital  Earnings  Equity 
                            
Balance at December 31, 2021  500,000  $50   3,496,150  $350   397,000  $40  $1,848,384  $4,664  $1,853,488 
                                     
Issuance of common stock  -   -   97,000   10   (97,000)  (10)  -   -   - 
                                     
Issuance of common stock issuable  -   -   300,000   30   (300,000)  (30)  -   -   - 
                                     
Issuance of common stock for services  -   -   36,684   4   -   -   1,117,778   -   1,117,782 
                                     
Net loss  -   -   -   -   -   -   -   (8,532,792)  (8,532,792)
                                     
Balance at September 30, 2022  500,000  $50   3,929,834  $394   -  $-  $2,966,162  $(8,528,128) $(5,561,522)

                             
  Preferred Stock  Common Stock  Additional
Paid-In
  Retained  Total
Stockholders’
 
  Shares  Amount  Shares  Amount  Capital  Earnings  Equity 
                      
Balance at June 30, 2022  500,000  $50   3,929,834  $394 -$2,966,162  $(5,723,881) $(2,757,275)
                             
Net loss  -   -   -   - - -   (2,804,247)  (2,804,247)
                             
Balance at September 30, 2022  500,000  $50   3,929,834  $394 -$2,966,162  $(8,528,128) $(5,561,522)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

F-4

LIMITLESS X HOLDINGS INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

         
  For the nine months ended September 30, 
  2023  2022 
Cash flows from operating activities:        
Net loss $

(13,469,271

) $(8,532,792)
         
Adjustments to reconcile net loss to net cash provided by operating activities:        
Depreciation  3,334   3,613 
Common stock issued for professional fees  141,020   1,117,782 
Loss on settlement of debt  142,551   - 
Gain on deconsolidation of subsidiary  (241,365)  - 
Changes in assets and liabilities:        
Accounts receivables, net  192,121   (258,820)
Holdback receivables  (1,306,069)  (2,180,270)
Inventories  868,324   172,813 
Due from related party  (2,514)  - 
Other assets  21,783   (75,811)
Accounts payable and accrued expenses  

5,463,942

   1,967,850 
Refunds payable  (179,257)  165,550 
Royalty payable  398,149   704,203 
Chargebacks payable  263,352   153,969 
Income tax payable        
Net cash used in operating activities  

(7,703,900

)  (6,761,913)
         
Cash flows from investing activities:        
Purchases of equipment  (1,604)  - 
Proceeds from disposition of asset  -   28,397 
Net cash provided by (used in) financing activities  (1,604)  28,397 
         
Cash flows from financing activities:        
Proceeds from convertible debt  500,000   3,585,000 

Proceeds from borrowings from stockholder

  

1,488,817

   3,672,028 
Proceeds from borrowings from related parties  -   317,610 
 Proceeds from borrowing        
Shareholders’ contributions        
Net cash provided by financing activities  

1,988,817

   7,574,638 
         
Net increase (decrease) in cash  (5,716,687)  841,122 
         
Deconsolidation - Cash  (41,107)  - 
         
Cash – beginning of period  5,843,323   78,856 
         
Cash – end of period $85,529  $919,978 
         
Supplemental disclosures of cash flow information        
Cash paid during the periods for:        
Interest $2,334  $1,125 
Income taxes $-  $- 
         
Non-cash investing and financing activities:        
Due to Emblaze One, Inc. by Limitless X $1,167,011  $- 
Due from Vybe Labs, Inc. by Limitless X $(1,356,750) $- 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

F-5

LIMITLESS X HOLDINGS INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 1 – Organization and History

On May 11, 2022, Bio Lab Naturals, Inc., a Delaware corporation (“Bio Lab”), entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with Limitless X, Inc., a Nevada corporation (“LimitlessX”), and its 11 shareholders (the “LimitlessX Acquisition”). The parties completed and closed the LimitlessX Acquisition on May 20, 2022 by issuing an aggregate of 3,233,334 shares of common stock of Bio Lab to the LimitlessX shareholders (the “Acquisition Closing”). According to the terms of the Share Exchange Agreement, Bio Lab then issued an additional 300,000 shares of common stock to the LimitlessX shareholders pro rata to their interests approximately six months from the Acquisition Closing as part of the LimitlessX Acquisition. Concurrently with the LimitlessX Acquisition, Jaspreet Mathur, the founder and principal shareholder of LimitlessX, also purchased from Helion Holdings LLC, 500,000 shares of Bio Lab’s Class A Preferred Convertible Stock, which at all times have a number of votes equal to 60% of all of the issued and outstanding shares of common stock of Bio Lab.

On June 10, 2022, Bio Lab changed its name to Limitless X Holdings Inc. (“Limitless”).

The LimitlessX Acquisition was accounted for as a “reverse merger” following the completion of the transaction. For accounting purposes, LimitlessX was deemed to be the accounting acquirer in the transaction and, consequently, the transaction was treated as a recapitalization of Bio Lab. Accordingly, LimitlessX’s assets, liabilities, and results of operations became the historical financial statements of the registrant. No step-up in basis or intangible assets or goodwill was recorded in this transaction.

The Company (as defined below) is a lifestyle brand, focused in the health and wellness industry. Initially, the Company focused on nutritional supplements, wellness studies, and interactive training videos and has since focused its business on performance marketing, sales of digital services, and sales of products. The Company’s mission is to provide businesses a turnkey solution to sell their products. Company teams include sales, marketing, user interface design (UI), user experience design (UX), fulfillment, customer support, labeling, product manufacturing, consulting, retailing, and payment processing, among others.

The Company currently offers products online only. The Company has manufacturing and distribution licensing agreements to market, manufacture, sell, and distribute branded products on behalf of its clients. The Company orders products from third party partner manufacturers that make the products according to the Company’s custom formulations, and brands them using the Company’s licensed trademarks. Products are then marketed and sold direct to consumers online. Orders are fulfilled and shipped directly from the Company’s licensors. The Company plans to offer global marketing services across all areas of the sales process, including market research, brand and product development, and digital advertising operating as an integrated marketing agency.

The Company operates in the following product and service sectors: (i) health products and (ii) digital marketing services. The health products sector included the sales of health products in two primary vertical markets: (1) health & wellness; and (2) beauty & skincare. The digital marketing service sector includes digital marketing; digital and print design; social media marketing; and direct-to-consumer marketing.

Note 2 – Summary of Significant Accounting Policies

Principles of Consolidation and Reporting

The accompanying consolidated financial statements include the accounts of Limitless X Holdings Inc. (a holding company) and its wholly owned operating subsidiaries: Limitless X, Inc. and Prime Time Live, Inc. (collectively, the “Company”). All intercompany balances have been eliminated during consolidation.

F-6

Use of Estimates in the Preparation of Consolidated Financial Statements

The preparation of consolidated financial statements in conformity with generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Estimates also affect the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all liquid investments purchased with an initial maturity of three months or less to be cash equivalents. Cash and cash equivalents include demand deposits carried at cost which approximates fair value. The Company maintains its cash in institutions insured by the Federal Deposit Insurance Corporation (“FDIC”).

Concentration of Credit Risk

The Company offers its products and services to a large number of customers. The risk of non-payment by these customers is considered minimal and the Company does not generally obtain collateral for sales. The Company continually monitors the credit standing of its customers.

Accounts Receivable, net

Accounts receivable, net consists primarily of trade receivables, net of allowances for doubtful accounts. The Company sells its products for cash or on credit terms, which are established in accordance with local and industry practices and typically require payment within 30 days of delivery. The Company estimates its allowance for doubtful accounts and the related expected credit loss based upon the Company’s historical credit loss experience, adjusted for asset-specific risk characteristics, current economic conditions, and reasonable forecasts. Accounts receivables are written off when determined to be uncollectible. For the nine months ended September 30, 2023, the Company required an allowance for doubtful accounts of $232,374.

Holdback Receivables

The Company primarily sells its products online using various third party sales affiliates. These affiliates (online marketing campaign companies) are paid certain commission based on their ability to provide the Company’s products through online sales. All payments are processed through various gateways and are settled through the Company’s payment gateway settler. The Company payment gateway settler is not responsible for settlements that are not paid due to processing bank failure. The Company holds responsibility for all the risk in all transactions and processing systems. The payment gateway settler charges a reserve fee to mitigate the risk on their end for any loss of funds or damages.

Distributions of the holdback receivables from the third-party payment gateway settler are based on several criteria, such as return and chargeback history, associated risk for the specific business vertical, average transaction amount, and so on. In order to mitigate processing risks, there are policies regarding reserve requirements and payment in arrears in place.

The total holdback receivables balance reflects the 0 to 10% reserve on gross sales and additional reserves by the third-party processor for additional returns and chargebacks if needed. Based on aging of the holdback receivables, the Company has determined that an allowance for doubtful accounts of $1,300,855 or 55% of holdback receivables should be deemed uncollectible recorded as bad debt expense. Thus, the adjusted holdback receivables balance was $1,043,991 as of December 31, 2022. As of September 30, 2023, the holdback receivables balance was $2,350,060.

Inventories

Inventories are valued at the lower of cost or net realizable value on a first-in, first-out basis, adjusted for the value of inventory that is determined to be excess, obsolete, expired, or unsaleable. Inventories primarily consisted of finished goods.

F-7

Advertising and Marketing

Advertising and marketing costs are charged to expense as incurred. Advertising and marketing costs were approximately $18,525,288 and $34,376,380 for the nine months ended September 30, 2023 and 2022, respectively, and are included in operating expenses in the accompanying statement of income.

Property and Equipment

Property and equipment are recorded at cost and consists of screen video and related equipment. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation of property and equipment is over the estimated useful life of five to ten years using the straight-line method for consolidated financial statement purposes.

Schedule of Equipment

  September 30,  December 31, 
  2023  2022 
       
Machinery and equipment $39,067  $37,463 
Total  39,067   37,463 
         
Less: accumulated depreciation  (8,541)  (5,207)
         
Total property and equipment, net $30,526  $32,256 

Depreciation expense for the three months ended September 30, 2023 and 2022 was $1,117 and $1,036, respectively. Depreciation expense for the nine months ended September 30, 2023 and 2022 was $3,334 and $4,649, respectively.

Revenue Recognition

Product Sales

The Company recognizes revenue when performance obligations under the terms of a contract with a customer are satisfied. The Company has determined that fulfilling and delivering products is a single performance obligation. Revenue is recognized at the point in time when the Company has satisfied its performance obligation and the customer has obtained control of the products. This generally occurs when the product is delivered to or picked up by the customer based on applicable shipping terms, which is typically within 15 days. Revenue is measured as the amount of consideration expected to be received in exchange for fulfilled product orders.

Customer remedies for defective or non-conforming products may include a refund or exchange. As a result, the right of return is estimated and recorded as a reduction in revenue at the time of sale, if necessary.

The Company’s customer contracts identify product quantity, price, and payment terms. Payment terms are granted consistent with industry standards. Although some payment terms may be extended, the majority of the Company’s payment terms are less than 30 days. As a result, revenue is not adjusted for the effects of a significant financing component. Amounts billed and due from customers are classified as Accounts Receivables on the Balance Sheet.

The Company utilizes third-party contract manufacturers for the manufacture of its products. The Company has evaluated whether it is the principal or agent in these relationships. The Company has determined that it is the principal in all cases as it retains the responsibility for fulfillment and risk of loss, as well as for establishing the price.

In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers, the Company has elected the practical expedient to expense the incremental costs to obtain a contract, because the amortization period would be less than one year, and the practical expedient for shipping and handling costs. Shipping and handling costs incurred to deliver products to customers are accounted for as fulfillment activities, rather than a promised service, and as such are included in Cost of Goods Sold in the Statements of Operations.

F-8

Service Revenue

Service revenue consists of digital marketing revenue.

Revenue related to digital marketing is recognized over time as services are provided to the customer. The Company sells digital marketing, digital and print design, social media marketing, and direct-to-consumer marketing and thus uses standalone selling prices as the basis for revenue. Payment for digital marketing services is typically received at the point when control transfers to the customer or in accordance with payment terms customary to the business. There was no deferred revenue related to services revenue as of September 30, 2023 and December 31, 2022.

Cost of Sales

Cost of sales includes the cost of inventory sold during the period, as well as commission fees, returns, chargebacks, distribution, and shipping and handling costs. The amount shown is net of various rebates from third-party vendors in the form of payments.

Refunds Payable

If customers are not satisfied for any reason, they may request a full refund, processed to the original form of payment, within 30 days from the order date. If the order has already been shipped, the Company charges a 20% restocking fee. The Company’s estimate of the reserve is based upon the Company’s most historical experience of actual customer returns.

As of September 30, 2023 and December 31, 2022, refunds payable were $34,673 and $213,930, respectively.

Chargebacks Payable

Once customers successfully dispute chargebacks with the payment processor, the Company returns such funds to the payment processor to return to the customer.

As of September 30, 2023 and December 31, 2022, chargebacks payable were $381,640 and $118,288, respectively.

Other Comprehensive Loss

The Company has no material components of other comprehensive loss and accordingly, net loss is equal to comprehensive loss for the period.

Convertible Debt

Convertible debt – derivative treatment – When the Company issues debt with a conversion feature, it must first assess whether the conversion feature meets the requirements to be treated as a derivative, as follows: a) one or more underlying terms, typically the price of the Company’s common stock; b) one or more notional amounts or payment provisions or both, generally the number of shares upon conversion; c) no initial net investment, which typically excludes the amount borrowed; and d) net settlement provisions, which in the case of convertible debt generally means the stock received upon conversion can be readily sold for cash. An embedded equity-linked component that meets the definition of a derivative does not have to be separated from the host instrument if the component qualifies for the scope exception for certain contracts involving an issuer’s own equity. The scope exception applies if the contract is both a) indexed to its own stock; and b) classified in shareholders’ equity in its statement of financial position.

If the conversion feature within convertible debt meets the requirements to be treated as a derivative, the Company estimates the fair value of the convertible debt derivative using the Black Scholes method upon the date of issuance. If the fair value of the convertible debt derivative is higher than the face value of the convertible debt, the excess is immediately recognized as interest expense. Otherwise, the fair value of the convertible debt derivative is recorded as a liability with an offsetting amount recorded as a debt discount, which offsets the carrying amount of the debt. The convertible debt derivative is revalued at the end of each reporting period and any change in fair value is recorded as a gain or loss in the Consolidated Statement of Operations. The debt discount is amortized through interest expense over the life of the debt.

F-9

If the conversion feature does not qualify for derivative treatment, the convertible debt is treated as traditional debt.

Income Taxes

The accounting standard on accounting for uncertainty in income taxes addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under that guidance, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.

Earnings (Loss) per Share

The Company calculates earnings per share in accordance with Financial Accounting Standards Board (“FASB”) ASC 260, Earnings Per Share, which requires a dual presentation of basic and diluted earnings per share. Basic earnings per share are computed using the weighted average number of shares outstanding during the fiscal year. There were 1,336,163 shares of common stock underlying convertible promissory notes during the nine months ended September 30, 2023 that were not included in the computation of diluted Earnings Per Share for the same period, as the inclusion would have been antidilutive, given the Company’s net loss.

Equity Based Payments

The Company accounts for equity-based payment accruals under authoritative guidance as set forth in the Topics of the ASC. The guidance requires all equity-based payments to employees and non-employees, including grants of employee and non-employee stock options and warrants, to be recognized in the consolidated financial statements based at their fair values. The Company applies the provisions of ASC 718, “Compensation - Stock Compensation,” using a modified prospective application, and the Black-Scholes model to value stock options. Under this application, the Company records compensation expense for all awards granted. Compensation costs will be recognized over the period that an employee provides service in exchange for the award. During the nine months ended September 30, 2023 and 2022, the Company granted no securities under its 2020 Stock Incentive Plan, 2022 Restricted Stock Plan, and 2022 Stock Option Plan.

General Concentrations of Risk

Financial instruments that potentially subject the Company to concentrations of credit risk are accounts receivable and other receivables arising from its normal business activities. The Company has a diversified customer base. The Company controls credit risk related to accounts receivable through credit approvals, credit limits, and monitoring procedures. The Company routinely assesses the financial strength of its customers and, based upon factors surrounding the credit risk, establishes an allowance, if required, for uncollectible accounts and, as a consequence, believes that its accounts receivable related credit risk exposure beyond such allowance is limited.

The Company purchases merchandise from six suppliers, and the Company’s three largest suppliers accounted for 95% of total purchases for the year ended December 31, 2022. A significant portion of the Company’s inventory is manufactured in Asia. Foreign imports subject the Company to the risks of changes in, or the imposition of new, import tariffs, duties or quotas, new restrictions on imports, loss of “most favored nation” status with the United States for a particular foreign country, antidumping or countervailing duty orders, retaliatory actions in response to illegal trade practices, work stoppages, delays in shipment, freight expense increases, product cost increases due to foreign currency fluctuations or revaluations, public health issues that could lead to temporary closures of facilities or shipping ports, and other economic uncertainties. If a disruption of trade were to occur from the countries in which the suppliers of the Company’s vendors are located, the Company may be unable to obtain sufficient quantities of products to satisfy its requirements, or the cost of obtaining products may increase.

F-10

A substantial amount of the Company’s inventory is manufactured in Asia. From time to time, shipping ports experience capacity constraints, labor strikes, work stoppages, or other disruptions that may delay the delivery of imported products. A contract dispute may lead to protracted delays in the movement of the Company’s products, which could further delay the delivery of products to the Company’s online stores and impact net sales and profitability. In addition, other conditions outside of the Company’s control, such as adverse weather conditions or acts of terrorism or war, could significantly disrupt operations at shipping ports or otherwise impact transportation of the imported merchandise the Company sells, either through supply chain disruptions or rising freight and fuel costs.

Operating Lease

In accordance with ASC 842, Leases, the Company determines whether an arrangement contains a lease at inception. A lease is a contract that provides the right to control an identified asset for a period of time in exchange for consideration. For identified leases, the Company determines whether it should be classified as an operating or finance lease. Operating leases are recorded in the balance sheet as: right-of-use asset (“ROU asset”) and operating lease liability. ROU asset represents the Company’s right to use an underlying asset for the lease term and lease liability represents the Company’s obligation to make lease payments arising from the lease. ROU assets and operating lease liabilities are recognized at the commencement date of the lease and measured based on the present value of lease payments over the lease term. The ROU asset also includes deferred rent liabilities. The Company’s lease arrangements generally do not provide an implicit interest rate. As a result, in such situations the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company includes options to extend or terminate the lease when it is reasonably certain that it will exercise that option in the measurement of its ROU asset and liability. Lease expense for the operating lease is recognized on a straight-line basis over the lease term. The Company has a lease agreement with lease and non-lease components, which are accounted for as a single lease component.

Recent Accounting Pronouncements

In December 2019, FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which amends existing guidance related to the accounting for income taxes. This ASU is intended to simplify the accounting for income taxes by removing certain exceptions to the general principles of accounting for income taxes and to improve the consistent application of GAAP for other areas of accounting for income taxes by clarifying and amending existing guidance. This ASU is effective for fiscal years beginning after December 15, 2020. The Company is currently evaluating the effects the adoption of this guidance will have on the financial statements and does not expect that the adoption of this ASU will be material to its financial statements.

F-11

Note 3 – Deconsolidation (Sale of Vybe Labs, Inc.)

On June 1, 2023, the Company entered into an Agreement for Purchase and Sale of Stock (the “Vybe Sale Agreement”) with Emblaze One, Inc., a Nevada corporation, (“Emblaze”) wherein the Company sold all 5,000 of its shares of common stock of its wholly owned subsidiary, Vybe Labs, Inc., a Delaware corporation (“Vybe”). Emblaze is a company 100% owned by the Company’s Chief Executive Officer, Chairman of the Board of Directors, and majority shareholder, Jaspreet Mathur.

The transaction is recorded as follows at the date of this transaction:

Schedule of Deconsolidation

  June 1, 
  2023 
    
Total assets and liabilities deconsolidated for Vybe:    
Total assets $1,156,733 
Total liabilities  (1,356,750)
     
Net assets (liabilities) $(241,365)
     
Net amount of deconsolidation – Recorded as a Gain on Deconsolidation of Subsidiary $241,365 

Note 4 – Fair Value Measurements

The Company utilizes ASC 820-10, Fair Value Measurement and Disclosure, for valuing financial assets and liabilities measured on a recurring basis. Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. The guidance also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability. The guidance establishes three levels of inputs that may be used to measure fair value:

Level 1.Observable inputs such as quoted prices in active markets;
Level 2.Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
Level 3.Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

The carrying value of financial assets and liabilities recorded at fair value is measured on a recurring or nonrecurring basis. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. There were no financial assets or liabilities carried and measured on a nonrecurring basis during the reporting periods. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. There have been no transfers between levels.

F-12

Note 5 – Commitments and Contingencies

Commitments

Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Generally, the implicit rate of interest in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The operating lease ROU asset includes any lease payments made and excludes lease incentives. The Company’s variable lease payments primarily consist of maintenance and other operating expenses from their real estate leases. Variable lease payments are excluded from the ROU assets and lease liabilities and are recognized in the period in which the obligation for those payments is incurred. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.

Contingencies

From time to time, the Company may be involved in certain legal actions and claims arising in the normal course of business. Management is of the opinion that such matters will be resolved without material effect on the Company’s financial condition or results of operations.

In accordance with ASC 842, the components of lease expense were as follows:

Schedule of Lease Cost

In accordance with ASC 842, other information related to leases was as follows:

Schedule of Other information Related to Leases

In accordance with ASC 842, maturities of operating lease liabilities as of December 31, 2022 were as follows:

Schedule of Maturities of Operating Lease Liabilities

Note 6 – Note Payable

On March 1, 2021, an individual loaned Prime Time Live, Inc. $35,000 in exchange for an unsecured promissory note, with interest at a rate of 10% per annum, and a maturity date of March 1, 2022, which was then extended to May 31, 2023. Interest is due and payable on the first day of each month. As of September 30, 2023 and December 31, 2022, the balance was $35,000 and $35,000, respectively.

F-13

Note 7 – Convertible Notes Payable

Convertible notes payable consisted of the following:

Schedule of Convertible Note Payables

  September 30,  December 31, 
  2023  2022 
       
August 3, 2022 ($5,000,000) $5,000,000  $5,000,000 
August 3, 2022 ($1,000,000)  1,000,000   1,000,000 
August 22, 2022 ($500,000)  500,000   500,000 
September 22, 2022 ($250,000)  250,000   250,000 
September 25, 2022 ($600,000)  600,000   600,000 
September 25, 2022 ($600,000)  600,000   600,000 
September 29, 2022 ($50,000)  50,000   50,000 
September 29, 2022 ($500,000)  500,000   500,000 
October 10, 2022 ($500,000)  500,000   500,000 
October 13, 2022 ($750,000)  75,000   75,000 
October 13, 2022 ($50,000)  50,000   50,000 
October 14, 2022 ($50,000)  50,000   50,000 
January 4, 2023 ($500,000)  500,000   - 
         
Total convertible notes payable (current) $9,675,000  $9,175,000 

From August 3, 2022 through January 4, 2023, the Company conducted a convertible note offering for a maximum offering of $15,000,000 and a minimum of $2,000,000 (the “Convertible Note Offering”).

Pursuant to the terms of the Convertible Note, the principal amount of the Note that may be outstanding from time to time bears interest per annum until paid in full at a rate equal to 6%, compounded annually. The principal and interest of the Note was due and payable to the noteholder on the one-year anniversary of the date of the Note (the “Maturity Date”) unless all principal and interest due under the Note had been converted by the Maturity Date.

The conversion price was equal to $0.25 per share of common stock. The Notes had an automatic conversion upon the date of effectiveness of registration of the Notes on a registration statement filed with the Securities and Exchange Commission (the “SEC”), and were subject to a 4.99% beneficial ownership limitation. The Notes were convertible into shares of common stock at the option of the Noteholder at any time prior to the Maturity Date.

The Company analyzed the conversion option in the Notes for derivative accounting treatment under ASC Topic 815, “Derivatives and Hedging,” and determined that the instruments do not qualify for derivative accounting.

As of December 31, 2022, the Company received $9,175,000 from a total of 12 accredited investors pursuant to the Convertible Note Offering.

As of September 30, 2023, the Company received $9,675,000 from a total of 13 accredited investors pursuant to the Convertible Note Offering.

On October 1, 2023, the Company entered into Conversion Agreements with each of the convertible noteholders to convert their respective notes into shares of Class B Preferred Stock. Pursuant to the Conversion Agreements, each noteholder agreed to receive one share of Class B Stock for each $2.00 of principal and unpaid interest accrued through the closing date of the Conversion Agreement. As of the closing date of the Conversion Agreement, and each of them, no portion of any of the Notes had been converted into shares of the Company’s common stock.

F-14

Note 8 – Loss on Settlement of Debt

On June 1, 2023, the Company agreed to a settlement of a debt in the amount of $1,167,011 and interest payable of $47,188 owed by the Company to Emblaze, a related party, under two Loan Authorization and Agreements dated April 1, 2022 and December 31, 2022, in the principal amounts of $237,610 and $929,401, respectively, and interest payable of $10,012 and $37,176, respectively, as part of the Vybe Sales Agreement with Emblaze.

The transaction is recorded as follows at the date of this transaction:

Schedule of Deconsolidation on Loss on Settlement of Debt

  June 1, 
  2023 
    
Total due to and due from between Limitless X and Vybe before deconsolidation:    
Due to Emblaze One, Inc. by Limitless X $1,167,011 
Interest payable  47,188 
Due from Vybe Labs, Inc. by Limitless X  (1,356,750)
     
Net due to (from) $(142,551)
     
Net amount of deconsolidation – Recorded as a Loss on Settlement of Debt $142,551 

Note 9 – Stockholders’ Deficit

Common Stock

As of September 30, 2023, the Company has 300,000,000 authorized shares of common stock par value $0.0001 per share. At September 30, 2023 and December 31, 2022, there was a total of 3,976,998 shares and 3,929,834 shares issued and outstanding, respectively.

Common Stock Issued for Services

On May 10, 2022 and June 10, 2022, the Company issued 36,000 and 684 shares of common stock, respectively, for services provided to the Company. These shares were valued at fair value at the time of issuance. On May 31, 2023, the Company issued 47,164 shares of common stock for services provided to the Company.

Preferred Stock

As of September 30, 2023, the Company has authorized 30,000,000 shares of preferred stock, 500,000 shares of which were designated as Class A Convertible Preferred Stock (“Class A Preferred Stock”).

Class A Convertible Stock

At September 30, 2023 and December 31, 2022, there were a total of 500,000 shares of Class A Preferred Stock issued and outstanding. The Class A Preferred Stock, when voting as a single class, have the votes of at least 60% of the voting power of the Company. Further, the holder of the Class A Preferred Stock can convert one share of Class A Preferred Stock into two shares of the Company’s common stock, subject to adjustment. In addition, the holder of the Class A Preferred Stock is entitled to a liquidation preference of the Company senior to all other securities of the Company.

Class B Convertible Stock

On October 23, 2023, pursuant to certain Conversion Agreements, the Company planned to issue an aggregate of 10,349,097 shares of Class B Preferred Stock before the completion of this offering and extinguish $9,675,000 of convertible debt including accumulated interest as of October 23, 2023 in the amount of $674,097. The holders of the Class B Preferred Stock are entitled to a liquidation preference senior to common stock and junior to the Class A Preferred Stock at a liquidation price of $3.00 per share of Class B Preferred Stock. The Class B Preferred Stock also has conversion rights, whereby each share of Class B Preferred Stock is convertible into two shares of Common Stock in the discretion of the holder, subject to beneficial ownership limitations. The holders of the Class B Preferred Stock have no voting rights, unless otherwise provided for in its Certificate of Designation or by law.

Schedule of Reconciliation of Restated Common Stock

F-15

Note 10 – Equity Based Payments

The Company accounts for equity-based payment accruals under authoritative guidance as set forth in the Topics of the ASC. The guidance requires all equity-based payments to employees and non-employees, including grants of employee and non-employee stock options and warrants, to be recognized in the consolidated financial statements based at their fair values.

Stock Incentive Plans

Effective January 15, 2020, the Company adopted its 2020 Stock Option and Award Plan (the “2020 Stock Incentive Plan”). A total of 2,222 shares of the Company’s common stock were reserved for the 2020 Stock Incentive Plan. As of September 30, 2023, there were no grants made under the 2020 Stock Incentive Plan. On May 4, 2023, the Company terminated the 2020 Stock Incentive Plan.

Effective August 9, 2022, the Company adopted its 2022 Incentive and Nonstatutory Stock Option Plan (the “2022 Stock Option Plan”). Under the 2022 Stock Option Plan, the Board of Directors may grant options to purchase common stock to officers, employees, and other persons who provide services to the Company. A total of 833,333 shares of the Company’s common stock is reserved for the 2022 Stock Option Plan. As of September 30, 2023, there have been no options to purchase shares of common stock granted under the 2022 Stock Option Plan.

Effective August 9, 2022, the Company adopted its 2022 Restricted Stock Plan (the “2022 Restricted Stock Plan”). Under the 2022 Restricted Stock Plan, the Board of Directors may grant restricted stock to officers, directors, and key employees. A total of 833,333 shares of common stock is reserved for the 2022 Restricted Stock Plan. As of September 30, 2023, there have been no shares of common stock granted under the 2022 Restricted Stock Plan.

Note 11 – Related Party Transactions

Consulting Fees

During the three and nine months ended September 30, 2023, the Company incurred consulting fees in the amount of $0 and $10,000, respectively, to an officer and an officer of one of its affiliates. This compares to $6,000 and $38,500 for the three and nine months ended September 30, 2022, respectively.

F-16

Royalty Payables

Limitless Performance Inc. (“LPI”), SMILZ INC. (“Smiles”), DIVATRIM INC. (“Divatrim”), and AMAROSE INC. (“Amarose,” and collectively with LPI, Smiles, and Divatrim, the “Licensors”) are all companies at least 50% owned by a shareholder of the Company. On December 1, 2021, the Company entered into manufacturing and distributorship license agreements (each, a “License Agreement”) with each of the Licensors to distribute each of the Licensors’ respective products and for payments to such Licensor for its product designs and distribution rights. Pursuant to the License Agreements, and each of them, the Company agreed to pay to such Licensors royalty payments equal to 4.00% of gross sales, excluding returns, chargebacks, and other such allowances.

The Company was required to start paying all earned royalties to each of the Licensors beginning on June 15, 2022. As of September 30, 2023 and December 31, 2022, the royalty payable is in the amount of $1,512,552 and $1,114,403, respectively.

On October 1, 2023, the Company terminated each of the License Agreements; however, the Company maintained its license for NZT-48 with LPI.

Notes payable to stockholder:

Schedule of Note Payables to Related Party Transaction

  September 30,  December 31, 
  2023  2022 
       
December 6, 2021 ($50,000) $50,000  $50,000 
February 11, 2022 ($150,000)  150,000   150,000 
May 8, 2022 ($550,000)  550,000   550,000 
May 9, 2022 ($1,100,000)  1,100,000   1,100,000 
May 16, 2022 ($450,000)  450,000   450,000 
June 1, 2022 ($500,000)  500,000   500,000 
June 30, 2022 ($922,028)  922,028   922,028 
August 25, 2022 ($290,000)  290,000   290,000 
November 15, 2022 ($450,000)  450,000   450,000 
May 16, 2023 ($150,000)  150,000   - 
May 18, 2023 ($50,000)  50,000   - 
June 5, 2023 ($150,000)  150,000   - 
June 20, 2023 ($50,000) – Funding Commitment  50,000   - 
July 13, 2023 ($50,000) – Funding Commitment  50,000   - 
August 1, 2023 ($190,000) – Funding Commitment  190,000   - 
August 7, 2023 ($50,000) – Funding Commitment  50,000   - 
September 30, 2023 ($660,000) – Funding Commitment  

660,000

   - 
September 30, 2023 ($138,817)  

138,817

   - 
Total notes payable to stockholder (current) $

5,950,845

  $4,462,028 

December 6, 2021 – $50,000

On December 6, 2021, the Company entered into a Loan Authorization and Agreement for a loan of $50,000 from a shareholder, the proceeds of which were used to be used for working capital purposes. As of September 30, 2023 and December 31, 2022, the principal balance was $50,000 and $50,000, respectively. Beginning on June 1, 2022, the loan required a payment of $4,303 per month, which included principal and interest with an interest rate of 6 % per annum. The total balance of principal and interest of $51,640 was due on May 1, 2023.

February 11, 2022 – $150,000

On February 11, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $150,000 from a shareholder, the proceeds of which were to be used for working capital purposes. As of September 30, 2023 and December 31, 2022, the principal balance was $150,000 and $150,000, respectively. Beginning on June 1, 2022, the loan required a payment of $12,910 per month, which included principal and interest with an interest rate of 6% per annum. The total balance of principal and interest of $154,920 was due on May 1, 2023.

F-17

May 8, 2022 – $550,000

On May 8, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $550,000 from a shareholder, the proceeds of which were to be used for working capital purposes. As of September 30, 2023 and December 31, 2022, the principal balance was $550,000 and $550,000, respectively. Beginning on June 1, 2022, the loan required a payment of $47,337 per month, which included principal and interest with an interest rate of 6% per annum. The total balance of principal and interest of $568,038 was due on May 1, 2023.

May 16, 2022 – $1,100,000

On May 16, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $1,100,000 from a shareholder, the proceeds of which were to be used for working capital purposes. As of September 30, 2023 and December 31, 2022, the principal balance was $1,100,000 and $1,100,000, respectively. Interest began accruing at the rate of 8.5% per annum on June 17, 2022 and was due on May 16, 2023.

May 18, 2022 – $450,000

On May 18, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $450,000 from a shareholder, the proceeds of which were to be used for working capital purposes. As of September 30, 2023 and December 31, 2022, the principal balance was $450,000 and $450,000, respectively. Interest began accruing at the rate of 8.5% per annum on June 19, 2022 and was due on May 18, 2023.

June 1, 2022 – $500,000

On June 1, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $500,000 from a shareholder, the proceeds of which were to be used for working capital purposes. As of September 30, 2023 and December 31, 2022, the principal balance was $500,000 and $500,000, respectively. Beginning on August 1, 2022, the loan required a payment of $43,494 per month, which included principal and interest with an interest rate of 8% per annum. The total balance of principal and interest of $521,931 was due on July 1, 2023.

September 30, 2022 – $922,028

On June 30, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $922,028 from a shareholder, the proceeds of which were to be used for working capital purposes. As of September 30, 2023 and December 31, 2022, the principal balance was $922,028 and $922,028, respectively. Beginning on August 1, 2022, the loan required a payment of $80,206 per month, which included principal and interest with an interest rate of 8% per annum. The total balance of principal and interest of $962,469 was due on August 1, 2023.

August 25, 2022 – $290,000

On August 25, 2022, the Company entered into a Loan Authorization Agreement for a loan of $290,000 from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of 10% per annum and is due on demand. As of September 30, 2023 and December 31, 2022, the principal balance was $290,000 and $290,000, respectively.

November 15, 2022 – $450,000

On November 15, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $450,000 from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of 10% per annum and is due on demand. As of September 30, 2023 and December 31, 2022, the principal balance was $450,000 and $450,000, respectively.

F-18

May 16, 2023 – $150,000

On May 16, 2023, the Company entered into a Loan Authorization and Agreement for a loan of $150,000 from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of 10% per annum and is due on demand. As of September 30, 2023, the principal balance was $150,000.

May 18, 2023 – $50,000

On May 18, 2023, the Company entered into a Loan Authorization and Agreement for a loan of $50,000 from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of 10% per annum and is due on demand. As of September 30, 2023, the principal balance was $50,000.

June 5, 2023 – $150,000

On June 5, 2023, the Company entered into a Loan Authorization and Agreement for a loan of $150,000 from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of 10% per annum and is due on demand. As of September 30, 2023, the principal balance was $150,000.

September 30, 2023 – $138,817

On September 30, 2023, the Company entered into a Loan Authorization and Agreement for a loan of $138,817 from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of 10% per annum and is due on demand. As of September 30, 2023, the principal balance was $138,817.

Funding Commitment Agreement

On June 3, 2023, the Company entered into a Funding Commitment Agreement (the “Funding Commitment”) with its Chief Executive Officer and Chairman of the Board of Directors, Jaspreet Mathur, wherein Mr. Mathur committed to provide up to $1,000,000 of working capital to the Company over the next six months. Mr. Mathur agreed to the Funding Commitment in exchange for a one year convertible promissory note for each drawdown amount advanced to the Company with an annual interest rate of 10% and a balloon payment of principal and interest due at maturity, unless Mr. Mathur elects to convert the outstanding principal and interest into Class B Preferred Stock of the Company at the conversion price of $1.50 per share; provided, however, Mr. Mathur may only covert each note within the term of the Funding Commitment, in the event of the occurrence of the earlier of a public offering of securities of the Company pursuant to a registration statement filed with the SEC and declared effective pursuant to the Securities Act of 1933, upon completion of which the Company has a class of stock registered under the Securities Exchange Act of 1934 and that stock is listed on a national stock exchange, or a liquidation, merger, acquisition, sale of voting control or sale of substantially all of the assets of the Company in which the shareholders of the Company do not own a majority of the outstanding shares of the surviving corporation. For the avoidance of doubt, a national stock exchange includes Nasdaq, NYSE, and NYSE American, but excludes any over-the-counter quotation systems or trading platforms. The balance of the Funding Commitment are as follows:

Schedule of Funding Commitment

  September 30, 
  2023 
    
June 20, 2023 ($50,000) $50,000 
July 13, 2023 ($50,000)  50,000 
August 1, 2023 ($190,000)  190,000 
August 7, 2023 ($50,000)  50,000 
September 30, 2023 ($660,000)  660,000 
Total Funding Commitment $1,000,000 

As of September 30, 2023, the balance of the Funding Commitment was $1,000,000.

Notes payables to related parties:

Schedule of Note Payables to Related Party Transaction

  September 30,  December 31, 
  2023  2022 
       
April 1, 2022 ($237,610) $-  $237,610 
May 10, 2022 ($12,500)  12,500   12,500 
May 10, 2022 ($12,500)  12,500   12,500 
May 10, 2022 ($20,000)  20,000   20,000 
May 31, 2022 ($5,000)  5,000   5,000 
May 31, 2022 ($15,000)  15,000   15,000 
June 9, 2022 ($15,000)  15,000   15,000 
December 31, 2022 ($929,401)  -   929,401 
         
Total notes payable to related parties (current) $80,000  $1,247,011 

F-19

April 1, 2022 – $237,610

On April 1, 2022, Limitless X entered into a Loan Authorization and Agreement for a loan of $237,610 with Emblaze, the proceeds of which were to be used for working capital purposes. Beginning on September 1, 2022, the loan required a payment of $20,669 per month, which included principal and interest. The total balance of principal and interest of $248,032 was due on August 1, 2023. As of September 30, 2023 and December 31, 2022, the balance was $0 and $237,610, respectively.

On June 1, 2023, the Company entered into an Agreement for Purchase and Sale of Stock with Emblaze, wherein the Company sold all 5,000 of its shares of common stock of its wholly owned subsidiary, Vybe Labs, to Emblaze as full payment and settlement of the loan for the principal amount of $237,610 owed by the Company to Emblaze.

May 10, 2022 - $12,500

On May 10, 2022, a related party of the Company loaned Prime Time Live, Inc. $12,500 in exchange for a promissory note that includes interest at the rate of 10% per annum on the unpaid principal balance, with all unpaid principal and interest due on or before May 10, 2023. Interest began accruing on May 10, 2022. As of September 30, 2023 and December 31, 2022, the principal balance was $12,500 and $12,500, respectively.

May 10, 2022 - $12,500

On May 10, 2022, a related party of the Company loaned Prime Time Live, Inc. $12,500 in exchange for a promissory note that includes interest at the rate of 10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 10, 2023. Interest began accruing on May 10, 2022. As of September 30, 2023 and December 31, 2022, the principal balance was $12,500 and $12,500, respectively.

May 10, 2022 - $20,000

On May 10, 2022, a related party of the Company loaned Prime Time Live, Inc. $20,000 in exchange for a promissory note that included interest at the rate of 10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 10, 2023. Interest began accruing on May 10, 2022. As of September 30, 2023 and December 31, 2022, the principal balance was $20,000 and $20,000, respectively.

May 31, 2022 - $5,000

On May 31, 2022, a related party of the Company loaned Prime Time Live, Inc. $5,000 in exchange for a promissory note that included interest at the rate of 10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 31, 2023. Interest began accruing on May 31, 2022. As of September 30, 2023 and December 31, 2022, the principal balance was $5,000 and $5,000, respectively.

May 31, 2022 - $15,000

On May 31, 2022, a related party of the Company loaned Prime Time Live, Inc. $15,000 in exchange for a promissory note that included interest at the rate of 10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 31, 2023. Interest began accruing on May 31, 2022. As of September 30, 2023 and December 31, 2022, the principal balance was $15,000 and $15,000, respectively.

June 9, 2022 - $15,000

On May 10, 2022, a related party of the Company loaned Prime Time Live, Inc. $15,000 in exchange for a promissory note that included interest at the rate of 10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 10, 2023. Interest began accruing on May 10, 2022. As of September 30, 2023 and December 31, 2022, the principal balance was $15,000 and $15,000, respectively.

F-20

December 31, 2022 - $929,401

On December 31, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $929,401 from Emblaze, the proceeds of which were to be used for working capital purposes. The loan had an interest rate of 8% per annum and was due on December 1, 2023. As of September 30, 2023 and December 31, 2022, the balance was $0 and $929,401, respectively.

On June 1, 2023, the Company entered into an Agreement for Purchase and Sale of Stock with Emblaze wherein the Company sold all 5,000 of its shares of common stock of Vybe Labs, as full payment and settlement of a debt in the in the principal amount of $929,401 owed by the Company to Emblaze.

Note 12 – Subsequent Events

The Company evaluated all events or transactions that occurred after September 30, 2023. During this period, the Company did not have any material recognizable subsequent events required to be disclosed other than the following:

On October 1, 2023, the Company entered into Conversion Agreements with each of the convertible noteholders to convert their respective notes into shares of Class B Preferred Stock. Pursuant to the Conversion Agreements, each noteholder agreed to receive one share of Class B Preferred Stock for each $2.00 of principal and unpaid interest accrued through the closing date of the Conversion Agreement. As of the closing date of the Conversion Agreement, and each of them, no portion of any of the Notes had been converted into shares of the Company’s common stock.

On October 1, 2023, the Company terminated the License Agreement for LPI, Smiles, Divatrim, and Amarose; however, the Company maintained its license for NZT-48 with LPI.

On October 23, 2023, the Company filed a Certificate of Designation with the Secretary of State of the State of Delaware designating 5,000,000 shares of Class B Preferred Stock, as amended on November 9, 2023, to increase the designation to 11,000,000. The holders of the Class B Preferred Stock are entitled to a liquidation preference senior to common stock and junior to the Class A Preferred Stock at a liquidation price of $3.00 per share of Class B Preferred Stock. The Class B Preferred Stock also has conversion rights, whereby each share of Class B Preferred Stock is convertible into two shares of Common Stock in the discretion of the holder, subject to beneficial ownership limitations. The holders of the Class B Preferred Stock have no voting rights, unless otherwise provided for in its Certificate of Designation or by law.

On October 23, 2023, pursuant to the Conversion Agreements, the Company planned to issue an aggregate of 10,349,097 shares of Class B Preferred Stock before the completion of this offering and extinguish $9,675,000 of convertible debt including accumulated interest as of October 23, 2023 in the amount of $674,097.

F-21

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Stockholders

of Limitless X Holdings, Inc.

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of Limitless X Holdings, Inc. (the “Company”) as of December 31, 2022 and 2021, the related statements of operations, stockholders’ equity, and cash flows, and the related notes and schedules (referred to as the “financial statements”) for the year ended December 31, 2022 and for the period from September 27, 2021 (date of formation) through December 31, 2021. In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for the year ended December 31, 2022 and for the period from September 27, 2021 (date of formation) through December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ BF Borgers CPA PC

We have served as the Company’s auditor since 2022.

Lakewood, CO

April 17, 2023

F-22

LIMITLESS X HOLDINGS INC.

CONSOLIDATED BALANCE SHEETS

  December 31, 2022  December 31, 2021 
       
ASSETS        
         
Current Assets:        
Cash $5,843,323  $78,856 
Accounts receivables, net of allowance for doubtful accounts of $0 and $0, respectively  895,713   322,499 
Holdback receivables, net of allowance for doubtful accounts of $1,300,855 and $0, respectively  1,043,991   162,226 
Holdback receivables, net of allowance for doubtful accounts  1,043,991   162,226 
Inventories, net  3,855,946   1,875,146 
Total current assets  11,638,973   2,438,727 
         
Non-Current Assets:        
Operating lease right-of-use asset, net  91,032   224,202 
Equipment, net  32,256   - 
Other assets  78,965   10,985 
Total non-current assets  202,253   235,187 
         
Total assets $11,841,226  $2,673,914 
         
LIABILITIES AND STOCKHOLDERS’ EQUITY        
         
Current Liabilities:        
Accounts payable and accrued expenses $2,419,051  $215,176 
Current portion of operating lease liabilities  92,195   132,200 
Royalty payable  1,114,403   - 
Refunds payable  213,930   207,599 
Chargebacks payable  118,288   100,350 
Income tax payable  17,056   22,906 
Note payable  35,000   - 
Convertible note payables  9,175,000   - 
Current portion of loan payables to shareholder  4,462,028   28,802 
Note payables to related parties  1,247,011   - 
         
Total current liabilities  18,893,962   707,033 
Loan payables to shareholder, less current portion  -   21,198 
Operating lease liabilities, less current portion  -   92,195 
Total liabilities  18,893,962   820,426 
         
Commitments and contingencies  -   - 
         
Stockholders’ Equity        
Preferred Stock - $0.0001 par value; 30,000,000 authorized shares; 500,000 shares issued and outstanding and at December 31, 2022 and December 31, 2021  50   50 
Common Stock- $0.0001 par value; 300,000,000 authorized shares; 3,929,834 shares issued and outstanding and 3,496,150 shares issued and outstanding and 397,000 shares issuable at December 31, 2022 and December 31, 2021, respectively  394   390 
Additional paid-in-capital  2,966,162   1,848,384 
Retained earnings  (10,019,342)  4,664 
Total stockholders’ equity  (7,052,736)  1,853,488 
         
Total liabilities and stockholders’ equity $11,841,226  $2,673,914 

The accompanying notes are an integral part of these consolidated financial statements.

F-23

LIMITLESS X HOLDINGS INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

         
     For the period from 
     September 27, 2021 
  For the  (Date of formation) 
  year ended  through 
  December 31, 2022  December 31, 2021 
       
Revenue        
Product sales $40,364,955  $302,371 
Service revenue  18,308,341   - 
Rentals  15,000   - 
Total revenue  58,688,296   302,371 
         
Cost of sales        
Cost of sales  6,942,680   3,258 
Cost of sales - other  358   - 
Total cost of sales  6,943,038   3,258 
         
Gross profit  51,745,258   299,113 
         
Operating expenses:        
General and administrative  1,938,640   12,054 
Advertising and marketing  47,164,700   194,679 
Stock compensation for services  1,117,782   - 
Transaction fees  3,201,599   1,416 
Merchant fees  2,459,670   20,092 
Royalty fees  1,114,403   - 
Professional fees  1,647,787   14,000 
Payroll and payroll taxes  1,306,565   17,794 
Rent  205,497   11,508 
Bad debt expense  1,300,855   - 
Consulting fees, related party  43,500   - 
Total operating expenses  61,500,998   271,543 
         
Income (loss) from operations  (9,755,740)  27,570 
         
Other income (expense)        
Interest expense  (348,017)  - 
Other income  57,756   - 
Gain on disposal of assets  28,397   - 
Total other income (expense), net  (261,864)  - 
         
Income (loss) before income taxes  (10,017,604)  27,570 
         
Income tax provision  6,402   22,906 
         
Net income (loss) $(10,024,006) $4,664 
         
Net income (loss) per common share - basic and diluted $(2.71) $0.00 
         
Weighted average number of common shares  3,692,740   1,986,073 

The accompanying notes are an integral part of these consolidated financial statements.

F-24

LIMITLESS X HOLDINGS INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

                                     
              Common Stock  Additional     Total 
  Preferred Stock  Common Stock  Issuable  Paid-In  Retained  Stockholder’s 
  Shares  Amount  Shares  Amount  Shares  Amount  Capital  Earnings  Equity 
                            
Balance at December 31, 2021  500,000  $50   3,496,150  $350   397,000  $40  $1,848,384  $4,664  $1,853,488 
                                     
Issuance of common stock  -   -   97,000   10   (97,000)  (10)  -   -   - 
                                     
Issuance of common stock issuable  -   -   300,000   30   (300,000)  (30)  -   -   - 
                                     
Issuance of common stock for services  -   -   36,684   4   -   -   1,117,778   -   1,117,782 
                                     
Net loss  -   -   -   -   -   -   -   (10,024,006)  (10,024,006)
                                     
Balance at December 31, 2022  500,000  $50   3,929,834  $394   -  $-  $2,966,162  $(10,019,342) $(7,052,736)

              Common Stock  Additional     Total 
  Preferred Stock  Common Stock  Issuable  Paid-In  Retained  Stockholder’s 
  Shares  Amount  Shares  Amount  Shares  Amount  Capital  Earnings  Equity 
                            
Balance at September 27, 2021 (Date of formation)  500,000  $50   3,496,150  $350   397,000  $   40  $(440) $-  $- 
Balance  500,000  $50   3,496,150  $350   397,000  $   40  $(440) $-  $- 
                                     
Contributions  -   -   -   -   -   -   1,848,824   -   1,848,824 
                                     
Net income  -   -   -   -   -   -   -   4,664   4,664 
Net income (loss)  -   -   -   -   -   -   -   4,664   4,664 
                                     
Balance at December 31, 2021  500,000  $50   3,496,150  $350   397,000  $40  $1,848,384  $4,664  $1,853,488 
Balance  500,000  $50   3,496,150  $350   397,000  $40  $1,848,384  $4,664  $1,853,488 

The accompanying notes are an integral part of these consolidated financial statements.

F-25

LIMITLESS X HOLDINGS INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

         
     For the period from 
     September 27, 2021 
  For the  (Date of formation) 
  year ended  through 
  December 31, 2022  December 31, 2021 
       
Cash flows from operating activities:        
Net income (loss) $(10,024,006) $4,664 
         
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation  5,686   - 
Common stock issued for professional fees  1,117,782   - 
Changes in assets and liabilities:        
Accounts receivables, net  (573,214)  (322,499)
Holdback receivables  (881,765)  (162,226)
Inventories, net  (1,980,800)  (1,875,146)
Other assets  (67,980)  (10,985)
Accounts payable and accrued expenses  2,138,506   215,369 
Refunds payable  6,331   207,599 
Royalty payable  1,114,403   - 
Chargebacks payable  17,938   100,350 
Income tax payable  (5,850)  22,906 
Net cash used in operating activities  (9,132,969)  (1,819,968)
         
Cash flows from investing activities:        
Proceeds from disposition of asset  28,397   - 
Net cash provided by financing activities  28,397   - 
         
Cash flows from financing activities:        
Proceeds from borrowings from related parties  1,247,011   - 
Proceeds from borrowings from shareholder  4,412,028   50,000 
Proceeds from borrowing  9,210,000   - 
Shareholders’ contributions  -   1,848,824 
Net cash provided by financing activities  14,869,039   1,898,824 
         
Net increase in cash  5,764,467   78,856 
         
Cash – beginning of period  78,856   - 
         
Cash – end of period $5,843,323  $78,856 
         
Supplemental disclosures of cash flow information        
Cash paid during the periods for:        
Interest $1,125  $- 
Income taxes $5,850  $- 

The accompanying notes are an integral part of these consolidated financial statements.

F-26

LIMITLESS X HOLDINGS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1 – Organization and History

On May 13, 2022, Bio Lab entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with Limitless X, Inc., a Nevada corporation (“LimitlessX”), and its 11 shareholders (the “LimitlessX Acquisition”) on May 11, 2022 (the “Merger”). The parties completed and closed the LimitlessX Acquisition on May 20, 2022 by issuing an aggregate of 3,233,334 shares of common stock of Bio Lab to the LimitlessX shareholders (the “Acquisition Closing”). According to the terms of the Share Exchange Agreement, Bio Lab then issued an additional 300,000 shares of common stock to the LimitlessX shareholders pro rata to their interests in approximately six months from the Acquisition Closing as part of the Limitless Acquisition. Concurrently with the LimitlessX Acquisition, Jaspreet Mathur, the founder and principal shareholder of LimitlessX, also purchased from Helion Holdings LLC, 500,000 shares of Bio Lab’s Class A Preferred Convertible Stock, which at all times have a number of votes equal to 60% of all of the issued and outstanding shares of common stock of Bio Lab.

On June 10, 2022, Bio Lab changed its name to Limitless X Holdings, Inc. (“Limitless”).

The Merger was accounted for as a “reverse merger” following the completion of the transaction. For accounting purposes, LimitlessX was deemed to be the accounting acquirer in the transaction and, consequently, the transaction was treated as a recapitalization of Bio Lab. Accordingly, LimitlessX’s assets, liabilities, and results of operations became the historical financial statements of the registrant. No step-up in basis or intangible assets or goodwill was recorded in this transaction.

Limitless is a lifestyle brand, focused in the health and wellness industry. Limitless provides nutritional supplements, wellness studies, interactive training videos, and marketing products. The mission of Limitless is to provide businesses within its industry a turnkey solution to sell products both online and in retail stores. Limitless also provides its own products and wellness videos suitable for a wide range of ages and fitness. Limitless teams includes sales, marketing, user interface design (UI), user experience design (UX), fulfillment, customer support, labeling, product manufacturing, consulting, retailing, and payment processing, among others.

Limitless currently offer products online only, but anticipates expanding to the brick-and-motor retail  stores and wholesale marketplace in the future. Limitless has manufacturing and distribution licensing agreements to market, manufacture, sell, and distribute the branded products on behalf of its clients. Limitless orders products from third party partner manufacturers, that make the products according to the Company’s custom formulations, and brand them using the Limitless licensed trademarks. Products are then marketed and sold DTC online. Orders are fulfilled and shipped directly from the Company’s licensors. The Company plans to offers global marketing services across all areas of the sales process, including market research, brand and product development, and digital advertising operating as an integrated marketing agency.

The Company operate in the following products and services: (i) health products and (ii) digital marketing services. The health products includes the sales of health products three primary verticals: Health & Wellness, Beauty & Skincare, and the Vapor industry. The digital marketing includes digital marketing, digital and print design, social media marketing and direct-to-consumer marketing.

F-27

Note 2 – Summary of Significant Accounting Policies

 

Principles of Consolidation and Reporting

The accompanying consolidated financial statements include the accounts of Limitless X Holdings Inc. (a holding company) and its wholly owned operating subsidiaries: Limitless X, Inc., Vybe Lab Inc , and Prime Time Live, Inc. (collectively, the “Company”). All intercompany balances have been eliminated during consolidation.

Use of Estimates in the Preparation of Consolidated Financial Statements

The preparation of consolidated financial statements in conformity with generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Estimates also affect the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all liquid investments purchased with an initial maturity of three months or less to be cash equivalents. Cash and cash equivalents include demand deposits carried at cost which approximates fair value. The Company maintains its cash in institutions insured by the Federal Deposit Insurance Corporation (“FDIC”).

Concentration of Credit Risk

The Company offers its services to a small number of clients. This risk of non-payment by these clients is considered minimal and the Company does not generally obtain collateral for sales. The Company continually monitors the credit standing of its clients.

Accounts Receivable, net

Accounts receivable, net consists primarily of trade receivables, net of allowances for doubtful accounts. The Company sells its products and services for cash or on credit terms, which are established in accordance with local and industry practices and typically require payment within 30 days of delivery. The Company estimates its allowance for doubtful accounts and the related expected credit loss based upon the Company’s historical credit loss experience, adjusted for asset-specific risk characteristics, current economic conditions, and reasonable forecasts. Accounts receivables are written off when determined to be uncollectible. The Company did not require and did not have an allowance for doubtful accounts.

F-28

Holdback Receivables

Limitless primarily sells its products online using various third party sales affiliates. These affiliates (online marketing campaign companies) are paid certain commission based on their ability to provide the Company’s products through online sales. All payments are processed through various gateways and are settled through the Company’s payment gateway settler. The Company payment gateway settler is not responsible for settlements that are not paid to processing bank failure. The Company holds responsibility for all the risk in all transactions and processing systems. The payment gateway settler charges a reserve fee to mitigate the risk on their end for any loss of funds or damages.

Distributions of the holdback receivables from the third-party payment gateway settler are based on several criteria, such as return and chargeback history, associated risk for the specific business vertical, average transaction amount, and so on. In order to mitigate processing risks, there are policies regarding reserve requirements and payment in arrears in place.

The total holdback receivables balance reflects the 0-10% reserve on gross sales and additional reserves by the third-party processor for additional returns and chargebacks if needed. Based on aging of the holdback receivables, the Company has determined that an allowance for doubtful accounts of $1,300,855 or 55% of holdback receivables should be deemed uncollectible recorded as bad debt expense. Thus, the adjusted holdback receivables balance was $1,043,991 as of December 31, 2022.

Inventories

Inventories are valued at the lower of cost or net realizable value on a first-in, first-out basis, adjusted for the value of inventory that is determined to be excess, obsolete, expired, or unsaleable. Inventories primarily consisted of finished goods.

Advertising and Marketing

Advertising and marketing costs are charged to expense as incurred. Advertising and marketing costs were approximately $47,164,700 and $194,679 for the year ended December 31, 2022 and for the period from September 27, 2021 through December 31, 2021, respectively, and are included in operating expenses in the accompanying statement of income.

F-29

Equipment

Equipment is recorded at cost and consists of screen video and related equipment. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation of equipment is over the estimated useful life of five to ten years using the straight-line method for consolidated financial statement purposes.

Schedule of Equipment

  December 31, 2022  December 31, 2021 
       
Machinery and equipment $37,463  $       - 
Total  37,463   - 
         
Less: accumulated depreciation  (5,207)  - 
         
Total equipment, net $32,256  $- 

Depreciation expense for the year ended December 31, 2022 was $5,686.

During the year ended December 31, 2022, the Company reported a gain of $28,397 on the disposal of assets.

Revenue Recognition

Product Sales

The Company recognizes revenue when performance obligations under the terms of a contract with its customer are satisfied. The Company has determined that fulfilling and delivering products is a single performance obligation. Revenue is recognized at the point in time when the Company has satisfied its performance obligation and the customer has obtained control of the products or when the service is fully .. This generally occurs when the product is delivered to or picked up by the customer based on applicable shipping terms, which is typically within 15 days. Revenue is measured as the amount of consideration expected to be received in exchange for fulfilled product orders,

While customers generally have a right to return defective or non-conforming products, past experience has demonstrated that product returns have been immaterial. Customer remedies for defective or non-conforming products may include a refund or exchange. As a result, the right of return is estimated and recorded as a reduction in revenue at the time of sale, if necessary.

The Company’s customer contracts identify product quantity, price, and payment terms. Payment terms are granted consistent with industry standards. Although some payment terms may be more extended, the majority of the Company’s payment terms are less than 30 days. As a result, revenue is not adjusted for the effects of a significant financing component. Amounts billed and due from customers are classified as Accounts Receivables on the Balance Sheet.

F-30

The Company utilizes third-party contract manufacturers for the manufacture of its products. The Company has evaluated whether it is the principal or agent in these relationships. The Company has determined that it is the principal in all cases, as it retains the responsibility for fulfillment and risk of loss, as well as for establishing the price.

In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers, the Company has elected the practical expedient to expense the incremental costs to obtain a contract, because the amortization period would be less than one year, and the practical expedient for shipping and handling costs. Shipping and handling costs incurred to deliver products to customers are accounted for as fulfillment activities, rather than a promised service, and as such are included in Cost of Goods Sold in the Statements of Operations.

Service Revenue

Service revenue consists of digital marketing revenue.

Revenue related to digital marketing is recognized over time as services are provided to the customer. We sell digital marketing, digital and print design, social media marketing and direct-to-consumer marketing and thus use standalone selling prices as the basis for revenue. Payment for digital marketing services are typically received at the point when control transfers to the customer or in accordance with payment terms customary to the business. There was no deferred revenue related to services revenue as of December 31, 2022 and 2021.

Cost of Sales

Cost of goods sold includes the cost of inventory sold during the period, as well as, commission fees, returns, chargebacks, distribution, and, shipping and handling costs. The amount shown is net of various rebates from third-party vendors in the form of payments.

Refunds Payable

If customers are not satisfied for any reason, they may request a full refund, processed to the original form of payment, within 30 days from the order date. If the order has already been shipped, the Company charges a 20% restocking fee. The Company’s estimate of the reserve is based upon the Company’s most historical experience of actual customer returns. Additionally, the Company considers other factors in estimating the reserve, such as hiring a new internal team with more resources for the refund process. For the year ended December 31, 2022, the average rate of return is 17%. For the year ended December 31, 2022, the Company determined the refund reserve to be $213,930 by using the last two weeks of sales of the period of $1,292,475 with the average rate of return of 17% for the year ended December 31, 2022.

As of December 31, 2022 and December 31, 2021, refunds payable were $213,930 and $207,599, respectively.

Chargebacks Payable

Once customers successfully dispute chargebacks with the payment processor, the Company returns such funds to the payment processor to return to the customer. For the year ended December 31, 2022, the average rate of return was 9%. For the year ended December 31, 2022, the Company determined the chargeback reserve to be $118,288 by using the last two weeks of sales of the period of $1,292,475 with the average rate of chargebacks of 8% for the year ended December 31, 2022.

As of December 31, 2022 and December 31, 2021, chargebacks payable were $118,288 and $100,350, respectively.

Other Comprehensive Loss

The Company has no material components of other comprehensive loss and accordingly, net loss is equal to comprehensive loss for the period.

Debt

Convertible debt – derivative treatment – When the Company issues debt with a conversion feature, we must first assess whether the conversion feature meets the requirements to be treated as a derivative, as follows: a) one or more underlying, typically the price of our common stock; b) one or more notional amounts or payment provisions or both, generally the number of shares upon conversion; c) no initial net investment, which typically excludes the amount borrowed; and d) net settlement provisions, which in the case of convertible debt generally means the stock received upon conversion can be readily sold for cash. An embedded equity-linked component that meets the definition of a derivative does not have to be separated from the host instrument if the component qualifies for the scope exception for certain contracts involving an issuer’s own equity. The scope exception applies if the contract is both a) indexed to its own stock; and b) classified in shareholders’ equity in its statement of financial position.

If the conversion feature within convertible debt meets the requirements to be treated as a derivative, we estimate the fair value of the convertible debt derivative using the Black Scholes method upon the date of issuance. If the fair value of the convertible debt derivative is higher than the face value of the convertible debt, the excess is immediately recognized as interest expense. Otherwise, the fair value of the convertible debt derivative is recorded as a liability with an offsetting amount recorded as a debt discount, which offsets the carrying amount of the debt. The convertible debt derivative is revalued at the end of each reporting period and any change in fair value is recorded as a gain or loss in the Consolidated Statement of Operations. The debt discount is amortized through interest expense over the life of the debt.

If the conversion feature does not qualify for either the derivative treatment, the convertible debt is treated as traditional debt.

F-32

Income Taxes

The accounting standard on accounting for uncertainty in income taxes addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under that guidance, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.

Earnings (Loss) per Share

The Company calculates earnings per share in accordance with Financial Accounting Standards Board (“FASB”) ASC 260, Earnings Per Share, which requires a dual presentation of basic and diluted earnings per share. Basic earnings per share are computed using the weighted average number of shares outstanding during the fiscal year. 36,700,00 convertible common stock during the year ended December 31, 2022 were not included in the computation of diluted Earnings Per Share for the same period as the inclusion would have been antidilutive, given the Company’s net loss.

The Company did not have any dilutive common shares for the period from September 27, 2021 through December 31, 2021.

Equity Based Payments

The Company accounts for equity-based payment accruals under authoritative guidance as set forth in the Topics of the ASC. The guidance requires all equity-based payments to employees and non-employees, including grants of employee and non-employee stock options and warrants, to be recognized in the consolidated financial statements based at their fair values. The Company applies the provisions of ASC 718, “Compensation - Stock Compensation,” using a modified prospective application, and the Black-Scholes model to value stock options. Under this application, the Company records compensation expense for all awards granted. Compensation costs will be recognized over the period that an employee provides service in exchange for the award. During the year ended December 31, 2022, the Company granted no options under the 2020 Stock Incentive Plan and 2022 Stock Option Plan.

General Concentrations of Risk

Financial instruments that potentially subject the Company to concentrations of credit risk are accounts receivable and other receivables arising from its normal business activities. The Company has a diversified customer base. The Company controls credit risk related to accounts receivable through credit approvals, credit limits, and monitoring procedures. The Company routinely assesses the financial strength of its customers and, based upon factors surrounding the credit risk, establishes an allowance, if required, for uncollectible accounts and, as a consequence, believes that its accounts receivable related credit risk exposure beyond such allowance is limited.

The Company purchases merchandise from 6 suppliers, and the Company’s 3 largest suppliers accounted for 95% of total purchases in fiscal 2022. A significant portion of the Company’s inventory is manufactured abroad in Asia. Foreign imports subject the Company to the risks of changes in, or the imposition of new, import tariffs, duties or quotas, new restrictions on imports, loss of “most favored nation” status with the United States for a particular foreign country, antidumping or countervailing duty orders, retaliatory actions in response to illegal trade practices, work stoppages, delays in shipment, freight expense increases, product cost increases due to foreign currency fluctuations or revaluations, public health issues that could lead to temporary closures of facilities or shipping ports, such as the recent outbreak of COVID-19, and other economic uncertainties. If a disruption of trade were to occur from the countries in which the suppliers of the Company’s vendors are located, the Company may be unable to obtain sufficient quantities of products to satisfy its requirements, or the cost of obtaining products may increase.

A substantial amount of the Company’s inventory is manufactured abroad. From time to time, shipping ports experience capacity constraints (such as delays associated with COVID-19), labor strikes, work stoppages or other disruptions that may delay the delivery of imported products. A contract dispute may lead to protracted delays in the movement of the Company’s products, which could further delay the delivery of products to the Company’s stores and impact net sales and profitability. In addition, other conditions outside of the Company’s control, such as adverse weather conditions or acts of terrorism or war, such as the current conflict in Ukraine, could significantly disrupt operations at shipping ports or otherwise impact transportation of the imported merchandise we sell, either through supply chain disruptions, or rising freight and fuel costs.

F-33

Operating Lease

In accordance with ASC 842, Leases, the Company determines whether an arrangement contains a lease at inception. A lease is a contract that provides the right to control an identified asset for a period of time in exchange for consideration. For identified leases, the Company determines whether it should be classified as an operating or finance lease. Operating leases are recorded in the balance sheet as: right-of-use asset (“ROU asset”) and operating lease liability. ROU asset represents the Company’s right to use an underlying asset for the lease term and lease liability represents the Company’s obligation to make lease payments arising from the lease. ROU assets and operating lease liabilities are recognized at the commencement date of the lease and measured based on the present value of lease payments over the lease term. The ROU asset also includes deferred rent liabilities. The Company’s lease arrangement generally do not provide an implicit interest rate. As a result, in such situations the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company includes options to extend or terminate the lease when it is reasonably certain that it will exercise that option in the measurement of its ROU asset and liability. Lease expense for the operating lease is recognized on a straight-line basis over the lease term. The Company has a lease agreement with lease and non-lease components, which are accounted for as a single lease component.

Recent Accounting Pronouncements

In December 2019, FASB issued Accounting Standards Update (“ASU”) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which amends existing guidance related to the accounting for income taxes. This ASU is intended to simplify the accounting for income taxes by removing certain exceptions to the general principles of accounting for income taxes and to improve the consistent application of GAAP for other areas of accounting for income taxes by clarifying and amending existing guidance. This ASU is effective for fiscal years beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the effects adoption of this guidance will have on the financial statements and does not expect that the adoption of this ASU will be material to its financial statements.

Note 3 – Fair Value Measurements

The Company utilizes ASC 820-10, Fair Value Measurement and Disclosure, for valuing financial assets and liabilities measured on a recurring basis. Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. The guidance also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability. The guidance establishes three levels of inputs that may be used to measure fair value:

Level 1.Observable inputs such as quoted prices in active markets;

F-34

Level 2.Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

Level 3.Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

The carrying value of financial assets and liabilities recorded at fair value is measured on a recurring or nonrecurring basis. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. There were no financial assets or liabilities carried and measured on a nonrecurring basis during the reporting periods. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. There have been no transfers between levels.

Note 4 – Commitments and Contingencies

Commitments

Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Generally, the implicit rate of interest in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The operating lease ROU asset includes any lease payments made and excludes lease incentives. The Company’s variable lease payments primarily consist of maintenance and other operating expenses from their real estate leases. Variable lease payments are excluded from the ROU assets and lease liabilities and are recognized in the period in which the obligation for those payments is incurred. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.

The Company has lease agreements with lease and non-lease components. The Company has elected to account for these lease and non-lease components as a single lease component.

F-35

In accordance with ASC 842, the components of lease expense were as follows:

Schedule of Lease Cost

       
     For the period from 
     September 27, 2021 
  For the  (Date of formation) 
  year ended  through 
  December 31, 2022  December 31, 2021 
Operating lease expense $138,108  $11,509 
Total lease expense $138,108  $11,509 

In accordance with ASC 842, other information related to leases was as follows:

Schedule of Other information Related to Leases

       
     For the period from 
     September 27, 2021 
  For the  (Date of formation) 
  year ended  through 
  December 31, 2022  December 31, 2021 
Operating cash flows from operating leases $137,138  $11,315 
Cash paid for amounts included in the measurement of lease liabilities $137,138  $11,315 

Weighted-average remaining lease term—operating leases0.7 Years 
Weighted-average discount rate—operating leases3%

F-36

In accordance with ASC 842, maturities of operating lease liabilities as of December 31, 2022 were as follows:

Schedule of Maturities of Operating Lease Liabilities

  Operating 
Year ending: Lease 
2023 $93,236 
2024  - 
2025  - 
2026  - 
2027  - 
Total undiscounted cash flows $93,236 
     
Reconciliation of lease liabilities:    
Weighted-average remaining lease terms   0.7 Years 
Weighted-average discount rate  3%
Present values $92,195 
     
Lease liabilities—current  92,195 
Lease liabilities—long-term  - 
Lease liabilities—total $92,195 
     
Difference between undiscounted and discounted cash flows $1,041 

Contingencies

From time to time, the Company may be involved in certain legal actions and claims arising in the normal course of business. Management is of the opinion that any such matters will be resolved without material effect on the Company’s financial condition or results of operations.

Note 5 – Debt

Convertible Notes Payable

Note payable

March 1, 2021 – $35,000

On March 1, 2021, an individual loaned the predecessor company $35,000 in exchange for an unsecured promissory note that included interest at the rate of 10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before March 1, 2022. The maturity date was extended to December 31, 2022. Interest is due and payable on the first day of each month. At December 31, 2022, Prime Time Live, Inc. owes $35,000 in principal and accrued interest of $1,095 for the year ended December 31, 2022.

F-37

Convertible note payables

Schedule of Convertible Note Payables

         
  December 31,  December 31, 
  2022  2021 
       
August 3, 2022 ($5,000,000) $5,000,000  $- 
August 3, 2022 ($1,000,000)  1,000,000   - 
August 22, 2022 ($500,000)  500,000   - 
September 22, 2022 ($250,000)  250,000             - 
September 25, 2022 ($600,000)  600,000   - 
September 25, 2022 ($600,000)  600,000   - 
September 29, 2022 ($50,000)  50,000   - 
September 29, 2022 ($500,000)  500,000   - 
October 10, 2022 ($500,000)  500,000   - 
October 13, 2022 ($750,000)  75,000   - 
October 13, 2022 ($50,000)  50,000   - 
October 14, 2022 ($50,000)  50,000   - 
         
Total convertible note payables (current) $9,175,000  $- 

From August 3, 2022 through November 28, 2022, the Company conducted a convertible note offering for a maximum offering of $15,000,000 and a minimum of $2,000,000 (the “Convertible Note Offering”).

Pursuant to the terms of the Convertible Note, the principal amount of the Note that may be outstanding from time to time shall bear interest per annum until paid in full at a rate equal to 6%, compounded annually. The principal and interest of the Note shall be due and payable to the noteholder on the one-year anniversary of the date of the Note (the “Maturity Date”) unless all principal and interest due under the Note had been converted by the Maturity Date.

F-38

The conversion price shall be equal to $0.25 per share of Common Stock. Any time prior to the Maturity Date, and upon the date of effectiveness of registration of the Notes on a registration statement filed with the Securities and Exchange Commission (the “SEC”), the Note shall automatically convert to shares of common stock of the Company at the Conversion Price (the “Automatic Conversion”); provided however, that in the event that Conversion Shares represent greater than 4.99% of the total Common Shares of the Company (the portion above 4.99% referred to herein as the “Excess Shares”), then the Automatic Conversion shall only apply to such portion of the Note up to 4.99% and not include the Excess Shares. This Note is convertible at the option of the Noteholder, in holder’s sole discretion, in whole or in part, at any time prior to the Maturity Date or payment in full of the Note, whichever occurs first, all or any portion of principal or interest, into shares of Common Stock of the Company at the Conversion Price.

The Company analyzed the conversion option in the notes for derivative accounting treatment under ASC Topic 815, “Derivatives and Hedging,” and determined that the instruments do not qualify for derivative accounting.

As of December 31, 2022, the Company has received $9,175,000   from 12 accredited investors pursuant to the Convertible Note Offering.

Note 6 – Stockholders’ Equity

Stockholders’ Deficit

Preferred Stock

Class A Convertible Stock

As of December 31, 2022, the Company has authorized 30,000,000 shares of preferred stock, At December 31, 2022 and December 31, 2021, there are a total of 500,000 shares of Class A Convertible shares of preferred stock (“Class A”) issued and outstanding. The Class A shares provide that when voting as a single class, the shares shall have the votes and the voting power at all times of at least 60% of the voting power of the Company. Further, the holders of the Class A shares at their discretion , can convert their one share of Class A into two shares of the Company’s common stock, subject to adjustment. In addition, the holder of the shares of Class A is entitled to a liquidation preference of the Company senior to all other securities of the Company.

Common Stock

As of December 31, 2022 the Company has authorized shares of common stock par value $0.0001 per share. At December 31, 2022 and December 31, 2021, there was a total of 3,929,834 shares issued and outstanding and 3,496,150 shares issued and outstanding and 397,000 shares issuable, respectively.

Common Stock Issued for Services

On May 10, 2022 and June 10, 2022, the Company issued 36,000 and 684 shares of common stock, respectively, for services provided to the Company. These shares were valued at fair value at the time of issuance.

Common Stock and Recapitalization

As a result of the LimitlessX Acquisition and LimitlessX being the acquirer, the Company retrospectively restated its common stock as if the transaction occurred beginning of the period. The following is the reconciliation of retrospectively restated common stock:

Schedule of Reconciliation of Restated Common Stock

             
  December 31, 2021 
  Issued  Issuable  Total 
          
Common stock – Limitless X Inc. – as original  1,616,667   50,000   1,666,667 
Common stock split (1 to 1.94) – Limitless X Inc.  1,519,366   47,000   1,566,366 
Common stock issuable (additional stock split) – Limitless X Inc.  -   300,000   300,000 
Common stock (Bio Lab) – prior to reverse merger  360,117   -   360,117 
             
Total as of December 31, 2021 – as retrospectively restated  3,496,150   397,000   3,893,150 

Note 7 – Equity Based Payments

Stock Incentive Plans

Effective January 15, 2020, the Company adopted its 2020 Stock Option and Award Plan (the “2020 Stock Incentive Plan”). Under the 2020 Stock Incentive Plan, the Board of Directors may grant options or purchase rights to purchase common stock to officers, employees, and other persons who provide services to the Company or any related company. The participants to whom awards are granted, the type of awards granted, the number of shares covered for each award, and the purchase price, conditions and other terms of each award are determined by the Board of Directors, except that the term of the options shall not exceed ten years. A total of 2,222 shares of the Company’s common stock is reserved for the 2020 Stock Incentive Plan. The shares issued for the 2020 Stock Incentive Plan may be either treasury or authorized and unissued shares. During the year ended December 31, 2022 and the period from September 27, 2021 through December 31, 2021, the Company granted no options under the 2020 Stock Incentive Plan.

F-40

Effective August 9, 2022, the Company adopted its 2022 Incentive and Nonstatutory Stock Option Plan (the “2022 Stock Option Plan”). Under the 2022 Stock Option Plan, the Board of Directors may grant options to purchase common stock to officers, employees, and other persons who provide services to the Company. A total of 833,333 shares   of the Company’s common stock is reserved for the 2022 Stock Option Plan. During the year ended December 31, 2022, the Company granted no options under the 2022 Stock Option Plan.

Effective August 9, 2022, we adopted our 2022 Restricted Stock Plan (the “2022 Restricted Stock Plan”). Under the 2022 Restricted Stock Plan, the Board of Directors may grant restricted stock to officers, directors, and key employees. A total of 833,333 shares of common stock is reserved for the 2022 Stock Option Plan. During the year ended December 31, 2022, there have been no shares of common stock granted under the 2022 Restricted Stock Plan.

Stocks Issued for Services

On May 19, 2022, the Company issued 36,000 unregistered shares of common stock to several people who provided services to the Company. On June 10, 2022, the Company issued 684 unregistered shares of common stock to a person who provided services to the Company.

Note 8 – Related Party Transactions

Consulting Fees

During the year ended December 31, 2022, the Company incurred consulting fees in the amount of $32,500 to an officer and an officer of one of its affiliates.

Royalty Payables

Limitless Performance Inc. (“LPI”), SMILZ INC. (“Smiles”), DIVATRIM INC. (“Divatrim”), and AMAROSE INC. (“Amarose”) are all companies at least 50% owned by a shareholder of the Company.

On December 1, 2021, the Company entered into a manufacturing and distributorship license agreement with LPI for the Company to distribute LPI products and for payments to LPI for its product designs and distribution rights. The Company shall pay to LPI from time to time royalty payments equal to 4.00% of gross sales, excluding returns, chargebacks, and other such allowances.

On December 1, 2021, the Company entered into a manufacturing and distributorship license agreement with Smiles for the Company to distribute Smiles products and for payments to Smiles for its product designs and distribution rights. The Company shall pay to Smiles from time to time royalty payments equal to 4.00% of gross sales, excluding returns, chargebacks, and other such allowances.

On December 1, 2021, the Company entered into a manufacturing and distributorship license agreement with Divatrim for the Company to distribute Divatrim products and for payments to Smiles for its product designs and distribution rights. The Company shall pay to Divatrim from time to time royalty payments equal to 4.00% of gross sales, excluding returns, chargebacks, and other such allowances.

F-41

On December 1, 2021, the Company entered into a manufacturing and distributorship license agreement with Amarose for the Company to distribute Amarose products and for payments to Smiles for its product designs and distribution rights. The Company shall pay to Amarose from time to time royalty payments equal to 4.00% of gross sales, excluding returns, chargebacks, and other such allowances.

The Company was required to start paying all earned royalties to LPI, Smiles, Divatrim, and Amarose beginning on June 15, 2022. As of December 31, 2022, the royalty payable is in the amount of $1,114,403.

Note payables to shareholder

Schedule of Note Payables to Related Party Transaction

         
  December 31,  December 31, 
  2022  2021 
       
December 6, 2021 ($50,000) $50,000  $50,000 
February 11, 2022 ($150,000)  150,000   - 
May 8, 2022 ($550,000)  550,000   - 
May 16, 2022 ($1,100,000)  1,100,000   - 
May 18, 2022 ($450,000)  450,000   - 
June 1, 2022 ($500,000)  500,000   - 
June 30, 2022 ($922,028)  922,028   - 
August 25, 2022 ($290,000)  290,000   - 
November 15, 2022 ($450,000)  450,000   - 
Total loan payables to shareholder  4,462,028   50,000 
Less - current portion  (4,462,028)  (28,802)
         
Total loan payables to shareholder (current) $-  $21,198 

F-42

December 6, 2021 – $50,000

On December 6, 2021, the Company executed the standard loan documents required for securing a loan of $50,000 from a shareholder. As of December 31, 2022 and December 31, 2021, the balance was $50,000 and $50,000, respectively.

Pursuant to that certain Loan Authorization and Agreement, the Company borrowed an aggregate principal amount of $50,000, with proceeds to be used for working capital purposes. Beginning on June 1, 2022, the loan requires a payment of $4,303 per month which includes principal and interest with an interest rate of 6%. The total balance of principal and interest of $51,640 is due on May 1, 2023.

February 11, 2022 – $150,000

On February 11, 2022, the Company executed standard loan documents required for securing a loan of $150,000 from a shareholder. As of December 31, 2022, the balance was $150,000.

Pursuant to that certain Loan Authorization and Agreement, the Company borrowed an aggregate principal amount of $150,000, with proceeds to be used for working capital purposes. Beginning on June 1, 2022, the loan requires a payment of $12,910 per month which includes principal and interest with an interest rate of 6%. The total balance of principal and interest of $154,920 is due on May 1, 2023.

May 8, 2022 – $550,000

On May 8, 2022, the Company executed standard loan documents required for securing a loan of $550,000 from a shareholder. As of December 31, 2022, the balance was $550,000.

Pursuant to that certain Loan Authorization and Agreement, the Company borrowed an aggregate principal amount of $550,000, with proceeds to be used for working capital purposes. Beginning on June 1, 2022, the loan requires a payment of $47,337 per month which includes principal and interest with an interest rate of 6%. The total balance of principal and interest of $568,038 is due on May 1, 2023.

May 16, 2022 – $1,100,000

On May 16, 2022, the Company executed standard loan documents required for securing a loan of $1,100,000 from a shareholder. As of December 31, 2022, the balance was $1,100,00.

Pursuant to that certain Loan Authorization and Agreement, the Company borrowed an aggregate principal amount of $1,100,000, with proceeds to be used for working capital purposes. Interest began accruing at the rate of 8.5% on June 17, 2022.

F-43

May 18, 2022 – $450,000

On May 18, 2022, the Company executed standard loan documents required for securing a loan of $450,000 from a shareholder. As of December 31, 2022, the balance was $450,000.

Pursuant to that certain Loan Authorization and Agreement, the Company borrowed an aggregate principal amount of $450,000, with proceeds to be used for working capital purposes. Interest began accruing at the rate of 8.5% on June 19, 2022.

June 1, 2022 – $500,000

On June 1, 2022, the Company executed standard loan documents required for securing a loan of $500,000 from a shareholder. As of December 31, 2022, the balance was $500,000.

Pursuant to that certain Loan Authorization and Agreement, the Company borrowed an aggregate principal amount of $500,000, with proceeds to be used for working capital purposes. Beginning on August 1, 2022, the loan requires a payment of $43,494 per month which includes principal and interest with an interest rate of 8%. The total balance of principal and interest of $521,931 is due on July 1, 2023.

June 30, 2022 – $922,028

On June 30, 2022, the Company executed standard loan documents required for securing a loan of $922,028 from a shareholder. As of December 31, 2022, the balance was $922,028.

Pursuant to that certain Loan Authorization and Agreement, the Company borrowed an aggregate principal amount of $922,028, with proceeds to be used for working capital purposes. Beginning on August 1, 2022, the loan requires a payment of $80,206 per month which includes principal and interest with an interest rate of 8%. The total balance of principal and interest of $962,469 is due on August 1, 2023.

August 25, 2022 – $290,000

On August 25, 2022, the Company executed standard loan documents required for securing a loan of $290,000 from a shareholder due on demand. As of December 31, 2022, the balance was $290,000.

Pursuant to that certain Loan Authorization and Agreement, the Company borrowed an aggregate principal amount of $290,000 to be used for working capital purposes and with an interest rate of 10%.

November 15, 2022 – $450,000

On November 15, 2022, the Company executed standard loan documents required for securing a loan of $450,000 from a shareholder due on demand. As of December 31, 2022, the balance was $450,000.

F-44

Pursuant to that certain Loan Authorization and Agreement, the Company borrowed an aggregate principal amount of $450,000 to be used for working capital purposes and with an interest rate of 10%.

Note payables to related parties

Schedule of Note Payables to Related Party Transaction

         
  December 31,  December 31, 
  2022  2021 
       
April 1, 2022 ($237,610) $237,610  $- 
May 10, 2022 ($12,500)  12,500   - 
May 10, 2022 ($12,500)  12,500   - 
May 10, 2022 ($20,000)  20,000                   - 
May 31, 2022 ($5,000)  5,000   - 
May 31, 2022 ($15,000)  15,000   - 
June 9, 2022 ($15,000)  15,000   - 
December 31, 2022 ($929,401)  929,401   - 
         
Total note payables to related parties (current) $1,247,011  $- 

April 1, 2022 – $237,610

On April 1, 2022, the Company executed standard loan documents required for securing a loan of $237,610 from Emblaze One, a company owned by a shareholder. As of December 31, 2022, the balance was $237,610.

Pursuant to that certain Loan Authorization and Agreement, the Company borrowed an aggregate principal amount of $237,610 to be used for working capital purposes. Beginning on September 1, 2022, the loan requires a payment of $20,669 per month which includes principal and interest with an interest rate of 8%. The total balance of principal and interest of $248,032 is due on August 1, 2023.

May 10, 2022 ($12,500)

On May 10, 2022, a related party of the predecessor company loaned the predecessor company $12,500 in exchange for a promissory note that included interest at the rate of 10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 10, 2023. Interest began accruing at the rate of 10% on May 10, 2022.

F-45

May 10, 2022 ($12,500)

On May 10, 2022, a related party of the predecessor company loaned the predecessor company $12,500 in exchange for a promissory note that included interest at the rate of 10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 10, 2023. Interest began accruing at the rate of 10% on May 10, 2022.

May 10, 2022 ($20,000)

On May 10, 2022, a related party of the predecessor company loaned the predecessor company $20,000 in exchange for a promissory note that included interest at the rate of 10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 10, 2023. Interest began accruing at the rate of 10% on May 10, 2022.

May 31, 2022 ($5,000)

On May 31, 2022, a related party of the predecessor company loaned the predecessor company $5,000 in exchange for a promissory note that included interest at the rate of 10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 31, 2023. Interest began accruing at the rate of 10% on May 31, 2022.

May 31, 2022 ($15,000)

On May 31, 2022, a related party of the predecessor company loaned the predecessor company $15,000 in exchange for a promissory note that included interest at the rate of 10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 31, 2023. Interest will began accruing at the rate of 10% on May 31, 2022.

June 9, 2022 ($15,000)

On May 10, 2022, a related party of the predecessor company loaned the predecessor company $15,000 in exchange for a promissory note that included interest at the rate of 10% per annum on the unpaid principal balance with all unpaid principal and interest due on or before May 10, 2023. Interest began accruing at the rate of 10% on May 10, 2022.

December 31, 2022 – $929,401

On December 31, 2022, the Company executed standard loan documents required for securing a loan of $929,401 from Emblaze One, a company owned by a shareholder. As of December 31, 2022, the balance was $929,401.

Pursuant to that certain Loan Authorization and Agreement, the Company borrowed an aggregate principal amount of $929,401 with an interest rate of 8% to be used for working capital purposes due on December 1, 2023.

Note 9 – Subsequent Events

The Company evaluated all events or transactions that occurred after December 31, 2022. During this period, the Company did not have any material recognizable subsequent events required to be disclosed other than the following:

 

/s/ W. Edward NicholsOn June 1, 2023, the Company agreed to a settlement of a debt in the amount of $1,167,011 and interest payable of $47,188 owed by the Company to Emblaze, a related party, under two Loan Authorization and Agreements dated April 1, 2022 and December 31, 2022, in the principal amounts of $237,610 and $929,401, respectively, and interest payable of $10,012 and $37,176, respectively, as part of the Vybe Sales Agreement with Emblaze.

F-46

 May 16, 2023 – $150,000 (Loan Payable to Shareholder) - On May 16, 2023, the Company entered into a Loan Authorization and Agreement for a loan of $150,000 from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of 10% per annum and is due on demand. As of September 22 , 2020
W. Edward Nichols, Director30, 2023, the principal balance was $150,000.
   
 
/s/ Darrell AveyMay 18, 2023 – $50,000 (Loan Payable to Shareholder) – On May 18, 2023, the Company entered into a Loan Authorization and Agreement for a loan of $50,000 from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of 10% per annum and is due on demand. As of September 22 , 2020
Darrell Avey, Director

 /s/ Jeremy OstlerSeptember 22 , 2020
Jeremy Ostler, Director30, 2023, the principal balance was $50,000.
   
 
 /s/Calvin D. Smiley, Sr.
Calvin D. Smiley, Sr., DirectorJune 5, 2023 – $150,000 (Loan Payable to Shareholder) – On June 5, 2023, the Company entered into a Loan Authorization and Agreement for a loan of $150,000 from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of 10% per annum and is due on demand. As of September 22 , 202030, 2023, the principal balance was $150,000.
   
 September 30, 2023 – $138,817 (Loan Payable to Shareholder) – On September 30, 2023, the Company entered into a Loan Authorization and Agreement for a loan of $138,817 from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of 10% per annum and is due on demand. As of September 30, 2023, the principal balance was $138,817.
  
Funding Commitment Agreement – On June 3, 2023, the Company entered into a Funding Commitment Agreement (the “Funding Commitment”) with its Chief Executive Officer and Chairman of the Board of Directors, Jaspreet Mathur, wherein Mr. Mathur committed to provide up to $1,000,000 of working capital to the Company over the next six months. Mr. Mathur agreed to the Funding Commitment in exchange for a one year convertible promissory note for each drawdown amount advanced to the Company with an annual interest rate of 10% and a balloon payment of principal and interest due at maturity, unless Mr. Mathur elects to convert the outstanding principal and interest into Class B Preferred Stock of the Company at the conversion price of $1.50 per share; provided, however, Mr. Mathur may only covert each note within the term of the Funding Commitment, in the event of the occurrence of the earlier of a public offering of securities of the Company pursuant to a registration statement filed with the SEC and declared effective pursuant to the Securities Act of 1933, upon completion of which the Company has a class of stock registered under the Securities Exchange Act of 1934 and that stock is listed on a national stock exchange, or a liquidation, merger, acquisition, sale of voting control or sale of substantially all of the assets of the Company in which the shareholders of the Company do not own a majority of the outstanding shares of the surviving corporation. For the avoidance of doubt, a national stock exchange includes Nasdaq, NYSE, and NYSE American, but excludes any over-the-counter quotation systems or trading platforms. As of September 30, 2023, the balance of the Funding Commitment was $1,000,000.
On October 1, 2023, the Company entered into Conversion Agreements with each of the convertible noteholders to convert their respective notes into shares of Class B Preferred Stock. Pursuant to the Conversion Agreements, each noteholder agreed to receive one share of Class B Preferred Stock for each $2.00 of principal and unpaid interest accrued through the closing date of the Conversion Agreement. As of the closing date of the Conversion Agreement, and each of them, no portion of any of the Notes had been converted into shares of the Company’s common stock.
On October 1, 2023, the Company terminated the License Agreement for LPI, Smiles, Divatrim, and Amarose; however, the Company maintained its license for NZT-48 with LPI.
On October 23, 2023, the Company filed a Certificate of Designation with the Secretary of State of the State of Delaware designating 5,000,000 shares of Class B Preferred Stock, as amended on November 9, 2023, to increase the designation to 11,000,000. The holders of the Class B Preferred Stock are entitled to a liquidation preference senior to common stock and junior to the Class A Preferred Stock at a liquidation price of $3.00 per share of Class B Preferred Stock. The Class B Preferred Stock also has conversion rights, whereby each share of Class B Preferred Stock is convertible into two shares of Common Stock in the discretion of the holder, subject to beneficial ownership limitations. The holders of the Class B Preferred Stock have no voting rights, unless otherwise provided for in its Certificate of Designation or by law.
On October 23, 2023, pursuant to the Conversion Agreements, the Company planned to issue an aggregate of 10,349,097 shares of Class B Preferred Stock before completion of this offering and extinguish $9,675,000 of convertible debt including accumulated interest as of October 23, 2023 in the amount of $674,097.

F-47